|
|
| G
|
Abcc2
|
ATP binding cassette subfamily C member 2
|
increases expression
|
ISO
|
alfacalcidol results in increased expression of ABCC2 mRNA
|
CTD |
PMID:19581390 |
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471
|
|
| G
|
Abcc3
|
ATP binding cassette subfamily C member 3
|
increases expression
|
ISO
|
alfacalcidol results in increased expression of ABCC3 mRNA
|
CTD |
PMID:19581390 |
|
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494
|
|
| G
|
Abcc4
|
ATP binding cassette subfamily C member 4
|
increases expression
|
ISO
|
alfacalcidol results in increased expression of ABCC4 mRNA; alfacalcidol results in increased expression of ABCC4 protein
|
CTD |
PMID:19581390 |
|
NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375
|
|
| G
|
Alb
|
albumin
|
increases expression
|
ISO
|
alfacalcidol results in increased expression of ALB protein
|
CTD |
PMID:15044820 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
| G
|
Cd14
|
CD14 molecule
|
increases expression multiple interactions
|
ISO
|
alfacalcidol results in increased expression of CD14 protein [alfacalcidol co-treated with Lipopolysaccharides] results in increased expression of CD14 protein
|
CTD |
PMID:15946915 |
|
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292
|
|
| G
|
Cyp24a1
|
cytochrome P450, family 24, subfamily a, polypeptide 1
|
increases expression multiple interactions
|
EXP ISO
|
alfacalcidol results in increased expression of CYP24A1 mRNA; alfacalcidol results in increased expression of CYP24A1 protein [Ketoconazole results in decreased metabolism of alfacalcidol] which results in decreased expression of CYP24A1 mRNA
|
CTD |
PMID:8410379 PMID:16824767 PMID:18180267 PMID:19581390 |
|
NCBI chr 3:179,694,647...179,709,083
Ensembl chr 3:179,694,647...179,709,083
|
|
| G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
increases hydroxylation
|
ISO
|
CYP3A4 protein results in increased hydroxylation of alfacalcidol
|
CTD |
PMID:15005856 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
| G
|
Cyp7a1
|
cytochrome P450 family 7 subfamily A member 1
|
increases expression
|
ISO
|
alfacalcidol results in increased expression of CYP7A1 mRNA
|
CTD |
PMID:19581390 |
|
NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202
|
|
| G
|
Med1
|
mediator complex subunit 1
|
multiple interactions
|
ISO
|
alfacalcidol promotes the reaction [[VDR protein binds to RXRA protein] which binds to MED1 protein modified form]
|
CTD |
PMID:20947021 |
|
NCBI chr10:83,641,851...83,685,560
Ensembl chr10:83,641,862...83,685,545
|
|
| G
|
Ncoa1
|
nuclear receptor coactivator 1
|
multiple interactions
|
ISO
|
alfacalcidol promotes the reaction [[VDR protein binds to RXRA protein] which binds to NCOA1 protein modified form]
|
CTD |
PMID:20947021 |
|
NCBI chr 6:32,952,090...33,229,829
Ensembl chr 6:32,952,090...33,195,924
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions
|
EXP
|
alfacalcidol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; alfacalcidol promotes the reaction [Polyphenols inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]; alfacalcidol promotes the reaction [Tea inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]; Polyphenols promotes the reaction [alfacalcidol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]; Tea promotes the reaction [alfacalcidol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]
|
CTD |
PMID:20069278 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Pth
|
parathyroid hormone
|
decreases expression
|
EXP
|
alfacalcidol results in decreased expression of PTH protein
|
CTD |
PMID:11675047 |
|
NCBI chr 1:176,942,901...176,946,034
Ensembl chr 1:176,943,102...176,946,034
|
|
| G
|
Rxra
|
retinoid X receptor alpha
|
affects binding multiple interactions
|
ISO
|
alfacalcidol binds to [VDR protein binds to RXRA protein] alfacalcidol promotes the reaction [[VDR protein binds to RXRA protein] which binds to MED1 protein modified form]; alfacalcidol promotes the reaction [[VDR protein binds to RXRA protein] which binds to NCOA1 protein modified form]
|
CTD |
PMID:20947021 |
|
NCBI chr 3:31,387,892...31,474,415
Ensembl chr 3:31,388,223...31,474,417
|
|
| G
|
S100g
|
S100 calcium binding protein G
|
increases expression
|
ISO
|
alfacalcidol results in increased expression of S100G mRNA
|
CTD |
PMID:18180267 |
|
NCBI chr X:35,337,636...35,340,205
Ensembl chr X:35,337,675...35,340,205
|
|
| G
|
Slc10a2
|
solute carrier family 10 member 2
|
increases expression
|
ISO
|
alfacalcidol results in increased expression of SLC10A2 mRNA
|
CTD |
PMID:19581390 |
|
NCBI chr16:91,088,089...91,111,025
Ensembl chr16:91,076,423...91,111,025
|
|
| G
|
Slc51a
|
solute carrier family 51 member A
|
increases expression
|
ISO
|
alfacalcidol results in increased expression of SLC51A mRNA
|
CTD |
PMID:19581390 |
|
NCBI chr11:81,804,141...81,818,539
Ensembl chr11:81,803,972...81,818,539
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
affects response to substance
|
ISO
|
TGFB1 gene SNP affects the susceptibility to alfacalcidol
|
CTD |
PMID:10750555 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Tk1
|
thymidine kinase 1
|
multiple interactions
|
ISO
|
alfacalcidol inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TK1 mRNA]
|
CTD |
PMID:17893519 |
|
NCBI chr10:103,533,449...103,544,818
Ensembl chr10:103,533,449...103,556,228
|
|
| G
|
Tlr2
|
toll-like receptor 2
|
decreases expression
|
ISO
|
alfacalcidol results in decreased expression of TLR2 protein
|
CTD |
PMID:15946915 |
|
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
EXP
|
alfacalcidol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; alfacalcidol promotes the reaction [Polyphenols inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; alfacalcidol promotes the reaction [Tea inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; Polyphenols promotes the reaction [alfacalcidol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; Tea promotes the reaction [alfacalcidol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]
|
CTD |
PMID:20069278 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnfrsf1b
|
TNF receptor superfamily member 1B
|
decreases expression
|
ISO
|
alfacalcidol results in decreased expression of TNFRSF1B protein modified form
|
CTD |
PMID:15044820 |
|
NCBI chr 5:162,356,250...162,387,411
Ensembl chr 5:162,353,848...162,387,411
|
|
| G
|
Trpv5
|
transient receptor potential cation channel, subfamily V, member 5
|
increases expression
|
ISO
|
alfacalcidol results in increased expression of TRPV5 mRNA
|
CTD |
PMID:18180267 |
|
NCBI chr 4:71,503,085...71,531,134
Ensembl chr 4:71,503,093...71,529,384
|
|
| G
|
Trpv6
|
transient receptor potential cation channel, subfamily V, member 6
|
increases expression
|
ISO
|
alfacalcidol results in increased expression of TRPV6 mRNA
|
CTD |
PMID:18180267 |
|
NCBI chr 4:71,474,006...71,489,667
Ensembl chr 4:71,474,007...71,489,671
|
|
| G
|
Tshb
|
thyroid stimulating hormone subunit beta
|
multiple interactions
|
ISO
|
alfacalcidol promotes the reaction [Methimazole results in increased expression of TSHB protein]
|
CTD |
PMID:9322804 |
|
NCBI chr 2:192,913,171...192,918,054
Ensembl chr 2:192,913,171...192,942,984
|
|
| G
|
Vdr
|
vitamin D receptor
|
affects binding multiple interactions increases activity
|
ISO
|
alfacalcidol binds to [VDR protein binds to RXRA protein]; alfacalcidol binds to VDR protein modified form alfacalcidol promotes the reaction [[VDR protein binds to RXRA protein] which binds to MED1 protein modified form]; alfacalcidol promotes the reaction [[VDR protein binds to RXRA protein] which binds to NCOA1 protein modified form] alfacalcidol results in increased activity of VDR protein [alfacalcidol results in increased activity of VDR protein] which results in increased metabolism of Bile Acids and Salts
|
CTD |
PMID:17997857 PMID:19581390 PMID:20947021 |
|
NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:130,866,745...130,916,757
|
|
|
|
| G
|
Aard
|
alanine and arginine rich domain containing protein
|
increases expression
|
EXP
|
Calcifediol deficiency results in increased expression of AARD mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 7:85,254,322...85,259,163
Ensembl chr 7:85,253,992...85,259,163
|
|
| G
|
Actb
|
actin, beta
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of ACTB mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
multiple interactions
|
ISO
|
Calcifediol inhibits the reaction [TNF protein results in increased phosphorylation of AKT1 protein]
|
CTD |
PMID:34255241 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Aldoa
|
aldolase, fructose-bisphosphate A
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of ALDOA mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:190,832,820...190,838,211
|
|
| G
|
Alpl
|
alkaline phosphatase, biomineralization associated
|
increases expression multiple interactions
|
ISO
|
Calcifediol results in increased expression of ALPL mRNA; Calcifediol results in increased expression of ALPL protein CYP27B1 protein promotes the reaction [Calcifediol results in increased expression of ALPL mRNA]; CYP27B1 protein promotes the reaction [Calcifediol results in increased expression of ALPL protein]; Ketoconazole inhibits the reaction [Calcifediol results in increased expression of ALPL mRNA]
|
CTD |
PMID:21542014 |
|
NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167
|
|
| G
|
Apob
|
apolipoprotein B
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of APOB mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:36,563,704...36,611,814
|
|
| G
|
Aqp4
|
aquaporin 4
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of AQP4 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,782,389...6,799,098
|
|
| G
|
Atp1a1
|
ATPase Na+/K+ transporting subunit alpha 1
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of ATP1A1 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425
|
|
| G
|
Atp1a3
|
ATPase Na+/K+ transporting subunit alpha 3
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of ATP1A3 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 1:89,700,645...89,729,782
Ensembl chr 1:89,700,649...89,729,825
|
|
| G
|
Atp1b1
|
ATPase Na+/K+ transporting subunit beta 1
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of ATP1B1 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr13:79,319,708...79,340,226
Ensembl chr13:79,319,706...79,340,549
|
|
| G
|
Atp6v1b2
|
ATPase H+ transporting V1 subunit B2
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of ATP6V1B2 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr16:25,384,254...25,408,388
Ensembl chr16:25,384,257...25,408,839
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
decreases expression multiple interactions
|
ISO
|
Calcifediol results in decreased expression of BAX mRNA; Calcifediol results in decreased expression of BAX protein Ketoconazole inhibits the reaction [Calcifediol results in decreased expression of BAX mRNA]
|
CTD |
PMID:21542014 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcat1
|
branched chain amino acid transaminase 1
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of BCAT1 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 4:179,695,662...179,777,973
Ensembl chr 4:179,695,662...179,777,288
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
increases expression multiple interactions
|
ISO
|
Calcifediol results in increased expression of BCL2 mRNA; Calcifediol results in increased expression of BCL2 protein Ketoconazole inhibits the reaction [Calcifediol results in increased expression of BCL2 mRNA]
|
CTD |
PMID:21542014 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bnip3
|
BCL2 interacting protein 3
|
multiple interactions
|
ISO
|
Calcifediol inhibits the reaction [TNF protein promotes the reaction [BNIP3 protein binds to MAP1LC3B protein]]; Calcifediol inhibits the reaction [TNF protein results in increased expression of and affects the localization of BNIP3 protein] Calcifediol inhibits the reaction [TNF protein results in increased expression of BNIP3 protein]
|
CTD |
PMID:34255241 |
|
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
|
|
| G
|
Canx
|
calnexin
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of CANX mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr10:35,124,941...35,157,954
Ensembl chr10:35,124,941...35,157,857
|
|
| G
|
Cat
|
catalase
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of CAT mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Ccnd1
|
cyclin D1
|
decreases expression
|
ISO
|
Calcifediol results in decreased expression of CCND1 protein
|
CTD |
PMID:21542014 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Cd247
|
Cd247 molecule
|
multiple interactions
|
ISO
|
Calcifediol promotes the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased expression of VDR protein]; Ketoconazole inhibits the reaction [Calcifediol promotes the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased expression of VDR protein]]
|
CTD |
PMID:24792400 |
|
NCBI chr13:80,576,264...80,651,422
Ensembl chr13:80,576,202...80,655,248
|
|
| G
|
Cd28
|
Cd28 molecule
|
multiple interactions
|
ISO
|
Calcifediol promotes the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased expression of VDR protein]; Ketoconazole inhibits the reaction [Calcifediol promotes the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased expression of VDR protein]]
|
CTD |
PMID:24792400 |
|
NCBI chr 9:69,660,316...69,689,192
Ensembl chr 9:69,545,326...69,689,192
|
|
| G
|
Cd3d
|
CD3 delta subunit of T-cell receptor complex
|
multiple interactions
|
ISO
|
Calcifediol promotes the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased expression of VDR protein]; Ketoconazole inhibits the reaction [Calcifediol promotes the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased expression of VDR protein]]
|
CTD |
PMID:24792400 |
|
NCBI chr 8:54,184,573...54,190,112
Ensembl chr 8:54,175,155...54,196,722
|
|
| G
|
Cd3e
|
CD3 epsilon subunit of T-cell receptor complex
|
multiple interactions
|
ISO
|
Calcifediol promotes the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased expression of VDR protein]; Ketoconazole inhibits the reaction [Calcifediol promotes the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased expression of VDR protein]]
|
CTD |
PMID:24792400 |
|
NCBI chr 8:54,200,617...54,211,770
Ensembl chr 8:54,200,617...54,211,876
|
|
| G
|
Cd3g
|
CD3 gamma subunit of T-cell receptor complex
|
multiple interactions
|
ISO
|
Calcifediol promotes the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased expression of VDR protein]; Ketoconazole inhibits the reaction [Calcifediol promotes the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased expression of VDR protein]]
|
CTD |
PMID:24792400 |
|
NCBI chr 8:54,177,572...54,184,087
Ensembl chr 8:54,177,977...54,183,918
|
|
| G
|
Cdh2
|
cadherin 2
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of CDH2 protein
|
CTD |
PMID:26210580 |
|
NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288
|
|
| G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
increases expression
|
ISO
|
Calcifediol results in increased expression of CDKN1A protein
|
CTD |
PMID:21542014 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
| G
|
Ckb
|
creatine kinase B
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of CKB mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478
|
|
| G
|
Clta
|
clathrin, light chain A
|
increases expression
|
EXP
|
Calcifediol deficiency results in increased expression of CLTA mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 5:63,022,046...63,059,223
Ensembl chr 5:63,041,184...63,059,215
|
|
| G
|
Cplx2
|
complexin 2
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of CPLX2 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr17:10,224,673...10,297,974
Ensembl chr17:10,228,449...10,297,467
|
|
| G
|
Cspg5
|
chondroitin sulfate proteoglycan 5
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of CSPG5 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 8:119,098,932...119,113,191
Ensembl chr 8:119,098,925...119,143,907
|
|
| G
|
Cyb5a
|
cytochrome b5 type A
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of CYB5A mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr18:80,487,923...80,520,544
Ensembl chr18:14,453,966...14,455,094 Ensembl chr18:14,453,966...14,455,094
|
|
| G
|
Cycs
|
cytochrome c, somatic
|
increases expression
|
EXP
|
Calcifediol deficiency results in increased expression of CYCS mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816 Ensembl chr18:80,982,668...80,984,816
|
|
| G
|
Cyp24a1
|
cytochrome P450, family 24, subfamily a, polypeptide 1
|
multiple interactions increases expression
|
ISO
|
Dihydrotestosterone inhibits the reaction [Calcifediol results in increased expression of CYP24A1 mRNA]; Tretinoin inhibits the reaction [Calcifediol results in increased expression of CYP24A1 mRNA] Ketoconazole inhibits the reaction [Calcifediol results in increased expression of CYP24A1 mRNA]
|
CTD |
PMID:16289102 PMID:16524720 PMID:18840526 PMID:21542014 PMID:24792400 |
|
NCBI chr 3:179,694,647...179,709,083
Ensembl chr 3:179,694,647...179,709,083
|
|
| G
|
Cyp27b1
|
cytochrome P450, family 27, subfamily b, polypeptide 1
|
affects metabolic processing increases hydroxylation multiple interactions
|
ISO EXP
|
CYP27B1 protein affects the metabolism of Calcifediol CYP27B1 protein results in increased hydroxylation of Calcifediol CYP27B1 protein promotes the reaction [Calcifediol results in increased expression of ALPL mRNA]; CYP27B1 protein promotes the reaction [Calcifediol results in increased expression of ALPL protein]; CYP27B1 protein promotes the reaction [Calcifediol results in increased expression of IBSP mRNA]; CYP27B1 protein promotes the reaction [Calcifediol results in increased expression of RUNX2 mRNA]
|
CTD |
PMID:16061850 PMID:21542014 |
|
NCBI chr 7:64,756,626...64,761,570
Ensembl chr 7:64,756,626...64,761,570
|
|
| G
|
Cyp4b1
|
cytochrome P450, family 4, subfamily b, polypeptide 1
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of CYP4B1 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 5:134,375,807...134,413,635
Ensembl chr 5:134,375,807...134,393,116
|
|
| G
|
Dctn4
|
dynactin subunit 4
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of DCTN4 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr18:56,251,187...56,279,844
Ensembl chr18:56,252,780...56,279,842
|
|
| G
|
Dlg1
|
discs large MAGUK scaffold protein 1
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of DLG1 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr11:82,416,853...82,607,797
Ensembl chr11:82,416,853...82,607,797
|
|
| G
|
Dnm1l
|
dynamin 1-like
|
multiple interactions
|
ISO
|
Calcifediol inhibits the reaction [TNF protein affects the expression of and results in increased phosphorylation of DNM1L protein] Calcifediol inhibits the reaction [TNF protein results in increased expression of DNM1L protein]
|
CTD |
PMID:34255241 |
|
NCBI chr11:98,084,049...98,135,663
Ensembl chr11:98,085,397...98,137,420
|
|
| G
|
Dpp6
|
dipeptidyl peptidase like 6
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of DPP6 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 4:8,323,220...9,242,694
Ensembl chr 4:8,324,843...9,242,209
|
|
| G
|
Eif4h
|
eukaryotic translation initiation factor 4H
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of EIF4H mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr12:27,719,527...27,736,350
Ensembl chr12:27,719,321...27,736,346
|
|
| G
|
Fgf23
|
fibroblast growth factor 23
|
multiple interactions
|
EXP
|
Calcifediol inhibits the reaction [Theophylline results in increased expression of FGF23 protein]
|
CTD |
PMID:26851681 |
|
NCBI chr 4:161,600,439...161,609,991
Ensembl chr 4:161,600,383...161,609,991
|
|
| G
|
Fkbp1a
|
FKBP prolyl isomerase 1A
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of FKBP1A mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 3:160,500,748...160,520,492
Ensembl chr 3:160,500,726...160,524,233
|
|
| G
|
Gabbr1
|
gamma-aminobutyric acid type B receptor subunit 1
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of GABBR1 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr20:1,469,779...1,499,352
Ensembl chr20:1,469,779...1,498,607
|
|
| G
|
Gadd45a
|
growth arrest and DNA-damage-inducible, alpha
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of GADD45A mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807
|
|
| G
|
Gas5
|
growth arrest specific 5
|
increases expression
|
EXP
|
Calcifediol deficiency results in increased expression of GAS5 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr13:75,836,963...75,840,284
|
|
| G
|
Gfap
|
glial fibrillary acidic protein
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of GFAP mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685
|
|
| G
|
Gja1
|
gap junction protein, alpha 1
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of GJA1 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689
|
|
| G
|
Glul
|
glutamate-ammonia ligase
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of GLUL mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr13:68,519,500...68,585,554
Ensembl chr13:68,576,067...68,585,520
|
|
| G
|
Gna12
|
G protein subunit alpha 12
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of GNA12 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr12:18,919,629...19,000,185
Ensembl chr12:18,919,629...19,000,185
|
|
| G
|
Gnai1
|
G protein subunit alpha i1
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of GNAI1 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 4:17,706,061...17,790,176
Ensembl chr 4:17,706,025...17,789,198
|
|
| G
|
Gnrhr
|
gonadotropin releasing hormone receptor
|
increases expression
|
EXP
|
Calcifediol deficiency results in increased expression of GNRHR mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr14:22,211,666...22,229,654
|
|
| G
|
Guca2b
|
guanylate cyclase activator 2B
|
increases expression
|
EXP
|
Calcifediol deficiency results in increased expression of GUCA2B mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 5:138,532,160...138,534,210
Ensembl chr 5:138,532,178...138,534,235
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
multiple interactions
|
ISO
|
Calcifediol inhibits the reaction [TNF protein results in increased expression of HIF1A protein]
|
CTD |
PMID:34255241 |
|
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Hsd17b4
|
hydroxysteroid (17-beta) dehydrogenase 4
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of HSD17B4 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr18:45,515,427...45,604,467
Ensembl chr18:45,515,373...45,604,467
|
|
| G
|
Hsp90ab1
|
heat shock protein 90 alpha family class B member 1
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of HSP90AB1 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 9:22,930,249...22,935,929
Ensembl chr 9:22,931,070...22,935,926
|
|
| G
|
Ibsp
|
integrin-binding sialoprotein
|
increases expression multiple interactions
|
ISO
|
Calcifediol results in increased expression of IBSP mRNA CYP27B1 protein promotes the reaction [Calcifediol results in increased expression of IBSP mRNA]; Ketoconazole inhibits the reaction [Calcifediol results in increased expression of IBSP mRNA]
|
CTD |
PMID:21542014 |
|
NCBI chr14:5,744,497...5,757,242
Ensembl chr14:5,744,501...5,775,299
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
multiple interactions
|
ISO
|
Calcifediol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]
|
CTD |
PMID:34255241 |
|
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Igf1
|
insulin-like growth factor 1
|
increases expression
|
EXP
|
Calcifediol deficiency results in increased expression of IGF1 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
| G
|
Ins2
|
insulin 2
|
affects secretion
|
ISO
|
Calcifediol affects the secretion of INS protein
|
CTD |
PMID:24401716 |
|
NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805
|
|
| G
|
Kdr
|
kinase insert domain receptor
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of KDR mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,572,049...32,615,192
|
|
| G
|
Klc1
|
kinesin light chain 1
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of KLC1 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 6:136,644,592...136,690,399
Ensembl chr 6:136,644,307...136,689,760
|
|
| G
|
Krt14
|
keratin 14
|
increases expression
|
EXP
|
Calcifediol deficiency results in increased expression of KRT14 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr10:85,638,182...85,642,450
|
|
| G
|
Lre3
|
LINE retrotransposable element 3
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of LRE3 mRNA
|
CTD |
PMID:17293106 |
|
|
|
| G
|
Map1lc3b
|
microtubule-associated protein 1 light chain 3 beta
|
multiple interactions
|
ISO
|
Calcifediol inhibits the reaction [TNF protein promotes the reaction [BNIP3 protein binds to MAP1LC3B protein]]; Calcifediol inhibits the reaction [TNF protein results in increased expression of MAP1LC3B protein]
|
CTD |
PMID:34255241 |
|
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358 Ensembl chr16:66,574,407...66,584,358
|
|
| G
|
Map2
|
microtubule-associated protein 2
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of MAP2 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:75,288,262...75,428,459
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions
|
ISO
|
Calcifediol inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein]
|
CTD |
PMID:34255241 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions
|
ISO
|
Calcifediol inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:34255241 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Mapk9
|
mitogen-activated protein kinase 9
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of MAPK9 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
|
|
| G
|
Marcks
|
myristoylated alanine rich protein kinase C substrate
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of MARCKS mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr20:42,240,185...42,245,882
Ensembl chr20:42,240,185...42,245,882
|
|
| G
|
Mff
|
mitochondrial fission factor
|
multiple interactions
|
ISO
|
Calcifediol inhibits the reaction [TNF protein results in increased expression of MFF protein]
|
CTD |
PMID:34255241 |
|
NCBI chr 9:91,455,931...91,484,171
Ensembl chr 9:91,455,871...91,484,171
|
|
| G
|
Mobp
|
myelin-associated oligodendrocyte basic protein
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of MOBP mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 8:128,747,117...128,777,238
Ensembl chr 8:128,747,232...128,777,936
|
|
| G
|
Nckap1
|
NCK-associated protein 1
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of NCKAP1 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 3:85,824,333...85,898,748
Ensembl chr 3:85,824,336...85,898,797
|
|
| G
|
Nedd4
|
NEDD4 E3 ubiquitin protein ligase
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of NEDD4A mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 8:82,264,751...82,349,642
Ensembl chr 8:82,264,649...82,349,633
|
|
| G
|
Nsf
|
N-ethylmaleimide sensitive factor, vesicle fusing ATPase
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of NSF mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr10:89,227,937...89,357,383
Ensembl chr10:89,227,937...89,367,621
|
|
| G
|
P4hb
|
prolyl 4-hydroxylase subunit beta
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of P4HB mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr10:106,335,300...106,346,911
Ensembl chr10:106,335,300...106,346,911
|
|
| G
|
Pcna
|
proliferating cell nuclear antigen
|
decreases expression
|
ISO
|
Calcifediol results in decreased expression of PCNA protein
|
CTD |
PMID:21542014 |
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
| G
|
Pdia3
|
protein disulfide isomerase family A, member 3
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of PDIA3 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 3:128,841,781...128,865,733
Ensembl chr 3:128,841,917...128,867,327
|
|
| G
|
Pdpk1
|
3-phosphoinositide dependent protein kinase-1
|
increases expression
|
EXP
|
Calcifediol deficiency results in increased expression of PDPK1 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr10:13,610,000...13,687,226
Ensembl chr10:13,610,063...13,679,181
|
|
| G
|
Pmch
|
pro-melanin-concentrating hormone
|
increases expression
|
EXP
|
Calcifediol deficiency results in increased expression of PMCH mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 7:24,399,404...24,400,720
Ensembl chr 7:24,399,404...24,400,720
|
|
| G
|
Ppm1b
|
protein phosphatase, Mg2+/Mn2+ dependent, 1B
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of PPM1B mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 6:15,399,559...15,460,301
Ensembl chr 6:15,399,562...15,460,756
|
|
| G
|
Ppp3r1
|
protein phosphatase 3, regulatory subunit B, alpha
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of PPP3R1 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr14:95,758,333...95,808,015
|
|
| G
|
Psap
|
prosaposin
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of PSAP mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr20:28,756,951...28,783,422
Ensembl chr20:28,757,181...28,783,421
|
|
| G
|
Psat1
|
phosphoserine aminotransferase 1
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of PSAT1 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 1:222,623,553...222,646,187
Ensembl chr 1:222,623,556...222,655,693
|
|
| G
|
Psma2
|
proteasome 20S subunit alpha 2
|
increases expression
|
EXP
|
Calcifediol deficiency results in increased expression of PSMA2 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr17:55,250,054...55,260,441
Ensembl chr17:55,247,442...55,339,673
|
|
| G
|
Pth
|
parathyroid hormone
|
multiple interactions
|
EXP
|
Calcifediol inhibits the reaction [Theophylline results in increased expression of PTH protein]
|
CTD |
PMID:26851681 |
|
NCBI chr 1:176,942,901...176,946,034
Ensembl chr 1:176,943,102...176,946,034
|
|
| G
|
Pygb
|
glycogen phosphorylase B
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of PYGB mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 3:160,072,141...160,118,930
Ensembl chr 3:160,072,115...160,123,961
|
|
| G
|
Rasgrp1
|
RAS guanyl releasing protein 1
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of RASGRP1 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 3:124,624,039...124,684,079
Ensembl chr 3:124,622,313...124,684,434
|
|
| G
|
Rasl11a
|
RAS-like family 11 member A
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of RASL11A mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr12:13,372,023...13,374,784
Ensembl chr12:13,372,023...13,376,451
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
ISO
|
Calcifediol inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein]
|
CTD |
PMID:34255241 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Rhoa
|
ras homolog family member A
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of RHOA mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:117,870,270...117,904,302
|
|
| G
|
Runx2
|
RUNX family transcription factor 2
|
multiple interactions increases expression
|
ISO
|
CYP27B1 protein promotes the reaction [Calcifediol results in increased expression of RUNX2 mRNA]; Ketoconazole inhibits the reaction [Calcifediol results in increased expression of RUNX2 mRNA]
|
CTD |
PMID:21542014 |
|
NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:23,664,952...23,990,027
|
|
| G
|
Scd2
|
stearoyl-Coenzyme A desaturase 2
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of SCD2 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 1:253,118,377...253,131,436
Ensembl chr 1:253,117,655...253,128,874
|
|
| G
|
Sdc4
|
syndecan 4
|
increases expression
|
EXP
|
Calcifediol deficiency results in increased expression of SDC4 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 3:173,574,239...173,592,923
Ensembl chr 3:173,574,239...173,593,670
|
|
| G
|
Slc1a3
|
solute carrier family 1 member 3
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of SLC1A3 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 2:59,482,707...59,557,808
Ensembl chr 2:59,482,709...59,557,808
|
|
| G
|
Snrk
|
SNF related kinase
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of SNRK mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 8:130,657,204...130,711,461
Ensembl chr 8:130,657,266...130,711,457
|
|
| G
|
Sod2
|
superoxide dismutase 2
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of SOD2 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
| G
|
Sult2a1
|
sulfotransferase family 2A member 1
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of SULT2A1 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 1:84,582,011...84,639,001
|
|
| G
|
Sult2a6
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 6
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of SULT2A6 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 1:84,046,685...84,097,808
Ensembl chr 1:84,046,685...84,097,808
|
|
| G
|
Syt1
|
synaptotagmin 1
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of SYT1 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 7:45,699,649...46,244,460
Ensembl chr 7:45,702,228...46,244,213
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
ISO
|
Calcifediol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Calcifediol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Calcifediol inhibits the reaction [TNF protein affects the expression of and results in increased phosphorylation of DNM1L protein]; Calcifediol inhibits the reaction [TNF protein promotes the reaction [BNIP3 protein binds to MAP1LC3B protein]]; Calcifediol inhibits the reaction [TNF protein results in increased expression of and affects the localization of BNIP3 protein]; Calcifediol inhibits the reaction [TNF protein results in increased expression of HIF1A protein]; Calcifediol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; Calcifediol inhibits the reaction [TNF protein results in increased expression of MAP1LC3B protein]; Calcifediol inhibits the reaction [TNF protein results in increased expression of MFF protein]; Calcifediol inhibits the reaction [TNF protein results in increased phosphorylation of AKT1 protein]; Calcifediol inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein]; Calcifediol inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein]; Calcifediol inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein]; Ketoconazole inhibits the reaction [Calcifediol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; Ketoconazole inhibits the reaction [Calcifediol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]] Calcifediol inhibits the reaction [TNF protein results in increased expression of BNIP3 protein]; Calcifediol inhibits the reaction [TNF protein results in increased expression of DNM1L protein]; Calcifediol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; Calcifediol inhibits the reaction [TNF protein results in increased expression of MFF protein]
|
CTD |
PMID:11135059 PMID:34255241 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Ubqln1
|
ubiquilin 1
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of UBQLN1 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr17:6,438,456...6,482,498
Ensembl chr17:6,444,124...6,482,499
|
|
| G
|
Vcp
|
valosin-containing protein
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of VCP mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 5:62,005,984...62,025,387
Ensembl chr 5:62,005,985...62,025,387
|
|
| G
|
Vdac1
|
voltage-dependent anion channel 1
|
decreases expression
|
EXP
|
Calcifediol deficiency results in decreased expression of VDAC1 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr10:37,029,377...37,060,542
Ensembl chr10:37,023,145...37,060,541
|
|
| G
|
Vdr
|
vitamin D receptor
|
multiple interactions increases activity
|
ISO
|
Calcifediol promotes the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased expression of VDR protein]; Calcifediol results in decreased degradation of and affects the localization of VDR protein; Ketoconazole inhibits the reaction [Calcifediol promotes the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased expression of VDR protein]]; VDR protein promotes the reaction [Calcifediol results in increased abundance of Lipids] Calcifediol results in increased activity of VDR protein Calcifediol results in increased activity of VDR protein; Calcifediol results in increased activity of VDR protein mutant form
|
CTD |
PMID:17997857 PMID:20079722 PMID:21291553 PMID:24792400 |
|
NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:130,866,745...130,916,757
|
|
| G
|
Ybx1
|
Y box binding protein 1
|
increases expression
|
EXP
|
Calcifediol deficiency results in increased expression of YBX1 mRNA
|
CTD |
PMID:17293106 |
|
NCBI chr 5:138,167,444...138,188,155
Ensembl chr 5:138,167,444...138,184,188
|
|
|
|
| G
|
6430548M08Rikl
|
RIKEN cDNA 6430548M08 gene like
|
increases expression decreases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of KIAA0513 mRNA Calcitriol results in decreased expression of KIAA0513 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of KIAA0513 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr19:65,076,626...65,125,185
Ensembl chr19:65,077,790...65,125,177
|
|
| G
|
A2ml1
|
alpha-2-macroglobulin-like 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of OVOS2P mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:163,501,210...163,543,419
Ensembl chr 4:163,501,585...163,543,506
|
|
| G
|
Aard
|
alanine and arginine rich domain containing protein
|
increases expression
|
ISO
|
Calcitriol results in increased expression of AARD mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:85,254,322...85,259,163
Ensembl chr 7:85,253,992...85,259,163
|
|
| G
|
Abat
|
4-aminobutyrate aminotransferase
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ABAT mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:7,503,351...7,599,474
Ensembl chr10:7,492,022...7,599,474
|
|
| G
|
Abca1
|
ATP binding cassette subfamily A member 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ABCA1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473
|
|
| G
|
Abca12
|
ATP binding cassette subfamily A member 12
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ABCA12 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of ABCA12 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:80,272,121...80,445,340
Ensembl chr 9:80,272,127...80,445,340
|
|
| G
|
Abca3
|
ATP binding cassette subfamily A member 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ABCA3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:13,886,948...13,944,286
Ensembl chr10:13,887,083...13,944,285
|
|
| G
|
Abcb10
|
ATP binding cassette subfamily B member 10
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ABCB10 mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr19:68,850,108...68,881,689
Ensembl chr19:68,850,134...68,880,203
|
|
| G
|
Abcb1a
|
ATP binding cassette subfamily B member 1A
|
decreases activity multiple interactions increases expression
|
ISO
|
Calcitriol results in decreased activity of ABCB1 protein [Curcumin co-treated with Calcitriol] inhibits the reaction [Paclitaxel results in increased expression of ABCB1 protein]; Calcitriol promotes the reaction [Curcumin inhibits the reaction [Paclitaxel results in increased expression of ABCB1 protein]] Calcitriol results in increased expression of ABCB1 mRNA; Calcitriol results in increased expression of ABCB1 protein [Calcitriol co-treated with Curcumin] inhibits the reaction [Paclitaxel results in increased expression of ABCB1 protein]; [Calcitriol co-treated with Paclitaxel] results in increased expression of ABCB1 mRNA; [Calcitriol co-treated with Paclitaxel] results in increased expression of ABCB1 protein; [Curcumin co-treated with Calcitriol] inhibits the reaction [Paclitaxel results in increased expression of ABCB1 mRNA]; Calcitriol inhibits the reaction [[Curcumin co-treated with Paclitaxel] results in increased expression of ABCB1 protein]; Calcitriol inhibits the reaction [Paclitaxel results in increased expression of ABCB1 protein]; Curcumin inhibits the reaction [[Calcitriol co-treated with Paclitaxel] results in increased expression of ABCB1 mRNA]; Curcumin inhibits the reaction [[Calcitriol co-treated with Paclitaxel] results in increased expression of ABCB1 protein]; VDR protein promotes the reaction [Calcitriol results in increased expression of ABCB1 mRNA]
|
CTD |
PMID:12387747 PMID:19460946 PMID:26366751 PMID:27107558 PMID:31628941 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
|
|
| G
|
Abcb4
|
ATP binding cassette subfamily B member 4
|
multiple interactions
|
EXP
|
Calcitriol promotes the reaction [ABCB4 protein affects the transport of adefovir]
|
CTD |
PMID:21240898 PMID:21341280 |
|
NCBI chr 4:26,106,895...26,164,440
|
|
| G
|
Abcb5
|
ATP binding cassette subfamily B member 5
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ABCB5 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:145,978,860...146,075,776
Ensembl chr 6:145,978,906...146,077,039
|
|
| G
|
Abcc1
|
ATP binding cassette subfamily C member 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ABCC1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ABCC1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404
|
|
| G
|
Abcc2
|
ATP binding cassette subfamily C member 2
|
increases expression increases activity
|
EXP ISO
|
Calcitriol results in increased expression of ABCC2 protein Calcitriol results in increased expression of ABCC2 mRNA Calcitriol results in increased activity of ABCC2 protein
|
CTD |
PMID:21240898 PMID:21341280 PMID:27107558 |
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471
|
|
| G
|
Abcc3
|
ATP binding cassette subfamily C member 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ABCC3 mRNA
|
CTD |
PMID:15824121 |
|
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494
|
|
| G
|
Abcc4
|
ATP binding cassette subfamily C member 4
|
increases activity increases expression
|
EXP
|
Calcitriol results in increased activity of ABCC4 protein Calcitriol results in increased expression of ABCC4 protein
|
CTD |
PMID:21240898 PMID:21341280 |
|
NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375
|
|
| G
|
Abcd3
|
ATP binding cassette subfamily D member 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ABCD3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ABCD3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:212,536,791...212,590,379
Ensembl chr 2:212,536,791...212,590,504
|
|
| G
|
Abhd16b
|
abhydrolase domain containing 16B
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ABHD16B mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ABHD16B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:188,972,198...188,974,095
Ensembl chr 3:188,970,879...188,975,225
|
|
| G
|
Abhd3
|
abhydrolase domain containing 3, phospholipase
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of ABHD3 mRNA Calcitriol results in increased expression of ABHD3 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr18:1,996,010...2,051,311
Ensembl chr18:1,993,525...2,075,492
|
|
| G
|
Abi3bp
|
ABI family member 3 binding protein
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ABI3BP mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr11:57,381,282...57,597,989
Ensembl chr11:57,381,422...57,598,120
|
|
| G
|
Abl1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ABL1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ABL1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:35,377,587...35,480,843
Ensembl chr 3:35,377,391...35,480,846
|
|
| G
|
Ablim1
|
actin-binding LIM protein 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ABLIM1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:266,088,868...266,377,169
Ensembl chr 1:266,088,870...266,377,098
|
|
| G
|
Abtb1
|
ankyrin repeat and BTB domain containing 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of ABTB1 mRNA Calcitriol results in increased expression of ABTB1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:122,856,558...122,862,895
Ensembl chr 4:122,856,564...122,862,789
|
|
| G
|
Acadm
|
acyl-CoA dehydrogenase medium chain
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ACADM mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:245,518,693...245,542,864
Ensembl chr 2:245,518,693...245,542,864
|
|
| G
|
Acadsb
|
acyl-CoA dehydrogenase, short/branched chain
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ACADSB mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:195,619,088...195,660,564
Ensembl chr 1:195,619,038...195,660,561
|
|
| G
|
Acbd4
|
acyl-CoA binding domain containing 4
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of ACBD4 mRNA Calcitriol results in increased expression of ACBD4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:88,548,146...88,558,588
Ensembl chr10:88,548,158...88,558,587
|
|
| G
|
Acbd7
|
acyl-CoA binding domain containing 7
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ACBD7 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of ACBD7 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:79,813,106...79,821,254
Ensembl chr17:79,813,106...79,818,448
|
|
| G
|
Acin1
|
apoptotic chromatin condensation inducer 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ACIN1 mRNA
|
CTD |
PMID:12798352 |
|
NCBI chr15:32,072,121...32,117,004
Ensembl chr15:32,072,123...32,117,166
|
|
| G
|
Ackr3
|
atypical chemokine receptor 3
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ACKR3 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of ACKR3 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 9:98,247,300...98,258,877
Ensembl chr 9:98,246,605...98,260,214
|
|
| G
|
Acot11
|
acyl-CoA thioesterase 11
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of ACOT11 mRNA Calcitriol results in increased expression of ACOT11 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:126,756,255...126,804,526
Ensembl chr 5:126,756,255...126,804,507
|
|
| G
|
Acox2
|
acyl-CoA oxidase 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ACOX2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ACOX2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:19,090,820...19,122,392
Ensembl chr15:19,090,926...19,122,392
|
|
| G
|
Acox3
|
acyl-CoA oxidase 3, pristanoyl
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ACOX3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ACOX3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:79,358,604...79,405,160
Ensembl chr14:79,302,042...79,400,881
|
|
| G
|
Acp5
|
acid phosphatase 5, tartrate resistant
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ACP5 protein
|
CTD |
PMID:21985997 |
|
NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:28,939,985...28,943,929
|
|
| G
|
Acsl3
|
acyl-CoA synthetase long-chain family member 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ACSL3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ACSL3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:87,563,601...87,613,078
Ensembl chr 9:87,563,601...87,613,097
|
|
| G
|
Acss3
|
acyl-CoA synthetase short-chain family member 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ACSS3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ACSS3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:44,127,725...44,336,707
Ensembl chr 7:44,127,122...44,336,684
|
|
| G
|
Acta1
|
actin, alpha 1, skeletal muscle
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of ACTA1 mRNA Calcitriol results in increased expression of ACTA1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:68,781,168...68,784,194
Ensembl chr19:68,781,168...68,786,178
|
|
| G
|
Acta2
|
actin alpha 2, smooth muscle
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ACTA2 mRNA Calcitriol inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein] [Testosterone co-treated with Calcitriol] results in increased expression of ACTA2 mRNA; Calcitriol inhibits the reaction [sodium arsenite results in increased expression of ACTA2 protein]
|
CTD |
PMID:21592394 PMID:26520185 PMID:37968493 |
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503
|
|
| G
|
Actb
|
actin, beta
|
multiple interactions
|
EXP
|
[Calcium co-treated with Calcitriol] affects the expression of ACTB mRNA
|
CTD |
PMID:15913539 |
|
NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242
|
|
| G
|
Actg2
|
actin gamma 2, smooth muscle
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of ACTG2 mRNA Calcitriol results in increased expression of ACTG2 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 4:117,579,513...117,604,379
Ensembl chr 4:117,579,514...117,604,295
|
|
| G
|
Adam19
|
ADAM metallopeptidase domain 19
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ADAM19 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:30,992,713...31,084,455
Ensembl chr10:30,992,754...31,084,455
|
|
| G
|
Adam2
|
ADAM metallopeptidase domain 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ADAM2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of ADAM2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:44,418,191...44,459,570
Ensembl chr15:44,418,199...44,459,516
|
|
| G
|
Adam22
|
ADAM metallopeptidase domain 22
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ADAM22 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of ADAM22 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:26,670,984...26,925,843
Ensembl chr 4:26,671,112...26,925,843
|
|
| G
|
Adam28
|
ADAM metallopeptidase domain 28
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ADAM28 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr15:50,184,286...50,250,605
Ensembl chr15:50,127,516...50,250,526
|
|
| G
|
Adam33
|
ADAM metallopeptidase domain 33
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ADAM33 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:138,715,428...138,736,392
Ensembl chr 3:138,724,046...138,736,347
|
|
| G
|
Adam8
|
ADAM metallopeptidase domain 8
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ADAM8 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:204,206,206...204,218,988
Ensembl chr 1:204,206,199...204,218,485
|
|
| G
|
Adamts20
|
ADAM metallopeptidase with thrombospondin type 1 motif, 20
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ADAMTS20 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:127,275,538...127,407,325
Ensembl chr 7:127,275,538...127,407,296
|
|
| G
|
Adamts9
|
ADAM metallopeptidase with thrombospondin type 1 motif, 9
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ADAMTS9 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 4:126,847,726...127,019,924
Ensembl chr 4:126,847,729...127,019,876
|
|
| G
|
Adcy7
|
adenylate cyclase 7
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ADCY7 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr19:34,913,154...34,972,366
Ensembl chr19:34,914,322...34,936,743
|
|
| G
|
Adgrb2
|
adhesion G protein-coupled receptor B2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ADGRB2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of ADGRB2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:147,581,573...147,646,726
Ensembl chr 5:147,611,580...147,646,726
|
|
| G
|
Adgre5
|
adhesion G protein-coupled receptor E5
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ADGRE5 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr19:41,302,687...41,332,183
Ensembl chr19:41,303,213...41,324,641
|
|
| G
|
Adgrf4
|
adhesion G protein-coupled receptor F4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ADGRF4 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 9:25,769,265...25,800,438
Ensembl chr 9:25,769,265...25,800,438
|
|
| G
|
Adgrg1
|
adhesion G protein-coupled receptor G1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ADGRG1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr19:10,009,983...10,047,138
Ensembl chr19:10,010,031...10,047,124
|
|
| G
|
Adgrv1
|
adhesion G protein-coupled receptor V1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ADGRV1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:13,067,149...13,647,407
Ensembl chr 2:13,067,150...13,647,372
|
|
| G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
multiple interactions
|
ISO
|
[Calcitriol co-treated with Cortisone] results in decreased expression of ADIPOQ mRNA
|
CTD |
PMID:19918113 |
|
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
|
|
| G
|
Adissp
|
adipose secreted signaling protein
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of ADISSP mRNA Calcitriol results in decreased expression of ADISSP mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:138,817,752...138,832,208
Ensembl chr 3:138,813,179...138,831,847
|
|
| G
|
Adora1
|
adenosine A1 receptor
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of ADORA1 mRNA Calcitriol results in decreased expression of ADORA1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:48,210,922...48,247,826
Ensembl chr13:48,213,273...48,247,190
|
|
| G
|
Adora2b
|
adenosine A2B receptor
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of ADORA2B mRNA Calcitriol results in decreased expression of ADORA2B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:47,439,712...47,456,092
Ensembl chr10:47,439,701...47,456,091
|
|
| G
|
Adora3
|
adenosine A3 receptor
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ADORA3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:196,077,042...196,080,686
Ensembl chr 2:196,077,042...196,080,686
|
|
| G
|
Adra1b
|
adrenoceptor alpha 1B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ADRA1B mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:28,756,461...28,874,831
Ensembl chr10:28,756,461...28,814,347
|
|
| G
|
Adrb2
|
adrenoceptor beta 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ADRB2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803
|
|
| G
|
Afdn
|
afadin, adherens junction formation factor
|
increases expression
|
ISO
|
Calcitriol results in increased expression of AFDN mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:58,041,065...58,170,505
Ensembl chr 1:58,041,641...58,170,505
|
|
| G
|
Aff3
|
ALF transcription elongation factor 3
|
decreases expression increases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of AFF3 mRNA Calcitriol results in increased expression of AFF3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of AFF3 mRNA
|
CTD |
PMID:16002434 PMID:21592394 PMID:26485663 |
|
NCBI chr 9:47,894,903...48,352,380
Ensembl chr 9:47,894,903...48,353,000
|
|
| G
|
Afg2a
|
AFG2 AAA ATPase homolog A
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of AFG2A mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of AFG2A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:122,234,619...122,425,808
Ensembl chr 2:122,234,738...122,425,808
|
|
| G
|
Agap3
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of AGAP3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:11,567,191...11,617,610
Ensembl chr 4:11,567,191...11,617,285
|
|
| G
|
Ager
|
advanced glycosylation end product-specific receptor
|
decreases expression
|
EXP
|
Calcitriol results in decreased expression of AGER mRNA; Calcitriol results in decreased expression of AGER protein
|
CTD |
PMID:32147540 |
|
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685
|
|
| G
|
Agl
|
amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase
|
increases expression
|
ISO
|
Calcitriol results in increased expression of AGL mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:207,389,949...207,445,959
Ensembl chr 2:207,389,949...207,445,724
|
|
| G
|
Ago2
|
argonaute RISC catalytic component 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of AGO2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:106,907,209...106,994,124
Ensembl chr 7:106,918,125...106,993,980
|
|
| G
|
Agr2
|
anterior gradient 2, protein disulphide isomerase family member
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of AGR2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of AGR2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:58,435,908...58,456,678
Ensembl chr 6:58,435,908...58,456,677
|
|
| G
|
Agtr1b
|
angiotensin II receptor, type 1b
|
multiple interactions
|
EXP
|
[Calcium co-treated with Calcitriol] affects the expression of AGTR1B mRNA
|
CTD |
PMID:15913539 |
|
NCBI chr 2:104,774,005...104,849,262
Ensembl chr 2:104,773,930...104,849,310
|
|
| G
|
Ahnak
|
AHNAK nucleoprotein
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of AHNAK mRNA [Testosterone co-treated with Calcitriol] results in increased expression of AHNAK mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:215,311,289...215,400,010
Ensembl chr 1:215,321,931...215,400,675
|
|
| G
|
Aif1
|
allograft inflammatory factor 1
|
decreases expression
|
EXP
|
Calcitriol results in decreased expression of AIF1 protein
|
CTD |
PMID:32147540 |
|
NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,652,243...3,657,339
|
|
| G
|
Aig1
|
androgen-induced 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of AIG1 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 1:9,866,546...10,089,454
Ensembl chr 1:9,866,548...10,089,155
|
|
| G
|
Ak5
|
adenylate kinase 5
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of AK5 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:244,057,240...244,241,372
Ensembl chr 2:244,057,240...244,241,366
|
|
| G
|
Akap12
|
A-kinase anchoring protein 12
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of AKAP12 mRNA Calcitriol results in increased expression of AKAP12 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 1:43,135,515...43,225,245
Ensembl chr 1:43,199,008...43,225,557
|
|
| G
|
Akr1c1
|
aldo-keto reductase family 1, member C1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of AKR1C1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of AKR1C1 mRNA
|
CTD |
PMID:12040012 PMID:21592394 |
|
NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
multiple interactions
|
ISO
|
Calcitriol inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased phosphorylation of AKT1 protein]; Calcitriol inhibits the reaction [IL2 protein results in increased phosphorylation of AKT1 protein] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Glucose co-treated with Calcitriol] results in increased phosphorylation of AKT1 protein]; [Glucose co-treated with Calcitriol] results in increased phosphorylation of AKT1 protein
|
CTD |
PMID:15879110 PMID:33450223 PMID:36504884 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Aldh1a1
|
aldehyde dehydrogenase 1 family, member A1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ALDH1A1 mRNA; Calcitriol results in decreased expression of ALDH1A1 protein [Calcitriol co-treated with Curcumin] inhibits the reaction [Paclitaxel results in decreased expression of ALDH1A1 protein] [Calcitriol co-treated with Curcumin] promotes the reaction [Paclitaxel results in decreased expression of ALDH1A1 mRNA]; [Calcitriol co-treated with Paclitaxel] promotes the reaction [Curcumin results in decreased expression of ALDH1A1 mRNA]; [Curcumin co-treated with Calcitriol] inhibits the reaction [Paclitaxel results in decreased expression of ALDH1A1 protein]; [Curcumin co-treated with Paclitaxel] promotes the reaction [Calcitriol results in decreased expression of ALDH1A1 mRNA]; Paclitaxel promotes the reaction [Calcitriol results in decreased expression of ALDH1A1 mRNA]
|
CTD |
PMID:31628941 |
|
NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500
|
|
| G
|
Aldh1a3
|
aldehyde dehydrogenase 1 family, member A3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ALDH1A3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ALDH1A3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:129,392,516...129,436,552
Ensembl chr 1:129,392,516...129,427,777
|
|
| G
|
Aldh1b1
|
aldehyde dehydrogenase 1 family, member B1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ALDH1B1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:64,859,000...64,864,008
Ensembl chr 5:64,858,934...64,864,365
|
|
| G
|
Aldh3b2
|
aldehyde dehydrogenase 3 family, member B2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ALDH3B2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:210,679,749...210,694,187
Ensembl chr 1:210,675,302...210,694,155
|
|
| G
|
Aldh3b3
|
aldehyde dehydrogenase 3 family, member B3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ALDH3B2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:210,617,090...210,629,886
Ensembl chr 1:210,622,639...210,629,879
|
|
| G
|
Aldh4a1
|
aldehyde dehydrogenase 4 family, member A1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of ALDH4A1 mRNA Calcitriol results in increased expression of ALDH4A1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:157,163,189...157,188,673
Ensembl chr 5:157,162,945...157,188,673
|
|
| G
|
Alg13
|
ALG13, UDP-N-acetylglucosaminyltransferase subunit
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ALG13 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr X:112,703,015...112,764,924
Ensembl chr X:112,702,796...112,739,356
|
|
| G
|
Alkbh2
|
alkB homolog 2, alpha-ketoglutarate-dependent dioxygenase
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of ALKBH2 mRNA Calcitriol results in decreased expression of ALKBH2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr12:48,156,825...48,161,489
Ensembl chr12:48,156,827...48,161,483
|
|
| G
|
Alms1
|
ALMS1, centrosome and basal body associated protein
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ALMS1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:119,683,085...119,783,471
Ensembl chr 4:119,683,076...119,783,471
|
|
| G
|
Alox12
|
arachidonate 12-lipoxygenase, 12S type
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ALOX12 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:55,456,923...55,469,239
Ensembl chr10:55,456,928...55,469,199
|
|
| G
|
Alox15b
|
arachidonate 15-lipoxygenase, type B
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ALOX15B mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ALOX15B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:54,391,331...54,400,648
Ensembl chr10:54,391,302...54,400,648
|
|
| G
|
Alox5
|
arachidonate 5-lipoxygenase
|
increases activity increases expression multiple interactions
|
ISO
|
Calcitriol analog results in increased activity of ALOX5 protein Calcitriol results in increased expression of ALOX5 mRNA Benzo(a)pyrene promotes the reaction [Calcitriol results in increased expression of ALOX5 mRNA]
|
CTD |
PMID:10799658 PMID:16002434 PMID:16129123 PMID:19244278 |
|
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:151,203,949...151,251,126
|
|
| G
|
Alox5ap
|
arachidonate 5-lipoxygenase activating protein
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ALOX5AP mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr12:10,785,254...10,809,295
Ensembl chr12:10,785,257...10,817,038
|
|
| G
|
Alpk2
|
alpha-kinase 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ALPK2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ALPK2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:61,045,717...61,161,703
Ensembl chr18:61,045,380...61,175,985
|
|
| G
|
Alpk3
|
alpha-kinase 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ALPK3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ALPK3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:144,423,690...144,471,534
Ensembl chr 1:144,423,726...144,490,309
|
|
| G
|
Alpl
|
alkaline phosphatase, biomineralization associated
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ALPL mRNA; Calcitriol results in increased expression of ALPL protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL protein]]; Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]]; Sirolimus inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]]
|
CTD |
PMID:12016462 PMID:21542014 PMID:28105418 PMID:33450223 |
|
NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167
|
|
| G
|
Als2
|
alsin Rho guanine nucleotide exchange factor ALS2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ALS2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 9:68,107,310...68,180,192
Ensembl chr 9:68,107,528...68,179,660
|
|
| G
|
Als2cl
|
ALS2 C-terminal like
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of ALS2CL mRNA Calcitriol results in increased expression of ALS2CL mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 8:119,746,498...119,762,824
Ensembl chr 8:119,743,248...119,762,843
|
|
| G
|
Amacr
|
alpha-methylacyl-CoA racemase
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of AMACR mRNA Calcitriol results in increased expression of AMACR mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:61,673,291...61,685,381
Ensembl chr 2:61,670,475...61,685,379
|
|
| G
|
Ampd3
|
adenosine monophosphate deaminase 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of AMPD3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:174,319,526...174,364,605
Ensembl chr 1:174,294,867...174,364,608
|
|
| G
|
Angpt2
|
angiopoietin 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of ANGPT2 mRNA Calcitriol results in increased expression of ANGPT2 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr16:77,790,760...77,841,241
Ensembl chr16:77,790,563...77,841,239
|
|
| G
|
Ank1
|
ankyrin 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ANK1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ANK1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:75,578,824...75,757,464
Ensembl chr16:75,578,824...75,757,464
|
|
| G
|
Ankh
|
ANKH inorganic pyrophosphate transport regulator
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of ANKH mRNA Calcitriol results in increased expression of ANKH mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:79,883,350...80,011,222
Ensembl chr 2:79,883,544...80,011,699
|
|
| G
|
Ankmy2
|
ankyrin repeat and MYND domain containing 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ANKMY2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:58,616,251...58,657,634
Ensembl chr 6:58,615,243...58,657,685
|
|
| G
|
Ankrd22
|
ankyrin repeat domain 22
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ANKRD22 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ANKRD22 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:241,052,235...241,083,737
Ensembl chr 1:241,052,237...241,105,559
|
|
| G
|
Ankrd37
|
ankyrin repeat domain 37
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ANKRD37 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ANKRD37 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:53,001,487...53,004,545
Ensembl chr16:52,994,740...53,004,545
|
|
| G
|
Anln
|
anillin, actin binding protein
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ANLN mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of ANLN mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:29,134,222...29,197,513
Ensembl chr 8:29,134,222...29,197,513
|
|
| G
|
Ano10
|
anoctamin 10
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of ANO10 mRNA Calcitriol results in increased expression of ANO10 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 8:130,719,177...130,838,243
Ensembl chr 8:130,718,755...130,877,636
|
|
| G
|
Anp32e
|
acidic nuclear phosphoprotein 32 family member E
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of ANP32E mRNA Calcitriol results in decreased expression of ANP32E mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:186,161,520...186,177,984
Ensembl chr 2:186,161,532...186,177,986
|
|
| G
|
Antxr1
|
ANTXR cell adhesion molecule 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of ANTXR1 mRNA Calcitriol results in decreased expression of ANTXR1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:121,148,102...121,335,549
Ensembl chr 4:121,148,103...121,336,892
|
|
| G
|
Anxa2
|
annexin A2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ANXA2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ANXA2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:78,986,252...79,022,638
Ensembl chr 8:78,986,242...79,022,631
|
|
| G
|
Anxa3
|
annexin A3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ANXA3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ANXA3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:13,031,675...13,085,678
Ensembl chr14:13,023,762...13,085,849
|
|
| G
|
Aoc3
|
amine oxidase, copper containing 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of AOC3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:86,773,018...86,780,961
|
|
| G
|
Ap1g1
|
adaptor related protein complex 1 subunit gamma 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of AP1G1 mRNA
|
CTD |
PMID:14996990 |
|
NCBI chr19:54,654,101...54,740,586
Ensembl chr19:54,620,807...54,740,586
|
|
| G
|
Ap1m2
|
adaptor related protein complex 1 subunit mu 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of AP1M2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 8:28,114,748...28,132,767
Ensembl chr 8:28,114,748...28,132,642
|
|
| G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
multiple interactions
|
ISO
|
Calcitriol inhibits the reaction [bisphenol A results in increased expression of APAF1 mRNA]; Calcitriol inhibits the reaction [bisphenol A results in increased expression of APAF1 protein]
|
CTD |
PMID:38421590 |
|
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
| G
|
Apba2
|
amyloid beta precursor protein binding family A member 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of APBA2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:127,465,026...127,698,124
Ensembl chr 1:127,465,009...127,698,117
|
|
| G
|
Apcdd1
|
APC down-regulated 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of APCDD1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr18:58,655,696...58,686,359
Ensembl chr18:58,655,919...58,686,356
|
|
| G
|
Apcdd1l
|
APC down-regulated 1 like
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of APCDD1L mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:183,000,504...183,076,628
Ensembl chr 3:183,000,521...183,076,339
|
|
| G
|
Aph1b
|
aph-1 homolog B, gamma secretase subunit
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of APH1B mRNA [Testosterone co-treated with Calcitriol] results in increased expression of APH1B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:76,310,380...76,334,146
Ensembl chr 8:76,310,380...76,331,428
|
|
| G
|
Apof
|
apolipoprotein F
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of APOF mRNA [Testosterone co-treated with Calcitriol] results in increased expression of APOF mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:1,285,222...1,286,659
Ensembl chr 7:1,285,222...1,286,659
|
|
| G
|
Appbp2
|
amyloid beta precursor protein binding protein 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of APPBP2 mRNA Calcitriol results in increased expression of APPBP2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:70,555,212...70,597,267
Ensembl chr10:70,555,212...70,597,193
|
|
| G
|
Aqp10
|
aquaporin 10
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of AQP10 mRNA Calcitriol promotes the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AQP10 mRNA]
|
CTD |
PMID:36504884 |
|
NCBI chr 2:177,699,717...177,704,620
Ensembl chr 2:177,700,943...177,704,495
|
|
| G
|
Aqp5
|
aquaporin 5
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of AQP5 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:132,601,528...132,605,060
Ensembl chr 7:132,601,059...132,605,062
|
|
| G
|
Aqp7
|
aquaporin 7
|
multiple interactions decreases expression
|
ISO
|
Calcitriol inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AQP7 mRNA] Calcitriol results in decreased expression of AQP7 mRNA
|
CTD |
PMID:36504884 |
|
NCBI chr 5:60,968,495...60,982,618
Ensembl chr 5:60,967,558...60,982,618
|
|
| G
|
Aqp9
|
aquaporin 9
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of AQP9 mRNA Calcitriol inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AQP9 mRNA]
|
CTD |
PMID:36504884 |
|
NCBI chr 8:80,678,027...80,718,273
Ensembl chr 8:80,678,030...80,717,240
|
|
| G
|
Ar
|
androgen receptor
|
multiple interactions increases expression
|
ISO
|
[Calcitriol co-treated with Testosterone] results in increased expression of AR mRNA; [Calcitriol co-treated with Testosterone] results in increased expression of AR protein; AR protein affects the reaction [Calcitriol results in decreased expression of FOLH1 protein] Calcitriol results in increased expression of AR mRNA; Calcitriol results in increased expression of AR protein
|
CTD |
PMID:9231780 PMID:10875257 PMID:18247401 PMID:21592394 |
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
| G
|
Arap2
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ARAP2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ARAP2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:50,921,323...51,120,972
Ensembl chr14:50,921,713...51,120,962
|
|
| G
|
Areg
|
amphiregulin
|
increases expression multiple interactions
|
ISO EXP
|
Calcitriol results in increased expression of AREG mRNA Isotretinoin inhibits the reaction [Calcitriol results in increased expression of AREG mRNA]
|
CTD |
PMID:11237771 PMID:14996990 PMID:15509566 PMID:16002434 |
|
NCBI chr14:17,256,384...17,265,641
Ensembl chr14:17,256,384...17,265,641
|
|
| G
|
Arfgef3
|
ARFGEF family member 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ARFGEF3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:15,058,574...15,223,742
Ensembl chr 1:15,058,579...15,223,742
|
|
| G
|
Arg1
|
arginase 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ARG1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ARG1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713
|
|
| G
|
Arhgap10
|
Rho GTPase activating protein 10
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ARHGAP10 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr19:47,352,783...47,614,532
Ensembl chr19:47,352,276...47,614,531
|
|
| G
|
Arhgap11a
|
Rho GTPase activating protein 11A
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ARHGAP11A mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of ARHGAP11A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:121,045,187...121,071,985
Ensembl chr 3:121,045,187...121,061,468
|
|
| G
|
Arhgap19
|
Rho GTPase activating protein 19
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ARHGAP19 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of ARHGAP19 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:250,519,703...250,566,705
Ensembl chr 1:250,530,214...250,580,190
|
|
| G
|
Arhgap30
|
Rho GTPase activating protein 30
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ARHGAP30 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:86,354,448...86,376,552
Ensembl chr13:86,354,547...86,376,888
|
|
| G
|
Arhgap4
|
Rho GTPase activating protein 4
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ARHGAP4 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr X:156,787,566...156,802,841
Ensembl chr X:156,783,776...156,802,450
|
|
| G
|
Arhgap5
|
Rho GTPase activating protein 5
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ARHGAP5 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:75,711,199...75,774,636
Ensembl chr 6:75,711,515...75,774,636
|
|
| G
|
Arhgef16
|
Rho guanine nucleotide exchange factor 16
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ARHGEF16 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 5:170,126,573...170,148,624
Ensembl chr 5:170,126,575...170,148,624
|
|
| G
|
Arhgef18
|
Rho/Rac guanine nucleotide exchange factor 18
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of ARHGEF18 mRNA Calcitriol results in increased expression of ARHGEF18 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr12:6,192,958...6,300,997
Ensembl chr12:6,128,661...6,300,997
|
|
| G
|
Arhgef19
|
Rho guanine nucleotide exchange factor 19
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ARHGEF19 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:158,818,840...158,837,196
Ensembl chr 5:158,818,932...158,837,196
|
|
| G
|
Arhgef28
|
Rho guanine nucleotide exchange factor 28
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ARHGEF28 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 2:30,998,292...31,294,757
Ensembl chr 2:30,998,295...31,294,853
|
|
| G
|
Arhgef3
|
Rho guanine nucleotide exchange factor 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ARHGEF3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr16:2,308,311...2,588,634
Ensembl chr16:2,308,400...2,588,819
|
|
| G
|
Arhgef37
|
Rho guanine nucleotide exchange factor 37
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of ARHGEF37 mRNA Calcitriol results in increased expression of ARHGEF37 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr18:57,205,621...57,271,284
Ensembl chr18:57,230,117...57,271,031
|
|
| G
|
Arhgef39
|
Rho guanine nucleotide exchange factor 39
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of ARHGEF39 mRNA Calcitriol results in decreased expression of ARHGEF39 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:62,548,300...62,551,870
Ensembl chr 5:62,548,303...62,551,870
|
|
| G
|
Arhgef6
|
Rac/Cdc42 guanine nucleotide exchange factor 6
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ARHGEF6 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr X:140,182,734...140,302,812
Ensembl chr X:140,182,734...140,344,458
|
|
| G
|
Arid3b
|
AT-rich interaction domain 3B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ARID3B mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:67,089,141...67,136,764
Ensembl chr 8:67,083,802...67,152,245
|
|
| G
|
Arl14
|
ARF like GTPase 14
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ARL14 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:155,778,826...155,780,065
Ensembl chr 2:155,778,826...155,780,065
|
|
| G
|
Arl2bp
|
ARF like GTPase 2 binding protein
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ARL2BP mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr19:10,342,895...10,352,529
Ensembl chr19:10,342,895...10,352,514
|
|
| G
|
Arl4a
|
ARF like GTPase 4A
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ARL4A mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:62,809,287...62,811,297
Ensembl chr 6:62,804,548...62,820,760
|
|
| G
|
Arl4c
|
ARF like GTPase 4C
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ARL4C mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 9:96,748,075...96,751,510
Ensembl chr 9:96,745,069...96,752,772
|
|
| G
|
Arl5b
|
ARF like GTPase 5B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ARL8 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr17:82,864,315...82,888,458
Ensembl chr17:82,864,287...82,890,646
|
|
| G
|
Arl6ip6
|
ARF like GTPase 6 interacting protein 6
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of ARL6IP6 mRNA Calcitriol results in decreased expression of ARL6IP6 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:58,098,978...58,126,962
Ensembl chr 3:58,099,408...58,126,957
|
|
| G
|
Armc7
|
armadillo repeat containing 7
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ARMC7 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ARMC7 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:101,222,056...101,238,598
Ensembl chr10:101,222,067...101,238,597
|
|
| G
|
Arpc1b
|
actin related protein 2/3 complex, subunit 1B
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ARPC1B mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ARPC1B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr12:14,595,939...14,609,501
Ensembl chr12:14,595,678...14,609,504
|
|
| G
|
Arrdc3
|
arrestin domain containing 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ARRDC3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ARRDC3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:12,873,202...12,885,716
Ensembl chr 2:12,873,202...12,885,875
|
|
| G
|
Arrdc4
|
arrestin domain containing 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ARRDC4 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:131,779,436...131,793,438
Ensembl chr 1:131,779,437...131,793,565
|
|
| G
|
Arsa
|
arylsulfatase A
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ARSA mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ARSA mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:122,422,971...122,426,971
Ensembl chr 7:122,422,982...122,428,401
|
|
| G
|
Arsi
|
arylsulfatase family, member I
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ARSI mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr18:56,634,556...56,642,168
Ensembl chr18:56,625,487...56,642,168
|
|
| G
|
Asf1b
|
anti-silencing function 1B histone chaperone
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ASF1B mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of ASF1B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:41,085,786...41,100,352
Ensembl chr19:41,086,114...41,100,352
|
|
| G
|
Asnsd1
|
asparagine synthetase domain containing 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of ASNSD1 mRNA Calcitriol results in decreased expression of ASNSD1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:55,618,799...55,631,064
Ensembl chr 9:55,618,799...55,631,064
|
|
| G
|
Asph
|
aspartate-beta-hydroxylase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ASPH mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of ASPH mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:27,398,933...27,611,519
Ensembl chr 5:27,398,949...27,611,215
|
|
| G
|
Aspm
|
assembly factor for spindle microtubules
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of ASPM mRNA Calcitriol results in decreased expression of ASPM mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:53,625,584...53,674,489
Ensembl chr13:53,625,584...53,674,489
|
|
| G
|
Aspn
|
asporin
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ASPN mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr17:15,286,338...15,310,567
Ensembl chr17:15,287,065...15,310,632
|
|
| G
|
Asrgl1
|
asparaginase and isoaspartyl peptidase 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ASRGL1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ASRGL1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:215,436,180...215,456,188
Ensembl chr 1:215,435,218...215,456,198
|
|
| G
|
Ass1
|
argininosuccinate synthase 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ASS1 mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr 3:35,144,765...35,194,632
Ensembl chr 3:35,144,999...35,194,627
|
|
| G
|
Atad5
|
ATPase family, AAA domain containing 5
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of ATAD5 mRNA Calcitriol results in decreased expression of ATAD5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:65,568,569...65,616,379
Ensembl chr10:65,568,591...65,616,376
|
|
| G
|
Atf3
|
activating transcription factor 3
|
decreases expression multiple interactions increases expression
|
ISO
|
Calcitriol results in decreased expression of ATF3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ATF3 mRNA Calcitriol results in increased expression of ATF3 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750
|
|
| G
|
Atf5
|
activating transcription factor 5
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ATF5 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:104,432,094...104,437,611
Ensembl chr 1:104,432,094...104,436,183
|
|
| G
|
Atf6
|
activating transcription factor 6
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ATF6 mRNA [salinomycin co-treated with Calcitriol] results in increased expression of ATF6 mRNA
|
CTD |
PMID:16002434 PMID:35914560 |
|
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033
|
|
| G
|
Atg5
|
autophagy related 5
|
increases response to substance multiple interactions increases expression
|
ISO
|
ATG5 results in increased susceptibility to Calcitriol 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol results in increased activity of ATG5 mRNA]; [CAMP results in increased activity of CEBPB] affects the reaction [Calcitriol results in increased expression of ATG5 mRNA]; [CAMP results in increased activity of MAPK14] affects the reaction [Calcitriol results in increased expression of ATG5 mRNA]; [CAMP results in increased activity of MAPK1] affects the reaction [Calcitriol results in increased expression of ATG5 mRNA]; [CAMP results in increased activity of MAPK3] affects the reaction [Calcitriol results in increased expression of ATG5 mRNA]; CAMP mutant form inhibits the reaction [Calcitriol results in increased expression of ATG5 mRNA]; CEBPB mutant form inhibits the reaction [Calcitriol results in increased expression of ATG5 mRNA]; SB 203580 inhibits the reaction [Calcitriol results in increased activity of ATG5 mRNA]
|
CTD |
PMID:19748465 |
|
NCBI chr20:49,380,835...49,471,826
Ensembl chr20:49,380,813...49,471,821
|
|
| G
|
Atm
|
ATM serine/threonine kinase
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ATM mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:62,727,291...62,828,629
|
|
| G
|
Atosb
|
atos homolog B
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ATOSB mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ATOSB mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:62,056,654...62,070,338
Ensembl chr 5:62,056,654...62,064,613
|
|
| G
|
Atp10a
|
ATPase phospholipid transporting 10A (putative)
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ATP10A mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:118,692,456...118,866,117
Ensembl chr 1:118,692,478...118,866,114
|
|
| G
|
Atp1a1
|
ATPase Na+/K+ transporting subunit alpha 1
|
multiple interactions
|
EXP
|
[Calcium co-treated with Calcitriol] affects the expression of ATP1A1 mRNA
|
CTD |
PMID:15913539 |
|
NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425
|
|
| G
|
Atp1a2
|
ATPase Na+/K+ transporting subunit alpha 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ATP1A2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ATP1A2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:87,261,964...87,286,911
Ensembl chr13:87,261,968...87,286,911
|
|
| G
|
Atp1b1
|
ATPase Na+/K+ transporting subunit beta 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ATP1B1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of ATP1B1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:79,319,708...79,340,226
Ensembl chr13:79,319,706...79,340,549
|
|
| G
|
Atp23
|
ATP23 metallopeptidase and ATP synthase assembly factor homolog
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of ATP23 mRNA Calcitriol results in decreased expression of ATP23 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:64,600,100...64,615,240
Ensembl chr 7:64,600,100...64,615,392
|
|
| G
|
Atp2a3
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ATP2A3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:58,079,710...58,111,279
Ensembl chr10:58,079,852...58,111,278
|
|
| G
|
Atp2b1
|
ATPase plasma membrane Ca2+ transporting 1
|
increases expression multiple interactions
|
EXP ISO
|
Calcitriol results in increased expression of ATP2B1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ATP2B1 mRNA
|
CTD |
PMID:10927029 PMID:21592394 |
|
NCBI chr 7:35,622,267...35,731,904
Ensembl chr 7:35,622,461...35,731,904
|
|
| G
|
Atp5pb
|
ATP synthase peripheral stalk-membrane subunit b
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ATP5PB mRNA
|
CTD |
PMID:15951637 PMID:16847355 |
|
NCBI chr 2:196,112,459...196,123,737
Ensembl chr 2:196,112,108...196,124,387
|
|
| G
|
Atp6v1a
|
ATPase H+ transporting V1 subunit A
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ATP6V1A mRNA
|
CTD |
PMID:12798352 |
|
NCBI chr11:70,066,800...70,120,603
Ensembl chr11:70,035,134...70,120,603
|
|
| G
|
Atp8a1
|
ATPase phospholipid transporting 8A1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of ATP8A1 mRNA Calcitriol results in increased expression of ATP8A1 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr14:40,668,932...40,911,465
Ensembl chr14:40,731,846...40,911,463
|
|
| G
|
Atp8b1
|
ATPase phospholipid transporting 8B1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ATP8B1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr18:60,286,605...60,427,862
Ensembl chr18:60,288,464...60,427,027
|
|
| G
|
Atxn7l2
|
ataxin 7-like 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ATXN7L2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of ATXN7L2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:198,527,066...198,535,899
Ensembl chr 2:198,527,066...198,534,062
|
|
| G
|
Aunip
|
aurora kinase A and ninein interacting protein
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of AUNIP mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of AUNIP mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:152,006,021...152,018,614
Ensembl chr 5:152,006,042...152,020,190
|
|
| G
|
Aurka
|
aurora kinase A
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of AURKA mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of AURKA mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:181,546,742...181,562,771
|
|
| G
|
Aurkb
|
aurora kinase B
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of AURKB mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of AURKB mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:54,243,116...54,249,675
Ensembl chr10:54,242,850...54,252,285
|
|
| G
|
Axdnd1
|
axonemal dynein light chain domain containing 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of AXDND1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:71,022,215...71,100,010
Ensembl chr13:71,021,404...71,094,233
|
|
| G
|
Azgp1
|
alpha-2-glycoprotein 1, zinc-binding
|
increases expression
|
ISO
|
Calcitriol results in increased expression of AZGP1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr12:22,044,685...22,051,248
Ensembl chr12:22,044,751...22,053,020
|
|
| G
|
B2m
|
beta-2 microglobulin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of B2M protein
|
CTD |
PMID:8807625 |
|
NCBI chr 3:129,549,236...129,555,354
Ensembl chr 3:129,549,318...129,555,356
|
|
| G
|
B3galt4
|
Beta-1,3-galactosyltransferase 4
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of B3GALT4 mRNA Calcitriol results in increased expression of B3GALT4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:4,937,974...4,939,549
Ensembl chr20:4,937,674...4,939,885
|
|
| G
|
B3gnt2
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of B3GNT2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of B3GNT2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:101,009,682...101,034,507
Ensembl chr14:100,967,131...101,043,412
|
|
| G
|
B4galt1
|
beta-1,4-galactosyltransferase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of B4GALT1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:60,731,601...60,778,456
Ensembl chr 5:60,731,602...60,778,445
|
|
| G
|
B4galt6
|
beta-1,4-galactosyltransferase 6
|
increases expression
|
ISO
|
Calcitriol results in increased expression of B4GALT6 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr18:12,233,350...12,290,204
Ensembl chr18:12,233,351...12,290,204
|
|
| G
|
Bag1
|
BAG cochaperone 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of BAG1 protein alternative form
|
CTD |
PMID:12479363 |
|
NCBI chr 5:60,864,476...60,877,059
Ensembl chr 5:60,864,476...60,878,161
|
|
| G
|
Bag2
|
BAG cochaperone 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of BAG2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 9:43,465,993...43,476,637
Ensembl chr 9:43,465,995...43,476,752
|
|
| G
|
Baiap2
|
BAR/IMD domain containing adaptor protein 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of BAIAP2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:105,721,371...105,788,549
Ensembl chr10:105,721,417...105,788,549
|
|
| G
|
Baiap2l2
|
BAR/IMD domain containing adaptor protein 2 like 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of BAIAP2L2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:112,704,798...112,731,691
Ensembl chr 7:112,704,682...112,731,127
|
|
| G
|
Bard1
|
BRCA1 associated RING domain 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of BARD1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of BARD1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:80,069,960...80,144,167
Ensembl chr 9:80,069,960...80,176,873
|
|
| G
|
Barx1
|
BARX homeobox 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of BARX1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr17:16,196,764...16,200,239
Ensembl chr17:16,196,764...16,200,239
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions decreases expression increases expression
|
ISO EXP
|
[Arsenic Trioxide co-treated with Calcitriol] results in increased expression of BAX mRNA; [Arsenic Trioxide co-treated with Calcitriol] results in increased expression of BAX protein; [Calcitriol co-treated with Genistein] results in increased expression of BAX mRNA; [Testosterone co-treated with Calcitriol] results in decreased expression of BAX mRNA; Calcitriol inhibits the reaction [bisphenol A results in increased expression of BAX mRNA]; Calcitriol inhibits the reaction [bisphenol A results in increased expression of BAX protein]; Curcumin promotes the reaction [Paclitaxel promotes the reaction [Calcitriol results in increased expression of BAX protein]]; Paclitaxel promotes the reaction [Calcitriol results in increased expression of BAX protein] Calcitriol results in decreased expression of BAX protein bisphenol A diglycidyl ether inhibits the reaction [Calcitriol inhibits the reaction [Streptozocin results in increased expression of BAX protein]]; Calcitriol inhibits the reaction [sodium arsenite results in increased expression of BAX protein]; Calcitriol inhibits the reaction [Streptozocin results in increased expression of BAX protein] Calcitriol results in decreased expression of BAX mRNA; Calcitriol results in decreased expression of BAX protein Calcitriol results in increased expression of BAX mRNA; Calcitriol results in increased expression of BAX protein
|
CTD |
PMID:15955619 PMID:17570329 PMID:21542014 PMID:21592394 PMID:29953732 PMID:31628941 PMID:34025784 PMID:38421590 PMID:38725370 PMID:39771102 More...
|
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Baz2a
|
bromodomain adjacent to zinc finger domain, 2A
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of BAZ2A mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:1,107,377...1,145,507
Ensembl chr 7:1,107,796...1,145,507
|
|
| G
|
Bbc3
|
Bcl-2 binding component 3
|
multiple interactions
|
ISO
|
[salinomycin co-treated with Calcitriol] results in increased expression of BBC3 mRNA
|
CTD |
PMID:35914560 |
|
NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:86,141,603...86,150,666
|
|
| G
|
Bbs10
|
Bardet-Biedl syndrome 10
|
increases expression
|
ISO
|
Calcitriol results in increased expression of BBS10 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:48,637,324...48,640,395
Ensembl chr 7:48,637,356...48,640,391
|
|
| G
|
Bcam
|
basal cell adhesion molecule (Lutheran blood group)
|
increases expression
|
ISO
|
Calcitriol results in increased expression of BCAM mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:88,542,971...88,557,358
Ensembl chr 1:88,542,972...88,557,888
|
|
| G
|
Bcap29
|
B-cell receptor-associated protein 29
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of BCAP29 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of BCAP29 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:53,910,209...53,950,206
Ensembl chr 6:53,910,216...53,949,963
|
|
| G
|
Bcas1
|
brain enriched myelin associated protein 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of BCAS1 mRNA Calcitriol results in increased expression of BCAS1 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 3:179,554,754...179,637,800
Ensembl chr 3:179,551,704...179,637,743
|
|
| G
|
Bche
|
butyrylcholinesterase
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of BCHE mRNA Calcitriol results in decreased expression of BCHE mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760
|
|
| G
|
Bcl10
|
BCL10, immune signaling adaptor
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of BCL10 mRNA Calcitriol results in increased expression of BCL10 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:237,501,181...237,510,821
Ensembl chr 2:237,501,134...237,511,829
|
|
| G
|
Bcl11b
|
BCL11 transcription factor B
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of BCL11B mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:132,598,968...132,692,123
Ensembl chr 6:132,598,968...132,691,301
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
multiple interactions increases expression decreases expression
|
ISO EXP
|
[Arsenic Trioxide co-treated with Calcitriol] results in decreased expression of BCL2 mRNA; [Arsenic Trioxide co-treated with Calcitriol] results in decreased expression of BCL2 protein; [Calcitriol co-treated with Genistein] results in decreased expression of BCL2 mRNA; [Calcitriol co-treated with Tretinoin] results in decreased expression of BCL2 protein; [Curcumin co-treated with Calcitriol] promotes the reaction [Paclitaxel results in decreased expression of BCL2 protein]; [Testosterone co-treated with Calcitriol] results in decreased expression of BCL2 mRNA; Calcitriol promotes the reaction [Paclitaxel results in decreased expression of BCL2 protein]; Curcumin promotes the reaction [Calcitriol promotes the reaction [Paclitaxel results in decreased expression of BCL2 protein]] bisphenol A diglycidyl ether inhibits the reaction [Calcitriol inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein]]; Calcitriol inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein]; Calcitriol inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein] Calcitriol results in increased expression of BCL2 mRNA; Calcitriol results in increased expression of BCL2 protein Calcitriol results in decreased expression of BCL2; Calcitriol results in decreased expression of BCL2 mRNA; Calcitriol results in decreased expression of BCL2 protein
|
CTD |
PMID:8593782 PMID:9528999 PMID:10614618 PMID:10713328 PMID:12479363 PMID:15955619 PMID:17570329 PMID:19603526 PMID:21542014 PMID:21592394 PMID:29953732 PMID:31628941 PMID:34025784 PMID:39771102 More...
|
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bcl2a1
|
BCL2-related protein A1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of BCL2A1 mRNA
|
CTD |
PMID:15951637 PMID:16847355 |
|
NCBI chr 8:98,596,806...98,604,890
Ensembl chr 8:98,596,650...98,604,890
|
|
| G
|
Bcl2l1
|
Bcl2-like 1
|
increases expression multiple interactions decreases expression
|
EXP ISO
|
Calcitriol results in increased expression of BCL2L1 protein Calcitriol inhibits the reaction [bisphenol A results in decreased expression of BCL2L1 protein] Calcitriol results in decreased expression of BCL2L1 protein
|
CTD |
PMID:10614618 PMID:12479363 PMID:17570329 PMID:38725370 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
| G
|
Bcl2l11
|
Bcl2-like 11
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of BCL2L11 mRNA
|
CTD |
PMID:12071473 |
|
NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695
|
|
| G
|
Bcl2l12
|
Bcl2 like 12
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of BCL2L12 mRNA Calcitriol results in decreased expression of BCL2L12 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:104,608,753...104,617,472
Ensembl chr 1:104,608,753...104,617,472
|
|
| G
|
Bdkrb1
|
bradykinin receptor B1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of BDKRB1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of BDKRB1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:130,275,631...130,284,968
Ensembl chr 6:130,275,478...130,280,973
|
|
| G
|
Bdnf
|
brain-derived neurotrophic factor
|
increases expression
|
ISO
|
Calcitriol results in increased expression of BDNF mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
|
|
| G
|
Becn1
|
beclin 1
|
increases response to substance multiple interactions increases expression
|
ISO
|
BECN1 results in increased susceptibility to Calcitriol 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in increased expression of BECN1 protein]]; [Calcitriol co-treated with bisphenol A] results in increased expression of BECN1 protein; Calcitriol inhibits the reaction [Glucose results in increased expression of BECN1 protein]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in increased expression of BECN1 protein]] Calcitriol results in increased expression of BECN1 mRNA 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol results in increased activity of BECN1 mRNA]; [CAMP results in increased activity of CEBPB] affects the reaction [Calcitriol results in increased expression of BECN1 mRNA]; [CAMP results in increased activity of MAPK14] affects the reaction [Calcitriol results in increased expression of BECN1 mRNA]; [CAMP results in increased activity of MAPK1] affects the reaction [Calcitriol results in increased expression of BECN1 mRNA]; [CAMP results in increased activity of MAPK3] affects the reaction [Calcitriol results in increased expression of BECN1 mRNA]; CAMP mutant form inhibits the reaction [Calcitriol results in increased expression of BECN1 mRNA]; CEBPB mutant form inhibits the reaction [Calcitriol results in increased expression of BECN1 mRNA]; SB 203580 inhibits the reaction [Calcitriol results in increased activity of BECN1 mRNA]
|
CTD |
PMID:19748465 PMID:33450223 PMID:38725370 |
|
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
| G
|
Bglap
|
bone gamma-carboxyglutamate protein
|
multiple interactions increases expression decreases expression increases secretion
|
ISO EXP
|
[Calcitriol co-treated with Alitretinoin] results in increased expression of BGLAP mRNA; [Calcitriol co-treated with Alitretinoin] results in increased secretion of BGLAP protein; [Calcitriol co-treated with Resveratrol] results in increased expression of BGLAP mRNA; Alitretinoin promotes the reaction [Calcitriol results in increased expression of BGLAP mRNA]; Alitretinoin promotes the reaction [Calcitriol results in increased secretion of BGLAP protein]; Calcitriol promotes the reaction [VDR protein binds to BGLAP enhancer]; FST protein promotes the reaction [Calcitriol results in increased expression of BGLAP mRNA]; INHBA protein inhibits the reaction [Calcitriol results in increased expression of BGLAP mRNA]; perfluorooctanoic acid inhibits the reaction [Calcitriol results in increased expression of BGLAP mRNA] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP protein]]; Calcitriol inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of BGLAP protein]; Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]]; Sirolimus inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]] Aluminum inhibits the reaction [Calcitriol results in increased secretion of BGLAP protein]; Calcitriol inhibits the reaction [Aluminum results in decreased secretion of BGLAP protein] Calcitriol results in decreased expression of BGLAP mRNA
|
CTD |
PMID:9626627 PMID:10470102 PMID:12016462 PMID:12898515 PMID:16267019 PMID:16813520 PMID:16889531 PMID:17293108 PMID:23589129 PMID:28105418 PMID:33033332 PMID:33450223 More...
|
|
NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:176,136,341...176,137,318
|
|
| G
|
Bicdl1
|
BICD family like cargo adaptor 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of BICDL1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of BICDL1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr12:46,537,525...46,626,876
Ensembl chr12:46,538,396...46,628,866
|
|
| G
|
Birc2
|
baculoviral IAP repeat-containing 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of BIRC2 protein
|
CTD |
PMID:12479363 |
|
NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:13,253,706...13,271,911
|
|
| G
|
Birc3
|
baculoviral IAP repeat-containing 3
|
increases expression multiple interactions decreases expression
|
ISO
|
Calcitriol results in increased expression of BIRC3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of BIRC3 mRNA Calcitriol results in decreased expression of BIRC3 mRNA; Calcitriol results in decreased expression of BIRC3 protein
|
CTD |
PMID:12479363 PMID:16002434 PMID:21592394 |
|
NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:13,285,703...13,298,590
|
|
| G
|
Birc5
|
baculoviral IAP repeat-containing 5
|
multiple interactions decreases expression
|
ISO
|
[Arsenic Trioxide co-treated with Calcitriol] results in decreased expression of BIRC5 mRNA; [Arsenic Trioxide co-treated with Calcitriol] results in decreased expression of BIRC5 protein; [Testosterone co-treated with Calcitriol] results in decreased expression of BIRC5 mRNA; Calcitriol promotes the reaction [Testosterone results in increased expression of BIRC5 mRNA]; Testosterone promotes the reaction [Calcitriol results in increased expression of BIRC5 mRNA] Calcitriol results in decreased expression of BIRC5 mRNA
|
CTD |
PMID:21592394 PMID:34025784 |
|
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155
|
|
| G
|
Blm
|
BLM RecQ like helicase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of BLM mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of BLM mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:143,819,072...143,905,300
Ensembl chr 1:143,819,090...143,905,210
|
|
| G
|
Bltp3a
|
bridge-like lipid transfer protein family member 3A
|
increases expression
|
ISO
|
Calcitriol results in increased expression of BLTP3A mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr20:5,912,033...5,956,404
Ensembl chr20:5,912,106...5,956,403
|
|
| G
|
Blvra
|
biliverdin reductase A
|
increases expression
|
ISO
|
Calcitriol results in increased expression of BLVRA mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:134,793,397...134,819,367
Ensembl chr 3:134,794,203...134,819,785
|
|
| G
|
Bmerb1
|
bMERB domain containing 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of BMERB1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:2,286,999...2,453,890
Ensembl chr10:2,287,000...2,453,728
|
|
| G
|
Bmp2
|
bone morphogenetic protein 2
|
multiple interactions increases expression
|
ISO EXP
|
Calcitriol promotes the reaction [BMP2 protein results in increased expression of SOST mRNA] Calcitriol results in increased expression of BMP2 protein Calcitriol results in increased expression of BMP2 mRNA
|
CTD |
PMID:15268896 PMID:16002434 PMID:19092814 |
|
NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:141,264,646...141,274,760
|
|
| G
|
Bmp4
|
bone morphogenetic protein 4
|
multiple interactions
|
ISO
|
Calcitriol promotes the reaction [BMP4 protein results in increased expression of SOST mRNA]
|
CTD |
PMID:15268896 |
|
NCBI chr15:22,098,191...22,113,145
Ensembl chr15:22,098,470...22,105,172
|
|
| G
|
Bmp6
|
bone morphogenetic protein 6
|
multiple interactions increases expression
|
ISO
|
Calcitriol promotes the reaction [BMP6 protein results in increased expression of SOST mRNA] Calcitriol results in increased expression of BMP6 mRNA
|
CTD |
PMID:15268896 PMID:16002434 |
|
NCBI chr17:26,523,704...26,785,558
Ensembl chr17:26,523,704...26,675,261
|
|
| G
|
Bmp7
|
bone morphogenetic protein 7
|
decreases expression
|
EXP
|
Calcitriol results in decreased expression of BMP7 protein
|
CTD |
PMID:15728789 |
|
NCBI chr 3:182,059,318...182,135,273
Ensembl chr 3:182,052,337...182,135,137
|
|
| G
|
Bmpr1b
|
bone morphogenetic protein receptor type 1B
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of BMPR1B mRNA Calcitriol results in increased expression of BMPR1B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:233,211,525...233,544,344
Ensembl chr 2:233,211,525...233,544,311
|
|
| G
|
Bnc2
|
basonuclin zinc finger protein 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of BNC2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:103,724,934...104,061,890
Ensembl chr 5:103,724,934...104,125,428
|
|
| G
|
Bnip3l
|
BCL2 interacting protein 3 like
|
increases expression
|
ISO
|
Calcitriol results in increased expression of BNIP3L mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr15:45,350,081...45,373,213
Ensembl chr15:45,334,537...45,373,282
|
|
| G
|
Bpifa2
|
BPI fold containing family A, member 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of BPIFA2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:162,953,538...162,961,497
Ensembl chr 3:162,953,538...162,961,496
|
|
| G
|
Brca1
|
BRCA1, DNA repair associated
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of BRCA1 mRNA; Calcitriol promotes the reaction [Testosterone results in decreased expression of BRCA1 mRNA]; Testosterone promotes the reaction [Calcitriol results in decreased expression of BRCA1 mRNA]
|
CTD |
PMID:21592394 |
|
NCBI chr10:86,917,693...86,978,012
Ensembl chr10:86,917,693...86,977,763
|
|
| G
|
Brca2
|
BRCA2, DNA repair associated
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of BRCA2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of BRCA2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr12:4,895,092...4,939,340
Ensembl chr12:4,895,447...4,936,194
|
|
| G
|
Brinp1
|
BMP/retinoic acid inducible neural specific 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of BRINP1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:87,363,621...87,565,580
Ensembl chr 5:87,364,050...87,508,256
|
|
| G
|
Brip1
|
BRCA1 interacting DNA helicase 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of BRIP1 mRNA Calcitriol results in decreased expression of BRIP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:71,402,035...71,528,083
Ensembl chr10:71,401,151...71,575,206
|
|
| G
|
Brix1
|
biogenesis of ribosomes BRX1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of BRIX1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of BRIX1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:61,177,769...61,188,647
Ensembl chr 2:61,177,771...61,188,647
|
|
| G
|
Bspry
|
B-box and SPRY domain containing
|
increases expression
|
ISO
|
Calcitriol results in increased expression of BSPRY mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:80,942,974...80,965,157
Ensembl chr 5:80,942,979...80,988,154
|
|
| G
|
Btg1
|
BTG anti-proliferation factor 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of BTG1 mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr 7:33,228,149...33,230,406
Ensembl chr 7:33,227,833...33,230,406
|
|
| G
|
Btg2
|
BTG anti-proliferation factor 2
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of BTG2 mRNA Calcitriol results in decreased expression of BTG2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690
|
|
| G
|
Bub1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of BUB1 mRNA Calcitriol results in decreased expression of BUB1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:135,473,525...135,504,921
Ensembl chr 3:135,472,582...135,504,921
|
|
| G
|
Bub1b
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of BUB1B mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of BUB1B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:126,017,019...126,069,470
Ensembl chr 3:126,017,045...126,069,796
|
|
| G
|
C13h1orf116
|
similar to human chromosome 1 open reading frame 116
|
increases expression
|
ISO
|
Calcitriol results in increased expression of C1ORF116 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:44,739,716...44,753,695
Ensembl chr13:44,727,092...44,754,009
|
|
| G
|
C13h1orf21
|
similar to human chromosome 1 open reading frame 21
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of C1ORF21 mRNA Calcitriol results in increased expression of C1ORF21 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:66,540,245...66,749,631
Ensembl chr13:66,540,245...66,659,684
|
|
| G
|
C18h18orf54
|
similar to human chromosome 18 open reading frame 54
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of C18ORF54 mRNA Calcitriol results in decreased expression of C18ORF54 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:66,340,567...66,364,831
Ensembl chr18:66,340,567...66,362,348
|
|
| G
|
C1h6orf118
|
similar to human chromosome 6 open reading frame 118
|
increases expression
|
ISO
|
Calcitriol results in increased expression of C6ORF118 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:54,287,934...54,311,640
Ensembl chr 1:54,287,936...54,311,847
|
|
| G
|
C1h9orf40
|
similar to human chromosome 9 open reading frame 40
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of C9ORF40 mRNA Calcitriol results in decreased expression of C9ORF40 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:225,555,300...225,559,509
Ensembl chr 1:225,555,280...225,559,693
|
|
| G
|
C1h9orf85
|
similar to human chromosome 9 open reading frame 85
|
increases expression
|
ISO
|
Calcitriol results in increased expression of C9ORF85 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:228,562,621...228,624,472
Ensembl chr 1:228,564,731...228,624,278
|
|
| G
|
C1qb
|
complement C1q B chain
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of C1QB mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:154,402,276...154,407,827
Ensembl chr 5:154,402,279...154,407,840
|
|
| G
|
C1qc
|
complement C1q C chain
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of C1QC mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:154,410,845...154,414,208
Ensembl chr 5:154,410,848...154,414,468
|
|
| G
|
C1qtnf6
|
C1q and TNF related 6
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of C1QTNF6 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:111,958,348...111,964,948
Ensembl chr 7:111,958,350...111,966,871
|
|
| G
|
C1s
|
complement C1s
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of C1S mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 4:159,116,549...159,128,736
Ensembl chr 4:159,116,549...159,128,736
|
|
| G
|
C2
|
complement C2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of C2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr20:3,944,722...3,975,006
Ensembl chr20:3,955,776...3,981,740
|
|
| G
|
C20h21orf58
|
similar to human chromosome 21 open reading frame 58
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of C21ORF58 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of C21ORF58 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:12,165,853...12,187,271
Ensembl chr20:12,174,928...12,186,503
|
|
| G
|
C2cd4a
|
C2 calcium-dependent domain containing 4A
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of C2CD4A mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 8:77,348,161...77,359,996
Ensembl chr 8:77,348,310...77,359,958
|
|
| G
|
C2h1orf162
|
similar to human chromosome 1 open reading frame 162
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of C1ORF162 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:196,101,669...196,107,404
Ensembl chr 2:196,100,702...196,106,832
|
|
| G
|
C2h4orf46
|
similar to human chromosome 4 open reading frame 46
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of C4ORF46 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of C4ORF46 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:167,061,141...167,064,273
Ensembl chr 2:167,060,941...167,064,271
|
|
| G
|
C2h5orf34
|
similar to human chromosome 5 open reading frame 34
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of C5ORF34 mRNA Calcitriol results in decreased expression of C5ORF34 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:53,287,353...53,309,804
Ensembl chr 2:53,287,957...53,309,806
|
|
| G
|
C3ar1
|
complement C3a receptor 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of C3AR1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 4:157,747,419...157,756,609
Ensembl chr 4:157,746,089...157,776,323
|
|
| G
|
C5h8orf34
|
similar to human chromosome 8 open reading frame 34
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of C8ORF34 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:12,021,000...12,560,212
Ensembl chr 5:12,021,007...12,559,772
|
|
| G
|
C8h11orf54
|
similar to human chromosome 11 open reading frame 54
|
increases expression
|
ISO
|
Calcitriol results in increased expression of BKGD mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:20,405,240...20,427,811
Ensembl chr 8:20,405,241...20,427,811
|
|
| G
|
Ca12
|
carbonic anhydrase 12
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CA12 mRNA
|
CTD |
PMID:14996990 |
|
NCBI chr 8:76,169,723...76,225,465
Ensembl chr 8:76,169,815...76,225,465
|
|
| G
|
Ca9
|
carbonic anhydrase 9
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CA9 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:62,559,024...62,565,626
Ensembl chr 5:62,558,823...62,565,626
|
|
| G
|
Cab39
|
calcium binding protein 39
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CAB39 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 9:93,911,099...93,972,542
Ensembl chr 9:93,911,054...93,972,542
|
|
| G
|
Cab39l
|
calcium binding protein 39-like
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CAB39L mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CAB39L mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:37,782,778...37,885,191
Ensembl chr15:37,782,870...37,919,742
|
|
| G
|
Cacng4
|
calcium voltage-gated channel auxiliary subunit gamma 4
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of CACNG4 mRNA Calcitriol results in increased expression of CACNG4 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr10:93,183,410...93,245,470
Ensembl chr10:93,183,410...93,245,470
|
|
| G
|
Cadm3
|
cell adhesion molecule 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CADM3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:88,317,124...88,349,718
Ensembl chr13:88,317,124...88,350,114
|
|
| G
|
Cadps2
|
calcium dependent secretion activator 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CADPS2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CADPS2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:52,746,054...53,275,252
Ensembl chr 4:52,746,065...53,275,004
|
|
| G
|
Calb1
|
calbindin 1
|
increases expression multiple interactions
|
ISO EXP
|
Calcitriol results in increased expression of CALB1 mRNA; Calcitriol results in increased expression of CALB1 protein ZK159222 inhibits the reaction [Calcitriol results in increased expression of CALB1 mRNA]; ZK159222 inhibits the reaction [Calcitriol results in increased expression of CALB1 protein]
|
CTD |
PMID:15883024 PMID:15922086 PMID:16857747 |
|
NCBI chr 5:34,172,612...34,199,555
Ensembl chr 5:34,172,664...34,200,160
|
|
| G
|
Calml3
|
calmodulin-like 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CALML3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr17:71,329,438...71,333,068
Ensembl chr17:71,319,943...71,335,682
|
|
| G
|
Camk1d
|
calcium/calmodulin-dependent protein kinase ID
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CAMK1D mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CAMK1D mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:77,491,191...77,892,018
Ensembl chr17:77,491,220...77,892,012
|
|
| G
|
Camkk2
|
calcium/calmodulin-dependent protein kinase kinase 2
|
multiple interactions
|
ISO
|
CAMKK2 mutant form inhibits the reaction [Calcitriol affects the localization of CAMP protein]
|
CTD |
PMID:19748465 |
|
NCBI chr12:39,451,828...39,505,719
Ensembl chr12:39,451,834...39,514,964
|
|
| G
|
Camp
|
cathelicidin antimicrobial peptide
|
affects localization increases expression multiple interactions increases response to substance
|
ISO
|
Calcitriol affects the localization of CAMP protein Calcitriol results in increased expression of CAMP mRNA; Calcitriol results in increased expression of CAMP protein 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Calcitriol affects the localization of CAMP protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol promotes the reaction [Resveratrol results in increased expression of CAMP mRNA]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol results in increased expression of CAMP mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol promotes the reaction [Calcitriol results in increased expression of CAMP mRNA]]; [CAMP results in increased activity of CEBPB] affects the reaction [Calcitriol results in increased expression of ATG5 mRNA]; [CAMP results in increased activity of CEBPB] affects the reaction [Calcitriol results in increased expression of BECN1 mRNA]; [CAMP results in increased activity of MAPK14] affects the reaction [Calcitriol results in increased expression of ATG5 mRNA]; [CAMP results in increased activity of MAPK14] affects the reaction [Calcitriol results in increased expression of BECN1 mRNA]; [CAMP results in increased activity of MAPK1] affects the reaction [Calcitriol results in increased expression of ATG5 mRNA]; [CAMP results in increased activity of MAPK1] affects the reaction [Calcitriol results in increased expression of BECN1 mRNA]; [CAMP results in increased activity of MAPK3] affects the reaction [Calcitriol results in increased expression of ATG5 mRNA]; [CAMP results in increased activity of MAPK3] affects the reaction [Calcitriol results in increased expression of BECN1 mRNA]; AZD 6244 promotes the reaction [Calcitriol promotes the reaction [Resveratrol results in increased expression of CAMP mRNA]]; AZD 6244 promotes the reaction [Resveratrol promotes the reaction [Calcitriol results in increased expression of CAMP mRNA]]; Calcitriol promotes the reaction [pterostilbene results in increased expression of CAMP mRNA]; Calcitriol promotes the reaction [pterostilbene results in increased expression of CAMP protein]; Calcitriol promotes the reaction [Resveratrol results in increased expression of CAMP mRNA]; Calcitriol promotes the reaction [Resveratrol results in increased expression of CAMP protein]; Calcitriol promotes the reaction [VDR protein binds to CAMP promoter]; CAMKK2 mutant form inhibits the reaction [Calcitriol affects the localization of CAMP protein]; CAMP mutant form inhibits the reaction [Calcitriol results in increased activity of MAPK1 protein]; CAMP mutant form inhibits the reaction [Calcitriol results in increased activity of MAPK14 protein]; CAMP mutant form inhibits the reaction [Calcitriol results in increased activity of MAPK3 protein]; CAMP mutant form inhibits the reaction [Calcitriol results in increased expression of ATG5 mRNA]; CAMP mutant form inhibits the reaction [Calcitriol results in increased expression of BECN1 mRNA]; CAMP mutant form inhibits the reaction [Calcitriol results in increased expression of CEBPB mRNA]; dorsomorphin inhibits the reaction [Calcitriol affects the localization of CAMP protein]; HR protein promotes the reaction [Calcitriol results in increased expression of CAMP mRNA]; PRKAA1 mutant form inhibits the reaction [Calcitriol affects the localization of CAMP protein]; pterostilbene promotes the reaction [Calcitriol results in increased expression of CAMP mRNA]; pterostilbene promotes the reaction [Calcitriol results in increased expression of CAMP protein]; Resveratrol promotes the reaction [Calcitriol results in increased expression of CAMP mRNA]; Resveratrol promotes the reaction [Calcitriol results in increased expression of CAMP protein]; SB 203580 promotes the reaction [Calcitriol promotes the reaction [Resveratrol results in increased expression of CAMP mRNA]]; SB 203580 promotes the reaction [Resveratrol promotes the reaction [Calcitriol results in increased expression of CAMP mRNA]]; STO 609 inhibits the reaction [Calcitriol affects the localization of CAMP protein] CAMP results in increased susceptibility to Calcitriol
|
CTD |
PMID:15985530 PMID:18180267 PMID:19244278 PMID:19748465 PMID:22029407 PMID:22466564 PMID:24039193 More...
|
|
NCBI chr 8:118,720,184...118,721,998
Ensembl chr 8:118,720,184...118,721,998
|
|
| G
|
Camsap3
|
calmodulin regulated spectrin-associated protein family, member 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CAMSAP3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr12:6,440,959...6,464,582
Ensembl chr12:6,441,152...6,464,582
|
|
| G
|
Capg
|
capping actin protein, gelsolin like
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CAPG mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 4:106,152,912...106,170,010
Ensembl chr 4:106,152,890...106,170,672
|
|
| G
|
Capn12
|
calpain 12
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CAPN12 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CAPN12 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:93,298,571...93,311,220
Ensembl chr 1:93,298,571...93,310,630
|
|
| G
|
Capn2
|
calpain 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of CAPN2 mRNA Calcitriol results in increased expression of CAPN2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:96,681,902...96,732,625
Ensembl chr13:96,681,848...96,732,625
|
|
| G
|
Capn7
|
calpain 7
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CAPN7 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr16:6,552,048...6,588,317
Ensembl chr16:6,552,049...6,588,316
|
|
| G
|
Car2
|
carbonic anhydrase 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CA2 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:88,462,872...88,478,064
|
|
| G
|
Card10
|
caspase recruitment domain family, member 10
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CARD10 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:112,210,944...112,252,044
Ensembl chr 7:112,210,776...112,239,806
|
|
| G
|
Card6
|
caspase recruitment domain family, member 6
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CARD6 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CARD6 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:55,921,832...55,934,388
Ensembl chr 2:55,921,832...55,934,363
|
|
| G
|
Carhsp1
|
calcium regulated heat stable protein 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CARHSP1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:7,453,602...7,467,218
Ensembl chr10:7,452,978...7,467,770
|
|
| G
|
Carmil1
|
capping protein regulator and myosin 1 linker 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of CARMIL1 mRNA Calcitriol results in increased expression of CARMIL1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:41,235,819...41,516,204
Ensembl chr17:41,236,229...41,516,221
|
|
| G
|
Cask
|
calcium/calmodulin dependent serine protein kinase
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CASK mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr X:11,572,328...11,915,831
Ensembl chr X:11,572,636...11,911,948
|
|
| G
|
Casp1
|
caspase 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CASP1 mRNA [Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with Nanotubes, Carbon] affects the expression of CASP1 mRNA; [Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] affects the expression of and affects the activity of CASP1 protein; [IL13 protein co-treated with IL4 protein co-treated with Nanotubes, Carbon] inhibits the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] affects the expression of CASP1 protein]; [IL13 protein co-treated with IL4 protein] inhibits the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] affects the expression of CASP1 protein]; [IL4 protein co-treated with IL13 protein] inhibits the reaction [Nanotubes, Carbon promotes the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with Nanotubes, Carbon] affects the expression of CASP1 mRNA]]; IL13 protein inhibits the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] affects the expression of CASP1 protein]; IL4 protein inhibits the reaction [Nanotubes, Carbon promotes the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with Nanotubes, Carbon] affects the expression of CASP1 mRNA]]; JAK1 protein affects the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] affects the expression of and affects the activity of CASP1 protein]; leflunomide inhibits the reaction [[IL13 protein co-treated with IL4 protein] inhibits the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] affects the expression of and affects the activity of CASP1 protein]]; Nanotubes, Carbon promotes the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with Nanotubes, Carbon] affects the expression of CASP1 mRNA]
|
CTD |
PMID:16002434 PMID:26091108 |
|
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275
|
|
| G
|
Casp14
|
caspase 14
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CASP14 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:11,577,315...11,583,987
Ensembl chr 7:11,580,339...11,583,171
|
|
| G
|
Casp3
|
caspase 3
|
multiple interactions increases activity decreases expression
|
ISO EXP
|
[Calcitriol co-treated with Gemcitabine] results in increased expression of CASP3 protein; Calcitriol inhibits the reaction [bisphenol A results in increased expression of CASP3 mRNA]; Calcitriol inhibits the reaction [bisphenol A results in increased expression of CASP3 protein] Calcitriol inhibits the reaction [sodium arsenite results in increased expression of CASP3 protein] Calcitriol inhibits the reaction [Ethanol results in increased activity of CASP3 protein] Calcitriol results in increased activity of CASP3 protein Calcitriol results in decreased expression of CASP3 protein
|
CTD |
PMID:17570329 PMID:20699664 PMID:21933904 PMID:22892342 PMID:38421590 PMID:39771102 More...
|
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp4
|
caspase 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CASP4 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:10,883,817...10,919,978
Ensembl chr 8:10,883,769...10,920,727
|
|
| G
|
Casp6
|
caspase 6
|
multiple interactions
|
ISO
|
[Calcitriol co-treated with Gemcitabine] results in increased expression of CASP6 protein
|
CTD |
PMID:20699664 |
|
NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:221,140,256...221,152,726
|
|
| G
|
Casp7
|
caspase 7
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CASP7 protein [Calcitriol co-treated with Curcumin] promotes the reaction [Paclitaxel results in increased expression of CASP7 protein]; Calcitriol inhibits the reaction [Curcumin inhibits the reaction [Paclitaxel results in increased expression of CASP7 protein]]; Calcitriol inhibits the reaction [Paclitaxel results in increased expression of CASP7 protein]; Curcumin inhibits the reaction [Calcitriol inhibits the reaction [Paclitaxel results in increased expression of CASP7 protein]]
|
CTD |
PMID:31628941 |
|
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
|
|
| G
|
Casp8
|
caspase 8
|
multiple interactions affects expression
|
ISO
|
[Calcitriol co-treated with Gemcitabine] results in increased expression of CASP8 protein Calcitriol affects the expression of CASP8 mRNA
|
CTD |
PMID:15138306 PMID:20699664 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
| G
|
Casp9
|
caspase 9
|
multiple interactions increases expression
|
ISO EXP
|
[Calcitriol co-treated with Gemcitabine] results in increased expression of CASP9 protein; [Calcitriol co-treated with Paclitaxel] results in increased expression of CASP9 protein; [Curcumin co-treated with Calcitriol] promotes the reaction [Paclitaxel results in increased expression of CASP9 protein]; [Paclitaxel co-treated with Calcitriol] promotes the reaction [Curcumin results in increased expression of CASP9 protein]; [Paclitaxel co-treated with Curcumin] promotes the reaction [Calcitriol results in increased expression of CASP9 protein]; [salinomycin co-treated with Calcitriol] results in increased expression of CASP9 mRNA; Calcitriol inhibits the reaction [bisphenol A results in increased expression of CASP9 mRNA]; Calcitriol inhibits the reaction [Paclitaxel results in increased expression of CASP9 protein]; Curcumin promotes the reaction [[Calcitriol co-treated with Paclitaxel] results in increased expression of CASP9 protein] Calcitriol inhibits the reaction [sodium arsenite results in increased expression of CASP9 protein]
|
CTD |
PMID:20699664 PMID:31628941 PMID:35914560 PMID:38421590 PMID:39771102 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Casr
|
calcium-sensing receptor
|
increases expression
|
EXP
|
Calcitriol results in increased expression of CASR mRNA; Calcitriol results in increased expression of CASR protein
|
CTD |
PMID:15788476 |
|
NCBI chr11:77,738,398...77,813,639
Ensembl chr11:77,740,614...77,810,167
|
|
| G
|
Castor1
|
cytosolic arginine sensor for mTORC1 subunit 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CASTOR1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CASTOR1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:83,309,710...83,314,123
Ensembl chr14:83,309,504...83,314,127
|
|
| G
|
Casz1
|
castor zinc finger 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CASZ1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:164,527,083...164,677,037
Ensembl chr 5:164,527,112...164,677,014
|
|
| G
|
Cav1
|
caveolin 1
|
multiple interactions
|
ISO
|
Calcitriol results in increased localization of [VDR protein co-treated with CAV1 protein]
|
CTD |
PMID:20371703 |
|
NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740
|
|
| G
|
Cavin1
|
caveolae associated protein 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of CAVIN1 mRNA Calcitriol results in increased expression of CAVIN1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:86,384,401...86,398,240
Ensembl chr10:86,384,401...86,396,383
|
|
| G
|
Cblb
|
Cbl proto-oncogene B
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CBLB mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr11:62,058,829...62,225,904
Ensembl chr11:62,061,653...62,225,778
|
|
| G
|
Cbll1
|
Cbl proto-oncogene like 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CBLL1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CBLL1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:53,798,712...53,812,890
Ensembl chr 6:53,798,712...53,813,880
|
|
| G
|
Cbln2
|
cerebellin 2 precursor
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CBLN2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CBLN2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:82,215,210...82,222,648
Ensembl chr18:82,215,220...82,222,648
|
|
| G
|
Cbx2
|
chromobox 2
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of CBX2 mRNA Calcitriol results in decreased expression of CBX2 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr10:104,777,054...104,785,922
Ensembl chr10:104,777,056...104,785,926
|
|
| G
|
Ccdc121
|
coiled-coil domain containing 121
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CCDC121 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:30,690,831...30,693,437
Ensembl chr 6:30,690,831...30,693,437
|
|
| G
|
Ccdc138
|
coiled-coil domain containing 138
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CCDC138 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CCDC138 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:27,037,256...27,115,454
Ensembl chr20:27,038,349...27,115,452
|
|
| G
|
Ccdc14
|
coiled-coil domain containing 14
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CCDC14 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CCDC14 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr11:79,557,267...79,593,128
Ensembl chr11:79,557,274...79,593,285
|
|
| G
|
Ccdc15
|
coiled-coil domain containing 15
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CCDC15 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CCDC15 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:45,165,297...45,257,641
Ensembl chr 8:45,134,596...45,277,989
|
|
| G
|
Ccdc18
|
coiled-coil domain containing 18
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CCDC18 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CCDC18 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:1,646,725...1,752,581
Ensembl chr14:1,646,809...1,750,470
|
|
| G
|
Ccdc24
|
coiled-coil domain containing 24
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CCDC24 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CCDC24 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:136,684,206...136,697,855
Ensembl chr 5:136,693,499...136,697,469
|
|
| G
|
Ccdc34
|
coiled-coil domain containing 34
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CCDC34 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CCDC34 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:117,007,652...117,042,885
Ensembl chr 3:117,005,760...117,042,226
|
|
| G
|
Ccdc80
|
coiled-coil domain containing 80
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CCDC80 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr11:69,191,188...69,224,844
Ensembl chr11:69,191,189...69,224,844
|
|
| G
|
Ccdc85a
|
coiled-coil domain containing 85A
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of CCDC85A mRNA Calcitriol results in increased expression of CCDC85A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:106,327,580...106,560,205
Ensembl chr14:106,327,580...106,560,165
|
|
| G
|
Ccdc88c
|
coiled-coil domain containing 88C
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CCDC88C mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:125,899,337...126,019,162
Ensembl chr 6:125,899,526...126,018,865
|
|
| G
|
Ccdc93
|
coiled-coil domain containing 93
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CCDC93 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:35,160,354...35,233,877
Ensembl chr13:35,160,363...35,233,875
|
|
| G
|
Ccdc9b
|
coiled-coil domain containing 9B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CCDC9B mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:126,190,039...126,198,931
Ensembl chr 3:126,192,232...126,199,580
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CCL2 mRNA; Calcitriol results in decreased expression of CCL2 protein Calcitriol inhibits the reaction [Bleomycin results in increased expression of CCL2 mRNA]
|
CTD |
PMID:18379402 PMID:26485663 PMID:26520185 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccl20
|
C-C motif chemokine ligand 20
|
decreases expression increases expression
|
ISO
|
Calcitriol results in decreased expression of CCL20 mRNA Calcitriol results in increased expression of CCL20 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736
|
|
| G
|
Ccl3
|
C-C motif chemokine ligand 3
|
multiple interactions
|
ISO
|
Calcitriol inhibits the reaction [Bleomycin results in increased expression of CCL3 mRNA]
|
CTD |
PMID:26520185 |
|
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439
|
|
| G
|
Ccn1
|
cellular communication network factor 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CCN1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883
|
|
| G
|
Ccn4
|
cellular communication network factor 4
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CCN4 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:100,534,578...100,566,287
Ensembl chr 7:100,534,505...100,563,094
|
|
| G
|
Ccna1
|
cyclin A1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CCNA1 mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr 2:141,383,352...141,428,205
Ensembl chr 2:141,382,468...141,393,300
|
|
| G
|
Ccna2
|
cyclin A2
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of CCNA2 mRNA; Calcitriol promotes the reaction [Testosterone results in increased expression of CCNA2 mRNA]; Testosterone promotes the reaction [Calcitriol results in increased expression of CCNA2 mRNA] Calcitriol results in decreased expression of CCNA2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701
|
|
| G
|
Ccnb1
|
cyclin B1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CCNB1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CCNB1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225
|
|
| G
|
Ccnb2
|
cyclin B2
|
affects expression multiple interactions
|
ISO
|
Calcitriol affects the expression of CCNB2 mRNA Calcitriol promotes the reaction [Testosterone results in decreased expression of CCNB2 mRNA]
|
CTD |
PMID:21592394 |
|
NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:79,968,465...79,981,682
|
|
| G
|
Ccnc
|
cyclin C
|
decreases expression increases expression
|
ISO
|
Calcitriol results in decreased expression of CCNC protein Calcitriol results in increased expression of CCNC mRNA
|
CTD |
PMID:10825140 PMID:15890193 |
|
NCBI chr 5:40,063,589...40,081,731
Ensembl chr 5:40,063,623...40,093,370
|
|
| G
|
Ccnd1
|
cyclin D1
|
multiple interactions decreases expression
|
ISO
|
[Calcitriol co-treated with Genistein] results in decreased expression of CCND1 mRNA; [salinomycin co-treated with Calcitriol] results in decreased expression of CCND1 mRNA; Calcitriol inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CCND1 mRNA]; Calcitriol inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CCND1 protein] Calcitriol results in decreased expression of CCND1 mRNA; Calcitriol results in decreased expression of CCND1 protein
|
CTD |
PMID:9783903 PMID:10825140 PMID:15955619 PMID:17595320 PMID:21542014 PMID:35914560 PMID:36504884 More...
|
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Ccnd2
|
cyclin D2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CCND2 mRNA
|
CTD |
PMID:15951637 PMID:16002434 PMID:16847355 |
|
NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:161,653,048...161,680,301 Ensembl chr 4:161,653,048...161,680,301
|
|
| G
|
Ccne2
|
cyclin E2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CCNE2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CCNE2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:29,082,169...29,094,879
Ensembl chr 5:29,082,703...29,094,882
|
|
| G
|
Ccnf
|
cyclin F
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CCNF mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CCNF mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:13,757,884...13,783,669
Ensembl chr10:13,758,421...13,783,837
|
|
| G
|
Ccng2
|
cyclin G2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CCNG2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr14:15,088,694...15,097,190
Ensembl chr14:15,088,695...15,096,206
|
|
| G
|
Ccp110
|
centriolar coiled-coil protein 110
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CCP110 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CCP110 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:182,475,571...182,504,235
Ensembl chr 1:182,476,422...182,504,232
|
|
| G
|
Ccsap
|
centriole, cilia and spindle-associated protein
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CCSAP mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CCSAP mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:68,722,417...68,740,908
|
|
| G
|
Cd14
|
CD14 molecule
|
increases expression multiple interactions
|
ISO
|
Calcitriol analog results in increased expression of CD14 protein; Calcitriol results in increased expression of CD14 mRNA; Calcitriol results in increased expression of CD14 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol results in increased expression of CD14 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole promotes the reaction [Calcitriol results in increased expression of CD14 protein]; [Benzo(a)pyrene co-treated with Calcitriol] results in increased expression of CD14 protein; [Cadmium co-treated with Calcitriol] results in increased expression of CD14 protein; [Testosterone co-treated with Calcitriol] results in increased expression of CD14 mRNA; [Zinc co-treated with pyrithione] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Calcitriol results in increased expression of CD14 protein]]; Benzo(a)pyrene promotes the reaction [Calcitriol results in increased expression of CD14 mRNA]; Calcitriol promotes the reaction [MZF1 protein binds to CD14 promoter]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Calcitriol results in increased expression of CD14 protein]; parthenolide promotes the reaction [Calcitriol results in increased expression of CD14 protein]; parthenolide promotes the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Calcitriol results in increased expression of CD14 protein]]; pyrazolanthrone inhibits the reaction [Calcitriol results in increased expression of CD14 protein]; pyrithione promotes the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Calcitriol results in increased expression of CD14 protein]]; salvin promotes the reaction [Calcitriol results in increased expression of CD14 protein]; U 0126 inhibits the reaction [[Cadmium co-treated with Calcitriol] results in increased expression of CD14 protein]; ZK159222 inhibits the reaction [Calcitriol results in increased expression of CD14 protein]
|
CTD |
PMID:1450407 PMID:10799658 PMID:11158396 PMID:11504768 PMID:12441127 PMID:14729647 PMID:15489543 PMID:16002434 PMID:16766008 PMID:18180267 PMID:18495781 PMID:19244278 PMID:20089671 PMID:20868229 PMID:21592394 PMID:22751936 PMID:26485663 PMID:29524502 More...
|
|
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292
|
|
| G
|
Cd163
|
CD163 molecule
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CD163 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 4:158,770,751...158,804,146
Ensembl chr 4:158,770,749...158,804,146
|
|
| G
|
Cd24
|
CD24 molecule
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of CD24 mRNA Calcitriol results in increased expression of CD24 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr20:48,655,549...48,661,786
Ensembl chr20:48,655,805...48,661,785
|
|
| G
|
Cd247
|
Cd247 molecule
|
multiple interactions
|
ISO
|
[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased abundance of Calcitriol; Calcitriol promotes the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased expression of VDR protein]; Ketoconazole inhibits the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased abundance of Calcitriol]
|
CTD |
PMID:24792400 |
|
NCBI chr13:80,576,264...80,651,422
Ensembl chr13:80,576,202...80,655,248
|
|
| G
|
Cd274
|
CD274 molecule
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of CD274 mRNA Calcitriol results in increased expression of CD274 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 1:236,526,215...236,549,956
Ensembl chr 1:236,496,463...236,549,951
|
|
| G
|
Cd28
|
Cd28 molecule
|
multiple interactions
|
ISO
|
[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased abundance of Calcitriol; Calcitriol promotes the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased expression of VDR protein]; Ketoconazole inhibits the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased abundance of Calcitriol]
|
CTD |
PMID:24792400 |
|
NCBI chr 9:69,660,316...69,689,192
Ensembl chr 9:69,545,326...69,689,192
|
|
| G
|
Cd300a
|
Cd300a molecule
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CD300A mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:100,428,826...100,441,693
Ensembl chr10:100,428,826...100,442,958
|
|
| G
|
Cd38
|
CD38 molecule
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CD38 mRNA
|
CTD |
PMID:16329108 |
|
NCBI chr14:71,384,532...71,424,794
Ensembl chr14:71,384,532...71,424,505
|
|
| G
|
Cd3d
|
CD3 delta subunit of T-cell receptor complex
|
multiple interactions
|
ISO
|
[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased abundance of Calcitriol; Calcitriol promotes the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased expression of VDR protein]; Ketoconazole inhibits the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased abundance of Calcitriol]
|
CTD |
PMID:24792400 |
|
NCBI chr 8:54,184,573...54,190,112
Ensembl chr 8:54,175,155...54,196,722
|
|
| G
|
Cd3e
|
CD3 epsilon subunit of T-cell receptor complex
|
multiple interactions
|
ISO
|
[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased abundance of Calcitriol; Calcitriol promotes the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased expression of VDR protein]; Ketoconazole inhibits the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased abundance of Calcitriol]
|
CTD |
PMID:24792400 |
|
NCBI chr 8:54,200,617...54,211,770
Ensembl chr 8:54,200,617...54,211,876
|
|
| G
|
Cd3g
|
CD3 gamma subunit of T-cell receptor complex
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CD3G mRNA [[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased abundance of Calcitriol; Calcitriol promotes the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased expression of VDR protein]; Ketoconazole inhibits the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased abundance of Calcitriol]
|
CTD |
PMID:12875902 PMID:24792400 |
|
NCBI chr 8:54,177,572...54,184,087
Ensembl chr 8:54,177,977...54,183,918
|
|
| G
|
Cd40
|
CD40 molecule
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CD40 protein
|
CTD |
PMID:10679076 |
|
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847
|
|
| G
|
Cd40lg
|
CD40 ligand
|
multiple interactions
|
ISO
|
[CD40LG protein co-treated with Calcitriol] results in decreased expression of CD80 protein; [CD40LG protein co-treated with Calcitriol] results in decreased expression of CD86 protein; [CD40LG protein co-treated with Calcitriol] results in decreased secretion of and results in decreased expression of IL1B protein; [CD40LG protein co-treated with Calcitriol] results in decreased secretion of and results in decreased expression of TNF protein
|
CTD |
PMID:19186073 |
|
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:140,164,302...140,176,475
|
|
| G
|
Cd44
|
CD44 molecule
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CD44
|
CTD |
PMID:16051482 |
|
NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424
|
|
| G
|
Cd53
|
Cd53 molecule
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CD53 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:197,040,369...197,087,925
Ensembl chr 2:197,040,369...197,218,593
|
|
| G
|
Cd59b
|
CD59b molecule
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CD59 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CD59 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:110,914,008...110,932,489
Ensembl chr 3:110,914,091...110,935,310
|
|
| G
|
Cd68
|
Cd68 molecule
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of CD68 mRNA Calcitriol results in increased expression of CD68 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,880,563...54,882,540
|
|
| G
|
Cd7
|
Cd7 molecule
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CD7 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CD7 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:106,802,373...106,805,269
Ensembl chr10:106,802,383...106,805,294
|
|
| G
|
Cd80
|
Cd80 molecule
|
multiple interactions decreases expression
|
ISO
|
[CD40LG protein co-treated with Calcitriol] results in decreased expression of CD80 protein Calcitriol results in decreased expression of CD80 protein
|
CTD |
PMID:10679076 PMID:19186073 |
|
NCBI chr11:75,760,073...75,798,978
Ensembl chr11:75,760,147...75,797,540
|
|
| G
|
Cd82
|
Cd82 molecule
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CD82 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CD82 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:99,842,748...99,887,298
Ensembl chr 3:99,842,757...99,886,744
|
|
| G
|
Cd86
|
CD86 molecule
|
decreases expression multiple interactions increases expression
|
ISO
|
Calcitriol results in decreased expression of CD86 protein [CD40LG protein co-treated with Calcitriol] results in decreased expression of CD86 protein Calcitriol results in increased expression of CD86 mRNA
|
CTD |
PMID:10679076 PMID:16002434 PMID:19186073 |
|
NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361
|
|
| G
|
Cda
|
cytidine deaminase
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CDA mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:155,839,929...155,866,541
Ensembl chr 5:155,839,929...155,866,541
|
|
| G
|
Cdc20
|
cell division cycle 20
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of CDC20 mRNA; Calcitriol promotes the reaction [Testosterone results in increased expression of CDC20 mRNA]; Testosterone promotes the reaction [Calcitriol results in increased expression of CDC20 mRNA] Calcitriol results in decreased expression of CDC20 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:137,251,596...137,255,799
Ensembl chr 5:137,251,596...137,255,799
|
|
| G
|
Cdc25a
|
cell division cycle 25A
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CDC25A mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:118,742,824...118,761,190
Ensembl chr 8:118,742,426...118,761,188
|
|
| G
|
Cdc25b
|
cell division cycle 25B
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CDC25B mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CDC25B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:138,860,148...138,870,287
Ensembl chr 3:138,860,130...138,870,492
|
|
| G
|
Cdc25c
|
cell division cycle 25C
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CDC25C mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CDC25C mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:26,608,483...26,630,292
Ensembl chr18:26,609,959...26,630,292
|
|
| G
|
Cdc42ep3
|
CDC42 effector protein 3
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of CDC42EP3 mRNA Calcitriol results in increased expression of CDC42EP3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:21,463,081...21,483,553
Ensembl chr 6:21,461,762...21,508,540
|
|
| G
|
Cdc45
|
cell division cycle 45
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CDC45 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CDC45 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr11:95,689,702...95,714,980
Ensembl chr11:95,689,919...95,714,981
|
|
| G
|
Cdc6
|
cell division cycle 6
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CDC6 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CDC6 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:84,360,361...84,374,239
Ensembl chr10:84,360,381...84,374,241
|
|
| G
|
Cdca2
|
cell division cycle associated 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CDCA2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CDCA2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:46,071,360...46,117,524
Ensembl chr15:46,071,360...46,116,639
|
|
| G
|
Cdca3
|
cell division cycle associated 3
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CDCA3 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CDCA3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:159,321,203...159,325,072
Ensembl chr 4:159,321,014...159,325,068
|
|
| G
|
Cdca4
|
cell division cycle associated 4
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CDCA4 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CDCA4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:137,713,390...137,722,652
Ensembl chr 6:137,713,051...137,722,580
|
|
| G
|
Cdca5
|
cell division cycle associated 5
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CDCA5 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CDCA5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:212,807,863...212,821,313
Ensembl chr 1:212,804,014...212,821,309
|
|
| G
|
Cdca7
|
cell division cycle associated 7
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CDCA7 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CDCA7 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:77,730,315...77,740,950
Ensembl chr 3:77,729,970...77,740,947
|
|
| G
|
Cdca7l
|
cell division cycle associated 7 like
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CDCA7L mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CDCA7L mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:144,936,885...144,982,844
Ensembl chr 6:144,908,171...144,982,843
|
|
| G
|
Cdca8
|
cell division cycle associated 8
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CDCA8 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CDCA8 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:142,461,082...142,483,336
Ensembl chr 5:142,461,084...142,483,283
|
|
| G
|
Cdcp1
|
CUB domain containing protein 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CDCP1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 8:131,706,140...131,742,799
Ensembl chr 8:131,706,140...131,742,877
|
|
| G
|
Cdh1
|
cadherin 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CDH1; Calcitriol results in increased expression of CDH1 mRNA; Calcitriol results in increased expression of CDH1 protein [Calcitriol binds to and results in increased activity of VDR protein] which results in increased expression of CDH1 mRNA
|
CTD |
PMID:11519864 PMID:15489543 PMID:16051482 PMID:26485663 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
|
|
| G
|
Cdh2
|
cadherin 2
|
multiple interactions
|
ISO
|
[Calcitriol co-treated with VDR protein] results in increased expression of CDH2 protein
|
CTD |
PMID:26210580 |
|
NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288
|
|
| G
|
Cdh3
|
cadherin 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CDH3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr19:51,303,414...51,353,900
Ensembl chr19:51,300,083...51,354,257
|
|
| G
|
Cdk1
|
cyclin-dependent kinase 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CDK1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CDK1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455
|
|
| G
|
Cdk2
|
cyclin dependent kinase 2
|
decreases activity multiple interactions decreases localization decreases expression
|
ISO
|
Calcitriol results in decreased activity of CDK2 protein [Testosterone co-treated with Calcitriol] results in decreased expression of CDK2 mRNA Calcitriol results in decreased localization of CDK2 protein Calcitriol results in decreased expression of CDK2 mRNA
|
CTD |
PMID:12954644 PMID:21592394 |
|
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878
|
|
| G
|
Cdk4
|
cyclin-dependent kinase 4
|
multiple interactions
|
ISO
|
Calcitriol promotes the reaction [CDKN1B protein binds to CDK4 protein]
|
CTD |
PMID:16322758 |
|
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163
|
|
| G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
multiple interactions decreases expression increases expression
|
ISO
|
[Arsenic Trioxide co-treated with Calcitriol] results in increased expression of CDKN1A mRNA; [Arsenic Trioxide co-treated with Calcitriol] results in increased expression of CDKN1A protein; [Calcitriol co-treated with Genistein] results in increased expression of CDKN1A mRNA; [salinomycin co-treated with Calcitriol] results in increased expression of CDKN1A mRNA; Calcitriol inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDKN1A mRNA]; Calcitriol inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDKN1A protein]; perfluorooctanoic acid inhibits the reaction [Calcitriol results in increased expression of CDKN1A mRNA] Calcitriol results in decreased expression of CDKN1A protein Calcitriol inhibits the reaction [bisphenol A results in increased expression of CDKN1A protein] Calcitriol results in increased expression of CDKN1A; Calcitriol results in increased expression of CDKN1A mRNA; Calcitriol results in increased expression of CDKN1A protein
|
CTD |
PMID:9348195 PMID:9783903 PMID:10825140 PMID:11270487 PMID:11519864 PMID:12071473 PMID:15955619 PMID:16039115 PMID:16434701 PMID:21542014 PMID:33033332 PMID:34025784 PMID:35914560 PMID:36504884 PMID:38725370 More...
|
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
| G
|
Cdkn1b
|
cyclin-dependent kinase inhibitor 1B
|
multiple interactions decreases expression increases expression
|
ISO
|
[Arsenic Trioxide co-treated with Calcitriol] results in increased expression of CDKN1B mRNA; [Arsenic Trioxide co-treated with Calcitriol] results in increased expression of CDKN1B protein; Calcitriol promotes the reaction [CDKN1B protein binds to CDK4 protein]; Calcitriol results in decreased phosphorylation of and results in decreased degradation of and results in increased stability of CDKN1B protein Calcitriol results in decreased expression of CDKN1B protein Calcitriol results in increased expression of CDKN1B; Calcitriol results in increased expression of CDKN1B mRNA; Calcitriol results in increased expression of CDKN1B protein
|
CTD |
PMID:9783903 PMID:10825140 PMID:11270487 PMID:11519864 PMID:12954644 PMID:16039115 PMID:16322758 PMID:34025784 PMID:38725370 More...
|
|
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498
|
|
| G
|
Cdkn2b
|
cyclin-dependent kinase inhibitor 2B
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CDKN2B mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CDKN2B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:109,123,308...109,134,906
Ensembl chr 5:109,114,322...109,134,855
|
|
| G
|
Cdkn2c
|
cyclin-dependent kinase inhibitor 2C
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of CDKN2C mRNA Calcitriol results in decreased expression of CDKN2C mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:129,639,736...129,645,564
Ensembl chr 5:129,639,736...129,644,891
|
|
| G
|
Cdkn2d
|
cyclin dependent kinase inhibitor 2D
|
multiple interactions increases expression decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of CDKN2D mRNA Calcitriol results in increased expression of CDKN2D mRNA; Calcitriol results in increased expression of CDKN2D protein Calcitriol results in decreased expression of CDKN2D mRNA
|
CTD |
PMID:16322758 PMID:21592394 |
|
NCBI chr 8:28,108,036...28,110,809
Ensembl chr 8:28,108,044...28,110,809
|
|
| G
|
Cdkn3
|
cyclin-dependent kinase inhibitor 3
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CDKN3 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CDKN3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:22,502,299...22,513,725
Ensembl chr15:22,502,382...22,513,722
|
|
| G
|
Cdr2l
|
cerebellar degeneration-related protein 2-like
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CDR2L mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:101,123,777...101,137,634
Ensembl chr10:101,123,777...101,137,634
|
|
| G
|
Cdrt4
|
CMT1A duplicated region transcript 4
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CDRT4 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CDRT4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:48,124,695...48,156,717
Ensembl chr10:48,124,695...48,156,717
|
|
| G
|
Cds1
|
CDP-diacylglycerol synthase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CDS1 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr14:8,126,678...8,187,243
Ensembl chr14:8,124,838...8,187,218
|
|
| G
|
Cdt1
|
chromatin licensing and DNA replication factor 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of CDT1 mRNA Calcitriol results in decreased expression of CDT1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:67,529,249...67,534,195
Ensembl chr19:67,529,201...67,534,194
|
|
| G
|
Cdyl
|
chromodomain Y-like
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CDYL mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr17:29,188,697...29,409,805
Ensembl chr17:29,188,698...29,409,757
|
|
| G
|
Ceacam1
|
CEA cell adhesion molecule 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CEACAM1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:90,171,401...90,187,810
Ensembl chr 1:90,171,401...90,187,798
|
|
| G
|
Ceacam6
|
CEA cell adhesion molecule 6
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CEACAM6 mRNA
|
CTD |
PMID:14996990 PMID:26485663 |
|
NCBI chr 1:89,544,415...89,562,552
Ensembl chr 1:89,544,400...89,562,552
|
|
| G
|
Cebpa
|
CCAAT/enhancer binding protein alpha
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CEBPA mRNA
|
CTD |
PMID:16368784 |
|
NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309
|
|
| G
|
Cebpb
|
CCAAT/enhancer binding protein beta
|
multiple interactions decreases expression increases expression
|
ISO
|
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol results in increased expression of CEBPB mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol results in increased expression of CEBPB protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole promotes the reaction [Calcitriol results in increased expression of CEBPB mRNA]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole promotes the reaction [Calcitriol results in increased expression of CEBPB protein]; [CAMP results in increased activity of CEBPB] affects the reaction [Calcitriol results in increased expression of ATG5 mRNA]; [CAMP results in increased activity of CEBPB] affects the reaction [Calcitriol results in increased expression of BECN1 mRNA]; Calcitriol results in increased expression of and affects the localization of CEBPB protein; CAMP mutant form inhibits the reaction [Calcitriol results in increased expression of CEBPB mRNA]; CEBPB mutant form inhibits the reaction [Calcitriol results in increased expression of ATG5 mRNA]; CEBPB mutant form inhibits the reaction [Calcitriol results in increased expression of BECN1 mRNA]; pyrazolanthrone inhibits the reaction [Calcitriol results in increased expression of CEBPB mRNA]; pyrazolanthrone inhibits the reaction [Calcitriol results in increased expression of CEBPB protein]; ZK159222 inhibits the reaction [Calcitriol results in increased expression of CEBPB protein] [Calcitriol results in increased expression of RUNX1T1 protein] which results in decreased activity of CEBPB protein Calcitriol results in decreased expression of CEBPB mRNA; Calcitriol results in decreased expression of CEBPB protein Calcitriol results in increased expression of CEBPB mRNA; Calcitriol results in increased expression of CEBPB protein
|
CTD |
PMID:14729647 PMID:16002434 PMID:16467308 PMID:19748465 PMID:22751936 |
|
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072
|
|
| G
|
Cebpd
|
CCAAT/enhancer binding protein delta
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of CEBPD mRNA Calcitriol results in increased expression of CEBPD mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr11:98,268,856...98,269,994
Ensembl chr11:98,265,651...98,280,824
|
|
| G
|
Cel
|
carboxyl ester lipase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CEL mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CEL mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:32,281,518...32,289,019
Ensembl chr 3:32,281,518...32,289,019
|
|
| G
|
Celsr1
|
cadherin, EGF LAG seven-pass G-type receptor 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CELSR1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:118,867,450...119,004,859
Ensembl chr 7:118,867,450...119,004,856
|
|
| G
|
Celsr2
|
cadherin, EGF LAG seven-pass G-type receptor 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CELSR2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:198,717,333...198,741,689
Ensembl chr 2:198,717,896...198,741,581
|
|
| G
|
Cemip
|
cell migration inducing hyaluronidase 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CEMIP mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 1:147,316,052...147,471,552
Ensembl chr 1:147,316,052...147,471,768
|
|
| G
|
Cenpa
|
centromere protein A
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CENPA mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CENPA mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:31,420,062...31,431,703
|
|
| G
|
Cenpe
|
centromere protein E
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CENPE mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CENPE mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:226,310,970...226,369,636
Ensembl chr 2:226,300,798...226,369,636
|
|
| G
|
Cenpf
|
centromere protein F
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of CENPF mRNA Calcitriol results in decreased expression of CENPF mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:103,715,344...103,760,931
Ensembl chr13:103,715,344...103,760,886
|
|
| G
|
Cenph
|
centromere protein H
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of CENPH mRNA Calcitriol results in decreased expression of CENPH mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:33,630,738...33,644,258
Ensembl chr 2:33,630,738...33,644,242
|
|
| G
|
Cenpi
|
centromere protein I
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CENPI mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CENPI mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:101,809,192...101,860,935
Ensembl chr X:101,809,659...101,860,934
|
|
| G
|
Cenpk
|
centromere protein K
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CENPK mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CENPK mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:37,094,163...37,155,158
Ensembl chr 2:37,094,248...37,119,488
|
|
| G
|
Cenpl
|
centromere protein L
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CENPL mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CENPL mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:75,870,479...75,885,466
Ensembl chr13:75,870,489...75,905,250
|
|
| G
|
Cenpm
|
centromere protein M
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of CENPM mRNA Calcitriol results in decreased expression of CENPM mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:115,628,117...115,639,401
Ensembl chr 7:115,628,129...115,643,866
|
|
| G
|
Cenpo
|
centromere protein O
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of CENPO mRNA Calcitriol results in decreased expression of CENPO mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:32,923,127...32,937,879
Ensembl chr 6:32,908,025...32,937,853
|
|
| G
|
Cenpq
|
centromere protein Q
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CENPQ mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CENPQ mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:27,454,339...27,469,371
Ensembl chr 9:27,454,252...27,469,366
|
|
| G
|
Cenpu
|
centromere protein U
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CENPU mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CENPU mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:52,448,446...52,471,662
Ensembl chr16:52,425,096...52,471,662
|
|
| G
|
Cenpw
|
centromere protein W
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of CENPW mRNA Calcitriol results in decreased expression of CENPW mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:29,353,939...29,359,109
Ensembl chr 1:29,353,970...29,359,109
|
|
| G
|
Cep128
|
centrosomal protein 128
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CEP128 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CEP128 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:115,681,753...116,059,758
Ensembl chr 6:115,681,712...116,057,167
|
|
| G
|
Cep152
|
centrosomal protein 152
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of CEP152 mRNA Calcitriol results in decreased expression of CEP152 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:133,243,979...133,332,271
Ensembl chr 3:133,263,174...133,331,655 Ensembl chr 3:133,263,174...133,331,655
|
|
| G
|
Cep350
|
centrosomal protein 350
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CEP350 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CEP350 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:70,573,597...70,714,673
Ensembl chr13:70,573,597...70,714,673
|
|
| G
|
Cep55
|
centrosomal protein 55
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CEP55 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CEP55 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:245,245,272...245,260,835
Ensembl chr 1:245,245,306...245,260,890
|
|
| G
|
Cep57l1
|
centrosomal protein 57-like 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CEP57L1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CEP57L1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:46,820,350...46,876,911
Ensembl chr20:46,820,353...46,876,926
|
|
| G
|
Cep63
|
centrosomal protein 63
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of CEP63 mRNA Calcitriol results in decreased expression of CEP63 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:112,041,586...112,093,061
Ensembl chr 8:112,041,594...112,084,646
|
|
| G
|
Cep72
|
centrosomal protein 72
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CEP72 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CEP72 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:31,053,884...31,083,863
Ensembl chr 1:31,053,914...31,083,863
|
|
| G
|
Cep78
|
centrosomal protein 78
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CEP78 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CEP78 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:222,674,193...222,702,124
Ensembl chr 1:222,674,194...222,702,120
|
|
| G
|
Cfap69
|
cilia and flagella associated protein 69
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CFAP69 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CFAP69 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:29,334,624...29,405,513
Ensembl chr 4:29,334,415...29,408,727
|
|
| G
|
Cfd
|
complement factor D
|
multiple interactions decreases expression
|
ISO
|
Calcitriol inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of CFD mRNA] Calcitriol results in decreased expression of CFD mRNA
|
CTD |
PMID:9564879 PMID:26485663 |
|
NCBI chr 7:10,463,773...10,465,496
Ensembl chr 7:10,463,775...10,465,572
|
|
| G
|
Cfi
|
complement factor I
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CFI mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:221,062,206...221,104,790
Ensembl chr 2:221,062,212...221,104,786
|
|
| G
|
Cga
|
glycoprotein hormones, alpha polypeptide
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CGA mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:54,283,109...54,295,464
Ensembl chr 5:54,235,019...54,295,464
|
|
| G
|
Cgn
|
cingulin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CGN mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:184,997,425...185,024,785
Ensembl chr 2:184,997,425...185,023,635
|
|
| G
|
Cgnl1
|
cingulin-like 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CGNL1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:81,154,169...81,305,598
Ensembl chr 8:81,140,091...81,305,747
|
|
| G
|
Chac2
|
ChaC glutathione specific gamma-glutamylcyclotransferase 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CHAC2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CHAC2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:108,921,669...108,929,215
Ensembl chr14:108,921,341...108,929,469
|
|
| G
|
Chaf1a
|
chromatin assembly factor 1 subunit A
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of CHAF1A mRNA Calcitriol results in decreased expression of CHAF1A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:961,225...987,825
Ensembl chr 9:961,084...987,868
|
|
| G
|
Chaf1b
|
chromatin assembly factor 1 subunit B
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CHAF1B mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CHAF1B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr11:46,670,560...46,690,739
Ensembl chr11:46,670,630...46,690,733
|
|
| G
|
Chd9
|
chromodomain helicase DNA binding protein 9
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CHD9 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr19:32,114,379...32,337,488
Ensembl chr19:32,115,920...32,319,042
|
|
| G
|
Chdh
|
choline dehydrogenase
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CHDH mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr16:5,199,738...5,232,067
Ensembl chr16:5,200,763...5,232,997
|
|
| G
|
Chek2
|
checkpoint kinase 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CHEK2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CHEK2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr12:51,448,838...51,481,159
Ensembl chr12:51,449,140...51,480,667
|
|
| G
|
Chi3l1
|
chitinase 3 like 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CHI3L1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:48,193,839...48,201,822
Ensembl chr13:48,193,800...48,201,825
|
|
| G
|
Chic2
|
cysteine-rich hydrophobic domain 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CHIC2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr14:33,511,839...33,546,181
Ensembl chr14:33,511,535...33,548,558
|
|
| G
|
Chmp4c
|
charged multivesicular body protein 4C
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CHMP4C mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 2:93,299,152...93,336,075
Ensembl chr 2:93,299,157...93,360,850
|
|
| G
|
Chpf
|
chondroitin polymerizing factor
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CHPF mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CHPF mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:84,411,824...84,416,523
Ensembl chr 9:84,411,829...84,416,523
|
|
| G
|
Chrm3
|
cholinergic receptor, muscarinic 3
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CHRM3 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CHRM3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:64,696,549...65,158,622
Ensembl chr17:64,696,066...65,173,304
|
|
| G
|
Chrna2
|
cholinergic receptor nicotinic alpha 2 subunit
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CHRNA2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CHRNA2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:44,517,862...44,534,144
Ensembl chr15:44,517,862...44,534,144
|
|
| G
|
Chrne
|
cholinergic receptor nicotinic epsilon subunit
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CHRNE mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CHRNE mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:55,829,835...55,838,853
Ensembl chr10:55,829,836...55,834,154
|
|
| G
|
Chst11
|
carbohydrate sulfotransferase 11
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CHST11 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:22,412,121...22,630,577
Ensembl chr 7:22,415,686...22,630,441
|
|
| G
|
Chst3
|
carbohydrate sulfotransferase 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CHST3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr20:28,657,308...28,694,976
Ensembl chr20:28,657,308...28,694,526
|
|
| G
|
Chst7
|
carbohydrate sulfotransferase 7
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CHST7 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr X:4,949,810...4,986,372
Ensembl chr X:4,938,757...4,986,907
|
|
| G
|
Chtf18
|
chromosome transmission fidelity factor 18
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CHTF18 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CHTF18 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:15,247,525...15,255,573
Ensembl chr10:15,246,362...15,255,685
|
|
| G
|
Cilp
|
cartilage intermediate layer protein
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CILP mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 8:74,671,696...74,687,420
Ensembl chr 8:74,671,534...74,687,409
|
|
| G
|
Cip2a
|
cellular inhibitor of PP2A
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of CIP2A mRNA Calcitriol results in decreased expression of CIP2A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr11:65,255,123...65,285,914
Ensembl chr11:65,255,123...65,285,914
|
|
| G
|
Cit
|
citron rho-interacting serine/threonine kinase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CIT mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CIT mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr12:46,263,881...46,425,642
Ensembl chr12:46,266,369...46,424,656
|
|
| G
|
Cited4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CITED4 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:139,532,165...139,533,056
Ensembl chr 5:139,531,584...139,533,361
|
|
| G
|
Ckap2
|
cytoskeleton associated protein 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CKAP2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CKAP2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:76,542,114...76,567,297
Ensembl chr16:76,542,104...76,567,352
|
|
| G
|
Ckap2l
|
cytoskeleton associated protein 2-like
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CKAP2L mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CKAP2L mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:136,950,390...136,977,503
Ensembl chr 3:136,950,381...136,977,565
|
|
| G
|
Cklf
|
chemokine-like factor
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CKLF mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CKLF mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:704,528...712,998
Ensembl chr19:697,451...712,998
|
|
| G
|
Cks1b
|
CDC28 protein kinase regulatory subunit 1B
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CKS1B mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CKS1B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:177,130,751...177,135,333
Ensembl chr 2:177,130,777...177,135,365
|
|
| G
|
Cks2
|
CDC28 protein kinase regulatory subunit 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CKS2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CKS2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:13,722,360...13,727,519
Ensembl chr17:13,722,361...13,727,519
|
|
| G
|
Clcf1
|
cardiotrophin-like cytokine factor 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CLCF1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:210,937,763...210,947,064
Ensembl chr 1:210,937,255...210,947,064
|
|
| G
|
Clcn1
|
chloride voltage-gated channel 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of CLCN1 mRNA Calcitriol results in increased expression of CLCN1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:72,138,739...72,168,113
Ensembl chr 4:72,139,162...72,168,128
|
|
| G
|
Cldn1
|
claudin 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CLDN1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr11:87,926,376...87,941,533
Ensembl chr11:87,926,337...87,941,529
|
|
| G
|
Cldn11
|
claudin 11
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CLDN11 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:114,136,234...114,149,539
Ensembl chr 2:114,136,234...114,149,539
|
|
| G
|
Cldn12
|
claudin 12
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CLDN12 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CLDN12 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:29,477,468...29,488,465
Ensembl chr 4:29,477,342...29,493,776
|
|
| G
|
Cldn3
|
claudin 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CLDN3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr12:27,345,075...27,346,547
Ensembl chr12:27,345,076...27,348,841
|
|
| G
|
Cldn4
|
claudin 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CLDN4 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr12:27,388,160...27,389,958
Ensembl chr12:27,387,981...27,389,958
|
|
| G
|
Cldn7
|
claudin 7
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CLDN7 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:55,188,670...55,190,871
Ensembl chr10:55,188,684...55,190,905
|
|
| G
|
Cldn8
|
claudin 8
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CLDN8 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CLDN8 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr11:41,362,081...41,364,330
|
|
| G
|
Clec11a
|
C-type lectin domain containing 11A
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CLEC11A mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:103,938,029...103,941,170
Ensembl chr 1:103,935,185...103,946,784
|
|
| G
|
Clec2d
|
C-type lectin domain family 2, member D
|
increases expression decreases expression
|
ISO
|
Calcitriol results in increased expression of CLEC2D mRNA Calcitriol results in decreased expression of CLEC2D mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 4:163,902,124...163,925,587
Ensembl chr 4:163,902,547...163,925,587
|
|
| G
|
Clec3b
|
C-type lectin domain family 3, member B
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of CLEC3B mRNA; FST protein inhibits the reaction [Calcitriol results in decreased expression of CLEC3B mRNA]
|
CTD |
PMID:21592394 PMID:23589129 |
|
NCBI chr 8:131,687,575...131,693,292
|
|
| G
|
Clgn
|
calmegin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CLGN mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr19:41,601,568...41,633,207
Ensembl chr19:41,601,568...41,633,325
|
|
| G
|
Clip4
|
CAP-GLY domain containing linker protein family, member 4
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CLIP4 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CLIP4 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 6:29,359,628...29,449,365 NCBI chr 6:29,349,245...29,351,890
Ensembl chr 6:29,348,918...29,449,271
|
|
| G
|
Clmn
|
calmin
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CLMN mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CLMN mRNA; Ketoconazole promotes the reaction [Calcitriol results in increased expression of CLMN mRNA]
|
CTD |
PMID:16002434 PMID:21592394 PMID:26485663 |
|
NCBI chr 6:129,470,613...129,572,079
Ensembl chr 6:129,478,149...129,572,027
|
|
| G
|
Clspn
|
claspin
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CLSPN mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CLSPN mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:144,134,619...144,169,531
Ensembl chr 5:144,134,632...144,169,530
|
|
| G
|
Cltrn
|
collectrin, amino acid transport regulator
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CLTRN mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr X:33,993,825...34,027,124
Ensembl chr X:33,993,825...34,027,181
|
|
| G
|
Clu
|
clusterin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CLU; Calcitriol results in increased expression of CLU protein
|
CTD |
PMID:8593782 PMID:9528999 |
|
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860
|
|
| G
|
Cmip
|
c-Maf-inducing protein
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CMIP mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr19:62,213,402...62,419,443
Ensembl chr19:62,213,365...62,417,500
|
|
| G
|
Cmss1
|
cms1 ribosomal small subunit homolog
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CMSS1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CMSS1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr11:56,403,620...56,701,751
Ensembl chr11:56,403,499...56,701,755
|
|
| G
|
Cmtm3
|
CKLF-like MARVEL transmembrane domain containing 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CMTM3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr19:629,000...637,152
Ensembl chr19:628,895...636,225
|
|
| G
|
Cngb1
|
cyclic nucleotide gated channel subunit beta 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CNGB1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr19:9,732,646...9,798,864
Ensembl chr19:9,732,646...9,797,224
|
|
| G
|
Cnih2
|
cornichon family AMPA receptor auxiliary protein 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CNIH2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CNIH2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:211,828,791...211,834,474
Ensembl chr 1:211,828,794...211,834,437
|
|
| G
|
Cnksr1
|
connector enhancer of kinase suppressor of Ras 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CNKSR1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:151,731,222...151,742,049
Ensembl chr 5:151,731,224...151,742,203
|
|
| G
|
Cnn2
|
calponin 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CNN2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CNN2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:10,363,141...10,370,312
Ensembl chr 7:10,363,102...10,370,312
|
|
| G
|
Cntnap4
|
contactin associated protein family member 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CNTNAP4 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr19:57,477,447...57,765,173
Ensembl chr19:57,477,310...57,821,701
|
|
| G
|
Col11a1
|
collagen type XI alpha 1 chain
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of COL11A1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:204,509,136...204,702,264
Ensembl chr 2:204,509,136...204,702,264
|
|
| G
|
Col13a1
|
collagen type XIII alpha 1 chain
|
increases expression
|
ISO
|
Calcitriol results in increased expression of COL13A1 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr20:30,326,744...30,466,800
Ensembl chr20:30,326,744...30,466,800
|
|
| G
|
Col16a1
|
collagen type XVI alpha 1 chain
|
increases expression
|
ISO
|
Calcitriol results in increased expression of COL16A1 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 5:147,672,559...147,727,007
Ensembl chr 5:147,672,601...147,727,011
|
|
| G
|
Col17a1
|
collagen type XVII alpha 1 chain
|
increases expression
|
ISO
|
Calcitriol results in increased expression of COL17A1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:256,472,648...256,518,857
Ensembl chr 1:256,472,648...256,518,851
|
|
| G
|
Col1a1
|
collagen type I alpha 1 chain
|
increases expression multiple interactions
|
ISO EXP
|
Calcitriol results in increased expression of COL1A1 mRNA; Calcitriol results in increased expression of COL1A1 protein IGFBP5 protein inhibits the reaction [Calcitriol results in increased expression of COL1A1 protein]
|
CTD |
PMID:16002434 PMID:16813520 PMID:17595320 PMID:28105418 |
|
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
|
|
| G
|
Col1a2
|
collagen type I alpha 2 chain
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of COL1A2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995
|
|
| G
|
Col22a1
|
collagen type XXII alpha 1 chain
|
increases expression
|
ISO
|
Calcitriol results in increased expression of COL22A1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:105,619,776...105,857,246
Ensembl chr 7:105,619,757...105,856,960
|
|
| G
|
Col3a1
|
collagen type III alpha 1 chain
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of COL3A1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232
|
|
| G
|
Col4a2
|
collagen type IV alpha 2 chain
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of COL4A2 mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr16:84,749,672...84,885,520
Ensembl chr16:84,749,672...84,885,520
|
|
| G
|
Col4a5
|
collagen type IV alpha 5 chain
|
increases expression
|
ISO
|
Calcitriol results in increased expression of COL4A5 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr X:109,907,251...110,111,214
Ensembl chr X:109,907,346...110,111,214
|
|
| G
|
Col8a1
|
collagen type VIII alpha 1 chain
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of COL8A1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr11:56,245,998...56,378,586
Ensembl chr11:56,369,868...56,376,229
|
|
| G
|
Colec12
|
collectin sub-family member 12
|
increases expression decreases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of COLEC12 mRNA Calcitriol results in decreased expression of COLEC12 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of COLEC12 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr18:1,005,787...1,193,455
Ensembl chr18:1,005,741...1,195,297
|
|
| G
|
Comp
|
cartilage oligomeric matrix protein
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of COMP mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr16:19,081,172...19,089,548
Ensembl chr16:19,081,172...19,089,605
|
|
| G
|
Comt
|
catechol-O-methyltransferase
|
multiple interactions
|
ISO
|
[Calcitriol co-treated with VDR protein] results in increased expression of COMT mRNA; Calcitriol promotes the reaction [VDR protein binds to COMT promoter]
|
CTD |
PMID:27450565 |
|
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:96,072,489...96,092,533
|
|
| G
|
Coprs
|
coordinator of PRMT5 and differentiation stimulator
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of COPRS mRNA Calcitriol results in increased expression of COPRS mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:82,423,426...82,428,821
Ensembl chr16:82,407,580...82,431,737
|
|
| G
|
Copz2
|
COPI coat complex subunit zeta 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of COPZ2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:82,328,888...82,341,959
Ensembl chr10:82,328,660...82,341,959
|
|
| G
|
Coq3
|
coenzyme Q3 methyltransferase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of COQ3 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of COQ3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:40,226,313...40,257,383
Ensembl chr 5:40,226,368...40,257,617
|
|
| G
|
Coro1a
|
coronin 1A
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CORO1A mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:190,726,129...190,731,133
Ensembl chr 1:190,726,130...190,731,102
|
|
| G
|
Cox4i1
|
cytochrome c oxidase subunit 4i1
|
multiple interactions
|
EXP
|
[Calcitriol co-treated with bisphenol A] results in increased expression of COX4 protein
|
CTD |
PMID:30194976 |
|
NCBI chr19:65,630,383...65,636,623
Ensembl chr19:65,630,432...65,636,624
|
|
| G
|
Cox7b2
|
cytochrome c oxidase subunit 7B2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of COX7B2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of COX7B2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:37,047,081...37,159,288
Ensembl chr14:37,047,081...37,159,288
|
|
| G
|
Cp
|
ceruloplasmin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CP mRNA; Calcitriol results in increased expression of CP protein
|
CTD |
PMID:14996990 PMID:26485663 PMID:27107558 |
|
NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:104,368,456...104,427,087
|
|
| G
|
Cpa3
|
carboxypeptidase A3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CPA3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:104,641,619...104,673,253
Ensembl chr 2:104,641,621...104,673,237
|
|
| G
|
Cpa4
|
carboxypeptidase A4
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CPA4 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:60,155,675...60,179,644
Ensembl chr 4:60,118,682...60,183,448
|
|
| G
|
Cpap
|
centrosome assembly and centriole elongation protein
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CPAP mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CPAP mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:34,742,838...34,806,020
Ensembl chr15:34,742,838...34,802,421
|
|
| G
|
Cpd
|
carboxypeptidase D
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CPD mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:62,121,681...62,185,638
Ensembl chr10:62,121,679...62,185,638
|
|
| G
|
Cpeb2
|
cytoplasmic polyadenylation element binding protein 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CPEB2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CPEB2 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr14:71,999,958...72,056,012
Ensembl chr14:72,002,072...72,052,263
|
|
| G
|
Cpeb3
|
cytoplasmic polyadenylation element binding protein 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CPEB3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CPEB3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:244,161,690...244,343,765
Ensembl chr 1:244,161,690...244,343,561
|
|
| G
|
Cpne8
|
copine 8
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CPNE8 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:123,494,864...123,669,060
Ensembl chr 7:123,494,865...123,669,060
|
|
| G
|
Cpxm2
|
carboxypeptidase X (M14 family), member 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CPXM2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:196,266,930...196,377,350
Ensembl chr 1:196,266,930...196,377,347
|
|
| G
|
Cpz
|
carboxypeptidase Z
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CPZ mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr14:79,448,242...79,471,557
Ensembl chr14:79,448,139...79,471,556
|
|
| G
|
Crabp1
|
cellular retinoic acid binding protein 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CRABP1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 8:64,047,431...64,055,469
Ensembl chr 8:64,047,060...64,055,470
|
|
| G
|
Creb3
|
cAMP responsive element binding protein 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CREB3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CREB3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:62,613,652...62,619,019
Ensembl chr 5:62,613,638...62,619,500
|
|
| G
|
Creb3l1
|
cAMP responsive element binding protein 3-like 1
|
increases expression decreases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CREB3L1 mRNA Calcitriol results in decreased expression of CREB3L1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CREB3L1 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 3:98,408,240...98,449,104
Ensembl chr 3:98,408,058...98,449,104
|
|
| G
|
Crebbp
|
CREB binding protein
|
affects localization multiple interactions
|
ISO
|
Calcitriol affects the localization of CREBBP protein Calcitriol promotes the reaction [CREBBP protein binds to CYP24A1 promoter]; Calcitriol promotes the reaction [CREBBP protein binds to SPP1 promoter]
|
CTD |
PMID:15647825 |
|
NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,822,620...11,968,266
|
|
| G
|
Creg2
|
cellular repressor of E1A-stimulated genes 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CREG2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 9:49,367,693...49,441,133
Ensembl chr 9:49,399,114...49,440,985
|
|
| G
|
Crispld1
|
cysteine-rich secretory protein LCCL domain containing 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CRISPLD1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:6,050,970...6,098,265
Ensembl chr 5:6,051,891...6,098,265
|
|
| G
|
Crispld2
|
cysteine-rich secretory protein LCCL domain containing 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CRISPLD2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr19:64,961,764...65,020,099
Ensembl chr19:64,961,771...65,020,349
|
|
| G
|
Crlf1
|
cytokine receptor-like factor 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CRLF1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr16:18,958,695...18,970,026
Ensembl chr16:18,957,956...18,969,970
|
|
| G
|
Crls1
|
cardiolipin synthase 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CRLS1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:140,572,680...140,591,543
Ensembl chr 3:140,572,716...140,591,599
|
|
| G
|
Crp
|
C-reactive protein
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CRP protein
|
CTD |
PMID:21350317 |
|
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514
|
|
| G
|
Cryab
|
crystallin, alpha B
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CRYAB mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CRYAB mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:59,989,814...59,995,528
|
|
| G
|
Crybg3
|
crystallin beta-gamma domain containing 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CRYBG3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr11:54,218,399...54,330,962
Ensembl chr11:54,208,444...54,330,960
|
|
| G
|
Cse1l
|
chromosome segregation 1 like
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of CSE1L mRNA Calcitriol results in decreased expression of CSE1L mRNA
|
CTD |
PMID:12798352 PMID:21592394 |
|
NCBI chr 3:176,060,183...176,097,909
Ensembl chr 3:176,060,215...176,108,734
|
|
| G
|
Csf1
|
colony stimulating factor 1
|
increases expression multiple interactions decreases expression
|
ISO
|
Calcitriol results in increased expression of CSF1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CSF1 mRNA Calcitriol results in decreased expression of CSF1 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:198,065,405...198,084,468
|
|
| G
|
Csf1r
|
colony stimulating factor 1 receptor
|
increases expression increases response to substance multiple interactions
|
ISO
|
Calcitriol results in increased expression of CSF1R mRNA CSF1R results in increased susceptibility to Calcitriol CSF1R promotes the reaction [Calcitriol results in decreased phosphorylation of RB1 protein]
|
CTD |
PMID:9158000 PMID:12441127 |
|
NCBI chr18:56,834,152...56,860,804
Ensembl chr18:56,817,049...56,860,806
|
|
| G
|
Csf2
|
colony stimulating factor 2
|
decreases secretion decreases expression
|
ISO
|
Calcitriol results in decreased secretion of CSF2 protein Calcitriol results in decreased expression of CSF2 protein
|
CTD |
PMID:25458313 PMID:25773153 |
|
NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031
|
|
| G
|
Csf3r
|
colony stimulating factor 3 receptor
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CSF3R mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:143,583,126...143,604,382
Ensembl chr 5:143,583,213...143,602,411
|
|
| G
|
Csgalnact1
|
chondroitin sulfate N-acetylgalactosaminyltransferase 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CSGALNACT1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CSGALNACT1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:25,761,946...26,097,306
Ensembl chr16:26,002,530...26,096,065
|
|
| G
|
Csk
|
C-terminal Src kinase
|
multiple interactions increases phosphorylation
|
ISO
|
Calcitriol results in increased localization of [VDR protein co-treated with CSK protein]; CSK protein promotes the reaction [Calcitriol results in decreased expression of CYP7A1 mRNA]; CSK protein promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA] Calcitriol results in increased phosphorylation of CSK protein
|
CTD |
PMID:20371703 |
|
NCBI chr 8:66,925,650...66,944,861
Ensembl chr 8:66,925,651...66,930,274
|
|
| G
|
Csmd2
|
CUB and Sushi multiple domains 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CSMD2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:145,626,823...146,196,815
Ensembl chr 5:145,626,845...146,196,812
|
|
| G
|
Csrnp1
|
cysteine and serine rich nuclear protein 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of CSRNP1 mRNA Calcitriol results in increased expression of CSRNP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:128,582,364...128,594,163
Ensembl chr 8:128,582,365...128,588,469
|
|
| G
|
Csrnp2
|
cysteine and serine rich nuclear protein 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CSRNP2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:133,473,027...133,488,868
Ensembl chr 7:133,473,027...133,488,868
|
|
| G
|
Cst6
|
cystatin E/M
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CST6 mRNA
|
CTD |
PMID:12040012 PMID:16002434 |
|
NCBI chr 1:212,084,676...212,086,384
Ensembl chr 1:212,084,676...212,086,384
|
|
| G
|
Cthrc1
|
collagen triple helix repeat containing 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CTHRC1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:72,007,372...72,017,654
Ensembl chr 7:72,007,372...72,017,654
|
|
| G
|
Ctnna1
|
catenin alpha 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CTNNA1 mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr18:27,002,330...27,135,009
Ensembl chr18:26,999,820...27,135,007
|
|
| G
|
Ctnna2
|
catenin alpha 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CTNNA2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CTNNA2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:110,852,265...112,001,351
Ensembl chr 4:110,852,265...112,001,365
|
|
| G
|
Ctnnb1
|
catenin beta 1
|
multiple interactions decreases activity
|
ISO
|
[Calcitriol binds to VDR protein] which results in decreased activity of CTNNB1 mRNA; Calcitriol inhibits the reaction [CTNNB1 protein results in increased expression of DKK4 mRNA]; Calcitriol promotes the reaction [CTNNB1 protein binds to VDR protein] Calcitriol results in decreased activity of CTNNB1 protein
|
CTD |
PMID:16051482 PMID:20043299 |
|
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662
|
|
| G
|
Ctsb
|
cathepsin B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CTSB; Calcitriol results in increased expression of CTSB mRNA; Calcitriol results in increased expression of CTSB protein
|
CTD |
PMID:8593782 PMID:9528999 PMID:15951637 PMID:16847355 |
|
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478
|
|
| G
|
Ctsk
|
cathepsin K
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CTSK mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:185,747,548...185,758,512
Ensembl chr 2:185,747,165...185,765,582
|
|
| G
|
Ctsl
|
cathepsin L
|
multiple interactions
|
ISO
|
Calcitriol inhibits the reaction [Dexamethasone results in increased expression of CTSL mRNA]
|
CTD |
PMID:29962435 |
|
NCBI chr17:770,104...776,266
Ensembl chr17:770,093...777,113
|
|
| G
|
Ctu2
|
cytosolic thiouridylase subunit 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CTU2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of CTU2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:67,447,762...67,453,169
Ensembl chr19:67,447,487...67,453,163
|
|
| G
|
Cul3
|
cullin 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CUL3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 9:89,040,987...89,118,775
Ensembl chr 9:89,040,987...89,118,427
|
|
| G
|
Cxadr
|
CXADR, Ig-like cell adhesion molecule
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of CXADR mRNA Calcitriol results in increased expression of CXADR mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr11:30,469,778...30,516,990
Ensembl chr11:30,469,526...30,516,988
|
|
| G
|
Cxcl1
|
C-X-C motif chemokine ligand 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CXCL1 mRNA; Calcitriol results in decreased expression of CXCL1 protein
|
CTD |
PMID:22615136 |
|
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811
|
|
| G
|
Cxcl11
|
C-X-C motif chemokine ligand 11
|
increases expression multiple interactions decreases expression
|
ISO
|
Calcitriol results in increased expression of CXCL11 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CXCL11 mRNA Calcitriol results in decreased expression of CXCL11 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr14:15,973,728...15,976,503
Ensembl chr14:15,973,720...15,976,567
|
|
| G
|
Cxcl14
|
C-X-C motif chemokine ligand 14
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CXCL14 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr17:8,323,150...8,331,176
Ensembl chr17:8,323,143...8,331,172
|
|
| G
|
Cxcl17
|
C-X-C motif chemokine ligand 17
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CXCL17 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:90,112,561...90,124,648
Ensembl chr 1:90,112,771...90,124,535
|
|
| G
|
Cxcl2
|
C-X-C motif chemokine ligand 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CXCL2 mRNA; Calcitriol results in decreased expression of CXCL2 protein Calcitriol inhibits the reaction [Bleomycin results in increased expression of CXCL2 mRNA]
|
CTD |
PMID:22615136 PMID:26520185 |
|
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
|
|
| G
|
Cxcl3
|
C-X-C motif chemokine ligand 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CXCL1 mRNA; Calcitriol results in decreased expression of CXCL1 protein
|
CTD |
PMID:22615136 |
|
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624
|
|
| G
|
Cxcr4
|
C-X-C motif chemokine receptor 4
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CXCR4 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CXCR4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459
|
|
| G
|
Cyb561d1
|
cytochrome b561 family, member D1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CYB561D1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CYB561D1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:198,523,031...198,525,671
Ensembl chr 2:198,523,031...198,525,676
|
|
| G
|
Cyb561d2
|
cytochrome b561 family, member D2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CYB561D2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CYB561D2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:117,091,844...117,094,434
Ensembl chr 8:117,091,845...117,094,366
|
|
| G
|
Cyb5r2
|
cytochrome b5 reductase 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CYB5R2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:171,062,083...171,076,183
Ensembl chr 1:171,067,614...171,075,904
|
|
| G
|
Cyb5r4
|
cytochrome b5 reductase 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CYB5R4 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:96,860,415...96,925,789
Ensembl chr 8:96,861,090...96,926,094
|
|
| G
|
Cyba
|
cytochrome b-245 alpha chain
|
decreases expression
|
EXP
|
Calcitriol results in decreased expression of CYBA mRNA; Calcitriol results in decreased expression of CYBA protein
|
CTD |
PMID:32147540 |
|
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214
|
|
| G
|
Cybb
|
cytochrome b-245 beta chain
|
decreases expression
|
EXP
|
Calcitriol results in decreased expression of CYBB mRNA; Calcitriol results in decreased expression of CYBB protein
|
CTD |
PMID:32147540 |
|
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:16,030,596...16,065,065
|
|
| G
|
Cycs
|
cytochrome c, somatic
|
multiple interactions
|
ISO
|
Calcitriol inhibits the reaction [bisphenol A results in increased expression of CYCS mRNA]
|
CTD |
PMID:38421590 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816 Ensembl chr18:80,982,668...80,984,816
|
|
| G
|
Cyp11a1
|
cytochrome P450, family 11, subfamily a, polypeptide 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of CYP11A1 mRNA Calcitriol results in increased expression of CYP11A1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196
|
|
| G
|
Cyp19a1
|
cytochrome P450, family 19, subfamily a, polypeptide 1
|
multiple interactions increases expression increases activity
|
ISO
|
Calcitriol promotes the reaction [Dexamethasone results in increased activity of CYP19A1 protein] Calcitriol results in increased expression of CYP19A1 mRNA Calcitriol results in increased activity of CYP19A1 protein
|
CTD |
PMID:15862960 PMID:16002434 |
|
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917
|
|
| G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
multiple interactions increases expression
|
ISO
|
(25S)-26-adamantyl-25-hydroxy-2-methylene-22,23-didehydro-19,27-dinor-20-epi-vitamin D3 inhibits the reaction [Calcitriol promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]]; [Benzo(a)pyrene co-treated with Calcitriol] results in increased expression of CYP1A1 mRNA; alpha-naphthoflavone inhibits the reaction [Calcitriol promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]]; Benzo(a)pyrene affects the reaction [Calcitriol promotes the reaction [VDR protein binds to CYP1A1 promoter]]; Calcitriol affects the reaction [Benzo(a)pyrene results in increased activity of CYP1A1 protein]; Calcitriol promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; Calcitriol promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein]; Calcitriol promotes the reaction [CYP1A1 protein results in increased chemical synthesis of benzo(a)pyrene-DNA adduct]; Calcitriol promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; Calcitriol promotes the reaction [VDR protein binds to CYP1A1 promoter]; Cycloheximide promotes the reaction [[Benzo(a)pyrene co-treated with Calcitriol] results in increased expression of CYP1A1 mRNA]; VDR mutant form inhibits the reaction [Calcitriol promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]] Calcitriol results in increased expression of CYP1A1 mRNA
|
CTD |
PMID:19070657 PMID:22837390 PMID:26485663 PMID:27107558 PMID:29524502 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
| G
|
Cyp24a1
|
cytochrome P450, family 24, subfamily a, polypeptide 1
|
increases expression multiple interactions increases metabolic processing affects abundance increases activity increases response to substance affects expression increases degradation
|
ISO EXP
|
Calcitriol analog results in increased expression of CYP24A1; Calcitriol results in increased expression of CYP24A1; Calcitriol results in increased expression of CYP24A1 mRNA; Calcitriol results in increased expression of CYP24A1 protein Calcitriol affects the expression of and affects the activity of CYP24A1 protein; Calcitriol promotes the reaction [CREBBP protein binds to CYP24A1 promoter]; Calcitriol promotes the reaction [EP300 protein binds to CYP24A1 promoter]; Calcitriol promotes the reaction [MED1 protein binds to CYP24A1 promoter]; Calcitriol promotes the reaction [NCOA1 protein binds to CYP24A1 promoter]; Calcitriol promotes the reaction [NCOA2 protein binds to CYP24A1 promoter]; Calcitriol promotes the reaction [NCOA3 protein binds to CYP24A1 promoter]; Calcitriol promotes the reaction [RXRA protein binds to CYP24A1 promoter]; Calcitriol promotes the reaction [VDR protein binds to CYP24A1 promoter]; Ketoconazole promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA] [Benzo(a)pyrene co-treated with Calcitriol] results in increased expression of CYP24A1 mRNA; [Calcitriol binds to and results in increased activity of VDR protein] which results in increased expression of CYP24A1 mRNA; [Calcitriol co-treated with NR1I2 protein] results in increased expression of CYP24A1 mRNA; [Calcitriol co-treated with VDR protein] results in increased expression of CYP24A1 mRNA; [Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] which results in increased expression of CYP24A1 mRNA; [Ketoconazole results in decreased metabolism of Calcitriol] which results in increased expression of CYP24A1 mRNA; [Testosterone co-treated with Calcitriol] results in increased expression of CYP24A1 mRNA; alpha-Linolenic Acid inhibits the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [Calcitriol promotes the reaction [VDR protein binds to CYP24A1 promoter]]]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]]; alpha-naphthoflavone inhibits the reaction [Cycloheximide promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]]; Benzo(a)pyrene inhibits the reaction [Calcitriol promotes the reaction [RXRA protein binds to CYP24A1 promoter]]; Benzo(a)pyrene inhibits the reaction [Calcitriol promotes the reaction [VDR protein binds to CYP24A1 promoter]]; Benzo(a)pyrene promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]; Benzo(a)pyrene promotes the reaction [CYP24A1 protein results in increased degradation of Calcitriol]; Bezafibrate inhibits the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]; BMS453 inhibits the reaction [Tretinoin inhibits the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]]; Calcitriol inhibits the reaction [NCOR2 protein binds to CYP24A1 promoter]; Calcitriol promotes the reaction [[VDR protein binds to MED1 protein] which binds to CYP24A1 promoter]; Calcitriol promotes the reaction [[VDR protein binds to NCOA3 protein] which binds to CYP24A1 promoter]; Calcitriol promotes the reaction [[VDR protein binds to RXRA protein] which binds to CYP24A1 promoter]; Calcitriol promotes the reaction [HNF4A protein binds to CYP24A1 mRNA]; Calcitriol promotes the reaction [NCOA1 protein binds to CYP24A1 promoter]; Calcitriol promotes the reaction [NCOR1 protein binds to CYP24A1 mRNA]; Calcitriol promotes the reaction [NCOR2 protein binds to CYP24A1 mRNA]; Calcitriol promotes the reaction [RXRA protein binds to CYP24A1 mRNA]; Calcitriol promotes the reaction [RXRA protein binds to CYP24A1 promoter]; Calcitriol promotes the reaction [VDR protein binds to CYP24A1 mRNA]; Calcitriol promotes the reaction [VDR protein binds to CYP24A1 promoter]; CSK protein promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]; Cycloheximide inhibits the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]; CYP24A1 gene mutant form results in decreased metabolism of and results in increased abundance of Calcitriol; CYP24A1 protein results in increased metabolism of and results in decreased susceptibility to Calcitriol; Dihydrotestosterone inhibits the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]; Docosahexaenoic Acids promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]; Genistein inhibits the reaction [Calcitriol results in increased activity of CYP24A1 protein]; Genistein inhibits the reaction [CYP24A1 protein results in increased degradation of Calcitriol]; Genistein promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]; GW 501516 inhibits the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]; HR protein inhibits the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]; Ketoconazole promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]; lactacystin promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]; Methylcholanthrene promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]; NCOR1 protein inhibits the reaction [[Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] which results in increased expression of CYP24A1 mRNA]; NCOR2 protein inhibits the reaction [[Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] which results in increased expression of CYP24A1 mRNA]; perfluorooctanoic acid inhibits the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]; PPARGC1A protein promotes the reaction [[Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] which results in increased expression of CYP24A1 mRNA]; RELA protein promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]; saracatinib inhibits the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]; tamibarotene inhibits the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]; Tetrachlorodibenzodioxin promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]; Tetradecanoylphorbol Acetate promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]; Tretinoin inhibits the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]; trichostatin A promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]; trichostatin A promotes the reaction [Valproic Acid promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [NCOR2 protein binds to CYP24A1 mRNA]]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [VDR protein binds to CYP24A1 mRNA]]; Valproic Acid promotes the reaction [[Calcitriol co-treated with VDR protein] results in increased expression of CYP24A1 mRNA]; Valproic Acid promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA] CYP24A1 protein results in increased metabolism of Calcitriol CYP24A1 protein affects the abundance of Calcitriol [Calcium co-treated with Calcitriol] affects the expression of CYP24A1 mRNA; [Ketoconazole co-treated with Calcitriol] results in increased expression of CYP24A1 mRNA; Ketoconazole inhibits the reaction [Calcitriol results in increased activity of CYP24A1 protein] CYP24A1 protein results in increased susceptibility to Calcitriol Calcitriol affects the expression of CYP24A1 mRNA; Calcitriol affects the expression of CYP24A1 protein
|
CTD |
PMID:7530193 PMID:8164439 PMID:10694374 PMID:10927029 PMID:11796525 PMID:12846736 PMID:14996990 PMID:15489543 PMID:15538745 PMID:15647825 PMID:15867263 PMID:15890193 PMID:15913539 PMID:15919092 PMID:15955619 PMID:15992766 PMID:16002434 PMID:16039846 PMID:16061850 PMID:16289102 PMID:16365879 PMID:16483768 PMID:16824767 PMID:17035339 PMID:17244627 PMID:18180267 PMID:18840526 PMID:19106115 PMID:19244278 PMID:19667147 PMID:19667161 PMID:20206692 PMID:20371703 PMID:21115105 PMID:21542014 PMID:21592394 PMID:21917910 PMID:22337913 PMID:22466564 PMID:22751936 PMID:22837390 PMID:24039193 PMID:24792400 PMID:26038696 PMID:26485663 PMID:26704532 PMID:27107558 PMID:29524502 PMID:33033332 More...
|
|
NCBI chr 3:179,694,647...179,709,083
Ensembl chr 3:179,694,647...179,709,083
|
|
| G
|
Cyp26a1
|
cytochrome P450, family 26, subfamily a, polypeptide 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CYP26A1 mRNA
|
CTD |
PMID:27107558 |
|
NCBI chr 1:244,883,822...244,887,657
Ensembl chr 1:244,883,752...244,887,657
|
|
| G
|
Cyp26b1
|
cytochrome P450, family 26, subfamily b, polypeptide 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CYP26B1 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 4:118,599,356...118,616,176
Ensembl chr 4:118,599,356...118,616,176
|
|
| G
|
Cyp27a1
|
cytochrome P450, family 27, subfamily a, polypeptide 1
|
increases expression decreases expression
|
EXP ISO
|
Calcitriol results in increased expression of CYP27A1 protein Calcitriol results in decreased expression of CYP27A1 mRNA
|
CTD |
PMID:8164439 PMID:26485663 |
|
NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:83,713,293...83,743,215
|
|
| G
|
Cyp27b1
|
cytochrome P450, family 27, subfamily b, polypeptide 1
|
increases expression increases chemical synthesis decreases chemical synthesis multiple interactions affects abundance affects expression
|
ISO EXP
|
Calcitriol results in increased expression of CYP27B1 mRNA CYP27B1 protein results in increased chemical synthesis of Calcitriol CYP27B1 gene mutant form results in decreased chemical synthesis of Calcitriol GH1 protein affects the reaction [CYP27B1 protein affects the abundance of Calcitriol] Calcitriol affects the expression of CYP27B1 protein
|
CTD |
PMID:11316734 PMID:11796525 PMID:12846736 PMID:16061850 PMID:16494812 PMID:21542014 More...
|
|
NCBI chr 7:64,756,626...64,761,570
Ensembl chr 7:64,756,626...64,761,570
|
|
| G
|
Cyp2a3
|
cytochrome P450, family 2, subfamily a, polypeptide 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CYP2A7 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CYP2A7 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:91,299,584...91,307,650
Ensembl chr 1:91,299,561...91,307,649
|
|
| G
|
Cyp2c6
|
cytochrome P450, family 2, subfamily C, polypeptide 6
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CYP2C19 mRNA
|
CTD |
PMID:27107558 |
|
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
|
|
| G
|
Cyp2s1
|
cytochrome P450, family 2, subfamily s, polypeptide 1
|
decreases expression multiple interactions increases expression
|
ISO
|
Calcitriol results in decreased expression of CYP2S1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CYP2S1 mRNA Calcitriol results in increased expression of CYP2S1 mRNA
|
CTD |
PMID:16002434 PMID:21592394 PMID:27107558 |
|
NCBI chr 1:90,437,741...90,453,073
Ensembl chr 1:90,438,224...90,453,073
|
|
| G
|
Cyp2u1
|
cytochrome P450, family 2, subfamily u, polypeptide 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of CYP2U1 mRNA Calcitriol results in increased expression of CYP2U1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:222,523,516...222,541,055
Ensembl chr 2:222,523,518...222,541,124
|
|
| G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
multiple interactions increases activity increases expression
|
EXP ISO
|
Chenodeoxycholic Acid inhibits the reaction [Calcitriol results in increased expression of CYP3A2 mRNA] Calcitriol results in increased activity of CYP3A4 protein [Calcitriol results in increased expression of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; Calcitriol results in increased expression of CYP3A4 mRNA; Calcitriol results in increased expression of CYP3A4 protein 2-acetyltributylcitrate promotes the reaction [Calcitriol results in increased expression of CYP3A4 mRNA]; [Calcitriol binds to and results in increased activity of VDR protein] which results in increased expression of CYP3A4 mRNA; Ajmaline inhibits the reaction [Calcitriol results in increased expression of CYP3A4 protein]; Calcitriol promotes the reaction [2-acetyltributylcitrate results in increased activity of CYP3A4 protein]; Calcitriol promotes the reaction [2-acetyltributylcitrate results in increased expression of CYP3A4 mRNA]; Calcitriol promotes the reaction [Rifampin results in increased activity of CYP3A4 protein]; Calcitriol promotes the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; Calcitriol results in increased expression of and results in increased activity of CYP3A4 protein; chrysin inhibits the reaction [Calcitriol results in increased activity of CYP3A4 protein]; Curcumin inhibits the reaction [Calcitriol results in increased expression of and results in increased activity of CYP3A4 protein]; Curcumin inhibits the reaction [Calcitriol results in increased expression of CYP3A4 mRNA]; Genistein inhibits the reaction [Calcitriol results in increased activity of CYP3A4 protein]; Ketoconazole inhibits the reaction [Calcitriol results in increased expression of CYP3A4 protein]; Plant Extracts inhibits the reaction [Calcitriol results in increased expression of CYP3A4 protein]; pyrazolanthrone inhibits the reaction [Calcitriol results in increased expression of CYP3A4 mRNA]; Quercetin inhibits the reaction [Calcitriol results in increased activity of CYP3A4 protein]; raubasine inhibits the reaction [Calcitriol results in increased expression of CYP3A4 protein]; reserpic acid inhibits the reaction [Calcitriol results in increased expression of CYP3A4 protein]; Reserpine inhibits the reaction [Calcitriol results in increased expression of CYP3A4 protein]; Rifampin promotes the reaction [Calcitriol results in increased expression of CYP3A4 mRNA]; Staurosporine inhibits the reaction [Calcitriol results in increased expression of CYP3A4 mRNA]; VDR protein affects the reaction [Calcitriol results in increased expression of CYP3A4 mRNA]; Yohimbine analog inhibits the reaction [Calcitriol results in increased expression of CYP3A4 protein]
|
CTD |
PMID:11723248 PMID:15489543 PMID:15578590 PMID:15992766 PMID:17270371 PMID:17965521 PMID:19562681 PMID:19766177 PMID:20006981 PMID:21742782 PMID:22687401 PMID:26366751 PMID:27107558 PMID:29782822 More...
|
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
| G
|
Cyp3a23-3a1
|
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
|
increases expression multiple interactions
|
EXP
|
Calcitriol results in increased expression of CYP3A23-3A1 mRNA Chenodeoxycholic Acid inhibits the reaction [Calcitriol results in increased expression of CYP3A23-3A1 mRNA]
|
CTD |
PMID:20006981 |
|
NCBI chr12:14,369,950...14,398,803
Ensembl chr12:14,368,266...14,398,813
|
|
| G
|
Cyp3a9
|
cytochrome P450, family 3, subfamily a, polypeptide 9
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CYP3A5 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CYP3A5 mRNA
|
CTD |
PMID:16002434 PMID:21592394 PMID:27107558 |
|
NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154
|
|
| G
|
Cyp4b1
|
cytochrome P450, family 4, subfamily b, polypeptide 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CYP4B1 mRNA
|
CTD |
PMID:27107558 |
|
NCBI chr 5:134,375,807...134,413,635
Ensembl chr 5:134,375,807...134,393,116
|
|
| G
|
Cyp4f39
|
cytochrome P450, family 4, subfamily f, polypeptide 39
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CYP4F22 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:12,082,821...12,156,076
Ensembl chr 7:12,083,888...12,156,076
|
|
| G
|
Cyp4f40
|
cytochrome P450, family 4, subfamily f, polypeptide 40
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CYP4F11 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:12,342,121...12,357,974
Ensembl chr 7:12,342,590...12,356,733
|
|
| G
|
Cyp4x1
|
cytochrome P450, family 4, subfamily x, polypeptide 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CYP4X1 mRNA
|
CTD |
PMID:27107558 |
|
NCBI chr 5:133,888,439...133,923,254
Ensembl chr 5:133,888,439...133,919,642
|
|
| G
|
Cyp7a1
|
cytochrome P450 family 7 subfamily A member 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of CYP7A1 mRNA 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol results in decreased expression of CYP7A1 mRNA]; [Calcitriol binds to and results in increased activity of VDR protein] promotes the reaction [VDR protein binds to CYP7A1 promoter]; [Calcitriol binds to and results in increased activity of VDR protein] which results in decreased expression of CYP7A1 mRNA; [Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] inhibits the reaction [PPARGC1A protein results in increased expression of CYP7A1 mRNA]; [Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] which results in decreased expression of CYP7A1 mRNA; Calcitriol inhibits the reaction [HNF4A protein binds to CYP7A1 mRNA]; Calcitriol inhibits the reaction [HNF4A protein binds to CYP7A1 promoter]; Calcitriol inhibits the reaction [NCOA2 protein binds to CYP7A1 mRNA]; Calcitriol inhibits the reaction [NCOA2 protein binds to CYP7A1 promoter]; Calcitriol inhibits the reaction [PPARGC1A protein binds to CYP7A1 mRNA]; Calcitriol inhibits the reaction [PPARGC1A protein binds to CYP7A1 promoter]; Calcitriol promotes the reaction [NCOR1 protein binds to CYP7A1 mRNA]; Calcitriol promotes the reaction [NCOR1 protein binds to CYP7A1 promoter]; Calcitriol promotes the reaction [NCOR2 protein binds to CYP7A1 mRNA]; Calcitriol promotes the reaction [NCOR2 protein binds to CYP7A1 promoter]; Calcitriol promotes the reaction [RXRA protein binds to CYP7A1 mRNA]; Calcitriol promotes the reaction [VDR protein binds to CYP7A1 mRNA]; CSK protein promotes the reaction [Calcitriol results in decreased expression of CYP7A1 mRNA]; NCOR1 protein promotes the reaction [[Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] inhibits the reaction [PPARGC1A protein results in increased expression of CYP7A1 mRNA]]; NCOR2 protein promotes the reaction [[Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] inhibits the reaction [PPARGC1A protein results in increased expression of CYP7A1 mRNA]]; Okadaic Acid promotes the reaction [Calcitriol results in decreased expression of CYP7A1 mRNA]; saracatinib inhibits the reaction [Calcitriol results in decreased expression of CYP7A1 mRNA]; U 0126 inhibits the reaction [Calcitriol inhibits the reaction [HNF4A protein binds to CYP7A1 mRNA]]; U 0126 inhibits the reaction [Calcitriol inhibits the reaction [PPARGC1A protein binds to CYP7A1 mRNA]]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [NCOR1 protein binds to CYP7A1 mRNA]]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [NCOR2 protein binds to CYP7A1 mRNA]]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [RXRA protein binds to CYP7A1 mRNA]]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [VDR protein binds to CYP7A1 mRNA]]; U 0126 inhibits the reaction [Calcitriol results in decreased expression of CYP7A1 mRNA]
|
CTD |
PMID:19106115 PMID:20371703 |
|
NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202
|
|
| G
|
Cyp7b1
|
cytochrome P450 family 7 subfamily B member 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CYP7B1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:102,419,011...102,586,047
Ensembl chr 2:102,419,011...102,451,804
|
|
| G
|
Cyria
|
CYFIP related Rac1 interactor A
|
increases expression
|
ISO
|
Calcitriol results in increased expression of CYRIA mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:40,774,165...40,883,005
Ensembl chr 6:40,774,171...40,881,860
|
|
| G
|
Cysrt1
|
cysteine rich tail 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of CYSRT1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:28,452,359...28,456,006
Ensembl chr 3:28,451,219...28,456,118
|
|
| G
|
Cystm1
|
cysteine-rich transmembrane module containing 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of CYSTM1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of CYSTM1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:28,219,861...28,287,574
Ensembl chr18:28,220,004...28,287,574
|
|
| G
|
Dab2ip
|
DAB2 interacting protein
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of DAB2IP mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:39,312,745...39,483,730
Ensembl chr 3:39,312,745...39,483,730
|
|
| G
|
Dact3
|
dishevelled-binding antagonist of beta-catenin 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of DACT3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:86,674,989...86,686,722
Ensembl chr 1:86,674,734...86,687,421
|
|
| G
|
Dapk1
|
death associated protein kinase 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of DAPK1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of DAPK1 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr17:3,935,826...4,096,858
Ensembl chr17:3,935,625...4,096,581
|
|
| G
|
Dapk2
|
death-associated protein kinase 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of DAPK2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of DAPK2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:75,601,621...75,720,619
Ensembl chr 8:75,601,634...75,720,617
|
|
| G
|
Dbf4
|
DBF4-CDC7 kinase regulatory subunit
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of DBF4 mRNA Calcitriol results in decreased expression of DBF4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:26,631,491...26,656,080
Ensembl chr 4:26,631,514...26,656,562
|
|
| G
|
Dbf4b
|
DBF4B-CDC7 kinase regulatory subunit
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of DBF4B mRNA Calcitriol results in decreased expression of DBF4B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:88,209,913...88,219,336
|
|
| G
|
Dbndd1
|
dysbindin domain containing 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DBNDD1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr19:68,447,641...68,461,272
Ensembl chr19:68,447,635...68,458,797
|
|
| G
|
Dcbld2
|
discoidin, CUB and LCCL domain containing 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DCBLD2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr11:55,594,691...55,649,113
Ensembl chr11:55,594,691...55,649,085
|
|
| G
|
Dcn
|
decorin
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of DCN mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:34,163,011...34,218,926
|
|
| G
|
Ddb2
|
damage specific DNA binding protein 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of DDB2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of DDB2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:97,640,923...97,667,617
Ensembl chr 3:97,640,579...97,664,066
|
|
| G
|
Ddias
|
DNA damage-induced apoptosis suppressor
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of DDIAS mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of DDIAS mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:156,318,559...156,342,869
Ensembl chr 1:156,318,563...156,342,869
|
|
| G
|
Ddit3
|
DNA-damage inducible transcript 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of DDIT3 mRNA [salinomycin co-treated with Calcitriol] results in increased expression of DDIT3 mRNA; Calcitriol promotes the reaction [salinomycin results in increased expression of DDIT3 mRNA]
|
CTD |
PMID:16322758 PMID:35914560 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
| G
|
Ddr1
|
discoidin domain receptor tyrosine kinase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DDR1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr20:3,047,269...3,069,277
Ensembl chr20:3,050,375...3,069,276
|
|
| G
|
Ddx11
|
DEAD/H-box helicase 11
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of DDX11 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of DDX11 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:113,204,886...113,309,692
Ensembl chr 9:113,276,985...113,316,152
|
|
| G
|
Ddx39a
|
DExD-box helicase 39A
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of DDX39A mRNA Calcitriol results in decreased expression of DDX39A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:41,323,465...41,331,413
Ensembl chr19:41,322,836...41,332,306
|
|
| G
|
Def8
|
differentially expressed in FDCP 8 homolog
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DEF8 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr19:68,383,293...68,404,133
Ensembl chr19:68,383,349...68,404,125
|
|
| G
|
Defb1
|
defensin beta 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DEFB1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr16:77,001,326...77,016,068
Ensembl chr16:77,001,326...77,016,068
|
|
| G
|
Dek
|
DEK proto-oncogene
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of DEK mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of DEK mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:17,786,989...17,809,096
Ensembl chr17:17,787,139...17,810,122
|
|
| G
|
Dennd1b
|
DENN domain containing 1B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DENND1B mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:53,096,717...53,324,372
Ensembl chr13:53,092,261...53,324,369
|
|
| G
|
Dennd1c
|
DENN domain containing 1C
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of DENND1C mRNA [Testosterone co-treated with Calcitriol] results in increased expression of DENND1C mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:1,991,035...2,003,330
Ensembl chr 9:1,991,039...2,003,151
|
|
| G
|
Dennd4c
|
DENN domain containing 4C
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DENND4C mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:106,316,942...106,421,484
Ensembl chr 5:106,318,281...106,415,489
|
|
| G
|
Dennd6b
|
DENN domain containing 6B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DENND6B mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:122,139,159...122,154,720
Ensembl chr 7:122,141,317...122,153,131
|
|
| G
|
Depdc1
|
DEP domain containing 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of DEPDC1 mRNA Calcitriol results in decreased expression of DEPDC1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:251,343,250...251,376,709
Ensembl chr 2:251,343,281...251,376,709
|
|
| G
|
Depdc1b
|
DEP domain containing 1B
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of DEPDC1B mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of DEPDC1B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:41,605,686...41,697,207
Ensembl chr 2:41,624,922...41,697,202
|
|
| G
|
Depp1
|
DEPP autophagy regulator 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of DEPP1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of DEPP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:151,583,105...151,585,455
Ensembl chr 4:151,581,502...151,586,233
|
|
| G
|
Derl3
|
derlin 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of DERL3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr20:12,753,926...12,766,478
Ensembl chr20:12,762,981...12,766,477
|
|
| G
|
Dffb
|
DNA fragmentation factor subunit beta
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of DFFB mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of DFFB mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:169,804,873...169,817,157
Ensembl chr 5:169,804,889...169,817,225
|
|
| G
|
Dgat2
|
diacylglycerol O-acyltransferase 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DGAT2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:162,866,237...162,896,655
Ensembl chr 1:162,866,237...162,896,566
|
|
| G
|
Dgka
|
diacylglycerol kinase, alpha
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of DGKA mRNA Calcitriol results in increased expression of DGKA mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:1,733,247...1,761,181
Ensembl chr 7:1,733,248...1,759,569
|
|
| G
|
Dgkh
|
diacylglycerol kinase, eta
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of DGKH mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of DGKH mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:60,390,279...60,559,777
Ensembl chr15:60,402,004...60,560,218
|
|
| G
|
Dhcr24
|
24-dehydrocholesterol reductase
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DHCR24 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:126,573,366...126,599,940
Ensembl chr 5:126,573,338...126,599,936
|
|
| G
|
Dhcr7
|
7-dehydrocholesterol reductase
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DHCR7 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:208,444,434...208,460,408
Ensembl chr 1:208,444,434...208,461,382
|
|
| G
|
Dhrs2
|
dehydrogenase/reductase 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of DHRS2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of DHRS2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:32,658,855...32,673,591
Ensembl chr15:32,659,223...32,673,588
|
|
| G
|
Dhrs3
|
dehydrogenase/reductase 3
|
decreases expression multiple interactions increases expression
|
ISO
|
Calcitriol results in decreased expression of DHRS3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of DHRS3 mRNA Calcitriol results in increased expression of DHRS3 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 5:162,031,853...162,065,655
Ensembl chr 5:162,031,386...162,065,653
|
|
| G
|
Diaph3
|
diaphanous-related formin 3
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of DIAPH3 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of DIAPH3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:68,951,992...69,421,623
Ensembl chr15:68,951,989...69,421,552
|
|
| G
|
Dio2
|
iodothyronine deiodinase 2
|
increases activity
|
ISO
|
Calcitriol results in increased activity of DIO2 protein
|
CTD |
PMID:15471965 |
|
NCBI chr 6:115,396,308...115,410,594
Ensembl chr 6:115,396,308...115,410,594
|
|
| G
|
Dis3l2
|
DIS3-like 3'-5' exoribonuclease 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of DIS3L2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of DIS3L2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:94,802,056...95,184,523
Ensembl chr 9:94,804,382...95,184,522
|
|
| G
|
Disp1
|
dispatched RND transporter family member 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of DISP1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of DISP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:97,252,574...97,398,329
Ensembl chr13:97,252,574...97,398,460
|
|
| G
|
Dkk4
|
dickkopf WNT signaling pathway inhibitor 4
|
multiple interactions
|
ISO
|
Calcitriol inhibits the reaction [CTNNB1 protein results in increased expression of DKK4 mRNA]
|
CTD |
PMID:20043299 |
|
NCBI chr16:76,105,679...76,109,044
Ensembl chr16:76,105,679...76,109,044
|
|
| G
|
Dlgap1
|
DLG associated protein 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DLGAP1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 9:117,304,144...118,173,463
Ensembl chr 9:117,614,061...118,173,463
|
|
| G
|
Dlgap5
|
DLG associated protein 5
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of DLGAP5 mRNA Calcitriol results in decreased expression of DLGAP5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:23,113,678...23,144,281
Ensembl chr15:23,113,678...23,144,176
|
|
| G
|
Dlk2
|
delta like non-canonical Notch ligand 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of DLK2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 9:22,174,667...22,179,149
Ensembl chr 9:22,173,158...22,179,149
|
|
| G
|
Dmbx1
|
diencephalon/mesencephalon homeobox 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of DMBX1 mRNA Calcitriol results in decreased expression of DMBX1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:134,630,968...134,639,781
Ensembl chr 5:134,630,968...134,639,781
|
|
| G
|
Dmgdh
|
dimethylglycine dehydrogenase
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of DMGDH mRNA Calcitriol results in increased expression of DMGDH mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:26,647,540...26,722,496
Ensembl chr 2:26,647,565...26,723,071
|
|
| G
|
Dmkn
|
dermokine
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DMKN mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:95,140,737...95,158,676
Ensembl chr 1:95,141,620...95,157,439
|
|
| G
|
Dnajb14
|
DnaJ heat shock protein family (Hsp40) member B14
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of DNAJB14 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of DNAJB14 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:229,032,415...229,075,905
Ensembl chr 2:229,032,286...229,075,922
|
|
| G
|
Dnajb3
|
DnaJ heat shock protein family (Hsp40) member B3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of DNAJB3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of DNAJB3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:96,243,345...96,244,358
Ensembl chr 9:96,243,071...96,244,408
|
|
| G
|
Dnajc3
|
DnaJ heat shock protein family (Hsp40) member C3
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of DNAJC3 mRNA Calcitriol results in increased expression of DNAJC3 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr15:102,432,667...102,475,643
Ensembl chr15:102,432,663...102,475,643
|
|
| G
|
Dnajc9
|
DnaJ heat shock protein family (Hsp40) member C9
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of DNAJC9 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of DNAJC9 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:3,970,843...4,003,009
Ensembl chr15:3,970,114...3,977,304
|
|
| G
|
Dnd1
|
DND microRNA-mediated repression inhibitor 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of DND1 mRNA Calcitriol results in increased expression of DND1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:28,652,712...28,655,336
Ensembl chr18:28,652,712...28,655,336
|
|
| G
|
Dner
|
delta/notch-like EGF repeat containing
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DNER mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 9:93,035,108...93,350,568
Ensembl chr 9:93,035,108...93,350,568
|
|
| G
|
Dnm1
|
dynamin 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of DNM1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:36,002,535...36,055,220
Ensembl chr 3:36,002,064...36,046,289
|
|
| G
|
Dnmt1
|
DNA methyltransferase 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of DNMT1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of DNMT1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119
|
|
| G
|
Dnmt3b
|
DNA methyltransferase 3 beta
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of DNMT3B mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of DNMT3B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:162,604,037...162,629,313
|
|
| G
|
Dock11
|
dedicator of cytokinesis 11
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DOCK11 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr X:119,997,523...120,180,643
Ensembl chr X:119,997,552...120,180,634
|
|
| G
|
Dock2
|
dedicator of cytokinesis 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of DOCK2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:19,331,412...19,748,987
Ensembl chr10:19,331,412...19,748,969
|
|
| G
|
Dock4
|
dedicator of cytokinesis 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DOCK4 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:63,240,050...63,629,772
Ensembl chr 6:63,240,136...63,629,772
|
|
| G
|
Dock5
|
dedicator of cytokinesis 5
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DOCK5 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr15:46,155,124...46,334,127
Ensembl chr15:46,155,125...46,334,042
|
|
| G
|
Dock8
|
dedicator of cytokinesis 8
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of DOCK8 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of DOCK8 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:232,075,468...232,268,830
Ensembl chr 1:232,075,588...232,268,833
|
|
| G
|
Dok4
|
docking protein 4
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of DOK4 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of DOK4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:10,152,511...10,163,182
Ensembl chr19:10,152,458...10,164,190
|
|
| G
|
Dok5
|
docking protein 5
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DOK5 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:179,934,419...180,071,334
Ensembl chr 3:179,934,552...180,071,333
|
|
| G
|
Donson
|
DNA replication fork stabilization factor DONSON
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of DONSON mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of DONSON mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr11:44,405,794...44,419,099
Ensembl chr11:44,405,804...44,418,791
|
|
| G
|
Dpf1
|
double PHD fingers 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of DPF1 mRNA Calcitriol results in decreased expression of DPF1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:93,729,683...93,743,425
Ensembl chr 1:93,726,970...93,743,425
|
|
| G
|
Dpp4
|
dipeptidylpeptidase 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DPP4 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:67,370,794...67,452,422
Ensembl chr 3:67,370,804...67,452,422
|
|
| G
|
Dpt
|
dermatopontin
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of DPT mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:79,656,341...79,684,759
Ensembl chr13:79,655,985...79,684,758
|
|
| G
|
Dpy19l1
|
dpy-19 like C-mannosyltransferase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DPY19L1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:31,209,025...31,297,485
Ensembl chr 8:31,209,025...31,297,518
|
|
| G
|
Drd2
|
dopamine receptor D2
|
multiple interactions
|
ISO
|
Calcitriol promotes the reaction [VDR protein results in decreased expression of DRD2 mRNA]
|
CTD |
PMID:27450565 |
|
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:58,605,403...58,669,339
|
|
| G
|
Dsc1
|
desmocollin 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of DSC1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of DSC1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:11,774,711...11,831,868
Ensembl chr18:11,775,010...11,803,522
|
|
| G
|
Dsc2
|
desmocollin 2
|
decreases expression increases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of DSC2 mRNA Calcitriol results in increased expression of DSC2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of DSC2 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr18:11,725,466...11,757,591
Ensembl chr18:11,725,466...11,757,466
|
|
| G
|
Dsc3
|
desmocollin 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DSC3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr18:11,654,833...11,688,871
Ensembl chr18:11,653,832...11,688,871
|
|
| G
|
Dscc1
|
DNA replication and sister chromatid cohesion 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of DSCC1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of DSCC1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:88,372,349...88,390,815
Ensembl chr 7:88,372,146...88,387,973
|
|
| G
|
Dsel
|
dermatan sulfate epimerase-like
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of DSEL mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of DSEL mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:194,738...200,959
Ensembl chr13:179,618...200,993
|
|
| G
|
Dsg2
|
desmoglein 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DSG2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr18:12,121,287...12,179,590
Ensembl chr18:12,121,181...12,179,590
|
|
| G
|
Dsg3
|
desmoglein 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DSG3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr18:12,074,321...12,105,954
Ensembl chr18:12,074,321...12,111,766
|
|
| G
|
Dsp
|
desmoplakin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DSP mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr17:26,829,153...26,877,419
Ensembl chr17:26,829,153...26,877,121
|
|
| G
|
Dtl
|
denticleless E3 ubiquitin protein ligase homolog
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of DTL mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of DTL mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:105,646,908...105,685,921
Ensembl chr13:105,646,908...105,686,174
|
|
| G
|
Dtnb
|
dystrobrevin, beta
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DTNB mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 6:32,286,022...32,483,007
Ensembl chr 6:32,285,941...32,485,872
|
|
| G
|
Dtwd1
|
DTW domain containing 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DTWD1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:133,845,768...133,859,965
Ensembl chr 3:133,841,935...133,860,316
|
|
| G
|
Dtx4
|
deltex E3 ubiquitin ligase 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DTX4 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:218,882,391...218,969,837
Ensembl chr 1:218,832,284...218,917,130
|
|
| G
|
Dtymk
|
deoxythymidylate kinase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of DTYMK mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of DTYMK mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:101,762,899...101,771,733
Ensembl chr 9:101,762,899...101,774,504
|
|
| G
|
Duox1
|
dual oxidase 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of DUOX1 mRNA Calcitriol results in increased expression of DUOX1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:129,714,125...129,749,186
Ensembl chr 3:129,714,149...129,749,187
|
|
| G
|
Dusp1
|
dual specificity phosphatase 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of DUSP1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of DUSP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644
|
|
| G
|
Dusp10
|
dual specificity phosphatase 10
|
increases expression
|
ISO
|
Calcitriol results in increased expression of DUSP10 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:98,145,317...98,183,304
Ensembl chr13:98,145,893...98,183,304
|
|
| G
|
Dusp5
|
dual specificity phosphatase 5
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of DUSP5 mRNA Calcitriol results in increased expression of DUSP5 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 1:262,543,774...262,557,201
Ensembl chr 1:262,543,738...262,562,417
|
|
| G
|
Dusp7
|
dual specificity phosphatase 7
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of DUSP7 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of DUSP7 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:115,888,091...115,895,126
Ensembl chr 8:115,887,892...115,895,126
|
|
| G
|
Dut
|
deoxyuridine triphosphatase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of DUT mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of DUT mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:132,952,258...132,963,433
Ensembl chr 3:132,952,394...132,964,956
|
|
| G
|
Dync2i2
|
dynein 2 intermediate chain 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of DYNC2I2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of DYNC2I2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:33,703,882...33,719,960
Ensembl chr 3:33,703,882...33,719,960
|
|
| G
|
Dysf
|
dysferlin
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of DYSF mRNA Calcitriol results in increased expression of DYSF mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 4:118,048,460...118,248,273
Ensembl chr 4:118,047,989...118,248,273
|
|
| G
|
E2f1
|
E2F transcription factor 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of E2F1 mRNA; Calcitriol promotes the reaction [Testosterone results in decreased expression of E2F1 mRNA]; Testosterone promotes the reaction [Calcitriol results in decreased expression of E2F1 mRNA]
|
CTD |
PMID:21592394 |
|
NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:163,524,739...163,535,563
|
|
| G
|
E2f2
|
E2F transcription factor 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of E2F2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of E2F2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:153,682,789...153,706,087
Ensembl chr 5:153,682,789...153,706,087
|
|
| G
|
E2f7
|
E2F transcription factor 7
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of E2F7 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of E2F7 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:48,036,881...48,079,055
Ensembl chr 7:48,037,749...48,079,055
|
|
| G
|
E2f8
|
E2F transcription factor 8
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of E2F8 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of E2F8 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:107,701,985...107,720,538
Ensembl chr 1:107,701,985...107,720,009
|
|
| G
|
Eaf2
|
ELL associated factor 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of EAF2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr11:77,465,585...77,509,993
Ensembl chr11:77,406,020...77,509,993
|
|
| G
|
Ecm1
|
extracellular matrix protein 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ECM1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:185,976,439...185,981,656
Ensembl chr 2:185,976,440...185,981,606
|
|
| G
|
Ect2
|
epithelial cell transforming 2
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of ECT2 mRNA Calcitriol results in decreased expression of ECT2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:111,904,522...111,966,786
Ensembl chr 2:111,904,522...111,966,626
|
|
| G
|
Edn1
|
endothelin 1
|
decreases expression multiple interactions increases expression
|
ISO
|
Calcitriol results in decreased expression of EDN1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of EDN1 mRNA Calcitriol results in increased expression of EDN1 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
|
|
| G
|
Ednrb
|
endothelin receptor type B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of EDNRB mRNA
|
CTD |
PMID:12230499 |
|
NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765
|
|
| G
|
Eef1a1
|
eukaryotic translation elongation factor 1 alpha 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of EEF1A1 mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr 8:88,221,839...88,225,688
Ensembl chr 8:88,221,843...88,225,072
|
|
| G
|
Eef2
|
eukaryotic translation elongation factor 2
|
multiple interactions
|
EXP
|
[Calcium co-treated with Calcitriol] affects the expression of EEF2 mRNA
|
CTD |
PMID:15913539 |
|
NCBI chr 7:9,183,836...9,196,255
Ensembl chr 7:9,183,961...9,189,544
|
|
| G
|
Eepd1
|
endonuclease/exonuclease/phosphatase family domain containing 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of EEPD1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:32,233,834...32,340,148
Ensembl chr 8:32,233,070...32,340,147
|
|
| G
|
Efcab7
|
EF-hand calcium binding domain 7
|
increases expression
|
ISO
|
Calcitriol results in increased expression of EFCAB7 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:119,640,841...119,691,566
Ensembl chr 5:119,640,761...119,691,563
|
|
| G
|
Efemp2
|
EGF containing fibulin extracellular matrix protein 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of EFEMP2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:212,211,057...212,218,739
Ensembl chr 1:212,210,972...212,218,739
|
|
| G
|
Efl1
|
elongation factor like GTPase 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of EFL1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of EFL1 mRNA
|
CTD |
PMID:16002434 PMID:21592394 PMID:26485663 |
|
NCBI chr 1:146,047,734...146,172,719
Ensembl chr 1:146,048,592...146,173,532
|
|
| G
|
Efna1
|
ephrin A1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of EFNA1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:176,979,434...176,988,675
Ensembl chr 2:176,979,434...176,988,726
|
|
| G
|
Efna5
|
ephrin A5
|
increases expression
|
ISO
|
Calcitriol results in increased expression of EFNA5 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 9:109,763,786...110,042,396
Ensembl chr 9:109,767,252...110,042,348
|
|
| G
|
Efnb2
|
ephrin B2
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of EFNB2 mRNA Calcitriol results in decreased expression of EFNB2 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr16:87,485,215...87,529,224
Ensembl chr16:87,485,198...87,529,208
|
|
| G
|
Egf
|
epidermal growth factor
|
increases expression multiple interactions
|
ISO EXP
|
Calcitriol results in increased expression of EGF mRNA [Testosterone co-treated with Calcitriol] results in increased expression of EGF mRNA [Calcium co-treated with Calcitriol] affects the expression of EGF mRNA
|
CTD |
PMID:15913539 PMID:21592394 |
|
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297
|
|
| G
|
Egfr
|
epidermal growth factor receptor
|
increases expression multiple interactions
|
ISO EXP
|
Calcitriol results in increased expression of EGFR mRNA Calcitriol results in increased expression of and binds to EGFR protein [Testosterone co-treated with Calcitriol] results in increased expression of EGFR mRNA
|
CTD |
PMID:3498716 PMID:21592394 |
|
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358
|
|
| G
|
Egln1
|
egl-9 family hypoxia-inducible factor 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of EGLN1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr19:69,765,276...69,804,681
|
|
| G
|
Egln2
|
egl-9 family hypoxia-inducible factor 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of EGLN2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of EGLN2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:91,579,205...91,586,985
Ensembl chr 1:91,579,206...91,587,385
|
|
| G
|
Egr1
|
early growth response 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of EGR1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of EGR1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
|
|
| G
|
Egr3
|
early growth response 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of EGR3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr15:51,560,482...51,565,778
Ensembl chr15:51,560,344...51,565,712
|
|
| G
|
Ehbp1
|
EH domain binding protein 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of EHBP1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr14:100,294,585...100,581,764
Ensembl chr14:100,294,585...100,546,579
|
|
| G
|
Ehbp1l1
|
EH domain binding protein 1-like 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of EHBP1L1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:212,423,444...212,444,357
Ensembl chr 1:212,423,447...212,443,598
|
|
| G
|
Ehd1
|
EH-domain containing 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of EHD1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:213,009,113...213,031,488
Ensembl chr 1:213,008,049...213,031,485
|
|
| G
|
Ehd4
|
EH-domain containing 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of EHD4 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:127,511,973...127,575,856
Ensembl chr 3:127,511,954...127,576,072
|
|
| G
|
Ehf
|
ets homologous factor
|
increases expression
|
ISO
|
Calcitriol results in increased expression of EHF mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:110,094,770...110,134,991
Ensembl chr 3:110,096,756...110,134,928
|
|
| G
|
Eif2ak3
|
eukaryotic translation initiation factor 2 alpha kinase 3
|
multiple interactions
|
ISO
|
[salinomycin co-treated with Calcitriol] results in increased expression of EIF2AK3 mRNA
|
CTD |
PMID:35914560 |
|
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268
|
|
| G
|
Eif2ak4
|
eukaryotic translation initiation factor 2 alpha kinase 4
|
affects expression
|
ISO
|
Calcitriol affects the expression of EIF2AK4 mRNA
|
CTD |
PMID:15138306 |
|
NCBI chr 3:125,810,207...125,895,574
Ensembl chr 3:125,810,060...125,895,574
|
|
| G
|
Eif2s1
|
eukaryotic translation initiation factor 2 subunit alpha
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of EIF2S1 mRNA
|
CTD |
PMID:16847355 |
|
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649
|
|
| G
|
Eif2s2
|
eukaryotic translation initiation factor 2 subunit beta
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of EIF2S2 mRNA
|
CTD |
PMID:15951637 PMID:16847355 |
|
NCBI chr 3:163,834,846...163,855,733
Ensembl chr 3:163,834,851...163,855,570
|
|
| G
|
Eif2s3
|
eukaryotic translation initiation factor 2 subunit gamma
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of EIF2S3 mRNA
|
CTD |
PMID:16847355 |
|
NCBI chr X:62,910,292...62,933,936
Ensembl chr X:62,910,293...62,934,489
|
|
| G
|
Eif3b
|
eukaryotic translation initiation factor 3, subunit B
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of EIF3B mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr12:19,310,308...19,334,768
Ensembl chr12:19,310,311...19,334,939
|
|
| G
|
Eif4a1
|
eukaryotic translation initiation factor 4A1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of EIF4A1 mRNA
|
CTD |
PMID:12798352 |
|
NCBI chr10:54,883,093...54,888,602
Ensembl chr10:54,883,093...54,888,602
|
|
| G
|
Eif4a2
|
eukaryotic translation initiation factor 4A2
|
multiple interactions
|
EXP
|
[Calcium co-treated with Calcitriol] affects the expression of EIF4A2 mRNA
|
CTD |
PMID:15913539 |
|
NCBI chr11:91,268,730...91,276,738
Ensembl chr11:91,268,731...91,275,323
|
|
| G
|
Eif4ebp2
|
eukaryotic translation initiation factor 4E binding protein 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of EIF4EBP2 mRNA
|
CTD |
PMID:12798352 |
|
NCBI chr20:29,922,260...29,942,922
Ensembl chr20:29,922,260...29,942,922
|
|
| G
|
Eif4g2
|
eukaryotic translation initiation factor 4, gamma 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of EIF4G2 protein
|
CTD |
PMID:18491231 |
|
NCBI chr 1:174,616,102...174,628,252
Ensembl chr 1:174,616,103...174,628,252
|
|
| G
|
Eif5a2
|
eukaryotic translation initiation factor 5A2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of EIF5A2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:113,656,748...113,674,598
Ensembl chr 2:113,657,797...113,674,594
|
|
| G
|
Elapor1
|
endosome-lysosome associated apoptosis and autophagy regulator 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ELAPOR1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:198,777,323...198,856,497
Ensembl chr 2:198,777,323...198,856,497
|
|
| G
|
Elf1
|
E74 like ETS transcription factor 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ELF1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ELF1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:61,354,026...61,395,762
Ensembl chr15:61,330,877...61,395,758
|
|
| G
|
Elf2
|
E74 like ETS transcription factor 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ELF2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:137,445,787...137,536,512
Ensembl chr 2:137,445,788...137,470,355
|
|
| G
|
Elf3
|
E74 like ETS transcription factor 3
|
decreases expression increases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ELF3 mRNA Calcitriol results in increased expression of ELF3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ELF3 mRNA
|
CTD |
PMID:16002434 PMID:21592394 PMID:26485663 |
|
NCBI chr13:49,242,265...49,247,102
Ensembl chr13:49,242,267...49,247,380
|
|
| G
|
Elmo2
|
engulfment and cell motility 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ELMO2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ELMO2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:174,442,965...174,716,723
Ensembl chr 3:174,442,965...174,480,459
|
|
| G
|
Eln
|
elastin
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ELN mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr12:27,604,983...27,648,413
Ensembl chr12:27,604,680...27,648,413
|
|
| G
|
Elp4
|
elongator acetyltransferase complex subunit 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ELP4 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:112,617,020...112,839,963
Ensembl chr 3:112,617,035...112,839,963
|
|
| G
|
Emb
|
embigin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of EMB mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:50,803,468...50,858,001
Ensembl chr 2:50,801,973...50,862,920
|
|
| G
|
Eme1
|
essential meiotic structure-specific endonuclease 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of EME1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of EME1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:80,083,585...80,092,450
Ensembl chr10:80,083,585...80,092,301
|
|
| G
|
Emp1
|
epithelial membrane protein 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of EMP1 mRNA Calcitriol results in increased expression of EMP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:169,931,537...169,964,366
Ensembl chr 4:169,931,440...169,964,365
|
|
| G
|
Emp3
|
epithelial membrane protein 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of EMP3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:105,525,086...105,528,370
Ensembl chr 1:105,525,088...105,528,265
|
|
| G
|
Enosf1
|
enolase superfamily member 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ENOSF1 mRNA
|
CTD |
PMID:12875902 |
|
|
|
| G
|
Entpd2
|
ectonucleoside triphosphate diphosphohydrolase 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ENTPD2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:28,611,722...28,617,237
Ensembl chr 3:28,611,772...28,618,184
|
|
| G
|
Entpd3
|
ectonucleoside triphosphate diphosphohydrolase 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ENTPD3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:129,124,540...129,155,528
Ensembl chr 8:129,124,709...129,156,252
|
|
| G
|
Entpd8
|
ectonucleoside triphosphate diphosphohydrolase 8
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ENTPD8 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ENTPD8 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:28,283,392...28,295,686
Ensembl chr 3:28,285,777...28,293,686
|
|
| G
|
Entrep1
|
endosomal transmembrane epsin interactor 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ENTREP1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ENTREP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:231,018,987...231,073,474
Ensembl chr 1:231,018,987...231,102,708
|
|
| G
|
Eomes
|
eomesodermin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of EOMES mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:127,059,215...127,067,070
Ensembl chr 8:127,059,215...127,067,070
|
|
| G
|
Ep300
|
E1A binding protein p300
|
affects localization multiple interactions
|
ISO
|
Calcitriol affects the localization of EP300 protein Calcitriol promotes the reaction [EP300 protein binds to CYP24A1 promoter]; Calcitriol promotes the reaction [EP300 protein binds to SPP1 promoter]
|
CTD |
PMID:15647825 |
|
NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:114,946,982...115,058,574
|
|
| G
|
Epb41l3
|
erythrocyte membrane protein band 4.1-like 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of EPB41L3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of EPB41L3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:116,502,864...116,707,274
Ensembl chr 9:116,462,807...116,707,274
|
|
| G
|
Epb41l4b
|
erythrocyte membrane protein band 4.1 like 4B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of EPB41L4B mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:76,486,886...76,647,752
Ensembl chr 5:76,486,902...76,647,752
|
|
| G
|
Epha1
|
Eph receptor A1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of EPHA1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of EPHA1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:72,213,022...72,227,543
Ensembl chr 4:72,213,037...72,227,474
|
|
| G
|
Ephb6
|
Eph receptor B6
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of EPHB6 mRNA Calcitriol results in increased expression of EPHB6 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:71,458,632...71,473,889
Ensembl chr 4:71,458,971...71,476,659
|
|
| G
|
Eppk1
|
epiplakin 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of EPPK1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:109,697,607...109,718,468
Ensembl chr 7:109,697,607...109,718,468
|
|
| G
|
Eps8l1
|
EPS8 signaling adaptor L1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of EPS8L1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of EPS8L1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:78,386,916...78,409,972
Ensembl chr 1:78,386,916...78,406,187
|
|
| G
|
Epsti1
|
epithelial stromal interaction 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of EPSTI1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr15:59,692,712...59,791,376
Ensembl chr15:59,693,142...59,791,380
|
|
| G
|
Eqtn
|
equatorin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of EQTN mRNA
|
CTD |
PMID:36321694 |
|
NCBI chr 5:114,851,981...114,880,683
Ensembl chr 5:114,862,608...114,878,954
|
|
| G
|
Erbb3
|
erb-b2 receptor tyrosine kinase 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ERBB3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:1,579,079...1,600,379
Ensembl chr 7:1,579,816...1,601,120
|
|
| G
|
Ercc6l
|
ERCC excision repair 6 like, spindle assembly checkpoint helicase
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of ERCC6L mRNA Calcitriol results in decreased expression of ERCC6L mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:71,285,380...71,301,186
Ensembl chr X:71,285,380...71,301,186
|
|
| G
|
Ermp1
|
endoplasmic reticulum metallopeptidase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ERMP1 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 1:236,801,459...236,835,656
Ensembl chr 1:236,801,466...236,839,197
|
|
| G
|
Ero1a
|
endoplasmic reticulum oxidoreductase 1 alpha
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ERO1A mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ERO1A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:20,974,771...21,010,170
Ensembl chr15:20,972,679...21,018,039
|
|
| G
|
Errfi1
|
ERBB receptor feedback inhibitor 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ERRFI1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ERRFI1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:166,606,841...166,620,124
Ensembl chr 5:166,606,834...166,620,432
|
|
| G
|
Esco2
|
establishment of sister chromatid cohesion N-acetyltransferase 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ESCO2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of ESCO2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:44,210,124...44,230,785
Ensembl chr15:44,210,641...44,231,304 Ensembl chr15:44,210,641...44,231,304
|
|
| G
|
Espl1
|
extra spindle pole bodies like 1, separase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ESPL1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of ESPL1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:135,302,460...135,329,570
Ensembl chr 7:135,302,716...135,329,570
|
|
| G
|
Esr1
|
estrogen receptor 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ESR1 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Esrp1
|
epithelial splicing regulatory protein 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ESRP1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:29,224,831...29,279,381
Ensembl chr 5:29,225,360...29,279,278
|
|
| G
|
Etnk2
|
ethanolamine kinase 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ETNK2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:47,362,964...47,381,100
Ensembl chr13:47,363,060...47,381,100
|
|
| G
|
Ets2
|
ETS proto-oncogene 2, transcription factor
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ETS2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr11:48,491,057...48,507,843
Ensembl chr11:48,491,394...48,507,842
|
|
| G
|
Etv4
|
ETS variant transcription factor 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ETV4 mRNA
|
CTD |
PMID:12040012 |
|
NCBI chr10:87,206,977...87,222,202
Ensembl chr10:87,206,977...87,222,318
|
|
| G
|
Eva1a
|
eva-1 homolog A, regulator of programmed cell death
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of EVA1A mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 4:116,151,595...116,200,827
Ensembl chr 4:116,151,173...116,200,827
|
|
| G
|
Eva1b
|
eva-1 homolog B
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of EVA1B mRNA Calcitriol results in increased expression of EVA1B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:143,711,627...143,716,963
Ensembl chr 5:143,711,395...143,717,551
|
|
| G
|
Evc
|
EvC ciliary complex subunit 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of EVC mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of EVC mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:77,680,901...77,722,608
Ensembl chr14:77,680,943...77,723,100
|
|
| G
|
Evi2a
|
ecotropic viral integration site 2A
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of EVI2A mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:64,983,727...64,987,627
Ensembl chr10:64,983,705...64,999,516
|
|
| G
|
Evi2b
|
ecotropic viral integration site 2B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of EVI2B mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr10:64,970,659...64,972,277
Ensembl chr10:64,964,719...64,979,417
|
|
| G
|
Evi5
|
ecotropic viral integration site 5
|
increases expression
|
ISO
|
Calcitriol results in increased expression of EVI5 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr14:2,020,524...2,166,593
Ensembl chr14:2,020,581...2,166,593
|
|
| G
|
Evpl
|
envoplakin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of EVPL mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:101,957,107...101,973,656
Ensembl chr10:101,941,064...101,973,656
|
|
| G
|
Exo1
|
exonuclease 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of EXO1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of EXO1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:90,341,947...90,366,861
Ensembl chr13:90,342,018...90,366,861
|
|
| G
|
Exo5
|
exonuclease 5
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of EXO5 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of EXO5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:139,779,646...139,782,963
Ensembl chr 5:139,777,987...139,783,034
|
|
| G
|
Exosc2
|
exosome component 2
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of EXOSC2 mRNA Calcitriol results in decreased expression of EXOSC2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:35,360,652...35,370,948
Ensembl chr 3:35,360,666...35,371,373
|
|
| G
|
Exosc8
|
exosome component 8
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of EXOSC8 mRNA Calcitriol results in decreased expression of EXOSC8 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:141,080,568...141,087,112
Ensembl chr 2:141,080,568...141,087,229
|
|
| G
|
Exosc9
|
exosome component 9
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of EXOSC9 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of EXOSC9 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:121,344,154...121,355,110
Ensembl chr 2:121,344,175...121,374,232
|
|
| G
|
Ezh2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of EZH2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of EZH2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:77,624,223...77,698,598
Ensembl chr 4:77,624,223...77,687,183
|
|
| G
|
F13a1
|
coagulation factor XIII A1 chain
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of F13A1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr17:28,021,197...28,197,960
Ensembl chr17:28,020,845...28,197,948
|
|
| G
|
F13b
|
coagulation factor XIII B chain
|
increases expression
|
ISO
|
Calcitriol results in increased expression of F13B mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:53,681,639...53,707,114
Ensembl chr13:53,681,622...53,707,300
|
|
| G
|
F2rl2
|
coagulation factor II (thrombin) receptor-like 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of F2RL2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:28,706,766...28,711,808
Ensembl chr 2:28,706,501...28,712,473
|
|
| G
|
F5
|
coagulation factor V
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of F5 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of F5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:79,046,657...79,116,247
Ensembl chr13:79,046,448...79,116,247
|
|
| G
|
Fabp4
|
fatty acid binding protein 4
|
multiple interactions decreases expression
|
ISO
|
Calcitriol inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of FABP4 mRNA]; Calcitriol promotes the reaction [pregna-4,17-diene-3,16-dione results in decreased expression of FABP4 protein]; pregna-4,17-diene-3,16-dione promotes the reaction [Calcitriol results in decreased expression of FABP4 protein] Calcitriol results in decreased expression of FABP4 mRNA; Calcitriol results in decreased expression of FABP4 protein
|
CTD |
PMID:9564879 PMID:16368784 PMID:16813520 PMID:17959142 |
|
NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972
|
|
| G
|
Fads1
|
fatty acid desaturase 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of FADS1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of FADS1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:216,252,605...216,267,618
Ensembl chr 1:216,252,602...216,267,615
|
|
| G
|
Fam107b
|
family with sequence similarity 107, member B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of FAM107B mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr17:79,387,795...79,594,165
Ensembl chr17:79,387,795...79,594,288
|
|
| G
|
Fam110a
|
family with sequence similarity 110, member A
|
increases expression
|
ISO
|
Calcitriol results in increased expression of FAM110A mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:160,934,815...160,945,405
Ensembl chr 3:160,931,777...160,949,897
|
|
| G
|
Fam110c
|
family with sequence similarity 110, member C
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of FAM110C mRNA Calcitriol results in increased expression of FAM110C mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 6:53,366,013...53,372,270
Ensembl chr 6:53,352,870...53,401,117
|
|
| G
|
Fam131b
|
family with sequence similarity 131, member B
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of FAM131B mRNA [Testosterone co-treated with Calcitriol] results in increased expression of FAM131B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:72,167,667...72,176,924
Ensembl chr 4:72,165,578...72,176,858
|
|
| G
|
Fam20c
|
FAM20C, golgi associated secretory pathway kinase
|
increases expression
|
ISO
|
Calcitriol results in increased expression of FAM20C mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr12:20,940,654...20,999,072
Ensembl chr12:20,940,654...20,998,318
|
|
| G
|
Fam216a
|
family with sequence similarity 216, member A
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of FAM216A mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of FAM216A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr12:39,859,307...39,868,450
Ensembl chr12:39,859,172...39,868,442
|
|
| G
|
Fam234b
|
family with sequence similarity 234, member B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of FAM234B mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 4:169,779,651...169,854,024
Ensembl chr 4:169,779,737...169,828,678
|
|
| G
|
Fam43b
|
family with sequence similarity 43, member B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of FAM43B mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:155,893,961...155,896,359
Ensembl chr 5:155,893,968...155,898,755
|
|
| G
|
Fam81a
|
family with sequence similarity 81, member A
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of FAM81A mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of FAM81A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:79,643,754...79,702,792
Ensembl chr 8:79,644,516...79,702,767
|
|
| G
|
Fam83b
|
family with sequence similarity 83, member B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of FAM83B mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:86,167,778...86,244,222
Ensembl chr 8:86,167,778...86,244,222
|
|
| G
|
Fam83d
|
family with sequence similarity 83, member D
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of FAM83D mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of FAM83D mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:167,841,748...167,861,062
Ensembl chr 3:167,841,791...167,861,061
|
|
| G
|
Fam83e
|
family with sequence similarity 83, member E
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of FAM83E mRNA [Testosterone co-treated with Calcitriol] results in increased expression of FAM83E mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:105,328,297...105,337,641
Ensembl chr 1:105,328,247...105,337,638
|
|
| G
|
Fam83h
|
family with sequence similarity 83, member H
|
increases expression
|
ISO
|
Calcitriol results in increased expression of FAM83H mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:109,597,129...109,605,317
Ensembl chr 7:109,597,129...109,609,188
|
|
| G
|
Fanca
|
FA complementation group A
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of FANCA mRNA Calcitriol results in decreased expression of FANCA mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:68,210,562...68,271,080
Ensembl chr19:68,212,643...68,271,019
|
|
| G
|
Fancb
|
FA complementation group B
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of FANCB mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of FANCB mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:33,035,387...33,051,993
Ensembl chr X:33,035,387...33,051,808
|
|
| G
|
Fancc
|
FA complementation group C
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of FANCC mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of FANCC mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:1,686,374...1,818,672
Ensembl chr17:1,687,017...1,835,096
|
|
| G
|
Fancd2
|
FA complementation group D2
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of FANCD2 mRNA Calcitriol results in decreased expression of FANCD2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:148,234,633...148,299,035
Ensembl chr 4:148,234,708...148,299,035
|
|
| G
|
Fance
|
FA complementation group E
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of FANCE mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of FANCE mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:6,371,153...6,388,366
Ensembl chr20:6,377,234...6,388,365
|
|
| G
|
Fancg
|
FA complementation group G
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of FANCG mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of FANCG mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:62,027,494...62,037,202
Ensembl chr 5:62,027,500...62,035,787
|
|
| G
|
Fanci
|
FA complementation group I
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of FANCI mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of FANCI mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:142,736,636...142,792,999
Ensembl chr 1:142,736,653...142,792,999
|
|
| G
|
Fap
|
fibroblast activation protein, alpha
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of FAP mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:67,547,398...67,616,271
Ensembl chr 3:67,546,921...67,617,601
|
|
| G
|
Far2
|
fatty acyl CoA reductase 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of FAR2 mRNA Calcitriol results in increased expression of FAR2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:182,705,499...182,819,290
Ensembl chr 4:182,705,381...182,825,279
|
|
| G
|
Fas
|
Fas cell surface death receptor
|
increases expression decreases expression
|
ISO
|
Calcitriol results in increased expression of FAS mRNA Calcitriol results in decreased expression of FAS mRNA
|
CTD |
PMID:16002434 PMID:16368784 |
|
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
|
|
| G
|
Faslg
|
Fas ligand
|
decreases expression
|
EXP
|
Calcitriol results in decreased expression of FASLG protein
|
CTD |
PMID:17570329 |
|
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
|
|
| G
|
Fasn
|
fatty acid synthase
|
multiple interactions decreases expression
|
ISO
|
Cycloheximide inhibits the reaction [Calcitriol results in decreased expression of FASN mRNA]
|
CTD |
PMID:12798352 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
|
|
| G
|
Fblim1
|
filamin binding LIM protein 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of FBLIM1 mRNA Calcitriol results in increased expression of FBLIM1 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 5:159,167,004...159,198,578
Ensembl chr 5:159,167,004...159,196,853
|
|
| G
|
Fbln1
|
fibulin 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of FBLN1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:118,190,347...118,269,965
Ensembl chr 7:118,190,478...118,269,965
|
|
| G
|
Fbp1
|
fructose-bisphosphatase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of FBP1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr17:2,212,941...2,235,749
Ensembl chr17:2,213,492...2,235,746
|
|
| G
|
Fbxl16
|
F-box and leucine-rich repeat protein 16
|
increases expression
|
ISO
|
Calcitriol results in increased expression of FBXL16 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:15,333,996...15,346,253
Ensembl chr10:15,334,014...15,346,232
|
|
| G
|
Fbxo2
|
F-box protein 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of FBXO2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:163,876,079...163,881,508
Ensembl chr 5:163,875,757...163,881,508
|
|
| G
|
Fbxo3
|
F-box protein 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of FBXO3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:110,872,185...110,904,479
Ensembl chr 3:110,872,220...110,904,479
|
|
| G
|
Fbxo32
|
F-box protein 32
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of FBXO32 mRNA Calcitriol inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA]
|
CTD |
PMID:16002434 PMID:29962435 |
|
NCBI chr 7:91,620,925...91,654,491
Ensembl chr 7:91,620,925...91,654,491
|
|
| G
|
Fbxo4
|
F-box protein 4
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of FBXO4 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of FBXO4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:54,902,394...54,915,388
Ensembl chr 2:54,902,394...54,915,388
|
|
| G
|
Fbxo5
|
F-box protein 5
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of FBXO5 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of FBXO5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:44,601,412...44,607,781
Ensembl chr 1:44,601,412...44,607,781
|
|
| G
|
Fcer1g
|
Fc epsilon receptor Ig
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of FCER1G mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:86,181,908...86,186,766
Ensembl chr13:86,181,908...86,186,859
|
|
| G
|
Fcgr2a
|
Fc gamma receptor 2A
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of FCGR2A mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:85,813,516...85,830,269
Ensembl chr13:85,855,437...85,864,394 Ensembl chr13:85,855,437...85,864,394
|
|
| G
|
Fcgr3a
|
Fc gamma receptor 3A
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of FCGR3A mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:85,782,636...85,792,656
Ensembl chr13:85,782,490...85,792,651
|
|
| G
|
Fchsd2
|
FCH and double SH3 domains 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of FCHSD2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:164,775,916...165,097,391
Ensembl chr 1:164,775,926...165,097,391
|
|
| G
|
Fdxacb1
|
ferredoxin-fold anticodon binding domain containing 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of FDXACB1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:60,009,818...60,014,625
|
|
| G
|
Fen1
|
flap structure-specific endonuclease 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of FEN1 mRNA Calcitriol results in decreased expression of FEN1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:216,270,016...216,274,873
Ensembl chr 1:216,269,163...216,275,016
|
|
| G
|
Fermt3
|
FERM domain containing kindlin 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of FERMT3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:213,618,691...213,636,889
Ensembl chr 1:213,618,208...213,636,273
|
|
| G
|
Fgd3
|
FYVE, RhoGEF and PH domain containing 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of FGD3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr17:15,531,237...15,593,678
Ensembl chr17:15,543,236...15,593,676
|
|
| G
|
Fgd4
|
FYVE, RhoGEF and PH domain containing 4
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of FGD4 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of FGD4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr11:97,904,182...98,055,190
Ensembl chr11:97,904,182...98,055,190
|
|
| G
|
Fgf23
|
fibroblast growth factor 23
|
affects response to substance increases expression decreases abundance multiple interactions
|
ISO EXP
|
FGF23 protein affects the susceptibility to Calcitriol Calcitriol results in increased expression of FGF23 protein FGF23 protein results in decreased abundance of Calcitriol Calcitriol results in increased expression of FGF23 mRNA; Calcitriol results in increased expression of FGF23 protein [Calcitriol co-treated with Phosphates] results in increased expression of FGF23 mRNA; PHEX protein inhibits the reaction [FGF23 protein results in decreased abundance of Calcitriol]
|
CTD |
PMID:15264182 PMID:15531762 PMID:15671080 PMID:15698453 PMID:15917335 PMID:15956805 PMID:16020653 PMID:16234967 PMID:16449303 PMID:17293108 PMID:18256372 More...
|
|
NCBI chr 4:161,600,439...161,609,991
Ensembl chr 4:161,600,383...161,609,991
|
|
| G
|
Fgfbp1
|
fibroblast growth factor binding protein 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of FGFBP1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr14:71,316,171...71,319,965
Ensembl chr14:71,317,065...71,320,309
|
|
| G
|
Fgfr1
|
Fibroblast growth factor receptor 1
|
multiple interactions decreases expression
|
EXP ISO
|
[Calcium co-treated with Calcitriol] affects the expression of FGFR1 mRNA Calcitriol results in decreased expression of FGFR1 mRNA
|
CTD |
PMID:15913539 PMID:26485663 |
|
NCBI chr16:73,194,631...73,249,855
Ensembl chr16:73,194,631...73,249,855
|
|
| G
|
Fgfr2
|
fibroblast growth factor receptor 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of FGFR2 mRNA; Calcitriol results in increased expression of FGFR2 protein [Testosterone co-treated with Calcitriol] results in increased expression of FGFR2 mRNA
|
CTD |
PMID:12761878 PMID:21592394 |
|
NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:194,175,705...194,280,914
|
|
| G
|
Fgfr3
|
fibroblast growth factor receptor 3
|
decreases expression
|
EXP
|
Calcitriol results in decreased expression of FGFR3 protein
|
CTD |
PMID:15728789 |
|
NCBI chr14:81,211,800...81,227,215
Ensembl chr14:81,211,800...81,227,209
|
|
| G
|
Fgl1
|
fibrinogen-like 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of FGL1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of FGL1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:57,824,127...57,854,413
Ensembl chr16:57,824,200...57,854,429
|
|
| G
|
Fhl2
|
four and a half LIM domains 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of FHL2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of FHL2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:52,881,091...52,954,540
Ensembl chr 9:52,880,998...52,923,326
|
|
| G
|
Fhod3
|
formin homology 2 domain containing 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of FHOD3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr18:16,267,830...16,700,508
Ensembl chr18:16,267,977...16,700,508
|
|
| G
|
Fibin
|
fin bud initiation factor homolog
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of FIBIN mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:117,396,973...117,399,244
Ensembl chr 3:117,391,724...117,399,479
|
|
| G
|
Fignl1
|
fidgetin-like 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of FIGNL1 mRNA Calcitriol results in decreased expression of FIGNL1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:90,573,090...90,595,342
Ensembl chr14:90,581,771...90,592,316
|
|
| G
|
Filip1l
|
filamin A interacting protein 1-like
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of FILIP1L mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr11:56,403,467...56,646,422
Ensembl chr11:56,410,582...56,646,402
|
|
| G
|
Firrm
|
FIGNL1 interacting regulator of recombination and mitosis
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of FIRRM mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of FIRRM mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:78,835,081...78,879,022
Ensembl chr13:78,834,216...78,879,213
|
|
| G
|
Fkbp1b
|
FKBP prolyl isomerase 1B
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of FKBP1B mRNA [Testosterone co-treated with Calcitriol] results in increased expression of FKBP1B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:33,551,583...33,570,055
Ensembl chr 6:33,558,517...33,568,129
|
|
| G
|
Fkbp5
|
FKBP prolyl isomerase 5
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of FKBP5 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of FKBP5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,458,940...6,543,118
|
|
| G
|
Flg
|
filaggrin
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of FLG protein
|
CTD |
PMID:7508215 |
|
NCBI chr 2:181,583,801...181,596,464
Ensembl chr 2:181,583,808...181,595,968
|
|
| G
|
Flnc
|
filamin C
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of FLNC mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 4:58,999,445...59,027,240
Ensembl chr 4:58,999,547...59,027,240
|
|
| G
|
Flrt3
|
fibronectin leucine rich transmembrane protein 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of FLRT3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:148,448,115...148,461,458
Ensembl chr 3:148,439,354...148,461,650
|
|
| G
|
Flt1
|
Fms related receptor tyrosine kinase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of FLT1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr12:12,333,050...12,504,750
Ensembl chr12:12,333,430...12,504,750
|
|
| G
|
Fmnl1
|
formin-like 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of FMNL1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:88,615,290...88,643,411
Ensembl chr10:88,615,869...88,643,411
|
|
| G
|
Fmo2
|
flavin containing dimethylaniline monoxygenase 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of FMO2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:77,755,131...77,777,597
Ensembl chr13:77,757,629...77,777,534
|
|
| G
|
Fmo4
|
flavin containing dimethylaniline monoxygenase 4
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of FMO4 mRNA Calcitriol results in increased expression of FMO4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:77,687,909...77,706,100
Ensembl chr13:77,687,909...77,706,100
|
|
| G
|
Fmo5
|
flavin containing dimethylaniline monoxygenase 5
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of FMO5 mRNA Calcitriol results in increased expression of FMO5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:187,885,741...187,938,468
Ensembl chr 2:187,910,964...187,938,464
|
|
| G
|
Fnbp1l
|
formin binding protein 1-like
|
increases expression
|
ISO
|
Calcitriol results in increased expression of FNBP1L mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:213,331,871...213,432,821
Ensembl chr 2:213,318,662...213,423,051
|
|
| G
|
Focad
|
focadhesin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of FOCAD mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:107,610,489...107,932,485
Ensembl chr 5:107,610,416...107,933,109
|
|
| G
|
Folh1
|
folate hydrolase 1
|
multiple interactions decreases expression
|
ISO
|
AR protein affects the reaction [Calcitriol results in decreased expression of FOLH1 protein]
|
CTD |
PMID:18247401 |
|
NCBI chr 1:149,828,286...149,914,313
Ensembl chr 1:149,840,760...149,914,035
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of FOS mRNA Calcitriol results in increased expression of FOS mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
Fosl2
|
FOS like 2, AP-1 transcription factor subunit
|
increases expression
|
ISO
|
Calcitriol results in increased expression of FOSL2 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 6:30,017,952...30,039,269
Ensembl chr 6:30,021,916...30,039,406
|
|
| G
|
Foxc1
|
forkhead box C1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of FOXC1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of FOXC1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:32,840,119...32,844,100
Ensembl chr17:32,805,858...32,844,347
|
|
| G
|
Foxd4
|
forkhead box D4
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of FOXD4 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of FOXD4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:231,983,872...231,985,565
|
|
| G
|
Foxf2
|
forkhead box F2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of FOXF2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr17:33,044,446...33,051,259
Ensembl chr17:32,846,603...33,051,259
|
|
| G
|
Foxk1
|
forkhead box K1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of FOXK1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr12:17,223,599...17,288,564
Ensembl chr12:17,229,430...17,288,564
|
|
| G
|
Foxm1
|
forkhead box M1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of FOXM1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of FOXM1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:163,325,628...163,338,100
Ensembl chr 4:163,325,614...163,337,172
|
|
| G
|
Foxo1
|
forkhead box O1
|
increases expression multiple interactions decreases activity decreases expression
|
ISO
|
Calcitriol results in increased expression of FOXO1 mRNA 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased phosphorylation of and affects the localization of FOXO1 protein]]; Calcitriol inhibits the reaction [Glucose results in decreased phosphorylation of and affects the localization of FOXO1 protein]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in increased expression of BECN1 protein]] Calcitriol results in decreased activity of FOXO1 protein Calcitriol results in decreased expression of FOXO1 mRNA
|
CTD |
PMID:16002434 PMID:26485663 PMID:29962435 PMID:33450223 |
|
NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419
|
|
| G
|
Foxo4
|
forkhead box O4
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of FOXO4 mRNA Calcitriol results in increased expression of FOXO4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:70,425,218...70,432,120
Ensembl chr X:70,425,563...70,432,120
|
|
| G
|
Foxp3
|
forkhead box P3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of FOXP3
|
CTD |
PMID:21167785 |
|
NCBI chr X:17,580,380...17,601,181
Ensembl chr X:17,580,380...17,595,894
|
|
| G
|
Foxq1
|
forkhead box Q1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of FOXQ1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr17:33,121,454...33,124,087
Ensembl chr17:33,121,545...33,123,720
|
|
| G
|
Fpr1
|
formyl peptide receptor 1
|
multiple interactions decreases expression increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of FPR1 mRNA Calcitriol results in decreased expression of FPR1 mRNA Calcitriol results in increased expression of FPR1 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 1:67,417,991...67,429,813
Ensembl chr 1:67,421,313...67,422,520
|
|
| G
|
Fpr3
|
formyl peptide receptor 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of FPR3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:67,557,464...67,566,509
Ensembl chr 1:67,518,199...67,566,519
|
|
| G
|
Fras1
|
Fraser extracellular matrix complex subunit 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of FRAS1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr14:13,095,370...13,506,895
Ensembl chr14:13,095,370...13,504,664
|
|
| G
|
Frem1
|
Fras1 related extracellular matrix 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of FREM1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of FREM1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:102,367,201...102,515,464
Ensembl chr 5:102,367,201...102,515,404
|
|
| G
|
Frmpd2
|
FERM and PDZ domain containing 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of FRMPD2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of FRMPD2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:8,763,889...8,883,558
Ensembl chr16:8,763,956...8,883,551
|
|
| G
|
Fst
|
follistatin
|
multiple interactions decreases expression
|
ISO
|
FST protein inhibits the reaction [Calcitriol results in decreased expression of CLEC3B mRNA]; FST protein inhibits the reaction [Calcitriol results in decreased expression of SMAD7 mRNA]; FST protein promotes the reaction [Calcitriol results in increased expression of BGLAP mRNA] Calcitriol results in decreased expression of FST protein
|
CTD |
PMID:23589129 |
|
NCBI chr 2:47,856,345...47,863,670
Ensembl chr 2:47,856,345...47,863,491
|
|
| G
|
Fus
|
Fus RNA binding protein
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of FUS mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of FUS mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:192,007,011...192,020,887
Ensembl chr 1:192,007,006...192,020,884
|
|
| G
|
Fut11
|
fucosyltransferase 11
|
increases expression
|
ISO
|
Calcitriol results in increased expression of POFUT4 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr15:3,648,022...3,651,582
Ensembl chr15:3,643,009...3,651,610
|
|
| G
|
Fut4
|
fucosyltransferase 4
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of FUT4 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:19,868,178...19,872,139
Ensembl chr 8:19,868,079...19,872,436
|
|
| G
|
Fut8
|
fucosyltransferase 8
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of FUT8 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 6:101,682,354...101,909,784
Ensembl chr 6:101,683,007...101,909,775
|
|
| G
|
Fxyd3
|
FXYD domain-containing ion transport regulator 3
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of FXYD3 mRNA Calcitriol results in increased expression of FXYD3 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 1:95,432,918...95,440,129
Ensembl chr 1:95,432,919...95,439,702
|
|
| G
|
Fzd1
|
frizzled class receptor 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of FZD1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:30,265,074...30,269,472
Ensembl chr 4:30,247,228...30,833,176
|
|
| G
|
Fzd5
|
frizzled class receptor 5
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of FZD5 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of FZD5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:73,606,860...73,614,039
Ensembl chr 9:73,606,860...73,618,612
|
|
| G
|
G0s2
|
G0/G1switch 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of G0S2 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr13:107,335,036...107,335,948
Ensembl chr13:107,335,036...107,336,293
|
|
| G
|
G2e3
|
G2/M-phase specific E3 ubiquitin protein ligase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of G2E3 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of G2E3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:74,498,801...74,530,703
Ensembl chr 6:74,503,109...74,528,198
|
|
| G
|
G6pd
|
glucose-6-phosphate dehydrogenase
|
increases activity increases expression multiple interactions
|
ISO
|
Calcitriol results in increased activity of G6PD protein Calcitriol results in increased expression of G6PD mRNA [Testosterone co-treated with Calcitriol] results in increased expression of G6PD mRNA
|
CTD |
PMID:8910257 PMID:12040012 PMID:16002434 PMID:21592394 PMID:26485663 |
|
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:157,352,373...157,372,144
|
|
| G
|
Gab1
|
GRB2-associated binding protein 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of GAB1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr19:44,035,693...44,143,617
Ensembl chr19:44,035,063...44,143,617
|
|
| G
|
Gabrp
|
gamma-aminobutyric acid type A receptor subunit pi
|
increases expression
|
ISO
|
Calcitriol results in increased expression of GABRP mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:18,647,243...18,673,806
Ensembl chr10:18,647,243...18,673,727
|
|
| G
|
Gadd45a
|
growth arrest and DNA-damage-inducible, alpha
|
increases expression
|
ISO
|
Calcitriol results in increased expression of GADD45A mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807
|
|
| G
|
Gadd45b
|
growth arrest and DNA-damage-inducible, beta
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of GADD45B mRNA [Testosterone co-treated with Calcitriol] results in increased expression of GADD45B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:9,428,689...9,430,718
|
|
| G
|
Gadd45g
|
growth arrest and DNA-damage-inducible, gamma
|
multiple interactions increases expression
|
ISO
|
[salinomycin co-treated with Calcitriol] results in increased expression of GADD45G mRNA; [Testosterone co-treated with Calcitriol] results in increased expression of GADD45G mRNA; Calcitriol promotes the reaction [Testosterone results in increased expression of GADD45G mRNA]; Testosterone promotes the reaction [Calcitriol results in increased expression of GADD45G mRNA]
|
CTD |
PMID:21592394 PMID:35914560 |
|
NCBI chr17:13,528,606...13,530,351
Ensembl chr17:13,528,610...13,530,369
|
|
| G
|
Gal
|
galanin and GMAP prepropeptide
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of GAL mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of GAL mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:210,079,709...210,084,572
Ensembl chr 1:210,079,702...210,084,229
|
|
| G
|
Gal3st4
|
galactose-3-O-sulfotransferase 4
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of GAL3ST4 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr12:22,381,576...22,390,566
Ensembl chr12:22,381,576...22,390,824
|
|
| G
|
Galm
|
galactose mutarotase
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of GALM mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 6:20,589,775...20,641,516
Ensembl chr 6:20,589,776...20,644,417
|
|
| G
|
Galnt18
|
polypeptide N-acetylgalactosaminyltransferase 18
|
decreases expression multiple interactions increases expression
|
ISO
|
Calcitriol results in decreased expression of GALNT18 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of GALNT18 mRNA Calcitriol results in increased expression of GALNT18 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 1:175,027,832...175,338,883
Ensembl chr 1:175,027,839...175,338,883
|
|
| G
|
Galnt6
|
polypeptide N-acetylgalactosaminyltransferase 6
|
increases expression
|
ISO
|
Calcitriol results in increased expression of GALNT6 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:133,668,612...133,715,909
Ensembl chr 7:133,668,615...133,698,439
|
|
| G
|
Gap43
|
growth associated protein 43
|
increases expression
|
ISO
|
Calcitriol results in increased expression of GAP43 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr11:71,882,131...71,975,799
Ensembl chr11:71,882,131...71,975,797
|
|
| G
|
Gart
|
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of GART mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of GART mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr11:44,351,841...44,377,086
Ensembl chr11:44,351,851...44,377,086
|
|
| G
|
Gas1
|
growth arrest-specific 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of GAS1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr17:4,487,716...4,490,701
Ensembl chr17:4,484,283...4,497,657
|
|
| G
|
Gas2l3
|
growth arrest-specific 2 like 3
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of GAS2L3 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of GAS2L3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:25,690,929...25,726,806
Ensembl chr 7:25,693,660...25,716,942
|
|
| G
|
Gas7
|
growth arrest specific 7
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of GAS7 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:52,651,690...52,882,244
Ensembl chr10:52,651,690...52,882,244
|
|
| G
|
Gask1b
|
golgi associated kinase 1B
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of GASK1B mRNA Calcitriol results in increased expression of GASK1B mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 2:167,345,738...167,410,606
Ensembl chr 2:167,345,809...167,410,603
|
|
| G
|
Gata2
|
GATA binding protein 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of GATA2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:122,211,501...122,225,058
Ensembl chr 4:122,211,829...122,225,055
|
|
| G
|
Gata3
|
GATA binding protein 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of GATA3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr17:73,544,234...73,575,670
Ensembl chr17:73,553,548...73,575,670
|
|
| G
|
Gbp1
|
guanylate binding protein 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of GBP1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of GBP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:234,071,366...234,106,012
Ensembl chr 2:234,190,708...234,206,802 Ensembl chr 2:234,190,708...234,206,802
|
|
| G
|
Gbp2
|
guanylate binding protein 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of GBP2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of GBP2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:234,005,727...234,021,812
Ensembl chr 2:234,008,590...234,021,810
|
|
| G
|
Gbp3
|
guanylate binding protein 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of GBP3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of GBP3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:234,144,042...234,173,527
Ensembl chr 2:234,146,519...234,180,055
|
|
| G
|
Gc
|
GC, vitamin D binding protein
|
affects abundance affects binding affects transport
|
ISO EXP
|
GC protein affects the abundance of Calcitriol Calcitriol binds to GC protein GC protein polymorphism binds to Calcitriol GC protein affects the transport of Calcitriol
|
CTD |
PMID:6894152 PMID:8370586 PMID:15820770 PMID:17444814 |
|
NCBI chr14:18,916,255...18,951,670
Ensembl chr14:18,916,246...18,951,673
|
|
| G
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit
|
multiple interactions
|
EXP
|
[Calcium co-treated with Calcitriol] affects the expression of GCLC mRNA
|
CTD |
PMID:15913539 |
|
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
|
|
| G
|
Gcnt1
|
glucosaminyl (N-acetyl) transferase 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of GCNT1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:224,145,104...224,182,496
Ensembl chr 1:224,141,108...224,185,741
|
|
| G
|
Gcnt3
|
glucosaminyl (N-acetyl) transferase 3, mucin type
|
increases expression
|
ISO
|
Calcitriol results in increased expression of GCNT3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:79,570,081...79,577,389
Ensembl chr 8:79,566,753...79,581,595
|
|
| G
|
Gdf15
|
growth differentiation factor 15
|
increases expression
|
ISO
|
Calcitriol results in increased expression of GDF15 mRNA; Calcitriol results in increased expression of GDF15 protein
|
CTD |
PMID:15386353 PMID:16523695 |
|
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022
|
|
| G
|
Gdpd3
|
glycerophosphodiester phosphodiesterase domain containing 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of GDPD3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of GDPD3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:190,804,053...190,813,609
Ensembl chr 1:190,803,993...190,813,606
|
|
| G
|
Gem
|
GTP binding protein overexpressed in skeletal muscle
|
increases expression
|
ISO
|
Calcitriol results in increased expression of GEM mRNA
|
CTD |
PMID:14996990 PMID:16002434 |
|
NCBI chr 5:30,011,641...30,022,554
Ensembl chr 5:30,011,592...30,022,542
|
|
| G
|
Gemin2
|
gem (nuclear organelle) associated protein 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of GEMIN2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of GEMIN2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:82,442,419...82,456,050
Ensembl chr 6:82,442,350...82,456,048
|
|
| G
|
Gemin4
|
gem (nuclear organelle) associated protein 4
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of GEMIN4 mRNA Calcitriol results in decreased expression of GEMIN4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:61,560,172...61,571,765
Ensembl chr10:61,564,657...61,596,532
|
|
| G
|
Gen1
|
GEN1 Holliday junction 5' flap endonuclease
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of GEN1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of GEN1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:39,666,675...39,697,480
Ensembl chr 6:39,667,286...39,697,480
|
|
| G
|
Gfap
|
glial fibrillary acidic protein
|
affects expression
|
ISO
|
Calcitriol affects the expression of GFAP mRNA
|
CTD |
PMID:15138306 |
|
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685
|
|
| G
|
Gfpt2
|
glutamine-fructose-6-phosphate transaminase 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of GFPT2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:34,616,146...34,662,420
Ensembl chr10:34,615,370...34,662,419
|
|
| G
|
Ggh
|
gamma-glutamyl hydrolase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of GGH mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of GGH mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:38,326,747...38,349,655
Ensembl chr 5:38,326,594...38,349,647
|
|
| G
|
Gh1
|
growth hormone 1
|
multiple interactions
|
EXP
|
GH1 protein affects the reaction [CYP27B1 protein affects the abundance of Calcitriol]
|
CTD |
PMID:11316734 |
|
NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,727,884...91,729,859
|
|
| G
|
Ghr
|
growth hormone receptor
|
multiple interactions
|
EXP
|
[Calcium co-treated with Calcitriol] affects the expression of GHR mRNA
|
CTD |
PMID:15913539 |
|
NCBI chr 2:54,269,066...54,532,595
Ensembl chr 2:54,270,206...54,532,331
|
|
| G
|
Gimap8
|
GTPase, IMAP family member 8
|
increases expression
|
ISO
|
Calcitriol results in increased expression of GIMAP8 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:78,931,003...78,942,491
Ensembl chr 4:78,931,029...78,942,488
|
|
| G
|
Gins1
|
GINS complex subunit 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of GINS1 mRNA Calcitriol results in decreased expression of GINS1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:160,184,920...160,206,334
Ensembl chr 3:160,180,151...160,206,332
|
|
| G
|
Gins2
|
GINS complex subunit 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of GINS2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of GINS2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:65,535,492...65,548,270
Ensembl chr19:65,535,492...65,548,052
|
|
| G
|
Gins3
|
GINS complex subunit 3
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of GINS3 mRNA Calcitriol results in decreased expression of GINS3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:9,426,140...9,435,192
Ensembl chr19:9,399,759...9,434,679
|
|
| G
|
Gja4
|
gap junction protein, alpha 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of GJA4 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:144,917,791...144,920,324
Ensembl chr 5:144,914,147...144,921,216
|
|
| G
|
Gjb2
|
gap junction protein, beta 2
|
multiple interactions decreases expression increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of GJB2 mRNA Calcitriol results in decreased expression of GJB2 mRNA Calcitriol results in increased expression of GJB2 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr15:35,375,977...35,393,817
Ensembl chr15:35,375,692...35,393,877
|
|
| G
|
Gk5
|
glycerol kinase 5
|
increases expression
|
ISO
|
Calcitriol results in increased expression of GK5 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:105,562,018...105,630,975
Ensembl chr 8:105,562,050...105,631,978
|
|
| G
|
Gla
|
galactosidase, alpha
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of GLA mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of GLA mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:102,062,497...102,073,915
Ensembl chr X:102,056,718...102,073,915
|
|
| G
|
Glipr2
|
GLI pathogenesis-related 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of GLIPR2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of GLIPR2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:62,966,163...62,998,016
Ensembl chr 5:62,966,195...62,998,716
|
|
| G
|
Gls
|
glutaminase
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of GLS mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 9:56,836,584...56,908,861
Ensembl chr 9:56,836,584...56,908,861
|
|
| G
|
Glt8d2
|
glycosyltransferase 8 domain containing 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of GLT8D2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:22,917,055...22,968,616
Ensembl chr 7:22,917,100...22,968,930
|
|
| G
|
Glud1
|
glutamate dehydrogenase 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of GLUD1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of GLUD1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:9,646,569...9,680,215
Ensembl chr16:9,646,509...9,680,210
|
|
| G
|
Glul
|
glutamate-ammonia ligase
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of GLUL mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:68,519,500...68,585,554
Ensembl chr13:68,576,067...68,585,520
|
|
| G
|
Gmnn
|
geminin, DNA replication inhibitor
|
affects expression decreases expression multiple interactions
|
ISO
|
Calcitriol affects the expression of GMNN mRNA Calcitriol results in decreased expression of GMNN mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of GMNN mRNA; Calcitriol promotes the reaction [Testosterone results in decreased expression of GMNN mRNA]
|
CTD |
PMID:21592394 |
|
NCBI chr17:40,729,760...40,738,077
Ensembl chr17:40,729,824...40,738,068
|
|
| G
|
Gnmt
|
glycine N-methyltransferase
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of GNMT mRNA [Testosterone co-treated with Calcitriol] results in increased expression of GNMT mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:21,752,235...21,756,368
Ensembl chr 9:21,752,266...21,755,692
|
|
| G
|
Golm1
|
golgi membrane protein 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of GOLM1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr17:4,996,978...5,049,278
Ensembl chr17:4,996,223...5,047,414
|
|
| G
|
Gpc6
|
glypican 6
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of GPC6 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of GPC6 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:100,437,415...101,435,038
Ensembl chr15:100,437,943...101,435,027
|
|
| G
|
Gpld1
|
glycosylphosphatidylinositol specific phospholipase D1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of GPLD1 mRNA Calcitriol results in increased expression of GPLD1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:40,512,659...40,560,483
Ensembl chr17:40,512,660...40,554,975
|
|
| G
|
Gpr137b
|
G protein-coupled receptor 137B
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of GPR137B mRNA Calcitriol results in increased expression of GPR137B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:92,987,792...93,026,003
Ensembl chr17:92,942,559...93,025,911
|
|
| G
|
Gpr143
|
G protein-coupled receptor 143
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of GPR143 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of GPR143 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:25,498,601...25,523,408
Ensembl chr X:25,498,601...25,523,400
|
|
| G
|
Gpr153
|
G protein-coupled receptor 153
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of GPR153 mRNA Calcitriol results in increased expression of GPR153 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:168,064,134...168,075,697
Ensembl chr 5:168,064,311...168,074,532
|
|
| G
|
Gpr19
|
G protein-coupled receptor 19
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of GPR19 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of GPR19 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:169,442,278...169,468,805
Ensembl chr 4:169,436,658...169,471,249
|
|
| G
|
Gpr37l1
|
G protein-coupled receptor 37-like 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of GPR37L1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of GPR37L1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:49,150,355...49,157,204
Ensembl chr13:49,150,359...49,157,204
|
|
| G
|
Gpr39
|
G protein-coupled receptor 39
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of GPR39 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:39,667,908...39,879,944
Ensembl chr13:39,667,909...39,880,902
|
|
| G
|
Gpr50
|
G protein-coupled receptor 50
|
increases expression
|
ISO
|
Calcitriol results in increased expression of GPR50 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr X:154,413,592...154,419,236
Ensembl chr X:154,413,689...154,418,275
|
|
| G
|
Gprc5b
|
G protein-coupled receptor, class C, group 5, member B
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of GPRC5B mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:182,748,247...182,772,711
Ensembl chr 1:182,748,247...182,772,757
|
|
| G
|
Gpsm2
|
G-protein signaling modulator 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of GPSM2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of GPSM2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:199,015,250...199,063,788
Ensembl chr 2:199,015,250...199,063,056
|
|
| G
|
Gpt2
|
glutamic--pyruvic transaminase 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of GPT2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr19:37,700,023...37,734,551
Ensembl chr19:37,691,901...37,733,917
|
|
| G
|
Gpx1
|
glutathione peroxidase 1
|
multiple interactions
|
ISO
|
Calcitriol promotes the reaction [salinomycin results in increased expression of GPX1 mRNA]
|
CTD |
PMID:35914560 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
| G
|
Gpx2
|
glutathione peroxidase 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of GPX2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of GPX2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862
|
|
| G
|
Gpx7
|
glutathione peroxidase 7
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of GPX7 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:128,373,881...128,381,866
Ensembl chr 5:128,372,875...128,381,725
|
|
| G
|
Gpx8
|
glutathione peroxidase 8
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of GPX8 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:46,409,646...46,413,401
Ensembl chr 2:46,409,139...46,413,406
|
|
| G
|
Gramd4
|
GRAM domain containing 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of GRAMD4 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:119,030,225...119,103,875
Ensembl chr 7:119,030,225...119,103,875
|
|
| G
|
Grb2
|
growth factor receptor bound protein 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of GRB2 mRNA
|
CTD |
PMID:15951637 |
|
NCBI chr10:101,380,354...101,448,138
Ensembl chr10:101,380,356...101,448,138
|
|
| G
|
Grb7
|
growth factor receptor bound protein 7
|
increases expression
|
ISO
|
Calcitriol results in increased expression of GRB7 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:83,936,538...83,949,344
Ensembl chr10:83,939,299...83,949,382
|
|
| G
|
Greb1
|
growth regulating estrogen receptor binding 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of GREB1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of GREB1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:45,169,289...45,321,973
Ensembl chr 6:45,169,289...45,291,126
|
|
| G
|
Grem1
|
gremlin 1, DAN family BMP antagonist
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of GREM1 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 3:120,966,639...120,978,319
Ensembl chr 3:120,966,623...120,979,089
|
|
| G
|
Grhl1
|
grainyhead-like transcription factor 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of GRHL1 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 6:46,935,947...46,986,126
Ensembl chr 6:46,935,967...46,980,264
|
|
| G
|
Grhl2
|
grainyhead-like transcription factor 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of GRHL2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:70,280,360...70,415,277
Ensembl chr 7:70,285,310...70,415,274
|
|
| G
|
Grhl3
|
grainyhead-like transcription factor 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of GRHL3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:153,057,760...153,089,890
Ensembl chr 5:153,057,760...153,089,890
|
|
| G
|
Grik3
|
glutamate ionotropic receptor kainate type subunit 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of GRIK3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:143,052,442...143,268,873
Ensembl chr 5:143,052,442...143,268,873
|
|
| G
|
Grk5
|
G protein-coupled receptor kinase 5
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of GRK5 mRNA Calcitriol results in increased expression of GRK5 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 1:270,014,314...270,208,294
Ensembl chr 1:270,014,282...270,204,928
|
|
| G
|
Gsn
|
gelsolin
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of GSN mRNA [Testosterone co-treated with Calcitriol] results in increased expression of GSN mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:38,982,671...39,035,850
|
|
| G
|
Gstm1
|
glutathione S-transferase mu 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of GSTM1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of GSTM1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569
|
|
| G
|
Gstm2
|
glutathione S-transferase mu 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of GSTM2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of GSTM2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:198,312,179...198,316,962
|
|
| G
|
Gtse1
|
G-2 and S-phase expressed 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of GTSE1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of GTSE1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:118,829,793...118,846,662
Ensembl chr 7:118,829,903...118,846,661
|
|
| G
|
Gucy1a1
|
guanylate cyclase 1 soluble subunit alpha 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of GUCY1A1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:169,716,684...169,780,360
Ensembl chr 2:169,716,709...169,779,737
|
|
| G
|
H1f5
|
H1.5 linker histone, cluster member
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of H1-5 mRNA Calcitriol results in decreased expression of H1-5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:47,421,875...47,422,905
Ensembl chr17:47,421,843...47,477,387
|
|
| G
|
H2ax
|
H2A.X variant histone
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of H2AX mRNA [salinomycin co-treated with Calcitriol] results in decreased expression of H2AX mRNA; [Testosterone co-treated with Calcitriol] results in decreased expression of H2AX mRNA
|
CTD |
PMID:21592394 PMID:35914560 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
H2bc14
|
H2B clustered histone 14
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of H2BC5 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of H2BC5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:47,488,627...47,489,008
|
|
| G
|
H3c1
|
H3 clustered histone 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of H3C1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of H3C1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:41,796,236...41,796,759
Ensembl chr17:41,795,396...41,797,281 Ensembl chr17:41,795,396...41,797,281
|
|
| G
|
Hacd2
|
3-hydroxyacyl-CoA dehydratase 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of HACD2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr11:79,175,470...79,268,975
Ensembl chr11:79,175,482...79,268,126
|
|
| G
|
Hal
|
histidine ammonia lyase
|
increases expression
|
ISO
|
Calcitriol results in increased expression of HAL mRNA
|
CTD |
PMID:12798352 |
|
NCBI chr 7:29,894,495...29,924,744
Ensembl chr 7:29,893,855...29,924,744
|
|
| G
|
Has2
|
hyaluronan synthase 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of HAS2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:90,002,929...90,028,933
Ensembl chr 7:90,002,929...90,018,535
|
|
| G
|
Haspin
|
histone H3 associated protein kinase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of HASPIN mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of HASPIN mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:58,246,244...58,249,031
Ensembl chr10:58,240,447...58,249,249
|
|
| G
|
Haus4
|
HAUS augmin-like complex, subunit 4
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of HAUS4 mRNA Calcitriol results in decreased expression of HAUS4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:31,964,555...31,976,853
Ensembl chr15:31,964,556...31,975,941
|
|
| G
|
Haus5
|
HAUS augmin-like complex, subunit 5
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of HAUS5 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of HAUS5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:95,039,800...95,050,778
Ensembl chr 1:95,039,800...95,050,778
|
|
| G
|
Haus6
|
HAUS augmin like complex subunit 6
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of HAUS6 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of HAUS6 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:106,162,526...106,201,503
Ensembl chr 5:106,162,526...106,199,072
|
|
| G
|
Haus7
|
HAUS augmin-like complex, subunit 7
|
multiple interactions increases expression decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of HAUS7 mRNA Calcitriol results in increased expression of HAUS7 mRNA Calcitriol results in decreased expression of HAUS7 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr X:156,306,320...156,331,940
Ensembl chr X:156,306,320...156,352,158
|
|
| G
|
Haus8
|
HAUS augmin-like complex, subunit 8
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of HAUS8 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of HAUS8 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:17,964,813...17,979,313
Ensembl chr16:17,964,814...17,979,192
|
|
| G
|
Havcr2
|
hepatitis A virus cellular receptor 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of HAVCR2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:31,383,801...31,415,334
Ensembl chr10:31,383,925...31,413,872
|
|
| G
|
Hbegf
|
heparin-binding EGF-like growth factor
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of HBEGF mRNA Calcitriol results in increased expression of HBEGF mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,380,337...28,390,220
|
|
| G
|
Hbp1
|
HMG-box transcription factor 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of HBP1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of HBP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:54,257,118...54,283,373
Ensembl chr 6:54,256,864...54,283,366
|
|
| G
|
Hck
|
HCK proto-oncogene, Src family tyrosine kinase
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of HCK mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:162,031,833...162,074,933
Ensembl chr 3:162,031,817...162,074,935
|
|
| G
|
Hdac11
|
histone deacetylase 11
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of HDAC11 mRNA Calcitriol results in increased expression of HDAC11 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:125,203,044...125,224,584
Ensembl chr 4:125,202,299...125,224,582
|
|
| G
|
Hddc2
|
HD domain containing 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of HDDC2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of HDDC2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:28,100,669...28,133,008
Ensembl chr 1:28,083,521...28,132,977
|
|
| G
|
Hecw2
|
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of HECW2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of HECW2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:62,853,904...63,247,472
Ensembl chr 9:62,859,645...63,074,758
|
|
| G
|
Hells
|
helicase, lymphoid specific
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of HELLS mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of HELLS mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:246,113,580...246,159,230
Ensembl chr 1:246,114,096...246,159,228
|
|
| G
|
Hepacam
|
hepatic and glial cell adhesion molecule
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of HEPACAM mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of HEPACAM mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:45,276,594...45,294,006
Ensembl chr 8:45,276,683...45,295,548
|
|
| G
|
Hes1
|
hes family bHLH transcription factor 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of HES1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of HES1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr11:84,210,632...84,213,045
Ensembl chr11:84,210,633...84,213,061
|
|
| G
|
Hes2
|
hes family bHLH transcription factor 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of HES2 mRNA Calcitriol results in increased expression of HES2 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 5:167,947,948...167,964,660
Ensembl chr 5:167,949,918...167,955,601
|
|
| G
|
Hhip
|
Hedgehog-interacting protein
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of HHIP mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr19:44,768,038...44,856,878
Ensembl chr19:44,767,536...44,862,795
|
|
| G
|
Hhipl2
|
HHIP like 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of HHIPL2 mRNA Calcitriol results in increased expression of HHIPL2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:97,586,296...97,606,223
Ensembl chr13:97,586,341...97,606,223
|
|
| G
|
Hibch
|
3-hydroxyisobutyryl-CoA hydrolase
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of HIBCH mRNA Calcitriol results in increased expression of HIBCH mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:56,082,082...56,161,796
Ensembl chr 9:56,082,091...56,161,886
|
|
| G
|
Hid1
|
HID1 domain containing
|
increases expression
|
ISO
|
Calcitriol results in increased expression of HID1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:101,088,526...101,109,011
Ensembl chr10:101,088,526...101,109,011
|
|
| G
|
Hipk2
|
homeodomain interacting protein kinase 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of HIPK2 mRNA Calcitriol results in increased expression of HIPK2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:68,399,358...68,586,404
Ensembl chr 4:68,369,099...68,586,108
|
|
| G
|
Hirip3
|
HIRA interacting protein 3
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of HIRIP3 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of HIRIP3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:190,903,065...190,905,610
Ensembl chr 1:190,902,593...190,905,607
|
|
| G
|
Hivep2
|
HIVEP zinc finger 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of HIVEP2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:10,176,880...10,376,089
Ensembl chr 1:10,179,402...10,376,089
|
|
| G
|
Hjurp
|
Holliday junction recognition protein
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of HJURP mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of HJURP mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:96,301,183...96,315,587
Ensembl chr 9:96,302,530...96,315,657
|
|
| G
|
Hlf
|
HLF transcription factor, PAR bZIP family member
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of HLF mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of HLF mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:75,651,320...75,708,979
Ensembl chr10:75,654,534...75,708,619
|
|
| G
|
Hmcn1
|
hemicentin 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of HMCN1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:65,165,532...65,634,681
Ensembl chr13:65,165,532...65,634,519
|
|
| G
|
Hmgb1
|
high mobility group box 1
|
decreases expression multiple interactions
|
ISO EXP
|
Calcitriol results in decreased expression of HMGB1 mRNA Calcitriol results in decreased expression of HMGB1 mRNA; Calcitriol results in decreased expression of HMGB1 protein [Testosterone co-treated with Calcitriol] results in decreased expression of HMGB1 mRNA
|
CTD |
PMID:21592394 PMID:32147540 |
|
NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327 Ensembl chr12:39,039,050...39,041,327
|
|
| G
|
Hmgb2
|
high mobility group box 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of HMGB2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of HMGB2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:37,721,374...37,723,950
Ensembl chr16:37,721,379...37,723,860
|
|
| G
|
Hmgcs1
|
3-hydroxy-3-methylglutaryl-CoA synthase 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of HMGCS1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of HMGCS1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:53,382,643...53,399,802
|
|
| G
|
Hmmr
|
hyaluronan-mediated motility receptor
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of HMMR mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of HMMR mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:25,635,249...25,665,389
Ensembl chr10:25,635,915...25,665,390
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of HMOX1 mRNA Calcitriol inhibits the reaction [perfluorooctane sulfonic acid results in increased expression of HMOX1 protein] [Testosterone co-treated with Calcitriol] results in increased expression of HMOX1 mRNA; Calcitriol promotes the reaction [sodium arsenite results in increased expression of HMOX1 protein]
|
CTD |
PMID:21592394 PMID:36321694 PMID:37968493 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hnf4a
|
hepatocyte nuclear factor 4, alpha
|
multiple interactions
|
ISO
|
[Calcitriol binds to and results in increased activity of VDR protein] results in decreased activity of [HNF4A protein co-treated with PPARGC1A protein]; Calcitriol inhibits the reaction [HNF4A protein binds to CYP7A1 mRNA]; Calcitriol inhibits the reaction [HNF4A protein binds to CYP7A1 promoter]; Calcitriol promotes the reaction [HNF4A protein binds to CYP24A1 mRNA]; Calcitriol promotes the reaction [MAPK1 protein results in increased phosphorylation of HNF4A protein]; Calcitriol promotes the reaction [MAPK3 protein results in increased phosphorylation of HNF4A protein]; Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]; MAPK1 protein promotes the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]; MAPK3 protein promotes the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]; NCOA1 protein promotes the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]; NCOR1 protein inhibits the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]; NCOR2 protein inhibits the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]; PPARGC1A protein promotes the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]; U 0126 inhibits the reaction [Calcitriol inhibits the reaction [HNF4A protein binds to CYP7A1 mRNA]]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [MAPK1 protein results in increased phosphorylation of HNF4A protein]]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [MAPK3 protein results in increased phosphorylation of HNF4A protein]]; U 0126 inhibits the reaction [MAPK1 protein promotes the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]]; U 0126 inhibits the reaction [MAPK3 protein promotes the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]]
|
CTD |
PMID:19106115 PMID:20371703 |
|
NCBI chr 3:172,606,220...172,667,758
Ensembl chr 3:172,606,220...172,667,758
|
|
| G
|
Hnrnpa1
|
heterogeneous nuclear ribonucleoprotein A1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of HNRNPA1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of HNRNPA1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:136,253,633...136,260,085
Ensembl chr 7:136,253,278...136,260,085
|
|
| G
|
Homer2
|
homer scaffold protein 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of HOMER2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:144,968,207...145,069,022
Ensembl chr 1:144,976,436...145,068,997
|
|
| G
|
Hook1
|
hook microtubule-tethering protein 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of HOOK1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:115,940,199...116,003,482
Ensembl chr 5:115,940,080...116,003,482
|
|
| G
|
Hoxa10
|
homeobox A10
|
affects binding multiple interactions
|
ISO
|
[Calcitriol binds to VDR protein] which binds to HOXA10 promoter [Calcitriol binds to VDR protein] which results in increased expression of HOXA10 mRNA
|
CTD |
PMID:16632680 |
|
NCBI chr 4:82,662,204...82,671,490
Ensembl chr 4:82,662,204...82,665,922
|
|
| G
|
Hoxa5
|
homeo box A5
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of HOXA5 mRNA Calcitriol results in decreased expression of HOXA5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:82,632,958...82,636,851
Ensembl chr 4:82,632,306...82,639,038
|
|
| G
|
Hp
|
haptoglobin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of HP protein
|
CTD |
PMID:27107558 |
|
NCBI chr19:54,449,151...54,453,701
Ensembl chr19:54,446,217...54,467,518
|
|
| G
|
Hpgd
|
15-hydroxyprostaglandin dehydrogenase
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of HPGD mRNA [Testosterone co-treated with Calcitriol] results in increased expression of HPGD mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:38,996,876...39,034,831
Ensembl chr16:38,996,876...39,034,831
|
|
| G
|
Hpn
|
hepsin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of HPN mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:95,464,468...95,480,169
Ensembl chr 1:95,464,470...95,480,199
|
|
| G
|
Hprt1
|
hypoxanthine phosphoribosyltransferase 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of HPRT1 mRNA Calcitriol results in decreased expression of HPRT1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:137,655,744...137,687,718
Ensembl chr X:137,655,680...137,687,712
|
|
| G
|
Hr
|
HR, lysine demethylase and nuclear receptor corepressor
|
multiple interactions increases expression
|
ISO
|
HR protein inhibits the reaction [Calcitriol results in increased activity of VDR protein mutant form]; HR protein inhibits the reaction [Calcitriol results in increased activity of VDR protein]; HR protein inhibits the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]; HR protein promotes the reaction [Calcitriol results in increased expression of CAMP mRNA]; trichostatin A inhibits the reaction [HR protein inhibits the reaction [Calcitriol results in increased activity of VDR protein]] Calcitriol results in increased expression of HR mRNA
|
CTD |
PMID:16002434 PMID:22466564 PMID:26485663 |
|
NCBI chr15:52,036,540...52,056,019
Ensembl chr15:52,036,540...52,056,015
|
|
| G
|
Hrct1
|
histidine rich carboxyl terminus 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of HRCT1 mRNA Calcitriol results in increased expression of HRCT1 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 5:62,778,112...62,778,954
Ensembl chr 5:62,778,112...62,778,954
|
|
| G
|
Hrob
|
homologous recombination factor with OB-fold
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of HROB mRNA Calcitriol results in decreased expression of HROB mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:87,705,846...87,722,635
Ensembl chr10:87,706,194...87,722,635
|
|
| G
|
Hs3st3a1
|
heparan sulfate-glucosamine 3-sulfotransferase 3A1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of HS3ST3A1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:49,593,208...49,679,854
Ensembl chr10:49,593,009...49,679,854
|
|
| G
|
Hs6st2
|
heparan sulfate 6-O-sulfotransferase 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of HS6ST2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr X:135,887,224...136,182,388
Ensembl chr X:135,888,472...136,182,353
|
|
| G
|
Hsd11b1
|
hydroxysteroid 11-beta dehydrogenase 1
|
multiple interactions affects expression
|
ISO
|
[Calcitriol co-treated with Cortisone] results in increased expression of HSD11B1 mRNA Calcitriol affects the expression of HSD11B1 protein
|
CTD |
PMID:19918113 |
|
NCBI chr13:107,277,526...107,327,462
Ensembl chr13:107,257,239...107,327,432
|
|
| G
|
Hsd11b2
|
hydroxysteroid 11-beta dehydrogenase 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of HSD11B2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of HSD11B2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:50,307,569...50,312,812
Ensembl chr19:50,307,569...50,312,812
|
|
| G
|
Hsd17b11
|
hydroxysteroid (17-beta) dehydrogenase 11
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of HSD17B11 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of HSD17B11 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:5,997,893...6,047,816
Ensembl chr14:5,997,906...6,047,811
|
|
| G
|
Hsd17b12
|
hydroxysteroid (17-beta) dehydrogenase 12
|
multiple interactions
|
EXP
|
[Calcium co-treated with Calcitriol] affects the expression of HSD17B12 mRNA
|
CTD |
PMID:15913539 |
|
NCBI chr 3:100,445,393...100,568,898
Ensembl chr 3:100,445,400...100,568,938
|
|
| G
|
Hsd17b2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of HSD17B2 mRNA; Ketoconazole promotes the reaction [Calcitriol results in increased expression of HSD17B2 mRNA]
|
CTD |
PMID:12040012 PMID:16002434 PMID:21592394 |
|
NCBI chr19:62,662,320...62,733,944
Ensembl chr19:62,662,098...62,733,943
|
|
| G
|
Hsd3b1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of HSD3B1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of HSD3B1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:188,858,574...188,864,694
|
|
| G
|
Hsh2d
|
hematopoietic SH2 domain containing
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of HSH2D mRNA [Testosterone co-treated with Calcitriol] results in increased expression of HSH2D mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:17,664,548...17,686,976
Ensembl chr16:17,669,345...17,682,013
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
multiple interactions
|
ISO
|
[Calcitriol co-treated with salinomycin] results in increased expression of HSPA5 mRNA; Calcitriol promotes the reaction [salinomycin results in increased expression of HSPA5 mRNA]
|
CTD |
PMID:35914560 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Hspb3
|
heat shock protein family B (small) member 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of HSPB3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:47,028,451...47,029,165
Ensembl chr 2:47,024,757...47,029,373
|
|
| G
|
Hspb8
|
heat shock protein family B (small) member 8
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of HSPB8 mRNA Calcitriol results in increased expression of HSPB8 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr12:45,835,899...45,866,449
Ensembl chr12:45,837,066...45,851,937
|
|
| G
|
Hspd1
|
heat shock protein family D (Hsp60) member 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of HSPD1 mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037
|
|
| G
|
Hspe1
|
heat shock protein family E (Hsp10) member 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of HSPE1 mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr 9:64,084,327...64,087,415
Ensembl chr 9:64,085,068...64,087,502
|
|
| G
|
Hspg2
|
heparan sulfate proteoglycan 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of HSPG2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:154,960,818...155,061,971
Ensembl chr 5:154,960,846...155,061,971
|
|
| G
|
Htr2c
|
5-hydroxytryptamine receptor 2C
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of HTR2C mRNA Calcitriol results in increased expression of HTR2C mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr X:115,453,190...115,682,325
Ensembl chr X:115,452,842...115,682,324
|
|
| G
|
Htra2
|
HtrA serine peptidase 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of HTRA2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of HTRA2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:117,114,631...117,117,793
Ensembl chr 4:117,114,633...117,117,793
|
|
| G
|
Hycc1
|
hyccin PI4KA lipid kinase complex subunit 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of HYCC1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:12,024,692...12,131,504
Ensembl chr 4:12,024,739...12,131,501
|
|
| G
|
Ibsp
|
integrin-binding sialoprotein
|
increases expression
|
ISO
|
Calcitriol results in increased expression of IBSP mRNA
|
CTD |
PMID:21542014 PMID:28105418 |
|
NCBI chr14:5,744,497...5,757,242
Ensembl chr14:5,744,501...5,775,299
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
multiple interactions
|
ISO
|
Calcitriol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]
|
CTD |
PMID:34255241 |
|
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Id2
|
inhibitor of DNA binding 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ID2 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 6:47,469,162...47,470,995
Ensembl chr 6:47,457,554...47,472,961
|
|
| G
|
Ier3
|
immediate early response 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of IER3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377
|
|
| G
|
Iffo1
|
intermediate filament family orphan 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of IFFO1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 4:159,631,309...159,648,531
Ensembl chr 4:159,630,763...159,648,527
|
|
| G
|
Ifi27
|
interferon, alpha-inducible protein 27
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of IFI27 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 6:128,355,312...128,361,783
Ensembl chr 6:128,355,079...128,361,781
|
|
| G
|
Ifi35
|
interferon-induced protein 35
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of IFI35 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of IFI35 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:86,881,270...86,889,523
Ensembl chr10:86,887,122...86,889,750
|
|
| G
|
Ifit2
|
interferon-induced protein with tetratricopeptide repeats 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of IFIT2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:241,515,735...241,521,799
Ensembl chr 1:241,515,709...241,521,798
|
|
| G
|
Ifit3
|
interferon-induced protein with tetratricopeptide repeats 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of IFIT3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:241,527,326...241,532,469
Ensembl chr 1:241,526,880...241,532,521
|
|
| G
|
Ifitm1
|
interferon induced transmembrane protein 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of IFITM1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:205,496,757...205,498,796
Ensembl chr 1:205,496,807...205,498,776
|
|
| G
|
Ifitm10
|
interferon induced transmembrane protein 10
|
increases expression
|
ISO
|
Calcitriol results in increased expression of IFITM10 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:206,936,979...206,954,594
Ensembl chr 1:206,936,444...206,954,629
|
|
| G
|
Ifng
|
interferon gamma
|
multiple interactions decreases expression
|
ISO
|
Calcitriol inhibits the reaction [isopentenyl pyrophosphate results in increased expression of IFNG protein] Calcitriol results in decreased expression of IFNG protein
|
CTD |
PMID:15879110 PMID:15939587 PMID:25458313 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Igf1
|
insulin-like growth factor 1
|
affects expression
|
ISO
|
Calcitriol affects the expression of IGF1 mRNA
|
CTD |
PMID:19918113 |
|
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
| G
|
Igf1r
|
insulin-like growth factor 1 receptor
|
affects expression increases expression multiple interactions
|
ISO
|
Calcitriol affects the expression of IGF1R mRNA Calcitriol results in increased expression of IGF1R mRNA [Testosterone co-treated with Calcitriol] results in increased expression of IGF1R mRNA
|
CTD |
PMID:19918113 PMID:21592394 |
|
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664
|
|
| G
|
Igfbp1
|
insulin-like growth factor binding protein 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of IGFBP1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of IGFBP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:86,261,277...86,266,344
Ensembl chr14:86,261,277...86,266,344
|
|
| G
|
Igfbp3
|
insulin-like growth factor binding protein 3
|
multiple interactions increases expression
|
ISO
|
[Calcitriol co-treated with Genistein] results in increased expression of IGFBP3 mRNA; [Calcitriol co-treated with Metribolone] results in increased expression of IGFBP3 mRNA Calcitriol results in increased expression of IGFBP3 mRNA
|
CTD |
PMID:15955619 PMID:16825320 |
|
NCBI chr14:86,270,208...86,277,944
Ensembl chr14:86,270,208...86,277,944
|
|
| G
|
Igfbp5
|
insulin-like growth factor binding protein 5
|
multiple interactions
|
ISO
|
IGFBP5 protein inhibits the reaction [Calcitriol results in increased expression of COL1A1 protein]
|
CTD |
PMID:17595320 |
|
NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:81,897,616...81,914,390
|
|
| G
|
Igflr1
|
IGF-like family receptor 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of IGFLR1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:94,945,866...94,948,476
Ensembl chr 1:94,945,967...94,948,473
|
|
| G
|
Igsf3
|
immunoglobulin superfamily, member 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of IGSF3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:191,499,972...191,588,249
Ensembl chr 2:191,500,045...191,588,249
|
|
| G
|
Igsf9
|
immunoglobulin superfamily, member 9
|
decreases expression increases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of IGSF9 mRNA Calcitriol results in increased expression of IGSF9 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of IGSF9 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr13:87,480,979...87,497,974
Ensembl chr13:87,481,279...87,497,974
|
|
| G
|
Ikbkb
|
inhibitor of nuclear factor kappa B kinase subunit beta
|
decreases phosphorylation
|
EXP
|
Calcitriol results in decreased phosphorylation of IKBKB protein
|
CTD |
PMID:32147540 |
|
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911
|
|
| G
|
Ikbke
|
inhibitor of nuclear factor kappa B kinase subunit epsilon
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of IKBKE mRNA Calcitriol results in increased expression of IKBKE mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:45,264,404...45,290,737
Ensembl chr13:45,264,412...45,289,396
|
|
| G
|
Ikzf1
|
IKAROS family zinc finger 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of IKZF1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr14:90,468,696...90,556,522
Ensembl chr14:90,469,172...90,557,574
|
|
| G
|
Il10
|
interleukin 10
|
increases expression multiple interactions
|
EXP ISO
|
Calcitriol results in increased expression of IL10 protein Calcitriol inhibits the reaction [sodium arsenite results in decreased secretion of IL10 protein] Calcitriol results in increased expression of IL10 mRNA
|
CTD |
PMID:11679963 PMID:16322758 PMID:22615136 PMID:39771102 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il12b
|
interleukin 12B
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of IL12B protein
|
CTD |
PMID:15939587 |
|
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194
|
|
| G
|
Il13
|
interleukin 13
|
multiple interactions
|
ISO
|
[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with IL13 protein co-treated with IL4 protein] affects the phosphorylation of STAT6 protein; [Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with IL13 protein co-treated with Nanotubes, Carbon co-treated with IL4 protein] affects the phosphorylation of STAT6 protein; [Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with IL13 protein co-treated with Nanotubes, Carbon] affects the phosphorylation of STAT6 protein; [Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with IL13 protein] affects the phosphorylation of STAT6 protein; [IL13 protein co-treated with IL4 protein co-treated with Nanotubes, Carbon] inhibits the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] affects the expression of CASP1 protein]; [IL13 protein co-treated with IL4 protein] inhibits the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] affects the expression of CASP1 protein]; [IL4 protein co-treated with IL13 protein] inhibits the reaction [Nanotubes, Carbon promotes the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with Nanotubes, Carbon] affects the expression of CASP1 mRNA]]; IL13 protein inhibits the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with Nanotubes, Carbon] affects the secretion of IL1B protein]; IL13 protein inhibits the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] affects the expression of CASP1 protein]; leflunomide inhibits the reaction [[IL13 protein co-treated with IL4 protein] inhibits the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] affects the expression of and affects the activity of CASP1 protein]]
|
CTD |
PMID:26091108 |
|
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:38,290,926...38,293,483
|
|
| G
|
Il16
|
interleukin 16
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of IL16 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:147,026,852...147,127,177
Ensembl chr 1:147,027,097...147,127,023
|
|
| G
|
Il17ra
|
interleukin 17 receptor A
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of IL17R mRNA [Testosterone co-treated with Calcitriol] results in increased expression of IL17R mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:155,339,742...155,362,382
Ensembl chr 4:155,339,400...155,362,382
|
|
| G
|
Il17rb
|
interleukin 17 receptor B
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of IL17RB mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of IL17RB mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:5,186,961...5,200,657
Ensembl chr16:5,186,961...5,200,694
|
|
| G
|
Il1a
|
interleukin 1 alpha
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of IL1A protein
|
CTD |
PMID:2525134 |
|
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
|
|
| G
|
Il1b
|
interleukin 1 beta
|
multiple interactions decreases expression
|
ISO EXP
|
[Calcitriol co-treated with Lipopolysaccharides] results in increased expression of IL1B protein; [Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with Nanotubes, Carbon] affects the expression of IL1B mRNA; [Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with Nanotubes, Carbon] affects the expression of IL1B protein; [Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with Nanotubes, Carbon] affects the secretion of IL1B protein; [CD40LG protein co-treated with Calcitriol] results in decreased secretion of and results in decreased expression of IL1B protein; Calcitriol inhibits the reaction [IL1B protein results in increased degradation of NFKBIA protein]; Calcitriol inhibits the reaction [IL1B protein results in increased expression of CXCL8 protein]; Calcitriol inhibits the reaction [IL1B protein results in increased phosphorylation of RELA protein]; IL13 protein inhibits the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with Nanotubes, Carbon] affects the secretion of IL1B protein]; IL4 protein inhibits the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with Nanotubes, Carbon] affects the secretion of IL1B protein] Calcitriol inhibits the reaction [sodium arsenite results in increased secretion of IL1B protein] Calcitriol results in decreased expression of IL1B mRNA; Calcitriol results in decreased expression of IL1B protein Calcitriol inhibits the reaction [Bleomycin results in increased expression of IL1B mRNA]
|
CTD |
PMID:1450407 PMID:2525134 PMID:18515093 PMID:19186073 PMID:22615136 PMID:26091108 PMID:26520185 PMID:32147540 PMID:39771102 More...
|
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il1r1
|
interleukin 1 receptor type 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of IL1R1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 9:50,000,558...50,076,579
Ensembl chr 9:50,000,566...50,076,579
|
|
| G
|
Il1r2
|
interleukin 1 receptor type 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of IL1R2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 9:49,879,928...49,920,374
Ensembl chr 9:49,877,266...49,920,374
|
|
| G
|
Il1rap
|
interleukin 1 receptor accessory protein
|
increases expression
|
ISO
|
Calcitriol results in increased expression of IL1RAP mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr11:87,567,813...87,704,346
Ensembl chr11:87,575,116...87,704,342
|
|
| G
|
Il1rl1
|
interleukin 1 receptor-like 1
|
multiple interactions increases expression
|
ISO
|
Ketoconazole promotes the reaction [Calcitriol results in increased expression of IL1RL1 mRNA]
|
CTD |
PMID:12040012 PMID:16002434 PMID:26485663 |
|
NCBI chr 9:50,157,326...50,222,888
Ensembl chr 9:50,204,551...50,222,891
|
|
| G
|
Il1rn
|
interleukin 1 receptor antagonist
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of IL1RN mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732
|
|
| G
|
Il2
|
interleukin 2
|
multiple interactions decreases expression decreases secretion
|
ISO EXP
|
Calcitriol inhibits the reaction [IL2 protein results in increased phosphorylation of AKT1 protein]; Calcitriol inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK1 protein]; Calcitriol inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK3 protein] Calcitriol results in decreased expression of IL2 protein Calcitriol results in decreased secretion of IL2 protein Calcitriol results in decreased expression of IL2 mRNA; Calcitriol results in decreased expression of IL2 protein
|
CTD |
PMID:2525134 PMID:2783896 PMID:3002965 PMID:3093070 PMID:11679963 PMID:15879110 More...
|
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
|
|
| G
|
Il24
|
interleukin 24
|
increases expression
|
ISO
|
Calcitriol results in increased expression of IL24 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:44,905,362...44,910,760
Ensembl chr13:44,905,363...44,910,760
|
|
| G
|
Il2ra
|
interleukin 2 receptor subunit alpha
|
multiple interactions decreases expression
|
ISO
|
Calcitriol inhibits the reaction [isopentenyl pyrophosphate results in increased expression of IL2RA protein] Calcitriol results in decreased expression of IL2RA mRNA
|
CTD |
PMID:3093070 PMID:15879110 |
|
NCBI chr17:71,759,802...71,808,475
Ensembl chr17:71,759,802...71,808,507
|
|
| G
|
Il2rg
|
interleukin 2 receptor subunit gamma
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of IL2RG mRNA Calcitriol results in increased expression of IL2RG mRNA
|
CTD |
PMID:16129123 PMID:21592394 |
|
NCBI chr X:70,435,340...70,439,052
Ensembl chr X:70,435,343...70,439,161
|
|
| G
|
Il33
|
interleukin 33
|
increases expression
|
ISO
|
Calcitriol results in increased expression of IL33 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:237,115,478...237,149,897
Ensembl chr 1:237,115,572...237,150,901
|
|
| G
|
Il34
|
interleukin 34
|
increases expression
|
ISO
|
Calcitriol results in increased expression of IL34 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr19:55,624,368...55,690,576
Ensembl chr19:55,624,369...55,673,376
|
|
| G
|
Il4
|
interleukin 4
|
increases expression multiple interactions
|
EXP ISO
|
Calcitriol results in increased expression of IL4 protein [Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with IL13 protein co-treated with IL4 protein] affects the phosphorylation of STAT6 protein; [Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with IL13 protein co-treated with Nanotubes, Carbon co-treated with IL4 protein] affects the phosphorylation of STAT6 protein; [Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with IL4 protein co-treated with Nanotubes, Carbon] affects the phosphorylation of STAT6 protein; [Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with IL4 protein] affects the phosphorylation of STAT6 protein; [IL13 protein co-treated with IL4 protein co-treated with Nanotubes, Carbon] inhibits the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] affects the expression of CASP1 protein]; [IL13 protein co-treated with IL4 protein] inhibits the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] affects the expression of CASP1 protein]; [IL4 protein co-treated with IL13 protein] inhibits the reaction [Nanotubes, Carbon promotes the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with Nanotubes, Carbon] affects the expression of CASP1 mRNA]]; IL4 protein inhibits the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with Nanotubes, Carbon] affects the secretion of IL1B protein]; IL4 protein inhibits the reaction [Nanotubes, Carbon promotes the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with Nanotubes, Carbon] affects the expression of CASP1 mRNA]]; Leflunomide inhibits the reaction [[IL13 protein co-treated with IL4 protein] inhibits the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] affects the expression of and affects the activity of CASP1 protein]] Calcitriol results in increased expression of IL4 mRNA
|
CTD |
PMID:11679963 PMID:22615136 PMID:26091108 |
|
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
|
|
| G
|
Il4r
|
interleukin 4 receptor
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of IL4R mRNA [Testosterone co-treated with Calcitriol] results in increased expression of IL4R mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:189,544,988...189,570,636
|
|
| G
|
Il6
|
interleukin 6
|
multiple interactions decreases expression
|
ISO EXP
|
Calcitriol inhibits the reaction [Mustard Gas results in increased secretion of IL6 protein] Calcitriol inhibits the reaction [sodium arsenite results in increased secretion of IL6 protein] Calcitriol results in decreased expression of IL6 mRNA; Calcitriol results in decreased expression of IL6 protein Calcitriol inhibits the reaction [Bleomycin results in increased expression of IL6 mRNA]
|
CTD |
PMID:12753408 PMID:21350317 PMID:26520185 PMID:32147540 PMID:39771102 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Il6st
|
interleukin 6 cytokine family signal transducer
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of IL6ST mRNA Calcitriol results in increased expression of IL6ST mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:45,798,872...45,839,501
Ensembl chr 2:45,799,380...45,843,182
|
|
| G
|
Il7r
|
interleukin 7 receptor
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of IL7R mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 2:60,179,561...60,204,937
Ensembl chr 2:60,181,382...60,211,027
|
|
| G
|
Ildr1
|
immunoglobulin-like domain containing receptor 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ILDR1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr11:77,591,146...77,624,268
Ensembl chr11:77,569,621...77,624,140
|
|
| G
|
Inava
|
innate immunity activator
|
increases expression
|
ISO
|
Calcitriol results in increased expression of INAVA mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:50,218,149...50,238,430
Ensembl chr13:50,218,150...50,238,454
|
|
| G
|
Incenp
|
inner centromere protein
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of INCENP mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of INCENP mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:215,945,558...216,017,247
Ensembl chr 1:215,948,283...215,977,084
|
|
| G
|
Inhba
|
inhibin subunit beta A
|
decreases expression multiple interactions increases expression
|
ISO
|
Calcitriol results in decreased expression of INHBA mRNA INHBA protein inhibits the reaction [Calcitriol results in increased expression of BGLAP mRNA] Calcitriol results in increased expression of INHBA mRNA; Calcitriol results in increased expression of INHBA protein
|
CTD |
PMID:16002434 PMID:23589129 |
|
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:53,791,444...53,804,508
|
|
| G
|
Inpp4b
|
inositol polyphosphate-4-phosphatase type II B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of INPP4B mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr19:42,824,710...43,575,039
Ensembl chr19:42,829,871...43,185,091
|
|
| G
|
Insig1
|
insulin induced gene 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of INSIG1 mRNA Calcitriol results in increased expression of INSIG1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778
|
|
| G
|
Insig2
|
insulin induced gene 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of INSIG2 mRNA Calcitriol results in increased expression of INSIG2 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr13:35,025,160...35,052,937
Ensembl chr13:35,025,164...35,047,658
|
|
| G
|
Ints6l
|
integrator complex subunit 6 like
|
increases expression
|
ISO
|
Calcitriol results in increased expression of INTS6L mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr X:139,295,490...139,363,090
Ensembl chr X:139,295,512...139,359,161
|
|
| G
|
Ipo13
|
importin 13
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of IPO13 mRNA
|
CTD |
PMID:16847355 |
|
NCBI chr 5:136,719,204...136,740,118
Ensembl chr 5:136,719,204...136,741,847
|
|
| G
|
Ipo5
|
importin 5
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of IPO5 mRNA
|
CTD |
PMID:16847355 |
|
NCBI chr15:104,397,626...104,447,985
Ensembl chr15:104,397,276...104,447,985
|
|
| G
|
Ipo7
|
importin 7
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of IPO7 mRNA
|
CTD |
PMID:16847355 |
|
NCBI chr 1:173,497,472...173,537,707
Ensembl chr 1:173,497,503...173,536,778
|
|
| G
|
Ipo8
|
importin 8
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of IPO8 mRNA
|
CTD |
PMID:16847355 |
|
NCBI chr 4:183,460,583...183,529,259
Ensembl chr 4:183,460,583...183,524,519
|
|
| G
|
Ipo9
|
importin 9
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of IPO9 mRNA
|
CTD |
PMID:16847355 |
|
NCBI chr13:49,362,244...49,414,477
Ensembl chr13:49,365,716...49,414,477
|
|
| G
|
Iqca1
|
IQ motif containing with AAA domain 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of DRC11 mRNA Calcitriol results in increased expression of DRC11 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:98,074,389...98,190,233
Ensembl chr 9:98,073,887...98,190,066
|
|
| G
|
Iqcb1
|
IQ motif containing B1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of IQCB1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr11:77,410,986...77,465,540
Ensembl chr11:77,410,314...77,465,478
|
|
| G
|
Iqgap3
|
IQ motif containing GTPase activating protein 3
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of IQGAP3 mRNA Calcitriol results in decreased expression of IQGAP3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:175,840,001...175,881,799
Ensembl chr 2:175,839,949...175,881,797
|
|
| G
|
Irag1
|
inositol 1,4,5-triphosphate receptor associated 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of IRAG1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:174,416,383...174,528,913
Ensembl chr 1:174,416,385...174,528,851
|
|
| G
|
Irak2
|
interleukin-1 receptor-associated kinase 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of IRAK2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:148,341,704...148,398,211
Ensembl chr 4:148,341,719...148,398,210
|
|
| G
|
Irf1
|
interferon regulatory factor 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of IRF1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:38,417,935...38,424,946
Ensembl chr10:38,417,148...38,424,947
|
|
| G
|
Irf6
|
interferon regulatory factor 6
|
increases expression
|
ISO
|
Calcitriol results in increased expression of IRF6 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:107,200,876...107,220,083
Ensembl chr13:107,200,731...107,220,049
|
|
| G
|
Irf7
|
interferon regulatory factor 7
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of IRF7 mRNA Calcitriol results in increased expression of IRF7 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:205,796,956...205,800,543
Ensembl chr 1:205,796,959...205,800,023
|
|
| G
|
Irs1
|
insulin receptor substrate 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of IRS1 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:90,993,519...91,054,538
|
|
| G
|
Irx3
|
iroquois homeobox 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of IRX3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr19:31,384,803...31,388,241
Ensembl chr19:31,384,833...31,388,238
|
|
| G
|
Irx4
|
iroquois homeobox 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of IRX4 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:31,859,101...31,868,089
Ensembl chr 1:31,859,101...31,868,089
|
|
| G
|
Isg20
|
interferon stimulated exonuclease gene 20
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ISG20 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ISG20 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:142,234,729...142,246,403
Ensembl chr 1:142,236,137...142,246,401
|
|
| G
|
Ism1
|
isthmin 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ISM1 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 3:147,476,983...147,555,900
Ensembl chr 3:147,475,533...147,555,908
|
|
| G
|
Isx
|
intestine-specific homeobox
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ISX mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ISX mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:13,222,834...13,245,506
Ensembl chr19:13,223,385...13,245,501
|
|
| G
|
Itga10
|
integrin subunit alpha 10
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ITGA10 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:186,871,711...186,891,012
Ensembl chr 2:186,871,711...186,891,012
|
|
| G
|
Itga11
|
integrin subunit alpha 11
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ITGA11 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 8:72,041,432...72,150,137
Ensembl chr 8:72,016,652...72,150,137
|
|
| G
|
Itga2
|
integrin subunit alpha 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of ITGA2 mRNA Calcitriol results in increased expression of ITGA2 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 2:48,253,412...48,354,509
Ensembl chr 2:48,253,412...48,354,509
|
|
| G
|
Itga3
|
integrin subunit alpha 3
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of ITGA3 mRNA Calcitriol results in increased expression of ITGA3 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr10:80,486,998...80,522,548
Ensembl chr10:80,486,999...80,518,901
|
|
| G
|
Itga7
|
integrin subunit alpha 7
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ITGA7 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:1,944,447...1,973,347
Ensembl chr 7:1,944,460...1,973,339
|
|
| G
|
Itgam
|
integrin subunit alpha M
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ITGAM mRNA; Calcitriol results in increased expression of ITGAM protein [Benzo(a)pyrene co-treated with Calcitriol] results in increased expression of ITGAM protein; [Cadmium co-treated with Calcitriol] results in increased expression of ITGAM protein; [Zinc co-treated with pyrithione] inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Calcitriol results in increased expression of ITGAM protein]]; Calcitriol promotes the reaction [Curcumin results in increased expression of ITGAM]; Calcitriol promotes the reaction [MZF1 protein binds to ITGAM promoter]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Calcitriol results in increased expression of ITGAM protein]; parthenolide promotes the reaction [Calcitriol results in increased expression of ITGAM protein]; parthenolide promotes the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Calcitriol results in increased expression of ITGAM protein]]; pyrithione promotes the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Calcitriol results in increased expression of ITGAM protein]]; salvin promotes the reaction [Calcitriol results in increased expression of ITGAM protein]; U 0126 inhibits the reaction [[Cadmium co-treated with Calcitriol] results in increased expression of ITGAM protein]
|
CTD |
PMID:9112257 PMID:11504768 PMID:12441127 PMID:14729647 PMID:15489543 PMID:18180267 PMID:18242698 PMID:18495781 PMID:20089671 PMID:20868229 PMID:29524502 More...
|
|
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:192,089,542...192,139,943
|
|
| G
|
Itgax
|
integrin subunit alpha X
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ITGAX mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:192,140,089...192,171,151
Ensembl chr 1:192,149,905...192,171,151
|
|
| G
|
Itgb4
|
integrin subunit beta 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ITGB4 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:101,705,592...101,741,933
Ensembl chr10:101,705,587...101,741,932
|
|
| G
|
Itgb6
|
integrin subunit beta 6
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of ITGB6 mRNA Calcitriol results in increased expression of ITGB6 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:65,454,964...65,579,179
Ensembl chr 3:65,456,713...65,530,333
|
|
| G
|
Itgb8
|
integrin subunit beta 8
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ITGB8 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 6:146,267,982...146,351,245
Ensembl chr 6:146,165,484...146,351,245
|
|
| G
|
Itgbl1
|
integrin subunit beta like 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ITGBL1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr15:107,186,792...107,448,335
Ensembl chr15:107,186,689...107,451,098
|
|
| G
|
Itpkc
|
inositol-trisphosphate 3-kinase C
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ITPKC mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ITPKC mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:91,628,606...91,650,182
Ensembl chr 1:91,628,608...91,653,350
|
|
| G
|
Itpr1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of ITPR1 mRNA; Testosterone promotes the reaction [Calcitriol results in increased expression of ITPR1 mRNA]
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 4:142,743,401...143,066,505
Ensembl chr 4:142,743,334...143,066,504
|
|
| G
|
Itsn2
|
intersectin 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ITSN2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:33,336,086...33,446,818
Ensembl chr 6:33,336,441...33,446,818
|
|
| G
|
Ivl
|
involucrin
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of IVL protein
|
CTD |
PMID:7508215 PMID:8950452 |
|
NCBI chr 2:180,842,307...180,854,646
Ensembl chr 2:180,842,307...180,846,578
|
|
| G
|
Iyd
|
iodotyrosine deiodinase
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of IYD mRNA [Testosterone co-treated with Calcitriol] results in increased expression of IYD mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:42,410,099...42,425,414
Ensembl chr 1:42,410,130...42,426,386
|
|
| G
|
Jag2
|
jagged canonical Notch ligand 2
|
decreases expression increases expression
|
ISO
|
Calcitriol results in decreased expression of JAG2 mRNA Calcitriol results in increased expression of JAG2 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 6:137,804,133...137,826,738
Ensembl chr 6:137,804,133...137,826,738
|
|
| G
|
Jak1
|
Janus kinase 1
|
multiple interactions
|
ISO
|
JAK1 protein affects the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] affects the expression of and affects the activity of CASP1 protein]
|
CTD |
PMID:26091108 |
|
NCBI chr 5:120,895,606...121,004,207
Ensembl chr 5:120,896,046...120,996,758
|
|
| G
|
Jmy
|
junction mediating and regulatory protein, p53 cofactor
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of JMY mRNA Calcitriol results in increased expression of JMY mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:26,401,047...26,465,959
Ensembl chr 2:26,409,969...26,465,649
|
|
| G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions decreases expression
|
ISO
|
[alitretinoin co-treated with Tretinoin co-treated with Calcitriol] results in increased expression of JUN protein Calcitriol results in decreased expression of JUN protein
|
CTD |
PMID:8950452 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
| G
|
Junb
|
JunB proto-oncogene, AP-1 transcription factor subunit
|
increases expression
|
ISO
|
Calcitriol results in increased expression of JUNB mRNA
|
CTD |
PMID:14996990 PMID:16002434 |
|
NCBI chr19:40,081,126...40,082,910
Ensembl chr19:40,073,541...40,085,218
|
|
| G
|
Jund
|
JunD proto-oncogene, AP-1 transcription factor subunit
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of JUND mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr16:18,768,093...18,769,771
Ensembl chr16:18,764,985...18,782,148
|
|
| G
|
Jup
|
junction plakoglobin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of JUP mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:85,800,812...85,827,881
Ensembl chr10:85,800,814...85,827,429
|
|
| G
|
Kcnc4
|
potassium voltage-gated channel subfamily C member 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KCNC4 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:197,747,095...197,788,467
Ensembl chr 2:197,759,010...197,788,433
|
|
| G
|
Kcnd2
|
potassium voltage-gated channel subfamily D member 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of KCND2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of KCND2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:50,741,595...51,243,540
Ensembl chr 4:50,742,839...51,243,522
|
|
| G
|
Kcnd3
|
potassium voltage-gated channel subfamily D member 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of KCND3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of KCND3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:195,626,316...195,843,690
Ensembl chr 2:195,626,316...195,843,690
|
|
| G
|
Kcnh2
|
potassium voltage-gated channel subfamily H member 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of KCNH2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of KCNH2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:11,692,980...11,751,421
|
|
| G
|
Kcnh6
|
potassium voltage-gated channel subfamily H member 6
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of KCNH6 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of KCNH6 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:91,449,025...91,471,012
Ensembl chr10:91,449,651...91,470,506
|
|
| G
|
Kcnj1
|
potassium inwardly-rectifying channel, subfamily J, member 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of KCNJ1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of KCNJ1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:39,014,822...39,066,716
Ensembl chr 8:39,037,992...39,066,715
|
|
| G
|
Kcnj15
|
potassium inwardly-rectifying channel, subfamily J, member 15
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of KCNJ15 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr11:48,046,953...48,091,285
Ensembl chr11:48,035,655...48,092,457
|
|
| G
|
Kcnk3
|
potassium two pore domain channel subfamily K member 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KCNK3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 6:31,483,129...31,519,061
Ensembl chr 6:31,483,140...31,519,061
|
|
| G
|
Kcnk5
|
potassium two pore domain channel subfamily K member 5
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of KCNK5 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of KCNK5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:4,171,625...4,213,896
Ensembl chr15:4,171,610...4,213,897
|
|
| G
|
Kcnk9
|
potassium two pore domain channel subfamily K member 9
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KCNK9 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:106,316,783...106,362,452
Ensembl chr 7:106,326,684...106,361,921
|
|
| G
|
Kcnmb4
|
potassium calcium-activated channel subfamily M regulatory beta subunit 4
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of KCNMB4 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of KCNMB4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:53,952,150...54,005,101
Ensembl chr 7:53,949,881...54,005,281
|
|
| G
|
Kcnn2
|
potassium calcium-activated channel subfamily N member 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of KCNN2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of KCNN2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:40,004,693...40,445,043
Ensembl chr18:40,155,939...40,445,045
|
|
| G
|
Kcns3
|
potassium voltage-gated channel, modifier subfamily S, member 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KCNS3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:39,527,410...39,584,105
Ensembl chr 6:39,523,777...39,618,848
|
|
| G
|
Kcnt2
|
potassium sodium-activated channel subfamily T member 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KCNT2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:54,214,831...54,609,889
Ensembl chr13:54,215,307...54,607,924
|
|
| G
|
Kctd12
|
potassium channel tetramerization domain containing 12
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KCTD12 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr15:86,214,786...86,220,725
Ensembl chr15:86,214,840...86,224,539
|
|
| G
|
Kdelr3
|
KDEL endoplasmic reticulum protein retention receptor 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of KDELR3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of KDELR3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:112,959,632...112,969,858
Ensembl chr 7:112,959,718...112,969,858
|
|
| G
|
Kdm1a
|
lysine demethylase 1A
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KDM1A mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:154,066,436...154,121,913
Ensembl chr 5:154,065,543...154,121,775
|
|
| G
|
Kdm1b
|
lysine demethylase 1B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KDM1B mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr17:17,809,232...17,850,141
Ensembl chr17:17,809,232...17,850,068
|
|
| G
|
Kdm2b
|
lysine demethylase 2B
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of KDM2B mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of KDM2B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr12:39,224,422...39,362,126
Ensembl chr12:39,235,301...39,362,127
|
|
| G
|
Kdm4b
|
lysine demethylase 4B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KDM4B mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 9:1,245,885...1,324,384
Ensembl chr 9:1,245,899...1,324,384
|
|
| G
|
Kdr
|
kinase insert domain receptor
|
decreases expression
|
EXP
|
Calcitriol results in decreased expression of KDR protein
|
CTD |
PMID:19092814 |
|
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,572,049...32,615,192
|
|
| G
|
Keap1
|
Kelch-like ECH-associated protein 1
|
multiple interactions
|
ISO
|
Calcitriol promotes the reaction [sodium arsenite results in decreased expression of KEAP1 protein]
|
CTD |
PMID:37968493 |
|
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042
|
|
| G
|
Kiaa1671
|
KIAA1671 homolog
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KIAA1671 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr12:49,069,929...49,212,604
Ensembl chr12:49,069,940...49,212,604
|
|
| G
|
Kif11
|
kinesin family member 11
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of KIF11 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of KIF11 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:244,494,916...244,589,250
Ensembl chr 1:244,494,875...244,589,250
|
|
| G
|
Kif14
|
kinesin family member 14
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of KIF14 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of KIF14 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:50,478,646...50,542,256
Ensembl chr13:50,478,721...50,542,248
|
|
| G
|
Kif15
|
kinesin family member 15
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of KIF15 mRNA Calcitriol results in decreased expression of KIF15 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:131,479,340...131,550,209
Ensembl chr 8:131,479,337...131,550,202
|
|
| G
|
Kif18a
|
kinesin family member 18A
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of KIF18A mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of KIF18A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:116,219,007...116,279,378
Ensembl chr 3:116,219,007...116,279,227
|
|
| G
|
Kif18b
|
kinesin family member 18B
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of KIF18B mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of KIF18B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:88,370,520...88,392,388
Ensembl chr10:88,370,524...88,389,691
|
|
| G
|
Kif1b
|
kinesin family member 1B
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of KIF1B mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of KIF1B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:164,890,778...165,025,848
Ensembl chr 5:164,894,763...165,008,841
|
|
| G
|
Kif20a
|
kinesin family member 20A
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of KIF20A mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of KIF20A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:26,504,422...26,512,908
Ensembl chr18:26,504,072...26,512,909
|
|
| G
|
Kif20b
|
kinesin family member 20B
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of KIF20B mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of KIF20B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:241,840,898...241,896,451
Ensembl chr 1:241,840,987...241,896,451
|
|
| G
|
Kif23
|
kinesin family member 23
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of KIF23 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of KIF23 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:71,293,439...71,321,911
Ensembl chr 8:71,293,482...71,320,856
|
|
| G
|
Kif24
|
kinesin family member 24
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of KIF24 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of KIF24 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:61,357,078...61,423,882
Ensembl chr 5:61,357,940...61,399,379
|
|
| G
|
Kif26a
|
kinesin family member 26A
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KIF26A mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:137,035,986...137,072,027
Ensembl chr 6:137,033,789...137,072,022
|
|
| G
|
Kif26b
|
kinesin family member 26B
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of KIF26B mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:92,815,427...93,221,071
Ensembl chr13:92,815,427...93,215,453
|
|
| G
|
Kif2c
|
kinesin family member 2C
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of KIF2C mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of KIF2C mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:135,873,925...135,899,267
Ensembl chr 5:135,873,925...135,899,212
|
|
| G
|
Kif3c
|
kinesin family member 3C
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KIF3C mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:32,086,879...32,125,812
Ensembl chr 6:32,086,124...32,126,066
|
|
| G
|
Kif4a
|
kinesin family member 4A
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of KIF4A mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of KIF4A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:69,761,803...69,864,335
Ensembl chr X:69,761,883...69,864,335
|
|
| G
|
Kif5c
|
kinesin family member 5C
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KIF5C mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:54,441,266...54,591,630
Ensembl chr 3:54,441,310...54,594,813
|
|
| G
|
Kif7
|
kinesin family member 7
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of KIF7 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of KIF7 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:143,041,206...143,067,873
Ensembl chr 1:143,049,036...143,067,890
|
|
| G
|
Kifap3
|
kinesin-associated protein 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KIFAP3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:78,660,849...78,797,821
Ensembl chr13:78,660,871...78,797,820
|
|
| G
|
Kifc1
|
kinesin family member C1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of KIFC1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of KIFC1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:5,000,929...5,018,967
Ensembl chr20:5,000,648...5,018,988
|
|
| G
|
Kit
|
KIT proto-oncogene receptor tyrosine kinase
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of KIT mRNA; Calcitriol results in decreased expression of KIT protein
|
CTD |
PMID:8931875 |
|
NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,903,033...32,978,812
|
|
| G
|
Kitlg
|
KIT ligand
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of KITLG mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:36,782,621...36,863,796
Ensembl chr 7:36,782,638...36,863,793
|
|
| G
|
Klf11
|
KLF transcription factor 11
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KLF11 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:47,014,312...47,026,152
Ensembl chr 6:47,014,326...47,037,044
|
|
| G
|
Klf4
|
KLF transcription factor 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KLF4 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:75,074,107...75,079,182
Ensembl chr 5:75,074,236...75,078,592
|
|
| G
|
Klf5
|
KLF transcription factor 5
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of KLF5 mRNA Calcitriol results in increased expression of KLF5 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr15:82,472,081...82,487,267
Ensembl chr15:82,472,065...82,487,262
|
|
| G
|
Klf8
|
KLF transcription factor 8
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KLF8 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr X:21,329,081...21,508,720
|
|
| G
|
Klhdc7b
|
kelch domain containing 7B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KLHDC7B mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:122,331,708...122,335,364
Ensembl chr 7:122,331,708...122,335,364
|
|
| G
|
Klhl14
|
kelch-like family member 14
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KLHL14 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr18:13,079,159...13,192,728
Ensembl chr18:13,079,159...13,193,557
|
|
| G
|
Klhl5
|
kelch-like family member 5
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KLHL5 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr14:43,497,915...43,565,833
Ensembl chr14:43,497,918...43,537,894
|
|
| G
|
Klk10
|
kallikrein related-peptidase 10
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KLK10 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:103,371,638...103,375,918
Ensembl chr 1:103,371,638...103,375,918
|
|
| G
|
Klk13
|
kallikrein related-peptidase 13
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KLK13 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:103,301,935...103,314,313
Ensembl chr 1:103,301,935...103,313,554
|
|
| G
|
Klk1c10
|
kallikrein 1-related peptidase C10
|
increases secretion increases expression multiple interactions
|
ISO
|
Calcitriol results in increased secretion of KLK3 protein Calcitriol results in increased expression of KLK3 mRNA [Calcitriol co-treated with Testosterone] results in increased expression of KLK3 mRNA; Dihydrotestosterone promotes the reaction [Calcitriol results in increased secretion of KLK3 protein]
|
CTD |
PMID:9231780 PMID:21592394 |
|
NCBI chr 1:103,539,527...103,543,586
Ensembl chr 1:103,539,527...103,543,586
|
|
| G
|
Klk5
|
kallikrein related-peptidase 5
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KLK5 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:103,432,743...103,442,011
Ensembl chr 1:103,433,065...103,441,305
|
|
| G
|
Klk6
|
kallikrein related-peptidase 6
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of KLK6 mRNA; Ketoconazole promotes the reaction [Calcitriol results in increased expression of KLK6 mRNA]
|
CTD |
PMID:12040012 PMID:16002434 PMID:20206692 PMID:21592394 PMID:26485663 |
|
NCBI chr 1:103,415,411...103,422,682
Ensembl chr 1:103,416,886...103,422,690
|
|
| G
|
Klk7
|
kallikrein-related peptidase 7
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KLK7 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:103,403,206...103,407,907
Ensembl chr 1:103,403,212...103,407,907
|
|
| G
|
Klk8
|
kallikrein related-peptidase 8
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KLK8 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:103,388,352...103,395,195
Ensembl chr 1:103,388,352...103,395,195
|
|
| G
|
Kmo
|
kynurenine 3-monooxygenase
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of KMO mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:90,089,340...90,121,108
Ensembl chr13:90,089,463...90,125,151
|
|
| G
|
Knl1
|
kinetochore scaffold 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of KNL1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of KNL1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:126,483,498...126,545,774
Ensembl chr 3:126,483,544...126,545,774
|
|
| G
|
Knstrn
|
kinetochore-localized astrin/SPAG5 binding protein
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of KNSTRN mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of KNSTRN mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:126,254,633...126,274,412
Ensembl chr 3:126,254,663...126,274,418
|
|
| G
|
Kntc1
|
kinetochore associated 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of KNTC1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of KNTC1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr12:38,429,925...38,500,564
Ensembl chr12:38,429,925...38,500,457
|
|
| G
|
Kpna1
|
karyopherin subunit alpha 1
|
decreases expression increases expression
|
ISO
|
Calcitriol results in decreased expression of KPNA1 mRNA Calcitriol results in increased expression of KPNA1 mRNA
|
CTD |
PMID:16847355 PMID:18614847 |
|
NCBI chr11:78,221,165...78,279,778
Ensembl chr11:78,222,884...78,267,067
|
|
| G
|
Kpna2
|
karyopherin subunit alpha 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of KPNA2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of KPNA2 mRNA
|
CTD |
PMID:16847355 PMID:18614847 PMID:21592394 |
|
NCBI chr10:92,433,678...92,445,841
Ensembl chr10:92,433,679...92,445,937
|
|
| G
|
Kpna3
|
karyopherin subunit alpha 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of KPNA3 mRNA
|
CTD |
PMID:16847355 |
|
NCBI chr15:39,712,375...39,786,127
Ensembl chr15:39,712,381...39,786,319
|
|
| G
|
Kpna4
|
karyopherin subunit alpha 4
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of KPNA4 mRNA
|
CTD |
PMID:16847355 PMID:18614847 |
|
NCBI chr 2:155,635,679...155,691,056
Ensembl chr 2:155,634,247...155,691,053
|
|
| G
|
Kpnb1
|
karyopherin subunit beta 1
|
decreases expression affects expression
|
ISO
|
Calcitriol results in decreased expression of KPNB1 mRNA Calcitriol affects the expression of KPNB1 mRNA
|
CTD |
PMID:16847355 PMID:18614847 |
|
NCBI chr10:82,642,082...82,670,856
Ensembl chr10:82,642,082...82,670,856
|
|
| G
|
Kremen1
|
kringle containing transmembrane protein 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of KREMEN1 mRNA Calcitriol results in increased expression of KREMEN1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:84,295,931...84,361,534
Ensembl chr14:84,297,700...84,361,614
|
|
| G
|
Krt10
|
keratin 10
|
decreases expression multiple interactions increases expression
|
ISO
|
Calcitriol results in decreased expression of KRT10 protein [Testosterone co-treated with Calcitriol] results in increased expression of KRT10 mRNA Calcitriol results in increased expression of KRT10 mRNA
|
CTD |
PMID:7508215 PMID:21592394 |
|
NCBI chr10:84,834,865...84,839,160
Ensembl chr10:84,834,840...84,839,160
|
|
| G
|
Krt15
|
keratin 15
|
increases expression decreases expression
|
ISO
|
Calcitriol results in increased expression of KRT15 mRNA Calcitriol results in decreased expression of KRT15 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:85,567,197...85,571,014
Ensembl chr10:85,567,202...85,571,142
|
|
| G
|
Krt16
|
keratin 16
|
decreases expression increases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of KRT16 protein Calcitriol results in increased expression of KRT16 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of KRT16 mRNA
|
CTD |
PMID:7508215 PMID:16002434 PMID:21592394 PMID:26485663 |
|
NCBI chr10:85,669,276...85,672,211
Ensembl chr10:85,669,276...85,672,211
|
|
| G
|
Krt17
|
keratin 17
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of KRT17 protein
|
CTD |
PMID:7508215 |
|
NCBI chr10:85,679,068...85,683,792
Ensembl chr10:85,679,070...85,683,787
|
|
| G
|
Krt18
|
keratin 18
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KRT18 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:135,036,168...135,039,844
Ensembl chr 7:135,035,982...135,039,848 Ensembl chr10:135,035,982...135,039,848
|
|
| G
|
Krt19
|
keratin 19
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KRT19 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:85,576,235...85,580,952
Ensembl chr10:85,576,235...85,580,952
|
|
| G
|
Krt2
|
keratin 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of KRT2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of KRT2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:134,819,584...134,826,736
Ensembl chr 7:134,819,584...134,827,011
|
|
| G
|
Krt23
|
keratin 23
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KRT23 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:84,930,603...84,946,929
Ensembl chr10:84,930,603...84,946,929
|
|
| G
|
Krt5
|
keratin 5
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KRT5 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:134,724,840...134,730,569
Ensembl chr 7:134,724,840...134,730,569
|
|
| G
|
Krt7
|
keratin 7
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KRT7 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:134,407,626...134,423,787
Ensembl chr 7:134,407,584...134,423,786
|
|
| G
|
Krt80
|
keratin 80
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of KRT80 mRNA Calcitriol results in increased expression of KRT80 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:134,341,951...134,363,872
Ensembl chr 7:134,341,956...134,364,211
|
|
| G
|
Krtcap3
|
keratinocyte associated protein 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KRTCAP3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 6:30,840,906...30,842,500
Ensembl chr 6:30,840,906...30,842,475
|
|
| G
|
Ksr1
|
kinase suppressor of ras 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of KSR1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:64,459,786...64,596,083
Ensembl chr10:64,459,786...64,596,082
|
|
| G
|
L3hypdh
|
trans-L-3-hydroxyproline dehydratase
|
increases expression
|
ISO
|
Calcitriol results in increased expression of L3HYPDH mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:96,372,243...96,383,039
|
|
| G
|
L3mbtl3
|
L3MBTL histone methyl-lysine binding protein 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of L3MBTL3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:20,807,679...20,908,609
Ensembl chr 1:20,808,973...20,908,608
|
|
| G
|
Lacc1
|
laccase domain containing 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LACC1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr15:58,799,477...58,816,840
Ensembl chr15:58,786,637...58,816,840
|
|
| G
|
Lactb2
|
lactamase, beta 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LACTB2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:10,352,165...10,374,928
Ensembl chr 5:10,352,154...10,379,255
|
|
| G
|
Lama2
|
laminin subunit alpha 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of LAMA2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:19,492,126...20,140,056
Ensembl chr 1:19,244,599...20,140,056
|
|
| G
|
Lama3
|
laminin subunit alpha 3
|
increases expression decreases expression
|
ISO
|
Calcitriol results in increased expression of LAMA3 mRNA Calcitriol results in decreased expression of LAMA3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr18:3,797,898...4,033,021
Ensembl chr18:3,797,939...4,026,449
|
|
| G
|
Lama5
|
laminin subunit alpha 5
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LAMA5 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:187,647,904...187,695,974
Ensembl chr 3:187,647,904...187,696,173
|
|
| G
|
Lamb3
|
laminin subunit beta 3
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of LAMB3 mRNA Calcitriol results in increased expression of LAMB3 mRNA
|
CTD |
PMID:16002434 PMID:21592394 PMID:26485663 |
|
NCBI chr13:107,362,514...107,404,081
Ensembl chr13:107,322,526...107,404,081
|
|
| G
|
Larp1b
|
La ribonucleoprotein 1B
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of LARP1B mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:125,860,935...125,897,189
Ensembl chr 2:125,863,997...125,897,189
|
|
| G
|
Larp4b
|
La ribonucleoprotein 4B
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of LARP4B mRNA
|
CTD |
PMID:12798352 |
|
NCBI chr17:65,813,125...65,908,920
Ensembl chr17:65,830,022...65,908,676
|
|
| G
|
Lat2
|
linker for activation of T cells family, member 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of LAT2 mRNA Calcitriol results in increased expression of LAT2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr12:27,740,647...27,754,760
Ensembl chr12:27,740,654...27,755,843
|
|
| G
|
Layn
|
layilin
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of LAYN mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:60,261,325...60,280,797
Ensembl chr 8:60,263,456...60,281,418
|
|
| G
|
Lbh
|
LBH regulator of WNT signaling pathway
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LBH mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:28,321,040...28,344,855
Ensembl chr 6:28,321,040...28,370,238
|
|
| G
|
Lbp
|
lipopolysaccharide binding protein
|
decreases expression increases expression
|
ISO
|
Calcitriol results in decreased expression of LBP mRNA Calcitriol results in increased expression of LBP mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:167,373,786...167,400,941
Ensembl chr 3:167,373,924...167,401,518
|
|
| G
|
Lbr
|
lamin B receptor
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of LBR mRNA Calcitriol results in decreased expression of LBR mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:96,071,058...96,095,709
Ensembl chr13:96,071,081...96,095,709
|
|
| G
|
Lcn2
|
lipocalin 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LCN2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842
|
|
| G
|
Lcorl
|
ligand dependent nuclear receptor corepressor-like
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of LCORL mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of LCORL mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:69,482,919...69,620,269
Ensembl chr14:69,518,837...69,587,177
|
|
| G
|
Ldha
|
lactate dehydrogenase A
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of LDHA mRNA
|
CTD |
PMID:15951637 PMID:16847355 |
|
NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:106,502,182...106,517,521
|
|
| G
|
Ldlr
|
low density lipoprotein receptor
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LDLR mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675
|
|
| G
|
Ldlrap1
|
low density lipoprotein receptor adaptor protein 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LDLRAP1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:152,239,296...152,262,290
Ensembl chr 5:152,229,505...152,262,290
|
|
| G
|
Lep
|
leptin
|
decreases abundance
|
ISO
|
LEP protein results in decreased abundance of Calcitriol
|
CTD |
PMID:14657008 |
|
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661
|
|
| G
|
Leprot
|
leptin receptor overlapping transcript
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of LEPROT mRNA [Testosterone co-treated with Calcitriol] results in increased expression of LEPROT mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:121,405,170...121,417,273
Ensembl chr 5:121,404,759...121,417,275
|
|
| G
|
Lfng
|
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of LFNG mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of LFNG mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr12:19,144,474...19,152,951
Ensembl chr12:19,124,662...19,152,918
|
|
| G
|
Lgals3
|
galectin 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of LGALS3 mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr15:23,099,795...23,111,731
Ensembl chr15:23,086,841...23,111,737
|
|
| G
|
Lgals8
|
galectin 8
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LGALS8 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr17:62,716,368...62,744,272
Ensembl chr17:62,719,828...62,744,482
|
|
| G
|
Lgals9
|
galectin 9
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of LGALS9 mRNA Calcitriol results in increased expression of LGALS9 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr10:64,405,044...64,428,249
Ensembl chr10:64,405,044...64,428,070
|
|
| G
|
Lgr4
|
leucine-rich repeat-containing G protein-coupled receptor 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LGR4 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:116,901,968...117,004,584
Ensembl chr 3:116,901,968...117,004,153
|
|
| G
|
Lhfpl2
|
LHFPL tetraspan subfamily member 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of LHFPL2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of LHFPL2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:27,016,404...27,169,830
Ensembl chr 2:27,016,700...27,162,859
|
|
| G
|
Lhx1
|
LIM homeobox 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LHX1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:69,894,288...69,901,076
Ensembl chr10:69,894,288...69,901,076
|
|
| G
|
Lhx4
|
LIM homeobox 4
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of LHX4 mRNA Calcitriol results in increased expression of LHX4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:70,423,768...70,477,337
Ensembl chr13:70,427,399...70,467,505
|
|
| G
|
Lifr
|
LIF receptor subunit alpha
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of LIFR mRNA [Testosterone co-treated with Calcitriol] results in increased expression of LIFR mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:57,951,787...58,020,357
Ensembl chr 2:57,952,975...58,020,364
|
|
| G
|
Lig1
|
DNA ligase 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of LIG1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of LIG1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:83,243,043...83,281,707
Ensembl chr 1:83,219,545...83,281,708
|
|
| G
|
Lilrb4
|
leukocyte immunoglobulin like receptor B4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LILRB4 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:78,847,685...78,853,294
Ensembl chr 1:78,847,685...78,853,326
|
|
| G
|
Limch1
|
LIM and calponin homology domains 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of LIMCH1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr14:41,466,433...41,779,477
Ensembl chr14:41,466,433...41,778,837
|
|
| G
|
Limd2
|
LIM domain containing 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of LIMD2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:91,590,079...91,592,747
Ensembl chr10:91,590,082...91,592,439
|
|
| G
|
Lims1
|
LIM zinc finger domain containing 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of LIMS1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of LIMS1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:26,851,364...26,961,607
Ensembl chr20:26,852,996...26,961,606
|
|
| G
|
Lin7a
|
lin-7 homolog A, crumbs cell polarity complex component
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of LIN7A mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of LIN7A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:44,473,568...44,629,074
Ensembl chr 7:44,473,347...44,625,208
|
|
| G
|
Lin9
|
lin-9 DREAM MuvB core complex component
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of LIN9 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of LIN9 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:94,906,185...94,951,541
Ensembl chr13:94,906,548...94,951,539
|
|
| G
|
Lingo1
|
leucine rich repeat and Ig domain containing 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LINGO1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 8:65,907,275...66,089,485
Ensembl chr 8:65,897,844...66,091,740
|
|
| G
|
Lipg
|
lipase G, endothelial type
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LIPG mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr18:70,790,077...70,811,259
Ensembl chr18:70,790,077...70,812,260
|
|
| G
|
Lmcd1
|
LIM and cysteine-rich domains 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LMCD1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:146,948,993...147,007,878
Ensembl chr 4:146,948,958...147,007,875
|
|
| G
|
Lmnb1
|
lamin B1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of LMNB1 mRNA Calcitriol results in decreased expression of LMNB1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:52,373,939...52,413,284
Ensembl chr18:52,373,757...52,413,283
|
|
| G
|
Lmntd1
|
lamin tail domain containing 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LMNTD1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:180,085,128...180,319,362
Ensembl chr 4:180,085,134...180,329,707
|
|
| G
|
Lmo2
|
LIM domain only 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of LMO2 mRNA Calcitriol results in increased expression of LMO2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:110,810,162...110,832,895
Ensembl chr 3:110,809,912...110,833,075
|
|
| G
|
Lmx1b
|
LIM homeobox transcription factor 1 beta
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LMX1B mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:37,257,025...37,338,675
Ensembl chr 3:37,259,855...37,338,557
|
|
| G
|
Lox
|
lysyl oxidase
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LOX mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr18:48,162,889...48,175,640
Ensembl chr18:48,165,688...48,239,810
|
|
| G
|
Loxl1
|
lysyl oxidase-like 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of LOXL1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 8:67,587,636...67,612,224
Ensembl chr 8:67,587,636...67,612,224
|
|
| G
|
Loxl4
|
lysyl oxidase-like 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LOXL4 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:251,345,445...251,365,640
Ensembl chr 1:251,347,238...251,365,577
|
|
| G
|
Lpal2
|
lipoprotein(a) like 2
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of LPAL2 mRNA Calcitriol results in decreased expression of LPAL2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:166,938,777...166,995,743
Ensembl chr 4:166,990,627...166,995,739
|
|
| G
|
Lpar1
|
lysophosphatidic acid receptor 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of LPAR1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:78,024,139...78,147,071
Ensembl chr 5:78,024,139...78,142,188
|
|
| G
|
Lpar6
|
lysophosphatidic acid receptor 6
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LPAR6 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr15:54,826,110...54,827,919
Ensembl chr15:54,823,717...54,978,783
|
|
| G
|
Lpgat1
|
lysophosphatidylglycerol acyltransferase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LPGAT1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:105,825,630...105,896,366
Ensembl chr13:105,820,468...105,896,364
|
|
| G
|
Lpl
|
lipoprotein lipase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of LPL mRNA troglitazone inhibits the reaction [Calcitriol results in decreased expression of LPL mRNA]
|
CTD |
PMID:16368784 |
|
NCBI chr16:25,596,205...25,621,928
Ensembl chr16:25,596,211...25,622,107
|
|
| G
|
Lpp
|
LIM domain containing preferred translocation partner in lipoma
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of LPP mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr11:89,292,060...89,933,973
Ensembl chr11:89,305,187...89,805,264
|
|
| G
|
Lratd1
|
LRAT domain containing 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LRATD1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 6:42,646,515...42,650,988
Ensembl chr 6:42,640,190...42,651,204
|
|
| G
|
Lratd2
|
LRAT domain containing 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LRATD2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:94,270,753...94,276,445
Ensembl chr 7:94,073,513...94,277,046
|
|
| G
|
Lrfn2
|
leucine rich repeat and fibronectin type III domain containing 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of LRFN2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of LRFN2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:19,395,099...19,563,849
Ensembl chr 9:19,395,145...19,561,163
|
|
| G
|
Lrig1
|
leucine-rich repeats and immunoglobulin-like domains 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of LRIG1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of LRIG1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:128,687,723...128,788,219
Ensembl chr 4:128,687,723...128,788,219
|
|
| G
|
Lrig3
|
leucine-rich repeats and immunoglobulin-like domains 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of LRIG3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:63,701,724...63,751,898
Ensembl chr 7:63,701,778...63,752,261
|
|
| G
|
Lrp10
|
LDL receptor related protein 10
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of LRP10 mRNA Calcitriol results in increased expression of LRP10 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:31,891,358...31,897,530
Ensembl chr15:31,891,362...31,897,528
|
|
| G
|
Lrp4
|
LDL receptor related protein 4
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of LRP4 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:97,885,373...97,939,366
Ensembl chr 3:97,885,400...97,939,370
|
|
| G
|
Lrp5
|
LDL receptor related protein 5
|
multiple interactions increases expression
|
ISO
|
Calcitriol promotes the reaction [VDR protein binds to LRP5 enhancer] Calcitriol results in increased expression of LRP5 mRNA
|
CTD |
PMID:17293108 |
|
NCBI chr 1:210,243,499...210,346,886
Ensembl chr 1:210,243,502...210,346,822
|
|
| G
|
Lrr1
|
leucine rich repeat protein 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of LRR1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of LRR1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:93,379,159...93,387,950
Ensembl chr 6:93,379,169...93,387,950
|
|
| G
|
Lrrc15
|
leucine rich repeat containing 15
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of LRRC15 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr11:83,974,708...83,989,157
Ensembl chr11:83,974,695...83,989,146
|
|
| G
|
Lrrc29
|
leucine rich repeat containing 29
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of FBXL9P mRNA [Testosterone co-treated with Calcitriol] results in increased expression of FBXL9P mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:50,098,274...50,113,488
Ensembl chr19:50,098,275...50,113,437
|
|
| G
|
Lrrc45
|
leucine rich repeat containing 45
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of LRRC45 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of LRRC45 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:106,492,846...106,500,751
Ensembl chr10:106,492,592...106,500,751
|
|
| G
|
Lrrc58
|
leucine rich repeat containing 58
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LRRC58 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr11:76,355,987...76,368,309
Ensembl chr11:76,344,923...76,368,309
|
|
| G
|
Lrrc75b
|
leucine rich repeat containing 75B
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of LRRC75B mRNA [Testosterone co-treated with Calcitriol] results in increased expression of LRRC75B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:13,099,741...13,105,942
Ensembl chr20:13,094,809...13,109,532
|
|
| G
|
Lrrc8a
|
leucine rich repeat containing 8 VRAC subunit A
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of LRRC8A mRNA Calcitriol results in increased expression of LRRC8A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:33,902,299...33,934,989
Ensembl chr 3:33,908,268...33,933,625
|
|
| G
|
Lrrk1
|
leucine-rich repeat kinase 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of LRRK1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of LRRK1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:129,254,815...129,390,217
Ensembl chr 1:129,254,515...129,389,941
|
|
| G
|
Lrrn1
|
leucine rich repeat neuronal 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of LRRN1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of LRRN1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:142,032,805...142,072,320
Ensembl chr 4:142,032,041...142,074,760
|
|
| G
|
Lsp1
|
lymphocyte-specific protein 1
|
increases expression decreases expression
|
ISO
|
Calcitriol results in increased expression of LSP1 mRNA Calcitriol results in decreased expression of LSP1 mRNA
|
CTD |
PMID:12875902 PMID:26485663 |
|
NCBI chr 1:207,044,157...207,077,891
Ensembl chr 1:207,044,159...207,077,893
|
|
| G
|
Lsr
|
lipolysis stimulated lipoprotein receptor
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LSR mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:95,313,830...95,329,471
Ensembl chr 1:95,313,033...95,329,354
|
|
| G
|
Lss
|
lanosterol synthase
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of LSS mRNA [Testosterone co-treated with Calcitriol] results in increased expression of LSS mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:12,090,641...12,118,230
Ensembl chr20:12,073,543...12,118,253
|
|
| G
|
Ltb
|
lymphotoxin beta
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LTB mRNA
|
CTD |
PMID:22615136 |
|
NCBI chr20:3,632,209...3,634,054
Ensembl chr20:3,632,210...3,634,054
|
|
| G
|
Ltb4r
|
leukotriene B4 receptor
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of LTB4R mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr15:33,233,120...33,235,636
Ensembl chr15:33,232,820...33,235,637
|
|
| G
|
Ltbp2
|
latent transforming growth factor beta binding protein 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LTBP2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:110,161,029...110,261,586
Ensembl chr 6:110,161,029...110,257,298
|
|
| G
|
Ltbp3
|
latent transforming growth factor beta binding protein 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of LTBP3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:212,458,362...212,475,302
Ensembl chr 1:212,459,185...212,475,302
|
|
| G
|
Ltf
|
lactotransferrin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LTF mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 8:119,878,344...119,901,189
Ensembl chr 8:119,878,344...119,901,189
|
|
| G
|
Lum
|
lumican
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of LUM mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:34,245,323...34,252,510
Ensembl chr 7:34,245,360...34,252,508
|
|
| G
|
Luzp2
|
leucine zipper protein 2
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of LUZP2 mRNA Calcitriol results in decreased expression of LUZP2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:114,733,026...115,119,374
Ensembl chr 1:114,733,455...115,119,630
|
|
| G
|
Lxn
|
latexin
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of LXN mRNA Calcitriol results in increased expression of LXN mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:154,037,604...154,043,473
Ensembl chr 2:154,037,292...154,043,488
|
|
| G
|
Ly96
|
lymphocyte antigen 96
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of LY96 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of LY96 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:7,365,536...7,397,864
Ensembl chr 5:7,365,557...7,395,816
|
|
| G
|
Lyar
|
Ly1 antibody reactive
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of LYAR mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of LYAR mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:76,789,193...76,802,973
Ensembl chr14:76,789,200...76,802,765
|
|
| G
|
Lyn
|
LYN proto-oncogene, Src family tyrosine kinase
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LYN mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr 5:21,437,127...21,553,097
Ensembl chr 5:21,437,084...21,554,461
|
|
| G
|
Lypd3
|
Ly6/Plaur domain containing 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LYPD3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:89,354,354...89,358,806
Ensembl chr 1:89,354,335...89,358,810
|
|
| G
|
Lypd5
|
Ly6/Plaur domain containing 5
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LYPD5 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:89,057,719...89,069,696
Ensembl chr 1:89,057,891...89,069,696
|
|
| G
|
Lypla1
|
lysophospholipase 1
|
multiple interactions
|
EXP
|
[Calcium co-treated with Calcitriol] affects the expression of LYPLA1 mRNA
|
CTD |
PMID:15913539 |
|
NCBI chr 5:19,477,408...19,506,568
Ensembl chr 5:19,477,409...19,506,522
|
|
| G
|
Lyz2
|
lysozyme 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LYZ mRNA
|
CTD |
PMID:16847355 PMID:26485663 |
|
NCBI chr 7:54,792,715...54,798,060
Ensembl chr 7:54,792,716...54,798,011
|
|
| G
|
Lzts1
|
leucine zipper tumor suppressor 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LZTS1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr16:25,309,502...25,364,942
Ensembl chr16:25,309,507...25,364,940
|
|
| G
|
Maco1
|
macoilin 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MACO1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:152,296,107...152,358,684
Ensembl chr 5:152,296,558...152,358,684
|
|
| G
|
Mad2l1
|
mitotic arrest deficient 2 like 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MAD2L1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MAD2L1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:97,236,419...97,247,603
Ensembl chr 4:97,236,503...97,243,222
|
|
| G
|
Mafb
|
MAF bZIP transcription factor B
|
increases expression decreases expression
|
ISO
|
Calcitriol results in increased expression of MAFB mRNA Calcitriol results in decreased expression of MAFB mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 3:169,417,890...169,419,810
Ensembl chr 3:169,416,945...169,419,975
|
|
| G
|
Maff
|
MAF bZIP transcription factor F
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MAFF mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MAFF mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:112,791,416...112,804,147
|
|
| G
|
Magi1
|
membrane associated guanylate kinase, WW and PDZ domain containing 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of MAGI1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:127,762,590...128,368,228
Ensembl chr 4:127,762,590...128,367,833
|
|
| G
|
Mall
|
mal, T-cell differentiation protein-like
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MALL mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:135,381,180...135,404,136
Ensembl chr 3:135,377,410...135,404,066
|
|
| G
|
Malt1
|
MALT1 paracaspase
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MALT1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MALT1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:61,212,290...61,266,272
Ensembl chr18:61,212,317...61,266,272
|
|
| G
|
Man1c1
|
mannosidase, alpha, class 1C, member 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MAN1C1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:152,057,839...152,197,737
Ensembl chr 5:152,057,967...152,197,138
|
|
| G
|
Maneal
|
mannosidase, endo-alpha-like
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MANEAL mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:142,399,816...142,406,960
Ensembl chr 5:142,400,213...142,407,027
|
|
| G
|
Maoa
|
monoamine oxidase A
|
multiple interactions
|
ISO
|
[Calcitriol co-treated with VDR protein] results in decreased expression of MAOA mRNA
|
CTD |
PMID:27450565 |
|
NCBI chr X:8,615,239...8,681,372
Ensembl chr X:8,615,239...8,682,631
|
|
| G
|
Maob
|
monoamine oxidase B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MAOB mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr X:8,490,405...8,594,065
Ensembl chr X:8,490,344...8,594,375
|
|
| G
|
Map1lc3b
|
microtubule-associated protein 1 light chain 3 beta
|
multiple interactions
|
ISO
|
Calcitriol promotes the reaction [bisphenol A results in increased expression of MAP1LC3B protein]
|
CTD |
PMID:38725370 |
|
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358 Ensembl chr16:66,574,407...66,584,358
|
|
| G
|
Map3k1
|
mitogen-activated protein kinase kinase kinase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MAP3K1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:45,081,889...45,150,555
Ensembl chr 2:45,081,889...45,149,897
|
|
| G
|
Map3k10
|
mitogen activated protein kinase kinase kinase 10
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MAP3K10 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MAP3K10 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:92,083,376...92,101,676
Ensembl chr 1:92,083,376...92,101,676
|
|
| G
|
Map3k14
|
mitogen-activated protein kinase kinase kinase 14
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MAP3K14 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MAP3K14 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:88,665,417...88,715,669
Ensembl chr10:88,665,417...88,715,592
|
|
| G
|
Map3k20
|
mitogen-activated protein kinase kinase kinase 20
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MAP3K20 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MAP3K20 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:77,538,146...77,697,540
Ensembl chr 3:77,537,956...77,697,538
|
|
| G
|
Map3k21
|
mitogen-activated protein kinase kinase kinase 21
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MAP3K21 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr19:70,776,233...70,810,889
Ensembl chr19:70,777,472...70,810,882
|
|
| G
|
Map3k5
|
mitogen-activated protein kinase kinase kinase 5
|
multiple interactions increases activity
|
ISO
|
[Calcitriol promotes the reaction [TXNIP protein binds to TNPO1 protein]] which results in increased activity of MAP3K5 protein Calcitriol results in increased activity of MAP3K5 protein
|
CTD |
PMID:10843682 |
|
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:16,505,596...16,723,898
|
|
| G
|
Map3k8
|
mitogen-activated protein kinase kinase kinase 8
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MAP3K8 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr17:58,078,175...58,098,455
Ensembl chr17:58,078,320...58,098,452
|
|
| G
|
Map7
|
microtubule-associated protein 7
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MAP7 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:16,730,000...16,857,173
Ensembl chr 1:16,730,075...16,857,170
|
|
| G
|
Map7d2
|
MAP7 domain containing 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MAP7D2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MAP7D2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:39,181,091...39,296,814
Ensembl chr X:39,181,091...39,296,695
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
increases activity increases phosphorylation multiple interactions
|
ISO
|
Calcitriol results in increased activity of MAPK1 protein Calcitriol results in increased phosphorylation of MAPK1 protein [CAMP results in increased activity of MAPK1] affects the reaction [Calcitriol results in increased expression of ATG5 mRNA]; [CAMP results in increased activity of MAPK1] affects the reaction [Calcitriol results in increased expression of BECN1 mRNA]; Calcitriol inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased phosphorylation of MAPK1 protein]; Calcitriol inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK1 protein]; Calcitriol promotes the reaction [MAPK1 protein results in increased phosphorylation of HNF4A protein]; Calcitriol promotes the reaction [MAPK1 protein results in increased phosphorylation of RXRA protein]; Calcitriol promotes the reaction [MAPK1 protein results in increased phosphorylation of VDR protein]; Calcitriol results in increased phosphorylation of and results in increased activity of MAPK1 protein; CAMP mutant form inhibits the reaction [Calcitriol results in increased activity of MAPK1 protein]; MAPK1 protein promotes the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]; RTKI cpd inhibits the reaction [Calcitriol results in increased phosphorylation of and results in increased activity of MAPK1 protein]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [MAPK1 protein results in increased phosphorylation of HNF4A protein]]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [MAPK1 protein results in increased phosphorylation of RXRA protein]]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [MAPK1 protein results in increased phosphorylation of VDR protein]]; U 0126 inhibits the reaction [MAPK1 protein promotes the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]]
|
CTD |
PMID:12761878 PMID:15879110 PMID:19748465 PMID:20371703 PMID:21803404 PMID:36504884 More...
|
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk11
|
mitogen-activated protein kinase 11
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MAPK11 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MAPK11 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:122,098,120...122,105,023
Ensembl chr 7:122,098,121...122,105,038
|
|
| G
|
Mapk13
|
mitogen activated protein kinase 13
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MAPK13 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr20:6,836,979...6,847,197
Ensembl chr20:6,837,013...6,847,191
|
|
| G
|
Mapk14
|
mitogen activated protein kinase 14
|
increases activity multiple interactions increases phosphorylation
|
ISO EXP
|
Calcitriol results in increased activity of MAPK14 protein [Calcitriol co-treated with TGFB1 protein] results in increased phosphorylation of MAPK14 protein Calcitriol results in increased phosphorylation of MAPK14 protein [CAMP results in increased activity of MAPK14] affects the reaction [Calcitriol results in increased expression of ATG5 mRNA]; [CAMP results in increased activity of MAPK14] affects the reaction [Calcitriol results in increased expression of BECN1 mRNA]; CAMP mutant form inhibits the reaction [Calcitriol results in increased activity of MAPK14 protein]
|
CTD |
PMID:16598785 PMID:19748465 |
|
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions increases phosphorylation increases activity
|
ISO
|
[CAMP results in increased activity of MAPK3] affects the reaction [Calcitriol results in increased expression of ATG5 mRNA]; [CAMP results in increased activity of MAPK3] affects the reaction [Calcitriol results in increased expression of BECN1 mRNA]; Calcitriol inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased phosphorylation of MAPK3 protein]; Calcitriol inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK3 protein]; Calcitriol promotes the reaction [MAPK3 protein results in increased phosphorylation of HNF4A protein]; Calcitriol promotes the reaction [MAPK3 protein results in increased phosphorylation of RXRA protein]; Calcitriol promotes the reaction [MAPK3 protein results in increased phosphorylation of VDR protein]; Calcitriol results in increased phosphorylation of and results in increased activity of MAPK3 protein; CAMP mutant form inhibits the reaction [Calcitriol results in increased activity of MAPK3 protein]; MAPK3 protein promotes the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]; RTKI cpd inhibits the reaction [Calcitriol results in increased phosphorylation of and results in increased activity of MAPK3 protein]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [MAPK3 protein results in increased phosphorylation of HNF4A protein]]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [MAPK3 protein results in increased phosphorylation of RXRA protein]]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [MAPK3 protein results in increased phosphorylation of VDR protein]]; U 0126 inhibits the reaction [MAPK3 protein promotes the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]] Calcitriol results in increased phosphorylation of MAPK3 protein
|
CTD |
PMID:12761878 PMID:15879110 PMID:19748465 PMID:20371703 PMID:21803404 PMID:36504884 More...
|
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
multiple interactions
|
ISO
|
Calcitriol results in decreased phosphorylation of and results in decreased activity of MAPK8 protein
|
CTD |
PMID:12761878 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mapk8ip2
|
mitogen-activated protein kinase 8 interacting protein 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MAPK8IP2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:122,406,350...122,416,602
Ensembl chr 7:122,406,350...122,416,602
|
|
| G
|
Mapt
|
microtubule-associated protein tau
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MAPT mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108
|
|
| G
|
Marchf1
|
membrane associated ring-CH-type finger 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MARCHF1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr16:28,022,159...28,880,872
Ensembl chr16:28,022,159...28,881,054
|
|
| G
|
Marchf11
|
membrane associated ring-CH-type finger 11
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MARCHF11 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MARCHF11 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:78,628,793...78,730,164
Ensembl chr 2:78,628,191...78,755,104
|
|
| G
|
Marchf3
|
membrane associated ring-CH-type finger 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MARCHF3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr18:52,435,292...52,587,321
Ensembl chr18:52,435,296...52,587,297
|
|
| G
|
Mast4
|
microtubule associated serine/threonine kinase family member 4
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MAST4 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MAST4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:35,627,190...36,219,090
Ensembl chr 2:35,627,190...36,218,832
|
|
| G
|
Matn3
|
matrilin 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MATN3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MATN3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:37,467,729...37,487,776
Ensembl chr 6:37,467,729...37,487,776
|
|
| G
|
Mbtd1
|
mbt domain containing 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MBTD1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:79,336,041...79,392,315
Ensembl chr10:79,335,235...79,392,315
|
|
| G
|
Mcl1
|
MCL1 apoptosis regulator, BCL2 family member
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of MCL1 protein
|
CTD |
PMID:12479363 |
|
NCBI chr 2:185,884,840...185,912,532
Ensembl chr 2:185,908,168...185,938,782
|
|
| G
|
Mcm10
|
minichromosome maintenance 10 replication initiation factor
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MCM10 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MCM10 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:78,172,049...78,197,644
Ensembl chr17:78,175,398...78,197,636
|
|
| G
|
Mcm2
|
minichromosome maintenance complex component 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MCM2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MCM2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:122,903,679...122,918,205
Ensembl chr 4:122,903,682...122,918,094
|
|
| G
|
Mcm3
|
minichromosome maintenance complex component 3
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MCM3 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MCM3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:30,715,602...30,733,746
Ensembl chr 9:30,715,602...30,733,746
|
|
| G
|
Mcm4
|
minichromosome maintenance complex component 4
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MCM4 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MCM4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr11:98,762,599...98,776,300
Ensembl chr11:98,762,634...98,776,536
|
|
| G
|
Mcm5
|
minichromosome maintenance complex component 5
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MCM5 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MCM5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:13,488,813...13,510,131
Ensembl chr19:13,488,813...13,517,758
|
|
| G
|
Mcm6
|
minichromosome maintenance complex component 6
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of MCM6 mRNA Calcitriol results in decreased expression of MCM6 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:42,379,161...42,404,352
Ensembl chr13:42,379,162...42,465,467
|
|
| G
|
Mcm7
|
minichromosome maintenance complex component 7
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MCM7 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MCM7 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr12:22,155,921...22,163,320
Ensembl chr12:22,155,921...22,163,771
|
|
| G
|
Mcm8
|
minichromosome maintenance 8 homologous recombination repair factor
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MCM8 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MCM8 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:140,539,590...140,569,891
Ensembl chr 3:140,539,647...140,569,891
|
|
| G
|
Mcmbp
|
minichromosome maintenance complex binding protein
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MCMBP mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MCMBP mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:192,702,383...192,747,381
Ensembl chr 1:192,702,385...192,755,975
|
|
| G
|
Mdc1
|
mediator of DNA damage checkpoint 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MDC1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MDC1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:2,898,496...2,914,960
Ensembl chr20:2,900,308...2,914,960
|
|
| G
|
Mdfic
|
MyoD family inhibitor domain containing
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MDFIC mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:44,938,301...45,018,157
Ensembl chr 4:44,938,480...45,018,156
|
|
| G
|
Mdm1
|
Mdm1 nuclear protein
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MDM1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:55,615,459...55,651,889
Ensembl chr 7:55,615,608...55,651,888
|
|
| G
|
Mecom
|
MDS1 and EVI1 complex locus
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of MECOM mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:114,837,815...115,393,052
Ensembl chr 2:114,837,840...115,393,038
|
|
| G
|
Med1
|
mediator complex subunit 1
|
multiple interactions increases expression affects localization
|
ISO
|
Calcitriol promotes the reaction [[VDR protein binds to MED1 protein] which binds to CYP24A1 promoter] Calcitriol results in increased expression of MED1 mRNA Calcitriol promotes the reaction [MED1 protein binds to CYP24A1 promoter]; Calcitriol promotes the reaction [MED1 protein binds to SPP1 promoter]; MED1 protein promotes the reaction [Calcitriol results in increased activity of VDR protein] Calcitriol affects the localization of MED1 protein
|
CTD |
PMID:15647825 PMID:15919092 PMID:16324150 |
|
NCBI chr10:83,641,851...83,685,560
Ensembl chr10:83,641,862...83,685,545
|
|
| G
|
Med13
|
mediator complex subunit 13
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MED13 mRNA
|
CTD |
PMID:16324150 |
|
NCBI chr10:71,584,354...71,674,614
Ensembl chr10:71,584,354...71,673,901
|
|
| G
|
Med14
|
mediator complex subunit 14
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MED14 mRNA
|
CTD |
PMID:16324150 |
|
NCBI chr X:12,709,406...12,800,642
Ensembl chr X:12,709,472...12,800,640
|
|
| G
|
Meg3
|
maternally expressed 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of MEG3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 6:134,274,056...134,306,249
|
|
| G
|
Megf6
|
multiple EGF-like-domains 6
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MEGF6 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MEGF6 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:170,020,699...170,121,557
Ensembl chr 5:170,020,778...170,121,554
|
|
| G
|
Melk
|
maternal embryonic leucine zipper kinase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MELK mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MELK mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:63,336,151...63,396,254
Ensembl chr 5:63,336,106...63,396,247
|
|
| G
|
Meltf
|
melanotransferrin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MELTF mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr11:82,389,420...82,411,270
Ensembl chr11:82,389,420...82,411,270
|
|
| G
|
Mepe
|
matrix extracellular phosphoglycoprotein
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of MEPE mRNA
|
CTD |
PMID:11414762 |
|
NCBI chr14:5,725,308...5,736,858
Ensembl chr14:5,725,175...5,736,996
|
|
| G
|
Mertk
|
MER proto-oncogene, tyrosine kinase
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MERTK mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MERTK mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:136,391,936...136,498,366
Ensembl chr 3:136,383,560...136,500,192
|
|
| G
|
Metrnl
|
meteorin-like, glial cell differentiation regulator
|
increases expression
|
ISO
|
Calcitriol results in increased expression of METRNL mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:107,462,148...107,476,143
Ensembl chr10:107,462,109...107,476,135
|
|
| G
|
Mettl8
|
methyltransferase 8, tRNA N3-cytidine
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of METTL8 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of METTL8 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:76,140,465...76,271,367
Ensembl chr 3:76,144,178...76,271,400
|
|
| G
|
Mex3a
|
mex-3 RNA binding family member A
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MEX3A mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MEX3A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:176,287,900...176,297,369
Ensembl chr 2:176,287,900...176,297,369
|
|
| G
|
Mfap2
|
microfibril associated protein 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of MFAP2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:158,595,121...158,603,283
Ensembl chr 5:158,597,512...158,610,656
|
|
| G
|
Mfap4
|
microfibril associated protein 4
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of MFAP4 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:46,666,552...46,669,613
Ensembl chr10:46,655,722...46,669,740
|
|
| G
|
Mfap5
|
microfibril associated protein 5
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of MFAP5 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 4:157,399,919...157,422,448
Ensembl chr 4:157,395,597...157,422,448
|
|
| G
|
Mfsd2a
|
MFSD2 lysolipid transporter A, lysophospholipid
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MFSD2A mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 5:140,510,933...140,525,828
Ensembl chr 5:140,510,953...140,525,916
|
|
| G
|
Mfsd6
|
major facilitator superfamily domain containing 6
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of MFSD6 mRNA Calcitriol results in increased expression of MFSD6 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 9:56,265,152...56,350,449
Ensembl chr 9:56,265,237...56,350,446
|
|
| G
|
Mgll
|
monoglyceride lipase
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MGLL mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MGLL mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:122,749,436...122,851,440
Ensembl chr 4:122,749,436...122,851,440
|
|
| G
|
Mgme1
|
mitochondrial genome maintenance exonuclease 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MGME1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MGME1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:152,094,514...152,103,314
Ensembl chr 3:152,094,658...152,103,313
|
|
| G
|
Mgp
|
matrix Gla protein
|
decreases expression
|
EXP
|
Calcitriol results in decreased expression of MGP protein
|
CTD |
PMID:19092814 |
|
NCBI chr 4:171,497,472...171,500,888
Ensembl chr 4:171,497,471...171,500,859
|
|
| G
|
Miat
|
myocardial infarction associated transcript
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of MIAT mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr12:50,075,026...50,090,259
|
|
| G
|
Mib1
|
MIB E3 ubiquitin protein ligase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MIB1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr18:2,075,309...2,199,774
Ensembl chr18:2,075,309...2,193,475
|
|
| G
|
Mical1
|
microtubule associated monooxygenase, calponin and LIM domain containing 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MICAL1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MICAL1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:46,547,983...46,568,487
Ensembl chr20:46,556,536...46,568,487
|
|
| G
|
Mical3
|
microtubule associated monooxygenase, calponin and LIM domain containing 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MICAL3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 4:155,824,941...156,025,003
Ensembl chr 4:155,824,946...156,005,238
|
|
| G
|
Micos10
|
mitochondrial contact site and cristae organizing system subunit 10
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of MICOS10 mRNA Calcitriol results in increased expression of MICOS10 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:156,624,356...156,650,631
Ensembl chr 5:156,624,357...156,650,633
|
|
| G
|
Minar1
|
membrane integral NOTCH2 associated receptor 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MINAR1 mRNA
|
CTD |
PMID:16129123 |
|
NCBI chr 8:99,017,228...99,049,003
Ensembl chr 8:99,017,228...99,048,989
|
|
| G
|
Minpp1
|
multiple inositol-polyphosphate phosphatase 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MINPP1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MINPP1 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 1:239,766,809...239,793,023
Ensembl chr 1:239,767,286...239,793,015
|
|
| G
|
Mir134
|
microRNA 134
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MIR134 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MIR134 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:134,570,313...134,570,385
|
|
| G
|
Mir17
|
microRNA 17
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MIR17 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MIR17 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:98,587,848...98,587,931
Ensembl chr15:98,587,848...98,587,931
|
|
| G
|
Mir20a
|
microRNA 20a
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MIR20A mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MIR20A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:98,588,303...98,588,387
Ensembl chr15:98,588,303...98,588,387
|
|
| G
|
Mir20b
|
microRNA 20b
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MIR20B mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MIR20B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:137,343,197...137,343,268
|
|
| G
|
Mir22
|
microRNA 22
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MIR22 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MIR22 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:60,805,331...60,805,425
Ensembl chr10:60,805,331...60,805,425
|
|
| G
|
Mir29a
|
microRNA 29a
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MIR29A mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MIR29A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:60,617,955...60,618,042
|
|
| G
|
Mis18a
|
MIS18 kinetochore protein A
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of MIS18A mRNA Calcitriol results in decreased expression of MIS18A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr11:43,454,129...43,467,157
Ensembl chr11:43,454,161...43,476,264
|
|
| G
|
Mis18bp1
|
MIS18 binding protein 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MIS18BP1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MIS18BP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:88,918,743...88,968,225
Ensembl chr 6:88,918,745...88,967,629
|
|
| G
|
Mitf
|
melanocyte inducing transcription factor
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of MITF mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:131,965,676...132,177,790
Ensembl chr 4:131,965,714...132,177,790
|
|
| G
|
Mki67
|
marker of proliferation Ki-67
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MKI67 mRNA; Calcitriol results in decreased expression of MKI67 protein [Testosterone co-treated with Calcitriol] results in decreased expression of MKI67 mRNA
|
CTD |
PMID:8950452 PMID:21592394 |
|
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593
|
|
| G
|
Mkln1
|
muskelin 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MKLN1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MKLN1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:60,939,239...61,095,214
Ensembl chr 4:60,937,817...61,095,210
|
|
| G
|
Mks1
|
MKS transition zone complex subunit 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MKS1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MKS1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:73,152,599...73,167,451
Ensembl chr10:73,153,186...73,163,886
|
|
| G
|
Mlf1
|
myeloid leukemia factor 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MLF1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:153,958,060...153,991,705
Ensembl chr 2:153,958,546...153,994,220
|
|
| G
|
Mmd
|
monocyte to macrophage differentiation-associated
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MMD mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:75,570,366...75,598,610
Ensembl chr10:75,570,397...75,598,609
|
|
| G
|
Mmp1
|
matrix metallopeptidase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MMP1 mRNA
|
CTD |
PMID:12040012 PMID:16002434 |
|
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:12,943,453...12,963,964
|
|
| G
|
Mmp12
|
matrix metallopeptidase 12
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MMP12 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MMP12 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:12,866,652...12,876,554
Ensembl chr 8:12,866,641...12,884,478
|
|
| G
|
Mmp13
|
matrix metallopeptidase 13
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of MMP13 mRNA
|
CTD |
PMID:12040012 PMID:26485663 |
|
NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:12,782,813...12,793,105
|
|
| G
|
Mmp16
|
matrix metallopeptidase 16
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MMP16 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MMP16 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:36,109,265...36,353,252
Ensembl chr 5:36,109,265...36,353,252
|
|
| G
|
Mmp19
|
matrix metallopeptidase 19
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of MMP19 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:1,805,732...1,814,054
Ensembl chr 7:1,805,860...1,814,863
|
|
| G
|
Mmp2
|
matrix metallopeptidase 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of MMP2 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
| G
|
Mmp3
|
matrix metallopeptidase 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MMP3 mRNA
|
CTD |
PMID:12040012 PMID:16002434 |
|
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:12,925,280...12,938,826
|
|
| G
|
Mmp7
|
matrix metallopeptidase 7
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MMP7 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:13,133,043...13,140,755
|
|
| G
|
Mmp8
|
matrix metallopeptidase 8
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MMP8 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 8:13,008,873...13,018,729
Ensembl chr 8:13,008,890...13,018,729
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of MMP9 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mms22l
|
MMS22-like, DNA repair protein
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MMS22L mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MMS22L mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:42,994,382...43,110,371
Ensembl chr 5:42,994,359...43,110,369
|
|
| G
|
Mmut
|
methylmalonyl-CoA mutase
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MMUT mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 9:27,425,935...27,454,202
Ensembl chr 9:27,425,935...27,454,342
|
|
| G
|
Mn1
|
MN1 proto-oncogene, transcriptional regulator
|
multiple interactions increases expression
|
ISO
|
Dactinomycin inhibits the reaction [Calcitriol results in increased expression of MN1 mRNA]
|
CTD |
PMID:15890672 PMID:16002434 |
|
NCBI chr12:50,841,632...50,880,795
Ensembl chr12:50,841,632...50,880,795
|
|
| G
|
Mnd1
|
meiotic nuclear divisions 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MND1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MND1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:171,731,523...171,794,124
Ensembl chr 2:171,731,523...171,794,095
|
|
| G
|
Mns1
|
meiosis-specific nuclear structural 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MNS1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MNS1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:82,029,587...82,050,276
Ensembl chr 8:82,029,587...82,050,274
|
|
| G
|
Mogat2
|
monoacylglycerol O-acyltransferase 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MOGAT2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MOGAT2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:162,933,964...162,957,896
Ensembl chr 1:162,933,966...162,957,896
|
|
| G
|
Mok
|
MOK protein kinase
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MOK mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:135,645,018...135,675,894
Ensembl chr 6:135,645,018...135,676,174
|
|
| G
|
Mosmo
|
modulator of smoothened
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MOSMO mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MOSMO mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 1:184,648,985...184,719,820
Ensembl chr 1:184,648,985...184,719,820
|
|
| G
|
Mpeg1
|
macrophage expressed 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of MPEG1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:218,876,848...218,881,364
Ensembl chr 1:218,876,069...218,908,715
|
|
| G
|
Mphosph6
|
M phase phosphoprotein 6
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MPHOSPH6 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr19:62,768,909...62,778,874
Ensembl chr19:62,768,909...62,778,950
|
|
| G
|
Mpp7
|
MAGUK p55 scaffold protein 7
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MPP7 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr17:60,135,096...60,401,814
Ensembl chr17:60,137,701...60,401,739
|
|
| G
|
Mprip
|
myosin phosphatase Rho interacting protein
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of MPRIP mRNA Calcitriol results in decreased expression of MPRIP mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:44,953,472...45,073,388
Ensembl chr10:44,953,500...45,073,388
|
|
| G
|
Mreg
|
melanoregulin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MREG mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 9:81,236,019...81,291,601
Ensembl chr 9:81,236,019...81,291,310
|
|
| G
|
Mrnip
|
MRN complex interacting protein
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MRNIP mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MRNIP mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:35,002,440...35,026,555
|
|
| G
|
Mrps12
|
mitochondrial ribosomal protein S12
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of MRPS12 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:93,153,424...93,156,422
Ensembl chr 1:93,153,425...93,159,629
|
|
| G
|
Mrps6
|
mitochondrial ribosomal protein S6
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MRPS6 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr11:44,778,667...44,834,420
Ensembl chr11:44,781,554...44,834,962
|
|
| G
|
Ms4a4a
|
membrane spanning 4-domains A4A
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of MS4A4A mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:217,495,704...217,510,019
Ensembl chr 1:217,487,996...217,510,503
|
|
| G
|
Ms4a7
|
membrane spanning 4-domains A7
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of MS4A7 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:217,394,019...217,409,643
Ensembl chr 1:217,394,019...217,409,643
|
|
| G
|
Msh5
|
mutS homolog 5
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MSH5 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MSH5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:3,779,180...3,797,996
Ensembl chr20:3,781,578...3,797,994
|
|
| G
|
Msi1
|
musashi RNA-binding protein 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MSI1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr12:46,815,225...46,911,852
Ensembl chr12:46,819,039...46,845,425
|
|
| G
|
Msmo1
|
methylsterol monooxygenase 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of MSMO1 mRNA Calcitriol results in increased expression of MSMO1 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr16:29,747,113...29,764,360
Ensembl chr16:29,747,137...29,764,445
|
|
| G
|
Msr1
|
macrophage scavenger receptor 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of MSR1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr16:59,421,250...59,507,070
Ensembl chr16:59,421,057...59,507,070
|
|
| G
|
Msrb3
|
methionine sulfoxide reductase B3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MSRB3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MSRB3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:58,188,827...58,311,459
Ensembl chr 7:57,968,124...58,311,116
|
|
| G
|
Msx2
|
msh homeobox 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MSX2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr17:11,102,284...11,107,949
Ensembl chr17:11,102,247...11,107,945
|
|
| G
|
Mt-co1
|
mitochondrially encoded cytochrome c oxidase I
|
increases expression multiple interactions
|
EXP
|
Calcitriol results in increased expression of COX1 protein Calcitriol inhibits the reaction [bisphenol A results in decreased expression of COX1 protein]
|
CTD |
PMID:30194976 |
|
NCBI chr MT:5,323...6,867
Ensembl chr MT:5,309...6,853
|
|
| G
|
Mtbp
|
MDM2 binding protein
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MTBP mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MTBP mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:88,862,939...88,945,491
Ensembl chr 7:88,862,927...88,945,493
|
|
| G
|
Mtfr2
|
mitochondrial fission regulator 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MTFR2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MTFR2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:16,942,814...16,958,218
|
|
| G
|
Mthfr
|
methylenetetrahydrofolate reductase
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MTHFR mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MTHFR mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:163,748,321...163,768,105
|
|
| G
|
Mtss1
|
MTSS I-BAR domain containing 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MTSS1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:92,378,228...92,517,444
Ensembl chr 7:92,378,238...92,517,303
|
|
| G
|
Mturn
|
maturin, neural progenitor differentiation regulator homolog
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MTURN mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MTURN mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:85,137,825...85,158,790
Ensembl chr 4:85,137,846...85,158,789
|
|
| G
|
Mtus1
|
microtubule associated scaffold protein 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of MTUS1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr16:57,905,991...58,051,466
Ensembl chr16:57,906,128...58,051,474
|
|
| G
|
Muc1
|
mucin 1, cell surface associated
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MUC1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:176,933,047...176,938,491
|
|
| G
|
Mvp
|
major vault protein
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MVP mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MVP mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:191,025,259...191,052,866
Ensembl chr 1:191,025,268...191,052,873
|
|
| G
|
Mxd1
|
max dimerization protein 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MXD1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:120,654,731...120,678,972
Ensembl chr 4:120,654,731...120,675,129
|
|
| G
|
Mxd3
|
Max dimerization protein 3
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MXD3 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MXD3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:9,306,552...9,310,278
Ensembl chr17:9,302,321...9,310,278
|
|
| G
|
Mxra8
|
matrix remodeling associated 8
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of MXRA8 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:171,731,153...171,735,879
Ensembl chr 5:171,731,353...171,735,879
|
|
| G
|
Myb
|
MYB proto-oncogene, transcription factor
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MYB mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MYB mRNA
|
CTD |
PMID:12875902 PMID:16002434 PMID:21592394 |
|
NCBI chr 1:17,759,309...17,793,306
Ensembl chr 1:17,759,309...17,792,547
|
|
| G
|
Mybl2
|
MYB proto-oncogene like 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MYBL2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MYBL2 mRNA
|
CTD |
PMID:12875902 PMID:21592394 |
|
NCBI chr 3:172,124,765...172,153,221
Ensembl chr 3:172,116,550...172,153,221
|
|
| G
|
Mybpc1
|
myosin binding protein C1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of MYBPC1 mRNA Calcitriol results in increased expression of MYBPC1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:24,817,770...24,903,681
Ensembl chr 7:24,817,561...24,903,544
|
|
| G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MYC; Calcitriol results in decreased expression of MYC mRNA [salinomycin co-treated with Calcitriol] results in decreased expression of MYC mRNA; [Testosterone co-treated with Calcitriol] results in decreased expression of MYC mRNA
|
CTD |
PMID:3093070 PMID:8243807 PMID:12414619 PMID:12875902 PMID:16051482 PMID:21592394 PMID:35914560 More...
|
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
|
|
| G
|
Mycl
|
MYCL proto-oncogene, bHLH transcription factor
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MYCL mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MYCL mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 5:140,559,843...140,566,704
Ensembl chr 5:140,560,152...140,566,699
|
|
| G
|
Myh14
|
myosin heavy chain 14
|
increases expression
|
ISO
|
Calcitriol results in increased expression of MYH14 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:104,232,778...104,295,369
Ensembl chr 1:104,232,778...104,323,404
|
|
| G
|
Myh7
|
myosin heavy chain 7
|
decreases expression
|
EXP
|
Calcitriol results in decreased expression of MYH7 mRNA
|
CTD |
PMID:32147540 |
|
NCBI chr15:32,416,525...32,439,851
Ensembl chr15:32,416,527...32,438,194
|
|
| G
|
Myl7
|
myosin light chain 7
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of MYL7 mRNA Calcitriol results in increased expression of MYL7 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:84,994,644...84,997,173
Ensembl chr14:84,993,736...84,997,372
|
|
| G
|
Myl9
|
myosin light chain 9
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of MYL9 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of MYL9 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:165,742,020...165,748,409
Ensembl chr 3:165,742,046...165,748,410
|
|
| G
|
Mylip
|
myosin regulatory light chain interacting protein
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of MYLIP mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr17:19,492,826...19,514,490
Ensembl chr17:19,492,826...19,514,471
|
|
| G
|
Mylk
|
myosin light chain kinase
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of MYLK mRNA Calcitriol results in increased expression of MYLK mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr11:79,288,243...79,535,450
Ensembl chr11:79,288,243...79,535,659
|
|
| G
|
Mynn
|
myoneurin
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MYNN mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MYNN mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:114,708,150...114,726,450
Ensembl chr 2:114,708,156...114,725,452
|
|
| G
|
Myo19
|
myosin XIX
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MYO19 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MYO19 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:70,250,500...70,279,867
Ensembl chr10:70,250,022...70,279,858
|
|
| G
|
Myo1d
|
myosin ID
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of MYO1D mRNA Calcitriol results in increased expression of MYO1D mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr10:65,986,900...66,263,538
Ensembl chr10:65,975,122...66,263,958
|
|
| G
|
Myo5b
|
myosin Vb
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of MYO5B mRNA Calcitriol results in increased expression of MYO5B mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr18:70,313,717...70,613,918
Ensembl chr18:70,311,990...70,613,918
|
|
| G
|
Mzf1
|
myeloid zinc finger 1
|
multiple interactions increases response to substance
|
ISO
|
Calcitriol promotes the reaction [MZF1 protein binds to CD14 promoter]; Calcitriol promotes the reaction [MZF1 protein binds to ITGAM promoter]; Calcitriol results in increased activity of and results in increased expression of MZF1 protein MZF1 protein results in increased susceptibility to Calcitriol
|
CTD |
PMID:18495781 |
|
NCBI chr 1:82,742,709...82,755,069
Ensembl chr 1:82,742,726...82,753,820
|
|
| G
|
Mzt1
|
mitotic spindle organizing protein 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of MZT1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of MZT1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:82,195,128...82,205,436
Ensembl chr15:82,195,128...82,205,436
|
|
| G
|
N4bp3
|
Nedd4 binding protein 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of N4BP3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:36,400,053...36,407,609
Ensembl chr10:36,400,057...36,407,637
|
|
| G
|
Nampt
|
nicotinamide phosphoribosyltransferase
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of NAMPT mRNA [Testosterone co-treated with Calcitriol] results in increased expression of NAMPT mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:55,151,926...55,189,544
|
|
| G
|
Nap1l1
|
nucleosome assembly protein 1-like 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of NAP1L1 mRNA
|
CTD |
PMID:12798352 |
|
NCBI chr 7:48,819,464...48,844,108
Ensembl chr 7:48,819,477...48,844,104
|
|
| G
|
Nap1l5
|
nucleosome assembly protein 1-like 5
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NAP1L5 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NAP1L5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:89,352,834...89,354,704
Ensembl chr 4:89,351,926...89,361,736
|
|
| G
|
Nasp
|
nuclear autoantigenic sperm protein
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NASP mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NASP mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:135,294,599...135,319,992
Ensembl chr 5:135,294,032...135,319,591
|
|
| G
|
Nat1
|
N-acetyltransferase 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of NAT1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of NAT1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:26,984,882...27,005,194
Ensembl chr16:26,982,625...26,986,527
|
|
| G
|
Nat2
|
N-acetyltransferase 2
|
increases expression decreases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of NAT2 mRNA Calcitriol results in decreased expression of NAT2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of NAT2 mRNA
|
CTD |
PMID:21592394 PMID:27107558 |
|
NCBI chr16:26,974,874...27,005,191
Ensembl chr16:26,974,601...26,976,304
|
|
| G
|
Nat8
|
N-acetyltransferase 8
|
increases expression
|
ISO
|
Calcitriol results in increased expression of NAT8 mRNA
|
CTD |
PMID:27107558 |
|
NCBI chr 4:119,836,986...119,837,764
Ensembl chr 4:119,835,645...119,843,159
|
|
| G
|
Nat8b
|
N-acetyltransferase 8B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of NAT8B mRNA
|
CTD |
PMID:27107558 |
|
NCBI chr 4:119,916,909...119,923,544
Ensembl chr 4:119,915,525...119,921,887
|
|
| G
|
Nav1
|
neuron navigator 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of NAV1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:49,418,755...49,671,117
Ensembl chr13:49,418,755...49,671,004
|
|
| G
|
Nav3
|
neuron navigator 3
|
decreases expression multiple interactions increases expression
|
ISO
|
Calcitriol results in decreased expression of NAV3 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NAV3 mRNA Calcitriol results in increased expression of NAV3 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 7:46,938,577...47,726,839
Ensembl chr 7:46,940,670...47,504,893
|
|
| G
|
Nbl1
|
NBL1, DAN family BMP antagonist
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of NBL1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of NBL1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:156,601,986...156,613,182
Ensembl chr 5:156,601,986...156,613,186
|
|
| G
|
Ncapd2
|
non-SMC condensin I complex, subunit D2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NCAPD2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NCAPD2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:159,655,051...159,677,938
Ensembl chr 4:159,655,051...159,677,938
|
|
| G
|
Ncapg
|
non-SMC condensin I complex, subunit G
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NCAPG mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NCAPG mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:69,616,473...69,645,445
Ensembl chr14:69,616,473...69,645,445
|
|
| G
|
Ncapg2
|
non-SMC condensin II complex, subunit G2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NCAPG2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NCAPG2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:143,484,651...143,561,850
Ensembl chr 6:143,485,944...143,560,249
|
|
| G
|
Ncaph
|
non-SMC condensin I complex, subunit H
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NCAPH mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NCAPH mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:134,825,271...134,852,502
Ensembl chr 3:134,825,271...134,852,502
|
|
| G
|
Nckap5
|
NCK-associated protein 5
|
increases expression
|
ISO
|
Calcitriol results in increased expression of NCKAP5 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:39,922,576...40,835,849
Ensembl chr13:39,922,737...40,835,521
|
|
| G
|
Ncoa1
|
nuclear receptor coactivator 1
|
affects localization increases response to substance multiple interactions
|
ISO
|
Calcitriol affects the localization of NCOA1 protein NCOA1 protein results in increased susceptibility to Calcitriol Calcitriol promotes the reaction [NCOA1 protein binds to CYP24A1 promoter]; Calcitriol promotes the reaction [NCOA1 protein binds to VDR protein]; Calcitriol promotes the reaction [NCOA1 protein binds to VDRA protein]; Calcitriol promotes the reaction [NCOA1 protein binds to VDRALPHA protein]; Calcitriol promotes the reaction [NCOA1 protein binds to VDRB protein]; Calcitriol promotes the reaction [VDR protein binds to NCOA1 protein]; NCOA1 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein binds to and results in increased activity of VDR protein]]; NCOA1 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein binds to and results in increased activity of VDRA protein]]; NCOA1 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein binds to and results in increased activity of VDRALPHA protein]]; NCOA1 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein binds to and results in increased activity of VDRB protein]]; NCOA1 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein mutant form binds to VDRA protein]]; NCOA1 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein mutant form binds to VDRALPHA protein]]; NCOA1 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein mutant form binds to VDRB protein]]; NCOA1 protein promotes the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]; RXRA protein inhibits the reaction [Calcitriol promotes the reaction [NCOA1 protein binds to VDRA protein]]; RXRA protein inhibits the reaction [Calcitriol promotes the reaction [NCOA1 protein binds to VDRALPHA protein]]; RXRA protein promotes the reaction [Calcitriol promotes the reaction [NCOA1 protein binds to VDR protein]]; RXRA protein promotes the reaction [Calcitriol promotes the reaction [NCOA1 protein binds to VDRB protein]] Calcitriol promotes the reaction [NCOA1 protein binds to CYP24A1 promoter]; Calcitriol promotes the reaction [NCOA1 protein binds to SPP1 promoter]
|
CTD |
PMID:15489543 PMID:15578590 PMID:15647825 PMID:20371703 PMID:21917910 PMID:22466564 PMID:25279795 More...
|
|
NCBI chr 6:32,952,090...33,229,829
Ensembl chr 6:32,952,090...33,195,924
|
|
| G
|
Ncoa2
|
nuclear receptor coactivator 2
|
affects localization increases response to substance multiple interactions
|
ISO
|
Calcitriol affects the localization of NCOA2 protein NCOA2 protein results in increased susceptibility to Calcitriol Calcitriol inhibits the reaction [NCOA2 protein binds to CYP7A1 mRNA]; Calcitriol inhibits the reaction [NCOA2 protein binds to CYP7A1 promoter]; Calcitriol promotes the reaction [NCOA2 protein binds to VDR protein]; Calcitriol promotes the reaction [NCOA2 protein binds to VDRA protein]; Calcitriol promotes the reaction [NCOA2 protein binds to VDRALPHA protein]; Calcitriol promotes the reaction [NCOA2 protein binds to VDRB protein]; Calcitriol promotes the reaction [VDR protein binds to NCOA2 protein]; NCOA2 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein results in increased activity of VDR protein]]; NCOA2 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein results in increased activity of VDRA protein]]; NCOA2 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein results in increased activity of VDRALPHA protein]]; NCOA2 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein results in increased activity of VDRB protein]]; RXRA protein inhibits the reaction [Calcitriol promotes the reaction [NCOA2 protein binds to VDRA protein]]; RXRA protein inhibits the reaction [Calcitriol promotes the reaction [NCOA2 protein binds to VDRALPHA protein]]; RXRA protein promotes the reaction [Calcitriol promotes the reaction [NCOA2 protein binds to VDR protein]]; RXRA protein promotes the reaction [Calcitriol promotes the reaction [NCOA2 protein binds to VDRB protein]] Calcitriol promotes the reaction [NCOA2 protein binds to CYP24A1 promoter]; Calcitriol promotes the reaction [NCOA2 protein binds to SPP1 promoter]
|
CTD |
PMID:15578590 PMID:15647825 PMID:19106115 PMID:20371703 PMID:25279795 |
|
NCBI chr 5:10,618,712...10,852,776
Ensembl chr 5:10,618,722...10,852,776
|
|
| G
|
Ncoa3
|
nuclear receptor coactivator 3
|
affects localization increases response to substance multiple interactions
|
ISO
|
Calcitriol affects the localization of NCOA3 protein NCOA3 protein results in increased susceptibility to Calcitriol Calcitriol promotes the reaction [[VDR protein binds to NCOA3 protein] which binds to CYP24A1 promoter]; Calcitriol promotes the reaction [VDR protein binds to NCOA3 protein]; NCOA3 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein results in increased activity of VDR protein]]; NCOA3 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein results in increased activity of VDRA protein]]; NCOA3 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein results in increased activity of VDRALPHA protein]]; NCOA3 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein results in increased activity of VDRB protein]] Calcitriol promotes the reaction [NCOA3 protein binds to CYP24A1 promoter]; Calcitriol promotes the reaction [NCOA3 protein binds to SPP1 promoter]
|
CTD |
PMID:15578590 PMID:15647825 PMID:15919092 PMID:25279795 |
|
NCBI chr 3:175,157,824...175,237,831
Ensembl chr 3:175,157,821...175,240,631
|
|
| G
|
Ncor1
|
nuclear receptor co-repressor 1
|
multiple interactions
|
ISO
|
Calcitriol inhibits the reaction [VDR protein binds to NCOR1 protein]; Calcitriol promotes the reaction [NCOR1 protein binds to CYP24A1 mRNA]; Calcitriol promotes the reaction [NCOR1 protein binds to CYP7A1 mRNA]; Calcitriol promotes the reaction [NCOR1 protein binds to CYP7A1 promoter]; NCOR1 protein inhibits the reaction [[Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] which results in increased expression of CYP24A1 mRNA]; NCOR1 protein inhibits the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]; NCOR1 protein promotes the reaction [[Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] inhibits the reaction [PPARGC1A protein results in increased expression of CYP7A1 mRNA]]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [NCOR1 protein binds to CYP7A1 mRNA]]
|
CTD |
PMID:19106115 PMID:20371703 PMID:22466564 |
|
NCBI chr10:47,498,852...47,641,612
Ensembl chr10:47,498,852...47,640,350
|
|
| G
|
Ncor2
|
nuclear receptor co-repressor 2
|
multiple interactions
|
ISO
|
Calcitriol inhibits the reaction [NCOR2 protein binds to CYP24A1 promoter]; Calcitriol inhibits the reaction [VDR protein binds to NCOR2 protein]; Calcitriol promotes the reaction [NCOR2 protein binds to CYP24A1 mRNA]; Calcitriol promotes the reaction [NCOR2 protein binds to CYP7A1 mRNA]; Calcitriol promotes the reaction [NCOR2 protein binds to CYP7A1 promoter]; NCOR2 protein inhibits the reaction [[Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] which results in increased expression of CYP24A1 mRNA]; NCOR2 protein inhibits the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]; NCOR2 protein promotes the reaction [[Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] inhibits the reaction [PPARGC1A protein results in increased expression of CYP7A1 mRNA]]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [NCOR2 protein binds to CYP24A1 mRNA]]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [NCOR2 protein binds to CYP7A1 mRNA]]
|
CTD |
PMID:19106115 PMID:20371703 PMID:21917910 PMID:22466564 |
|
NCBI chr12:37,127,736...37,289,612
Ensembl chr12:37,127,686...37,289,612
|
|
| G
|
Ndc80
|
NDC80 kinetochore complex component
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of NDC80 mRNA Calcitriol results in decreased expression of NDC80 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:118,853,806...118,887,582
Ensembl chr 9:118,853,806...118,887,568
|
|
| G
|
Nde1
|
nudE neurodevelopment protein 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NDE1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NDE1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:1,347,010...1,391,167
Ensembl chr10:1,347,018...1,383,447
|
|
| G
|
Ndufs1
|
NADH:ubiquinone oxidoreductase core subunit S1
|
multiple interactions
|
EXP
|
[Calcium co-treated with Calcitriol] affects the expression of NDUFS1 mRNA
|
CTD |
PMID:15913539 |
|
NCBI chr 9:72,040,286...72,073,605
Ensembl chr 9:72,040,090...72,073,605
|
|
| G
|
Nectin4
|
nectin cell adhesion molecule 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of NECTIN4 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:86,335,027...86,354,152
Ensembl chr13:86,335,831...86,353,967
|
|
| G
|
Nefl
|
neurofilament light chain
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of NEFL mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr15:46,477,330...46,481,203
Ensembl chr15:46,458,204...46,482,515
|
|
| G
|
Negr1
|
neuronal growth regulator 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of NEGR1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:248,283,164...249,015,538
Ensembl chr 2:248,283,353...249,018,410
|
|
| G
|
Neil3
|
nei-like DNA glycosylase 3
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NEIL3 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NEIL3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:45,091,401...45,151,419
Ensembl chr16:45,092,200...45,151,205
|
|
| G
|
Nek2
|
NIMA-related kinase 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NEK2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NEK2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:105,936,809...105,950,054
Ensembl chr13:105,936,788...105,950,056
|
|
| G
|
Nell2
|
neural EGFL like 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of NELL2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:128,222,333...128,542,127
Ensembl chr 7:128,078,103...128,651,917
|
|
| G
|
Nemp1
|
nuclear envelope integral membrane protein 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NEMP1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NEMP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:65,399,297...65,424,054
Ensembl chr 7:65,399,381...65,424,055
|
|
| G
|
Net1
|
neuroepithelial cell transforming 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of NET1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr17:71,251,145...71,280,345
Ensembl chr17:71,251,149...71,289,270
|
|
| G
|
Neto1
|
neuropilin and tolloid like 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NETO1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NETO1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:81,905,455...82,028,730
Ensembl chr18:81,910,355...82,024,505
|
|
| G
|
Nexn
|
nexilin (F actin binding protein)
|
increases expression decreases expression
|
ISO
|
Calcitriol results in increased expression of NEXN mRNA Calcitriol results in decreased expression of NEXN mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 2:243,846,736...243,878,268
Ensembl chr 2:243,846,433...243,887,114
|
|
| G
|
Nfasc
|
neurofascin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of NFASC mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:46,549,369...46,735,989
Ensembl chr13:46,549,369...46,736,139
|
|
| G
|
Nfatc2
|
nuclear factor of activated T-cells 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of NFATC2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:177,615,189...177,747,493
Ensembl chr 3:177,618,314...177,747,380
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of NFE2L2 mRNA Calcitriol promotes the reaction [sodium arsenite results in increased expression of NFE2L2 protein] Calcitriol inhibits the reaction [perfluorooctane sulfonic acid results in increased expression of NFE2L2 protein]
|
CTD |
PMID:12040012 PMID:36321694 PMID:37968493 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nfkb1
|
nuclear factor kappa B subunit 1
|
multiple interactions
|
ISO EXP
|
[salinomycin co-treated with Calcitriol] results in decreased expression of NFKB1 mRNA Calcitriol inhibits the reaction [sodium arsenite results in increased expression of and results in increased phosphorylation of NFKB1 protein]
|
CTD |
PMID:35914560 PMID:39771102 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
|
|
| G
|
Nfkbia
|
NFKB inhibitor alpha
|
multiple interactions
|
ISO EXP
|
Calcitriol inhibits the reaction [IL1B protein results in increased degradation of NFKBIA protein] bisphenol A diglycidyl ether inhibits the reaction [Calcitriol inhibits the reaction [Streptozocin results in decreased expression of NFKBIA protein]]; Calcitriol inhibits the reaction [Streptozocin results in decreased expression of NFKBIA protein]
|
CTD |
PMID:18515093 PMID:29953732 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
| G
|
Nfkbiz
|
NFKB inhibitor zeta
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of NFKBIZ mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr11:58,251,720...58,279,767
Ensembl chr11:58,251,721...58,279,767
|
|
| G
|
Ngf
|
nerve growth factor
|
increases expression
|
ISO
|
Calcitriol results in increased expression of NGF mRNA
|
CTD |
PMID:16002434 PMID:19603526 |
|
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834
|
|
| G
|
Ngfr
|
nerve growth factor receptor
|
affects activity increases expression decreases expression
|
EXP ISO
|
Calcitriol affects the activity of NGFR promoter Calcitriol results in increased expression of NGFR mRNA Calcitriol results in increased expression of NGFR mRNA; Calcitriol results in increased expression of NGFR protein Calcitriol results in decreased expression of NGFR mRNA
|
CTD |
PMID:8883959 PMID:26485663 |
|
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:81,012,089...81,030,305
|
|
| G
|
Nhs
|
NHS actin remodeling regulator
|
increases expression
|
ISO
|
Calcitriol results in increased expression of NHS mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr X:36,185,067...36,524,711
Ensembl chr X:36,438,178...36,524,708
|
|
| G
|
Nhsl3
|
NHS like 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of NHSL3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:146,848,747...146,877,504
Ensembl chr 5:146,848,747...146,877,504
|
|
| G
|
Niban1
|
niban apoptosis regulator 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of NIBAN1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:66,224,219...66,377,728
Ensembl chr13:66,224,021...66,377,724
|
|
| G
|
Nid2
|
nidogen 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of NID2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr15:4,507,224...4,562,949
Ensembl chr15:4,506,756...4,562,949
|
|
| G
|
Nif3l1
|
NGG1 interacting factor 3 like 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NIF3L1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NIF3L1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:67,474,286...67,494,350
Ensembl chr 9:67,474,351...67,494,350
|
|
| G
|
Ninj1
|
ninjurin 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of NINJ1 mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr17:15,659,208...15,668,115
Ensembl chr17:15,659,200...15,668,063
|
|
| G
|
Nipal2
|
NIPA-like domain containing 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of NIPAL2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:67,659,628...67,771,105
Ensembl chr 7:67,659,628...67,769,959
|
|
| G
|
Nkd2
|
NKD inhibitor of WNT signaling pathway 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of NKD2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:31,268,856...31,299,390
Ensembl chr 1:31,272,519...31,299,387
|
|
| G
|
Nlrc5
|
NLR family, CARD domain containing 5
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of NLRC5 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of NLRC5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:10,483,601...10,587,223
Ensembl chr19:10,483,755...10,555,786
|
|
| G
|
Nlrp1a
|
NLR family, pyrin domain containing 1A
|
increases expression
|
ISO
|
Calcitriol results in increased expression of NLRP1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:56,277,134...56,332,229
Ensembl chr10:56,277,134...56,323,880
|
|
| G
|
Nlrp5
|
NLR family, pyrin domain containing 5
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of NLRP5 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of NLRP5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:76,811,044...76,872,964
Ensembl chr 1:76,810,108...77,077,580
|
|
| G
|
Nme2
|
NME/NM23 nucleoside diphosphate kinase 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of NME2 mRNA
|
CTD |
PMID:15951637 PMID:16847355 |
|
NCBI chr10:79,394,999...79,400,418
Ensembl chr20:11,179,066...11,179,497 Ensembl chr10:11,179,066...11,179,497
|
|
| G
|
Nmnat2
|
nicotinamide nucleotide adenylyltransferase 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of NMNAT2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of NMNAT2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:67,655,794...67,831,609
Ensembl chr13:67,655,807...67,831,608
|
|
| G
|
Nmu
|
neuromedin U
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NMU mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NMU mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:32,198,789...32,226,397
Ensembl chr14:32,198,943...32,226,632
|
|
| G
|
Nod2
|
nucleotide-binding oligomerization domain containing 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of NOD2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr19:34,555,832...34,596,281
Ensembl chr19:34,555,832...34,722,846
|
|
| G
|
Nol4l
|
nucleolar protein 4-like
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of NOL4L mRNA Calcitriol results in increased expression of NOL4L mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:162,345,059...162,467,849
Ensembl chr 3:162,348,211...162,468,048
|
|
| G
|
Nop58
|
NOP58 ribonucleoprotein
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NOP58 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NOP58 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:68,614,992...68,638,911
Ensembl chr 9:68,615,010...68,638,909
|
|
| G
|
Nopchap1
|
NOP protein chaperone 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of NOPCHAP1 mRNA Calcitriol results in decreased expression of NOPCHAP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:22,241,236...22,247,150
Ensembl chr 7:22,241,236...22,247,150
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
decreases expression multiple interactions
|
ISO EXP
|
Calcitriol results in decreased expression of NOS2 protein [Maxepa co-treated with Calcitriol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOS2 mRNA]
|
CTD |
PMID:17600374 PMID:20599847 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
decreases expression
|
EXP
|
Calcitriol results in decreased expression of NOS3 protein
|
CTD |
PMID:19092814 |
|
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Nox1
|
NADPH oxidase 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of NOX1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of NOX1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:101,572,338...101,625,571
Ensembl chr X:101,572,340...101,595,520
|
|
| G
|
Nox4
|
NADPH oxidase 4
|
increases expression decreases expression
|
ISO EXP
|
Calcitriol results in increased expression of NOX4 mRNA Calcitriol results in decreased expression of NOX4 mRNA; Calcitriol results in decreased expression of NOX4 protein
|
CTD |
PMID:19918113 PMID:32147540 |
|
NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:150,313,728...150,491,483
|
|
| G
|
Nphs1
|
NPHS1 adhesion molecule, nephrin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of NPHS1 mRNA
|
CTD |
PMID:16820792 |
|
NCBI chr 1:94,848,261...94,876,522
Ensembl chr 1:94,848,261...94,876,521
|
|
| G
|
Npm1
|
nucleophosmin 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of NPM1 mRNA Calcitriol results in decreased expression of NPM1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:18,245,739...18,255,913
Ensembl chr10:18,245,740...18,256,024 Ensembl chr X:18,245,740...18,256,024
|
|
| G
|
Nppa
|
natriuretic peptide A
|
decreases expression
|
EXP
|
Calcitriol results in decreased expression of NPPA mRNA
|
CTD |
PMID:32147540 |
|
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:163,712,184...163,713,493
|
|
| G
|
Nppb
|
natriuretic peptide B
|
decreases expression
|
EXP
|
Calcitriol results in decreased expression of NPPB mRNA
|
CTD |
PMID:32147540 |
|
NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:163,699,839...163,701,310
|
|
| G
|
Nppc
|
natriuretic peptide C
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of NPPC mRNA [Testosterone co-treated with Calcitriol] results in increased expression of NPPC mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:94,767,986...94,772,186
Ensembl chr 9:94,767,986...94,772,186
|
|
| G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
multiple interactions
|
ISO
|
Calcitriol promotes the reaction [sodium arsenite results in increased expression of NQO1 protein]
|
CTD |
PMID:37968493 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
| G
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2
|
multiple interactions increases expression
|
ISO
|
[Calcitriol co-treated with NR1I2 protein] results in increased expression of CYP24A1 mRNA [Calcitriol results in increased expression of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; Calcitriol results in increased expression of NR1I2 mRNA; Calcitriol results in increased expression of NR1I2 protein
|
CTD |
PMID:21115105 PMID:22687401 |
|
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
|
|
| G
|
Nr2c2ap
|
nuclear receptor 2C2-associated protein
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NR2C2AP mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NR2C2AP mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:19,322,395...19,324,912
Ensembl chr16:19,322,405...19,324,637
|
|
| G
|
Nr2f1
|
nuclear receptor subfamily 2, group F, member 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of NR2F1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:9,776,179...9,785,924
Ensembl chr 2:9,776,179...9,785,924
|
|
| G
|
Nr4a1
|
nuclear receptor subfamily 4, group A, member 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of NR4A1 mRNA Calcitriol results in increased expression of NR4A1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:134,247,153...134,268,044
Ensembl chr 7:134,247,192...134,268,041
|
|
| G
|
Nrarp
|
Notch-regulated ankyrin repeat protein
|
decreases expression increases expression
|
ISO
|
Calcitriol results in decreased expression of NRARP mRNA Calcitriol results in increased expression of NRARP mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 3:28,390,745...28,393,299
Ensembl chr 3:28,390,733...28,393,453
|
|
| G
|
Nrf1
|
nuclear respiratory factor 1
|
increases expression
|
EXP
|
Calcitriol results in increased expression of NRF1 protein
|
CTD |
PMID:30194976 |
|
NCBI chr 4:59,632,366...59,738,166
Ensembl chr 4:59,632,372...59,738,353
|
|
| G
|
Nrg2
|
neuregulin 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of NRG2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr18:27,890,578...28,072,538
Ensembl chr18:27,890,578...28,072,538
|
|
| G
|
Nrip1
|
nuclear receptor interacting protein 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of NRIP1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr11:28,382,835...28,466,483
Ensembl chr11:28,378,878...28,467,353
|
|
| G
|
Nrm
|
nurim
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NRM mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NRM mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:2,893,126...2,897,725
Ensembl chr20:2,882,369...2,896,605
|
|
| G
|
Nrp1
|
neuropilin 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of NRP1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr19:73,256,557...73,411,705
Ensembl chr19:73,256,557...73,411,702
|
|
| G
|
Nrp2
|
neuropilin 2
|
decreases expression increases expression
|
ISO
|
Calcitriol results in decreased expression of NRP2 mRNA Calcitriol results in increased expression of NRP2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 9:71,616,602...71,731,869
Ensembl chr 9:71,616,657...71,731,871
|
|
| G
|
Nsd2
|
nuclear receptor binding SET domain protein 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NSD2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NSD2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:81,057,727...81,135,866
Ensembl chr14:81,057,727...81,123,027
|
|
| G
|
Nsun6
|
NOP2/Sun RNA methyltransferase 6
|
increases expression
|
ISO
|
Calcitriol results in increased expression of NSUN6 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr17:82,820,938...82,864,140
Ensembl chr17:82,820,941...82,858,539
|
|
| G
|
Ntng2
|
netrin G2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of NTNG2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of NTNG2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:32,889,856...32,949,032
Ensembl chr 3:32,890,575...32,943,821
|
|
| G
|
Ntrk3
|
neurotrophic receptor tyrosine kinase 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of NTRK3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:141,526,192...141,913,575
Ensembl chr 1:141,542,569...141,913,004
|
|
| G
|
Nucb2
|
nucleobindin 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of NUCB2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of NUCB2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:180,185,121...180,221,644
Ensembl chr 1:180,199,551...180,230,116
|
|
| G
|
Nudt1
|
nudix hydrolase 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NUDT1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NUDT1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr12:19,416,411...19,423,448
Ensembl chr12:19,416,411...19,424,158
|
|
| G
|
Nudt11
|
nudix hydrolase 11
|
increases expression
|
ISO
|
Calcitriol results in increased expression of NUDT11 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr X:18,998,587...19,005,208
Ensembl chr X:18,998,461...19,005,208
|
|
| G
|
Nudt18
|
nudix hydrolase 18
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of NUDT18 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of NUDT18 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:52,060,297...52,062,822
Ensembl chr15:52,060,293...52,063,661
|
|
| G
|
Nudt7
|
nudix hydrolase 7
|
increases expression
|
ISO
|
Calcitriol results in increased expression of NUDT7 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr19:59,034,808...59,049,148
Ensembl chr19:59,034,839...59,063,994
|
|
| G
|
Nuf2
|
NUF2 component of NDC80 kinetochore complex
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of NUF2 mRNA Calcitriol results in decreased expression of NUF2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:84,226,448...84,290,957
Ensembl chr13:84,226,509...84,255,598
|
|
| G
|
Numa1
|
nuclear mitotic apparatus protein 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of NUMA1 mRNA
|
CTD |
PMID:12798352 |
|
NCBI chr 1:165,709,893...165,784,848
Ensembl chr 1:165,709,905...165,784,848
|
|
| G
|
Nup107
|
nucleoporin 107
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NUP107 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NUP107 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:55,239,610...55,285,050
Ensembl chr 7:55,239,613...55,285,234
|
|
| G
|
Nup133
|
nucleoporin 133
|
increases expression
|
ISO
|
Calcitriol results in increased expression of NUP133 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr19:68,789,065...68,838,692
Ensembl chr19:68,789,065...68,838,692
|
|
| G
|
Nup153
|
nucleoporin 153
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of NUP153 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr17:18,178,434...18,231,109
Ensembl chr17:18,178,456...18,231,109
|
|
| G
|
Nup155
|
nucleoporin 155
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NUP155 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NUP155 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:58,927,171...58,980,162
Ensembl chr 2:58,928,537...58,981,242
|
|
| G
|
Nup35
|
nucleoporin 35
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NUP35 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NUP35 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:85,965,907...85,991,659
Ensembl chr 3:85,945,080...85,992,027
|
|
| G
|
Nup37
|
nucleoporin 37
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NUP37 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NUP37 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:24,443,998...24,497,088
Ensembl chr 7:24,463,301...24,508,741
|
|
| G
|
Nup54
|
nucleoporin 54
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NUP54 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NUP54 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:15,901,936...15,920,335
Ensembl chr14:15,901,991...15,920,334
|
|
| G
|
Nup62cl
|
nucleoporin 62 C-terminal like
|
increases expression multiple interactions decreases expression
|
ISO
|
Calcitriol results in increased expression of NUP62CL mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NUP62CL mRNA Calcitriol results in decreased expression of NUP62CL mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr X:108,457,043...108,513,525
Ensembl chr X:108,457,043...108,512,664
|
|
| G
|
Nusap1
|
nucleolar and spindle associated protein 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of NUSAP1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of NUSAP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:127,057,220...127,092,779
Ensembl chr 3:127,057,265...127,087,237
|
|
| G
|
Nxf7
|
nuclear RNA export factor 7
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of NXF5 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of NXF5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:102,828,592...102,845,799
Ensembl chr X:102,828,592...102,845,696
|
|
| G
|
Oas1a
|
2'-5' oligoadenylate synthetase 1A
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of OAS1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of OAS1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr12:41,330,423...41,341,130
Ensembl chr12:41,285,211...41,341,128
|
|
| G
|
Oas3
|
2'-5'-oligoadenylate synthetase 3
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of OAS3 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of OAS3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr12:41,439,645...41,463,392
Ensembl chr12:41,439,643...41,464,420
|
|
| G
|
Oasl
|
2'-5'-oligoadenylate synthetase-like
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of OASL mRNA
|
CTD |
PMID:12040012 PMID:16002434 |
|
NCBI chr12:47,343,551...47,356,509
Ensembl chr12:47,343,551...47,356,483
|
|
| G
|
Obscn
|
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF
|
increases expression
|
ISO
|
Calcitriol results in increased expression of OBSCN mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:44,273,686...44,419,275
Ensembl chr10:44,288,866...44,419,297
|
|
| G
|
Ocel1
|
occludin/ELL domain containing 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of OCEL1 mRNA Calcitriol results in increased expression of OCEL1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:18,076,428...18,079,068
Ensembl chr16:18,077,266...18,079,374
|
|
| G
|
Ocln
|
occludin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of OCLN mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:33,391,303...33,430,411
|
|
| G
|
Odam
|
odontogenic, ameloblast associated
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ODAM mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of ODAM mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:20,472,530...20,496,752
Ensembl chr14:20,472,546...20,481,760
|
|
| G
|
Odc1
|
ornithine decarboxylase 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ODC1 protein
|
CTD |
PMID:9224728 |
|
NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:46,058,463...46,065,146
|
|
| G
|
Oip5
|
Opa interacting protein 5
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of OIP5 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of OIP5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:127,047,559...127,057,043
Ensembl chr 3:127,047,559...127,057,043
|
|
| G
|
Olah
|
oleoyl-ACP hydrolase
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of OLAH mRNA Calcitriol results in increased expression of OLAH mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:79,786,441...79,811,692
Ensembl chr17:79,786,832...79,811,688
|
|
| G
|
Olfml1
|
olfactomedin-like 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of OLFML1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:170,889,912...170,914,300
Ensembl chr 1:170,889,980...170,915,762
|
|
| G
|
Olfml2b
|
olfactomedin-like 2B
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of OLFML2B mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:85,402,151...85,439,342
Ensembl chr13:85,402,169...85,439,342
|
|
| G
|
Olfml3
|
olfactomedin-like 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of OLFML3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:193,932,665...193,935,494
Ensembl chr 2:193,932,665...193,935,494
|
|
| G
|
Olr1
|
oxidized low density lipoprotein receptor 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of OLR1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:164,612,460...164,635,082
Ensembl chr 4:164,612,463...164,634,598
|
|
| G
|
Omg
|
oligodendrocyte-myelin glycoprotein
|
increases expression
|
ISO
|
Calcitriol results in increased expression of OMG mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr10:64,959,316...64,962,050
Ensembl chr10:64,936,145...64,962,050
|
|
| G
|
Ophn1
|
oligophrenin 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of OPHN1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of OPHN1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:67,639,956...68,018,217
Ensembl chr X:67,643,252...68,016,831
|
|
| G
|
Optn
|
optineurin
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of OPTN mRNA [Testosterone co-treated with Calcitriol] results in increased expression of OPTN mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:78,118,847...78,169,543
Ensembl chr17:78,118,866...78,169,543
|
|
| G
|
Orc1
|
origin recognition complex, subunit 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ORC1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of ORC1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:128,552,975...128,581,943
Ensembl chr 5:128,552,991...128,577,071
|
|
| G
|
Orc4
|
origin recognition complex, subunit 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ORC4 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:53,700,046...53,743,293
Ensembl chr 3:53,703,615...53,742,264
|
|
| G
|
Orc6
|
origin recognition complex, subunit 6
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ORC6 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of ORC6 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:37,931,085...37,938,856
Ensembl chr19:37,931,090...37,938,856
|
|
| G
|
Orm1
|
orosomucoid 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of ORM1 mRNA Calcitriol results in increased expression of ORM1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:81,788,509...81,791,661
Ensembl chr 5:81,788,395...81,791,667
|
|
| G
|
Osbpl1a
|
oxysterol binding protein-like 1A
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of OSBPL1A mRNA [Testosterone co-treated with Calcitriol] results in increased expression of OSBPL1A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:4,178,734...4,383,511
Ensembl chr18:4,179,631...4,369,421
|
|
| G
|
Osbpl7
|
oxysterol binding protein-like 7
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of OSBPL7 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of OSBPL7 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:82,532,335...82,549,999
Ensembl chr10:82,532,411...82,549,999
|
|
| G
|
Osgin1
|
oxidative stress induced growth inhibitor 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of OSGIN1 mRNA Calcitriol results in increased expression of OSGIN1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:64,380,336...64,409,165
Ensembl chr19:64,401,173...64,409,162
|
|
| G
|
Osr2
|
odd-skipped related transcription factor 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of OSR2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of OSR2 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 7:68,372,500...68,380,195
Ensembl chr 7:68,373,049...68,380,805
|
|
| G
|
Otud7b
|
OTU deubiquitinase 7B
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of OTUD7B mRNA [Testosterone co-treated with Calcitriol] results in increased expression of OTUD7B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:186,350,811...186,411,461
Ensembl chr 2:186,350,798...186,409,440
|
|
| G
|
Otulin
|
OTU deubiquitinase with linear linkage specificity
|
increases expression
|
ISO
|
Calcitriol results in increased expression of OTULIN mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:80,021,381...80,046,898
Ensembl chr 2:80,021,381...80,046,843
|
|
| G
|
Otulinl
|
OTU deubiquitinase with linear linkage specificity like
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of OTULINL mRNA [Testosterone co-treated with Calcitriol] results in increased expression of OTULINL mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:80,136,411...80,164,290
Ensembl chr 2:80,139,262...80,166,962
|
|
| G
|
Oxtr
|
oxytocin receptor
|
increases expression decreases expression
|
ISO
|
Calcitriol results in increased expression of OXTR mRNA Calcitriol results in decreased expression of OXTR mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 4:147,154,374...147,171,723
Ensembl chr 4:147,154,374...147,170,750
|
|
| G
|
P2ry10
|
P2Y receptor family member 10
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of P2RY10 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr X:76,184,064...76,279,996
Ensembl chr X:76,184,001...76,280,953
|
|
| G
|
P2ry2
|
purinergic receptor P2Y2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of P2RY2 mRNA
|
CTD |
PMID:12875902 PMID:16002434 |
|
NCBI chr 1:164,764,119...164,779,578
Ensembl chr 1:164,759,213...164,781,852
|
|
| G
|
P4ha3
|
prolyl 4-hydroxylase subunit alpha 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of P4HA3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:164,040,852...164,075,922
Ensembl chr 1:164,040,864...164,076,435
|
|
| G
|
P4hb
|
prolyl 4-hydroxylase subunit beta
|
multiple interactions
|
EXP
|
[Calcium co-treated with Calcitriol] affects the expression of P4HB mRNA
|
CTD |
PMID:15913539 |
|
NCBI chr10:106,335,300...106,346,911
Ensembl chr10:106,335,300...106,346,911
|
|
| G
|
Pacs1
|
phosphofurin acidic cluster sorting protein 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PACS1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PACS1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:211,866,872...211,998,828
Ensembl chr 1:211,866,874...211,998,828
|
|
| G
|
Pacsin1
|
protein kinase C and casein kinase substrate in neurons 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PACSIN1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PACSIN1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:5,719,929...5,769,492
Ensembl chr20:5,721,311...5,767,109
|
|
| G
|
Padi3
|
peptidyl arginine deiminase 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PADI3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:158,372,764...158,400,193
Ensembl chr 5:158,372,764...158,400,193
|
|
| G
|
Paep
|
progestagen associated endometrial protein
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PAEP mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PAEP mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:28,929,252...28,932,592
|
|
| G
|
Pak1ip1
|
PAK1 interacting protein 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PAK1IP1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PAK1IP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:23,947,978...23,959,055
Ensembl chr17:23,939,509...23,959,055
|
|
| G
|
Pak6
|
p21 (RAC1) activated kinase 6
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PAK6 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:126,092,576...126,128,320
Ensembl chr 3:126,093,013...126,128,318
|
|
| G
|
Palld
|
palladin, cytoskeletal associated protein
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PALLD mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr16:33,238,943...33,632,236
Ensembl chr16:33,238,956...33,632,232
|
|
| G
|
Pamr1
|
peptidase domain containing associated with muscle regeneration 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PAMR1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:109,340,411...109,443,595
Ensembl chr 3:109,341,476...109,443,585
|
|
| G
|
Pappa
|
pappalysin 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PAPPA mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:83,513,358...83,751,364
Ensembl chr 5:83,513,358...83,751,361
|
|
| G
|
Paqr5
|
progestin and adipoQ receptor family member 5
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PAQR5 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 8:71,327,397...71,409,201
Ensembl chr 8:71,327,397...71,409,201
|
|
| G
|
Parp2
|
poly (ADP-ribose) polymerase 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PARP2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PARP2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:26,494,722...26,517,893
Ensembl chr15:26,494,731...26,517,891
|
|
| G
|
Parp8
|
poly (ADP-ribose) polymerase family, member 8
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PARP8 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:50,408,404...50,581,513
Ensembl chr 2:50,408,404...50,581,233
|
|
| G
|
Parpbp
|
PARP1 binding protein
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PARPBP mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PARPBP mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:24,398,897...24,468,330
Ensembl chr 7:24,398,897...24,464,744
|
|
| G
|
Parvg
|
parvin, gamma
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PARVG mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:117,336,160...117,366,341
Ensembl chr 7:117,336,187...117,362,155
|
|
| G
|
Pask
|
PAS domain containing serine/threonine kinase
|
multiple interactions
|
EXP
|
[Calcium co-treated with Calcitriol] affects the expression of PASK mRNA
|
CTD |
PMID:15913539 |
|
NCBI chr 9:101,291,673...101,333,288
Ensembl chr 9:101,291,676...101,332,504
|
|
| G
|
Patj
|
PATJ, crumbs cell polarity complex component
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PATJ mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:118,177,557...118,480,301
Ensembl chr 5:118,177,565...118,480,301
|
|
| G
|
Pax1
|
paired box 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PAX1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PAX1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:155,244,961...155,254,836
Ensembl chr 3:155,245,529...155,254,836
|
|
| G
|
Pax9
|
paired box 9
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PAX9 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:79,917,466...79,938,551
Ensembl chr 6:79,921,801...79,938,549
|
|
| G
|
Pbk
|
PDZ binding kinase
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of PBK mRNA Calcitriol results in decreased expression of PBK mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:44,198,506...44,209,572
Ensembl chr15:44,198,544...44,209,570
|
|
| G
|
Pbx1
|
PBX homeobox 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PBX1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:82,811,664...83,121,447
Ensembl chr13:82,812,131...83,121,066
|
|
| G
|
Pcdh1
|
protocadherin 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of PCDH1 mRNA Calcitriol results in increased expression of PCDH1 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr18:30,258,154...30,290,828
Ensembl chr18:30,258,154...30,290,436
|
|
| G
|
Pcdh7
|
protocadherin 7
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PCDH7 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr14:56,684,817...57,114,976
Ensembl chr14:56,687,725...57,112,665
|
|
| G
|
Pcdhga5
|
protocadherin gamma subfamily A, 5
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PCDHGA5 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PCDHGA5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:29,770,940...29,919,095
|
|
| G
|
Pclaf
|
PCNA clamp associated factor
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PCLAF mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PCLAF mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:75,311,028...75,328,108
Ensembl chr 8:75,315,707...75,328,106
|
|
| G
|
Pcna
|
proliferating cell nuclear antigen
|
decreases expression increases expression multiple interactions
|
ISO EXP
|
Calcitriol results in decreased expression of PCNA mRNA; Calcitriol results in decreased expression of PCNA protein Calcitriol results in increased expression of PCNA protein [Testosterone co-treated with Calcitriol] results in decreased expression of PCNA mRNA
|
CTD |
PMID:15728789 PMID:15951637 PMID:19092814 PMID:19603526 PMID:21542014 PMID:21592394 More...
|
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
| G
|
Pcsk6
|
proprotein convertase subtilisin/kexin type 6
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of PCSK6 mRNA Calcitriol results in decreased expression of PCSK6 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:128,839,742...129,038,087
Ensembl chr 1:128,839,232...129,052,128
|
|
| G
|
Pctp
|
phosphatidylcholine transfer protein
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PCTP mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PCTP mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:75,305,999...75,351,919
Ensembl chr10:75,305,999...75,326,432
|
|
| G
|
Pdcd5
|
programmed cell death 5
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PDCD5 mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr 1:97,442,755...97,448,084
Ensembl chr 1:97,442,755...97,449,844
|
|
| G
|
Pdcd6ip
|
programmed cell death 6 interacting protein
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PDCD6IP mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:122,469,223...122,524,993
Ensembl chr 8:122,469,223...122,524,993
|
|
| G
|
Pde2a
|
phosphodiesterase 2A
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PDE2A mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:165,235,623...165,327,466
Ensembl chr 1:165,235,623...165,327,466
|
|
| G
|
Pde3a
|
phosphodiesterase 3A
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PDE3A mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PDE3A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:175,904,276...176,170,531
Ensembl chr 4:175,904,077...176,169,270
|
|
| G
|
Pde4b
|
phosphodiesterase 4B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PDE4B mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 5:122,028,956...122,598,267
Ensembl chr 5:122,135,174...122,598,267
|
|
| G
|
Pdgfrl
|
platelet-derived growth factor receptor-like
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PDGFRL mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr16:58,051,421...58,111,327
Ensembl chr16:58,051,440...58,111,327
|
|
| G
|
Pdk3
|
pyruvate dehydrogenase kinase 3
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PDK3 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PDK3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:62,480,535...62,547,371
Ensembl chr X:62,480,535...62,547,371
|
|
| G
|
Pdlim2
|
PDZ and LIM domain 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of PDLIM2 mRNA Calcitriol results in increased expression of PDLIM2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:51,647,195...51,659,904
Ensembl chr15:51,647,197...51,658,958
|
|
| G
|
Pdp1
|
pyruvate dehydrogenase phosphatase catalytic subunit 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PDP1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:30,245,699...30,252,494
Ensembl chr 5:30,242,704...30,253,960
|
|
| G
|
Pdpn
|
podoplanin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PDPN mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:160,884,995...160,919,112
Ensembl chr 5:160,884,993...160,925,637
|
|
| G
|
Pds5b
|
PDS5 cohesin associated factor B
|
multiple interactions increases expression
|
ISO
|
bicalutamide inhibits the reaction [Calcitriol results in increased expression of APRIN]
|
CTD |
PMID:15754350 |
|
NCBI chr12:5,038,114...5,181,208
Ensembl chr12:5,038,160...5,181,208
|
|
| G
|
Pdss1
|
decaprenyl diphosphate synthase subunit 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PDSS1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PDSS1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:89,964,768...90,006,819
Ensembl chr17:89,968,034...90,006,817
|
|
| G
|
Pdzd2
|
PDZ domain containing 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PDZD2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:63,111,650...63,497,520
Ensembl chr 2:63,111,650...63,497,478
|
|
| G
|
Pdzk1ip1
|
PDZK1 interacting protein 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of PDZK1IP1 mRNA Calcitriol results in increased expression of PDZK1IP1 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 5:133,841,586...133,859,894
Ensembl chr 5:133,841,313...133,859,893
|
|
| G
|
Pdzrn3
|
PDZ domain containing RING finger 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PDZRN3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 4:135,327,082...135,553,294
Ensembl chr 4:135,327,082...135,553,294
|
|
| G
|
Pebp4
|
phosphatidylethanolamine binding protein 4
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of PEBP4 mRNA Calcitriol results in increased expression of PEBP4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:51,328,127...51,543,920
Ensembl chr15:51,331,690...51,543,899
|
|
| G
|
Per2
|
period circadian regulator 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PER2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:99,454,830...99,496,993
|
|
| G
|
Pex13
|
peroxisomal biogenesis factor 13
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of PEX13 mRNA Calcitriol results in increased expression of PEX13 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:101,804,673...101,822,367
Ensembl chr14:101,804,673...101,822,367
|
|
| G
|
Pex3
|
peroxisomal biogenesis factor 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PEX3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:9,732,641...9,774,479
Ensembl chr 1:9,732,492...9,774,576
|
|
| G
|
Pfas
|
phosphoribosylformylglycinamidine synthase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PFAS mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PFAS mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:54,189,157...54,210,685
Ensembl chr10:54,189,157...54,207,272
|
|
| G
|
Pfdn5
|
prefoldin subunit 5
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PFDN5 mRNA
|
CTD |
PMID:16847355 |
|
NCBI chr 7:135,330,364...135,335,102
Ensembl chr 7:135,330,172...135,335,099
|
|
| G
|
Pfkfb2
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PFKFB2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PFKFB2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:44,683,499...44,727,135
Ensembl chr13:44,699,744...44,726,971
|
|
| G
|
Pgbd5
|
piggyBac transposable element derived 5
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PGBD5 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr19:69,234,171...69,299,315
Ensembl chr19:69,234,171...69,299,560
|
|
| G
|
Pgc
|
progastricsin
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PGC mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PGC mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:20,755,002...20,763,220
Ensembl chr 9:20,755,002...20,763,220
|
|
| G
|
Pgm3
|
phosphoglucomutase 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PGM3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PGM3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:96,398,331...96,416,045
Ensembl chr 8:96,398,269...96,416,021
|
|
| G
|
Pgpep1
|
pyroglutamyl-peptidase I
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PGPEP1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PGPEP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:18,804,408...18,817,466
Ensembl chr16:18,805,009...18,817,462
|
|
| G
|
Phb1
|
prohibitin 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PHB1 mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr10:81,102,043...81,114,815
Ensembl chr10:81,102,028...81,116,233
|
|
| G
|
Phex
|
phosphate regulating endopeptidase X-linked
|
multiple interactions decreases expression
|
ISO EXP
|
PHEX protein inhibits the reaction [FGF23 protein results in decreased abundance of Calcitriol] Calcitriol results in decreased expression of PHEX mRNA
|
CTD |
PMID:16449303 PMID:17293108 |
|
NCBI chr X:41,422,561...41,671,226
Ensembl chr X:41,426,101...41,671,226
|
|
| G
|
Phf1
|
PHD finger protein 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PHF1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PHF1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:5,019,650...5,024,732
Ensembl chr20:5,019,673...5,024,731
|
|
| G
|
Phf19
|
PHD finger protein 19
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PHF19 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PHF19 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:38,572,766...38,604,950
Ensembl chr 3:38,572,766...38,593,854
|
|
| G
|
Phgr1
|
proline, histidine and glycine rich 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of PHGR1 mRNA Calcitriol results in increased expression of PHGR1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:126,211,495...126,214,749
Ensembl chr 3:126,211,495...126,214,746
|
|
| G
|
Phldb2
|
pleckstrin homology-like domain, family B, member 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PHLDB2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr11:68,321,738...68,540,724
Ensembl chr11:68,355,959...68,540,734
|
|
| G
|
Phtf2
|
putative homeodomain transcription factor 2
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of PHTF2 mRNA Calcitriol results in decreased expression of PHTF2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:15,107,341...15,222,683
Ensembl chr 4:15,107,373...15,222,692
|
|
| G
|
Phykpl
|
5-phosphohydroxy-L-lysine phospho-lyase
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PHYKPL mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PHYKPL mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:36,340,905...36,372,555
Ensembl chr10:36,340,945...36,363,721
|
|
| G
|
Pias1
|
protein inhibitor of activated STAT, 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PIAS1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PIAS1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:72,233,566...72,347,085
Ensembl chr 8:72,233,566...72,334,315
|
|
| G
|
Pidd1
|
p53-induced death domain protein 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of PIDD1 mRNA Calcitriol results in decreased expression of PIDD1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:205,966,392...205,972,359
Ensembl chr 1:205,966,392...205,971,600
|
|
| G
|
Pif1
|
PIF1 5'-to-3' DNA helicase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PIF1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PIF1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:75,005,820...75,015,331
Ensembl chr 8:75,006,815...75,015,331
|
|
| G
|
Pigw
|
phosphatidylinositol glycan anchor biosynthesis, class W
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PIGW mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PIGW mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:70,246,904...70,248,412
Ensembl chr10:70,243,810...70,250,329
|
|
| G
|
Pik3ca
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PIK3CA mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:117,103,643...117,177,411
Ensembl chr 2:117,143,468...117,177,411
|
|
| G
|
Pik3ip1
|
phosphoinositide-3-kinase interacting protein 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PIK3IP1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PIK3IP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:82,428,315...82,440,261
Ensembl chr14:82,428,248...82,440,260
|
|
| G
|
Pik3r3
|
phosphoinositide-3-kinase regulatory subunit 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PIK3R3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:134,936,790...135,009,303
Ensembl chr 5:134,934,857...135,007,762
|
|
| G
|
Pik3r5
|
phosphoinositide-3-kinase, regulatory subunit 5
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PIK3R5 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:53,631,469...53,699,550
Ensembl chr10:53,631,476...53,699,539
|
|
| G
|
Pimreg
|
PICALM interacting mitotic regulator
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PIMREG mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PIMREG mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:57,168,136...57,173,713
Ensembl chr10:57,167,797...57,173,063
|
|
| G
|
Pink1
|
PTEN induced kinase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PINK1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:155,813,838...155,825,950
Ensembl chr 5:155,813,838...155,825,950
|
|
| G
|
Pip4k2c
|
phosphatidylinositol-5-phosphate 4-kinase type 2 gamma
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PIP4K2C mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:64,905,322...64,920,380
Ensembl chr 7:64,905,328...64,920,373
|
|
| G
|
Pkib
|
cAMP-dependent protein kinase inhibitor beta
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PKIB mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr20:37,511,564...37,608,607
Ensembl chr20:37,512,822...37,608,401
|
|
| G
|
Pkmyt1
|
protein kinase, membrane associated tyrosine/threonine 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PKMYT1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PKMYT1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:13,252,805...13,263,584
Ensembl chr10:13,252,816...13,264,263
|
|
| G
|
Pknox2
|
PBX/knotted 1 homeobox 2
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of PKNOX2 mRNA Calcitriol results in decreased expression of PKNOX2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:44,789,464...45,051,933
Ensembl chr 8:44,789,467...44,979,754
|
|
| G
|
Pkp2
|
plakophilin 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of PKP2 mRNA Calcitriol results in increased expression of PKP2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr11:98,165,974...98,231,916
Ensembl chr11:98,165,974...98,231,916
|
|
| G
|
Pkp3
|
plakophilin 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PKP3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:205,617,511...205,628,441
Ensembl chr 1:205,617,511...205,628,440
|
|
| G
|
Pkp4
|
plakophilin 4
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of PKP4 mRNA Calcitriol results in decreased expression of PKP4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:64,040,995...64,244,586
Ensembl chr 3:64,141,771...64,244,586
|
|
| G
|
Pla2g10
|
phospholipase A2, group X
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PLA2G10 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:2,104,927...2,117,998
Ensembl chr10:2,104,927...2,116,172
|
|
| G
|
Pla2g7
|
phospholipase A2 group VII
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PLA2G7 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 9:24,859,491...24,901,747
Ensembl chr 9:24,859,502...24,901,747
|
|
| G
|
Plac1
|
placenta enriched 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PLAC1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PLAC1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:137,740,896...137,874,688
Ensembl chr X:137,740,890...137,905,210
|
|
| G
|
Plac9
|
placenta associated 9
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PLAC9 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr16:1,466,231...1,481,060
Ensembl chr16:1,466,231...1,481,434
|
|
| G
|
Plaur
|
plasminogen activator, urokinase receptor
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PLAUR mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PLAUR mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:89,178,453...89,198,130
|
|
| G
|
Plcb1
|
phospholipase C beta 1
|
increases activity increases response to substance
|
EXP
|
Calcitriol results in increased activity of PLCB1 protein PLCB1 protein results in increased susceptibility to Calcitriol
|
CTD |
PMID:12798493 |
|
NCBI chr 3:142,512,765...143,224,042
Ensembl chr 3:142,513,033...143,225,646
|
|
| G
|
Plcb3
|
phospholipase C beta 3
|
increases activity increases response to substance
|
EXP
|
Calcitriol results in increased activity of PLCB3 protein PLCB3 protein results in increased susceptibility to Calcitriol
|
CTD |
PMID:12798493 |
|
NCBI chr 1:213,572,499...213,589,585
Ensembl chr 1:213,574,166...213,589,583
|
|
| G
|
Plcb4
|
phospholipase C, beta 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PLCB4 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:143,405,721...143,775,129
Ensembl chr 3:143,405,950...143,775,113
|
|
| G
|
Plcd3
|
phospholipase C, delta 3
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of PLCD3 mRNA Calcitriol results in increased expression of PLCD3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:88,526,802...88,548,116
Ensembl chr10:88,526,802...88,548,069
|
|
| G
|
Plch1
|
phospholipase C, eta 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PLCH1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PLCH1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:150,298,547...150,514,120
Ensembl chr 2:150,299,075...150,464,019
|
|
| G
|
Plcxd2
|
phosphatidylinositol-specific phospholipase C, X domain containing 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PLCXD2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr11:68,263,626...68,315,962
Ensembl chr11:68,263,566...68,316,327
|
|
| G
|
Pld2
|
phospholipase D2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of PLD2 mRNA Calcitriol results in increased expression of PLD2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:55,754,957...55,772,819
Ensembl chr10:55,754,988...55,771,435
|
|
| G
|
Plekha2
|
pleckstrin homology domain containing A2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PLEKHA2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr16:73,641,338...73,704,068
Ensembl chr16:73,641,344...73,703,087
|
|
| G
|
Plekha6
|
pleckstrin homology domain containing A6
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of PLEKHA6 mRNA Calcitriol results in increased expression of PLEKHA6 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr13:47,166,899...47,307,003
Ensembl chr13:47,167,160...47,307,003
|
|
| G
|
Plekha7
|
pleckstrin homology domain containing A7
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PLEKHA7 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:179,798,856...179,982,155
Ensembl chr 1:179,799,040...179,982,281
|
|
| G
|
Plekhb2
|
pleckstrin homology domain containing B2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PLEKHB2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PLEKHB2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:44,545,473...44,578,122
Ensembl chr 9:44,534,539...44,578,119
|
|
| G
|
Plekhg6
|
pleckstrin homology and RhoGEF domain containing G6
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of PLEKHG6 mRNA Calcitriol results in increased expression of PLEKHG6 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 4:159,849,987...159,885,730
Ensembl chr 4:159,849,364...159,868,122
|
|
| G
|
Plekho2
|
pleckstrin homology domain containing O2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PLEKHO2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:74,973,578...75,000,532
Ensembl chr 8:74,974,740...75,000,430
|
|
| G
|
Plk1
|
polo-like kinase 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of PLK1 mRNA Calcitriol results in decreased expression of PLK1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:186,147,658...186,157,637
Ensembl chr 1:186,147,658...186,157,637
|
|
| G
|
Plk4
|
polo-like kinase 4
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PLK4 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PLK4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:125,730,480...125,748,894
Ensembl chr 2:125,730,460...125,748,892
|
|
| G
|
Pllp
|
plasmolipin
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of PLLP mRNA Calcitriol results in increased expression of PLLP mRNA
|
CTD |
PMID:16002434 PMID:21592394 PMID:26485663 |
|
NCBI chr19:10,321,080...10,341,869
Ensembl chr19:10,321,080...10,342,226
|
|
| G
|
Plpp2
|
phospholipid phosphatase 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PLPP2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:10,826,534...10,834,628
Ensembl chr 7:10,826,549...10,834,627
|
|
| G
|
Plpp4
|
phospholipid phosphatase 4
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PLPP4 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:193,260,181...193,389,659
Ensembl chr 1:193,260,434...193,389,675
|
|
| G
|
Pltp
|
phospholipid transfer protein
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PLTP mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:173,994,162...174,011,982
Ensembl chr 3:173,994,162...174,012,505
|
|
| G
|
Plxdc2
|
plexin domain containing 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PLXDC2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr17:84,077,793...84,502,831
Ensembl chr17:84,104,864...84,497,999
|
|
| G
|
Plxna2
|
plexin A2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PLXNA2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:108,683,155...108,888,336
Ensembl chr13:108,691,530...108,887,453
|
|
| G
|
Plxna3
|
plexin A3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PLXNA3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PLXNA3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:157,266,986...157,282,896
Ensembl chr X:157,267,107...157,282,891
|
|
| G
|
Plxnb3
|
plexin B3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PLXNB3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr X:156,645,505...156,660,011
Ensembl chr X:156,645,182...156,660,003
|
|
| G
|
Plxnc1
|
plexin C1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PLXNC1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:31,276,978...31,430,823
Ensembl chr 7:31,276,978...31,431,092
|
|
| G
|
Pmaip1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
decreases expression increases expression
|
ISO
|
Calcitriol results in decreased expression of PMAIP1 mRNA Calcitriol results in increased expression of PMAIP1 mRNA
|
CTD |
PMID:12875902 PMID:16002434 |
|
NCBI chr18:62,255,970...62,262,384
Ensembl chr18:62,255,598...62,262,382
|
|
| G
|
Pmch
|
pro-melanin-concentrating hormone
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PMCH mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PMCH mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:24,399,404...24,400,720
Ensembl chr 7:24,399,404...24,400,720
|
|
| G
|
Pmepa1
|
prostate transmembrane protein, androgen induced 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PMEPA1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:182,430,193...182,478,649
Ensembl chr 3:182,430,193...182,478,649
|
|
| G
|
Pnkd
|
PNKD metallo-beta-lactamase domain containing
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PNKD mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 9:83,317,757...83,386,263
Ensembl chr 9:83,317,738...83,386,262
|
|
| G
|
Pnlip
|
pancreatic lipase
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PNLIP mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PNLIP mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:267,760,073...267,797,797
Ensembl chr 1:267,784,724...267,797,795
|
|
| G
|
Poc1a
|
POC1 centriolar protein A
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of POC1A mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of POC1A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:115,801,335...115,869,812
Ensembl chr 8:115,801,396...115,870,392
|
|
| G
|
Podn
|
podocan
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PODN mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:128,003,907...128,025,518
Ensembl chr 5:128,008,125...128,110,043
|
|
| G
|
Podxl
|
podocalyxin-like
|
decreases expression multiple interactions increases expression
|
ISO
|
Calcitriol results in decreased expression of PODXL mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PODXL mRNA Calcitriol results in increased expression of PODXL mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 4:61,102,434...61,149,131
Ensembl chr 4:61,102,419...61,149,789
|
|
| G
|
Pofut1
|
protein O-fucosyltransferase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of POFUT1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:162,168,855...162,195,798
Ensembl chr 3:162,168,606...162,195,018
|
|
| G
|
Pola2
|
DNA polymerase alpha 2, accessory subunit
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of POLA2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of POLA2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:212,656,500...212,680,667
Ensembl chr 1:212,656,501...212,680,542
|
|
| G
|
Pold1
|
DNA polymerase delta 1, catalytic subunit
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of POLD1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of POLD1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:104,161,984...104,178,074
Ensembl chr 1:104,162,016...104,172,982
|
|
| G
|
Pole2
|
DNA polymerase epsilon 2, accessory subunit
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of POLE2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of POLE2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:93,410,713...93,448,782
Ensembl chr 6:93,410,758...93,435,361
|
|
| G
|
Polq
|
DNA polymerase theta
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of POLQ mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of POLQ mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr11:77,179,190...77,281,270
Ensembl chr11:77,179,209...77,281,268
|
|
| G
|
Polr3g
|
RNA polymerase III subunit G
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of POLR3G mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of POLR3G mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:13,680,893...13,721,802
Ensembl chr 2:13,680,895...13,721,802
|
|
| G
|
Potec
|
POTE ankyrin domain family, member C
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of POTEC mRNA Calcitriol results in increased expression of POTEC mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:90,247,802...90,356,331
Ensembl chr17:90,195,584...90,356,331
|
|
| G
|
Poteg
|
POTE ankyrin domain family, member G
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of POTEG mRNA Calcitriol results in increased expression of POTEG mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:71,191,509...71,373,328
Ensembl chr16:71,334,466...71,373,280
|
|
| G
|
Poteh
|
POTE ankyrin domain family member H
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of POTEH mRNA [Testosterone co-treated with Calcitriol] results in increased expression of POTEH mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:19,559,450...19,654,345
|
|
| G
|
Potem
|
POTE ankyrin domain family member M
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of POTEM mRNA Calcitriol results in increased expression of POTEM mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:20,985,842...21,010,108
|
|
| G
|
Pou2af1
|
POU class 2 homeobox associating factor 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of POU2AF1 mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr 8:60,418,173...60,445,176
Ensembl chr 8:60,436,844...60,445,176
|
|
| G
|
Pou2af3
|
POU class 2 homeobox associating factor 3
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of POU2AF3 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of POU2AF3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:60,484,596...60,493,475
Ensembl chr 8:60,484,596...60,493,821
|
|
| G
|
Pou3f1
|
POU class 3 homeobox 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of POU3F1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:142,195,090...142,198,070
Ensembl chr 5:142,194,066...142,202,704
|
|
| G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
multiple interactions increases expression
|
ISO
|
[Calcitriol co-treated with GW 501516] results in increased expression of PPARA mRNA; [Testosterone co-treated with Calcitriol] results in increased expression of PPARA mRNA; Calcitriol promotes the reaction [alpha-Linolenic Acid results in increased expression of PPARA mRNA]; Calcitriol promotes the reaction [Bezafibrate results in increased expression of PPARA mRNA]; Calcitriol promotes the reaction [Docosahexaenoic Acids results in increased expression of PPARA mRNA]; Calcitriol promotes the reaction [pirinixic acid results in increased expression of PPARA mRNA] Calcitriol results in increased expression of PPARA mRNA
|
CTD |
PMID:19667161 PMID:21592394 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
|
|
| G
|
Ppard
|
peroxisome proliferator-activated receptor delta
|
multiple interactions increases expression
|
ISO
|
[Calcitriol co-treated with GW 501516] results in increased expression of PPARD mRNA; [Calcitriol co-treated with pirinixic acid] results in increased expression of PPARD mRNA; Calcitriol promotes the reaction [Bezafibrate results in increased expression of PPARD mRNA]; Calcitriol promotes the reaction [Docosahexaenoic Acids results in increased expression of PPARD mRNA] Calcitriol results in increased expression of [alpha-Linolenic Acid results in increased expression of PPARD mRNA]; Calcitriol results in increased expression of PPARD mRNA
|
CTD |
PMID:15890193 PMID:19667161 |
|
NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,352,183...6,365,707
|
|
| G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
decreases expression multiple interactions
|
ISO EXP
|
Calcitriol results in decreased expression of PPARG mRNA; Calcitriol results in decreased expression of PPARG protein bisphenol A diglycidyl ether inhibits the reaction [Calcitriol inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]]; bisphenol A diglycidyl ether inhibits the reaction [Calcitriol inhibits the reaction [Streptozocin results in decreased expression of PPARG protein]]; Calcitriol inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]; Calcitriol inhibits the reaction [Streptozocin results in decreased expression of PPARG protein]
|
CTD |
PMID:15036392 PMID:16368784 PMID:16813520 PMID:29953732 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
| G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
multiple interactions increases expression
|
ISO EXP
|
[Calcitriol binds to and results in increased activity of VDR protein] promotes the reaction [VDR protein binds to PPARGC1A protein]; [Calcitriol binds to and results in increased activity of VDR protein] results in decreased activity of [HNF4A protein co-treated with PPARGC1A protein]; [Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] inhibits the reaction [PPARGC1A protein results in increased expression of CYP7A1 mRNA]; Calcitriol inhibits the reaction [bisphenol A results in decreased expression of PPARGC1A protein]; Calcitriol inhibits the reaction [PPARGC1A protein binds to CYP7A1 mRNA]; Calcitriol inhibits the reaction [PPARGC1A protein binds to CYP7A1 promoter]; Calcitriol promotes the reaction [VDR protein binds to PPARGC1A protein]; NCOR1 protein promotes the reaction [[Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] inhibits the reaction [PPARGC1A protein results in increased expression of CYP7A1 mRNA]]; NCOR2 protein promotes the reaction [[Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] inhibits the reaction [PPARGC1A protein results in increased expression of CYP7A1 mRNA]]; PPARGC1A protein promotes the reaction [[Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] which results in increased expression of CYP24A1 mRNA]; PPARGC1A protein promotes the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]; U 0126 inhibits the reaction [Calcitriol inhibits the reaction [PPARGC1A protein binds to CYP7A1 mRNA]] Calcitriol results in increased expression of PPARGC1A protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol results in increased expression of PPARGC1A protein]
|
CTD |
PMID:19106115 PMID:20371703 PMID:30194976 PMID:38421590 |
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
|
|
| G
|
Ppfibp1
|
PPFIA binding protein 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PPFIBP1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:181,538,249...181,682,079
Ensembl chr 4:181,539,450...181,682,076
|
|
| G
|
Ppfibp2
|
PPFIA binding protein 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of PPFIBP2 mRNA Calcitriol results in increased expression of PPFIBP2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:170,916,649...171,062,096
Ensembl chr 1:170,916,649...171,065,618
|
|
| G
|
Ppic
|
peptidylprolyl isomerase C
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of PPIC mRNA Calcitriol results in increased expression of PPIC mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:49,040,690...49,053,296
Ensembl chr18:49,040,692...49,053,466
|
|
| G
|
Ppih
|
peptidylprolyl isomerase H
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PPIH mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PPIH mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:138,191,624...138,209,625
Ensembl chr 5:138,191,624...138,209,580
|
|
| G
|
Ppip5k1
|
diphosphoinositol pentakisphosphate kinase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PPIP5K1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:128,737,857...128,781,408
Ensembl chr 3:128,737,857...128,781,408
|
|
| G
|
Ppl
|
periplakin
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of PPL mRNA Calcitriol results in increased expression of PPL mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr10:10,957,388...11,003,035
Ensembl chr10:10,957,341...11,003,658
|
|
| G
|
Ppm1h
|
protein phosphatase, Mg2+/Mn2+ dependent, 1H
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PPM1H mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:60,224,087...60,484,947
Ensembl chr 7:60,223,745...60,488,140
|
|
| G
|
Ppm1m
|
protein phosphatase, Mg2+/Mn2+ dependent, 1M
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PPM1M mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 8:115,715,763...115,720,664
Ensembl chr 8:115,715,135...115,723,789
|
|
| G
|
Ppp1cb
|
protein phosphatase 1 catalytic subunit beta
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of PPP1CB mRNA Calcitriol results in increased expression of PPP1CB mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:29,681,099...29,712,835
Ensembl chr 6:29,681,100...29,712,924
|
|
| G
|
Ppp1r14c
|
protein phosphatase 1, regulatory (inhibitor) subunit 14c
|
decreases expression increases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PPP1R14C mRNA Calcitriol results in increased expression of PPP1R14C mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PPP1R14C mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 1:42,177,977...42,358,654
Ensembl chr 1:42,179,523...42,376,419
|
|
| G
|
Ppp1r1c
|
protein phosphatase 1, regulatory (inhibitor) subunit 1C
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PPP1R1C mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:85,023,621...85,126,609
Ensembl chr 3:85,023,621...85,131,413
|
|
| G
|
Ppp1r3b
|
protein phosphatase 1, regulatory subunit 3B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PPP1R3B mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr16:63,533,318...63,545,683
Ensembl chr16:63,532,842...63,549,997
|
|
| G
|
Ppp2r3a
|
protein phosphatase 2, regulatory subunit B'', alpha
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PPP2R3A mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:110,582,479...110,720,516
Ensembl chr 8:110,583,743...110,677,482
|
|
| G
|
Ppp2r3b
|
protein phosphatase 2, regulatory subunit B'', beta
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PPP2R3B mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PPP2R3B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:103,496...110,739
Ensembl chr14:103,374...110,739
|
|
| G
|
Ppp2r5a
|
protein phosphatase 2, regulatory subunit B', alpha
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PPP2R5A mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:105,462,371...105,506,767
Ensembl chr13:105,462,371...105,506,767
|
|
| G
|
Ppp2r5b
|
protein phosphatase 2, regulatory subunit B', beta
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PPP2R5B mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PPP2R5B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:212,956,533...212,964,706
Ensembl chr 1:212,956,533...212,964,662
|
|
| G
|
Ppp3ca
|
protein phosphatase 3 catalytic subunit alpha
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PPP3CA mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:227,839,058...228,113,560
Ensembl chr 2:227,839,062...228,113,554
|
|
| G
|
Ppp3cb
|
protein phosphatase 3 catalytic subunit beta
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PPP3CB mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr15:3,809,182...3,854,204
Ensembl chr15:3,809,262...3,854,203
|
|
| G
|
Prc1
|
protein regulator of cytokinesis 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PRC1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PRC1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:143,659,312...143,681,019
Ensembl chr 1:143,659,481...143,681,012
|
|
| G
|
Prdx1
|
peroxiredoxin 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PRDX1 mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr 5:135,383,906...135,399,504
Ensembl chr 5:135,383,906...135,399,504
|
|
| G
|
Prdx6
|
peroxiredoxin 6
|
multiple interactions
|
EXP
|
[Calcium co-treated with Calcitriol] affects the expression of PRDX6 mRNA
|
CTD |
PMID:15913539 |
|
NCBI chr13:76,062,082...76,072,631
Ensembl chr13:76,061,554...76,072,657
|
|
| G
|
Prelp
|
proline and arginine rich end leucine rich repeat protein
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PRELP mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:47,920,480...47,943,547
Ensembl chr13:47,922,590...47,932,324
|
|
| G
|
Prickle2
|
prickle planar cell polarity protein 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PRICKLE2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:126,426,767...126,771,986
Ensembl chr 4:126,426,771...126,772,008
|
|
| G
|
Prim1
|
DNA primase subunit 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PRIM1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PRIM1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:1,031,436...1,047,134
|
|
| G
|
Prima1
|
proline rich membrane anchor 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PRIMA1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PRIMA1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:128,094,686...128,155,592
Ensembl chr 6:128,103,175...128,154,865
|
|
| G
|
Primpol
|
primase and DNA directed polymerase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PRIMPOL mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PRIMPOL mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:52,413,894...52,450,975
Ensembl chr16:52,413,935...52,450,950
|
|
| G
|
Prkaa1
|
protein kinase AMP-activated catalytic subunit alpha 1
|
multiple interactions
|
ISO
|
PRKAA1 mutant form inhibits the reaction [Calcitriol affects the localization of CAMP protein]
|
CTD |
PMID:19748465 |
|
NCBI chr 2:55,967,766...56,003,450
Ensembl chr 2:55,967,351...56,003,450
|
|
| G
|
Prkd1
|
protein kinase D1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of PRKD1 mRNA Calcitriol results in decreased expression of PRKD1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:73,460,640...73,774,433
Ensembl chr 6:73,460,640...73,836,509
|
|
| G
|
Prlr
|
prolactin receptor
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PRLR mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:60,861,391...61,051,883
Ensembl chr 2:60,861,658...61,051,882
|
|
| G
|
Prmt2
|
protein arginine methyltransferase 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PRMT2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr20:12,391,388...12,420,096
Ensembl chr20:12,394,268...12,420,108
|
|
| G
|
Prnp
|
prion protein
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PRNP mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:139,639,076...139,654,420
Ensembl chr 3:139,630,144...139,658,436
|
|
| G
|
Prodh1
|
proline dehydrogenase 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of PRODH mRNA Calcitriol results in increased expression of PRODH mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr11:96,414,275...96,431,604
Ensembl chr11:96,414,224...96,433,418
|
|
| G
|
Prom2
|
prominin 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PROM2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:135,200,944...135,215,130
Ensembl chr 3:135,200,944...135,215,077
|
|
| G
|
Proser2
|
proline and serine rich 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PROSER2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PROSER2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:77,061,371...77,096,788
Ensembl chr17:77,077,727...77,095,194
|
|
| G
|
Prpf38a
|
pre-mRNA processing factor 38A
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PRPF38A mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PRPF38A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:128,541,166...128,552,865
Ensembl chr 5:128,541,166...128,552,865
|
|
| G
|
Prr11
|
proline rich 11
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PRR11 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PRR11 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:72,396,127...72,440,643
Ensembl chr10:72,398,667...72,418,275
|
|
| G
|
Prr16
|
proline rich 16
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of PRR16 mRNA Calcitriol results in decreased expression of PRR16 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr18:46,622,816...46,963,251
Ensembl chr18:46,623,058...46,830,385
|
|
| G
|
Prr3
|
proline rich 3
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PRR3 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PRR3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:2,797,677...2,804,674
Ensembl chr20:2,797,105...2,798,617
|
|
| G
|
Prr5l
|
proline rich 5 like
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PRR5L mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:108,458,107...108,628,552
Ensembl chr 3:108,458,633...108,537,763
|
|
| G
|
Prss21
|
serine protease 21
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PRSS21 mRNA
|
CTD |
PMID:36321694 |
|
NCBI chr10:13,404,820...13,410,195
Ensembl chr10:13,405,066...13,410,195
|
|
| G
|
Prss22
|
serine protease 22
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of PRSS22 mRNA Calcitriol results in increased expression of PRSS22 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr10:13,533,725...13,538,435
Ensembl chr10:13,533,725...13,538,435
|
|
| G
|
Prss23
|
serine protease 23
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PRSS23 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PRSS23 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:152,815,301...152,835,005
Ensembl chr 1:152,813,670...152,947,871
|
|
| G
|
Psap
|
prosaposin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PSAP mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr20:28,756,951...28,783,422
Ensembl chr20:28,757,181...28,783,421
|
|
| G
|
Psmb10
|
proteasome 20S subunit beta 10
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PSMB10 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PSMB10 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:50,740,808...50,743,292
Ensembl chr19:50,740,811...50,743,210
|
|
| G
|
Psmb9
|
proteasome 20S subunit beta 9
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PSMB9 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr20:4,668,952...4,674,421
Ensembl chr20:4,668,739...4,674,421
|
|
| G
|
Psmc3ip
|
PSMC3 interacting protein
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PSMC3IP mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PSMC3IP mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:86,524,546...86,527,764
Ensembl chr10:86,524,571...86,527,666
|
|
| G
|
Psmf1
|
proteasome inhibitor subunit 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PSMF1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:160,695,744...160,720,915
Ensembl chr 3:160,695,745...160,720,915
|
|
| G
|
Psrc1
|
proline and serine rich coiled-coil 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PSRC1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PSRC1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:198,710,427...198,715,001
Ensembl chr 2:198,705,839...198,714,997
|
|
| G
|
Ptgds
|
prostaglandin D2 synthase
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PTGDS mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:28,680,044...28,682,978
Ensembl chr 3:28,680,044...28,682,978
|
|
| G
|
Ptger2
|
prostaglandin E receptor 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PTGER2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr15:20,694,765...20,708,475
Ensembl chr15:20,696,013...20,708,950
|
|
| G
|
Ptger4
|
prostaglandin E receptor 4
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PTGER4 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:56,061,699...56,074,594
Ensembl chr 2:56,062,890...56,074,135
|
|
| G
|
Ptgfr
|
prostaglandin F receptor
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PTGFR mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:243,390,820...243,426,647
Ensembl chr 2:243,393,350...243,425,623
|
|
| G
|
Ptgis
|
prostaglandin I2 synthase
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PTGIS mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:176,347,589...176,383,251
Ensembl chr 3:176,335,437...176,407,650
|
|
| G
|
Ptgs1
|
prostaglandin-endoperoxide synthase 1
|
increases response to substance increases expression
|
EXP ISO
|
PTGS1 protein results in increased susceptibility to Calcitriol Calcitriol results in increased expression of PTGS1 mRNA
|
CTD |
PMID:11455568 PMID:16129123 PMID:18242698 |
|
NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:39,981,415...40,002,990
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
increases expression increases response to substance
|
ISO EXP
|
Calcitriol results in increased expression of PTGS2 mRNA PTGS2 protein results in increased susceptibility to Calcitriol
|
CTD |
PMID:11455568 PMID:16002434 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Pth
|
parathyroid hormone
|
affects expression multiple interactions decreases secretion decreases expression affects chemical synthesis
|
ISO EXP
|
Calcitriol affects the expression of PTH protein Calcium affects the reaction [Calcitriol results in decreased expression of PTH mRNA]; Calcium affects the reaction [Calcitriol results in decreased secretion of PTH protein] Calcitriol results in decreased expression of PTH mRNA; Calcitriol results in decreased expression of PTH protein PTH protein affects the chemical synthesis of Calcitriol [Calcitriol co-treated with Calcium] results in decreased expression of PTH protein
|
CTD |
PMID:80633 PMID:1453499 PMID:1752077 PMID:2051637 PMID:3626302 PMID:6760236 PMID:7847357 PMID:8052367 PMID:8261678 PMID:8711172 PMID:8807625 PMID:9263752 PMID:10027919 PMID:11305809 PMID:12369129 PMID:12399635 PMID:12631365 PMID:15891005 PMID:15956805 PMID:16189633 PMID:16316325 PMID:17444814 PMID:17984431 PMID:21350317 PMID:21985997 More...
|
|
NCBI chr 1:176,942,901...176,946,034
Ensembl chr 1:176,943,102...176,946,034
|
|
| G
|
Pth1r
|
parathyroid hormone 1 receptor
|
decreases expression
|
EXP ISO
|
Calcitriol results in decreased expression of PTH1R protein Calcitriol results in decreased expression of PTH1R mRNA
|
CTD |
PMID:15728789 PMID:26485663 |
|
NCBI chr 8:119,572,295...119,597,405
Ensembl chr 8:119,575,868...119,598,108
|
|
| G
|
Pthlh
|
parathyroid hormone-like hormone
|
multiple interactions increases degradation decreases expression
|
ISO
|
alitretinoin promotes the reaction [Calcitriol results in decreased expression of PTHLH mRNA]; Calcitriol results in decreased expression of and results in decreased stability of PTHLH mRNA; VDR mutant form inhibits the reaction [Calcitriol results in decreased expression of PTHLH mRNA] Calcitriol results in increased degradation of PTHLH protein Calcitriol results in decreased expression of PTHLH mRNA; Calcitriol results in decreased expression of PTHLH protein
|
CTD |
PMID:16002434 PMID:16243370 PMID:21664243 |
|
NCBI chr 4:181,919,400...181,930,454
Ensembl chr 4:181,919,400...181,930,454
|
|
| G
|
Ptn
|
pleiotrophin
|
decreases expression increases expression
|
ISO EXP
|
Calcitriol results in decreased expression of PTN mRNA Calcitriol results in increased expression of PTN mRNA
|
CTD |
PMID:21153232 |
|
NCBI chr 4:66,260,764...66,342,614
Ensembl chr 4:66,260,764...66,342,482
|
|
| G
|
Ptp4a1
|
protein tyrosine phosphatase 4A1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PTP4A1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 9:40,710,250...40,718,176
Ensembl chr 9:40,710,250...40,718,176
|
|
| G
|
Ptpa
|
protein phosphatase 2 phosphatase activator
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PTPA mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:34,087,637...34,118,100
Ensembl chr 3:34,087,575...34,162,772
|
|
| G
|
Ptpn1
|
protein tyrosine phosphatase, non-receptor type 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PTPN1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:177,056,588...177,106,424
Ensembl chr 3:177,057,659...177,106,416
|
|
| G
|
Ptpn21
|
protein tyrosine phosphatase, non-receptor type 21
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of PTPN21 mRNA Calcitriol results in increased expression of PTPN21 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:123,662,783...123,727,809
Ensembl chr 6:123,662,783...123,727,809
|
|
| G
|
Ptpn3
|
protein tyrosine phosphatase, non-receptor type 3
|
decreases expression increases expression
|
ISO
|
Calcitriol results in decreased expression of PTPN3 mRNA Calcitriol results in increased expression of PTPN3 mRNA
|
CTD |
PMID:16129123 PMID:26485663 |
|
NCBI chr 5:76,703,687...76,822,584
Ensembl chr 5:76,703,687...76,860,470
|
|
| G
|
Ptprc
|
protein tyrosine phosphatase, receptor type, C
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PTPRC mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:52,147,717...52,259,810
Ensembl chr13:52,147,717...52,259,746
|
|
| G
|
Ptprcap
|
protein tyrosine phosphatase, receptor type, C-associated protein
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PTPRCAP mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:210,878,593...210,880,752
Ensembl chr 1:210,878,573...210,881,753
|
|
| G
|
Ptprd
|
protein tyrosine phosphatase, receptor type, D
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PTPRD mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:95,093,221...97,415,498
Ensembl chr 5:95,095,858...96,178,903
|
|
| G
|
Ptpre
|
protein tyrosine phosphatase, receptor type, E
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PTPRE mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:199,774,195...199,924,646
Ensembl chr 1:199,774,198...199,922,242
|
|
| G
|
Ptprf
|
protein tyrosine phosphatase, receptor type, F
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PTPRF mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:137,027,376...137,109,405
Ensembl chr 5:137,028,164...137,095,426
|
|
| G
|
Ptprm
|
protein tyrosine phosphatase, receptor type, M
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of PTPRM mRNA Calcitriol results in increased expression of PTPRM mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 9:114,086,380...114,791,000
Ensembl chr 9:114,086,380...114,790,477
|
|
| G
|
Ptprn
|
protein tyrosine phosphatase, receptor type, N
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PTPRN mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 9:84,189,676...84,205,364
Ensembl chr 9:84,189,676...84,204,850
|
|
| G
|
Ptprn2
|
protein tyrosine phosphatase, receptor type N2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of PTPRN2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of PTPRN2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:143,582,568...144,334,573
Ensembl chr 6:143,582,547...144,336,744
|
|
| G
|
Ptprz1
|
protein tyrosine phosphatase, receptor type Z1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of PTPRZ1 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 4:52,363,006...52,560,905
Ensembl chr 4:52,363,295...52,560,903
|
|
| G
|
Pttg1
|
PTTG1 regulator of sister chromatid separation, securin
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of PTTG1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of PTTG1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:28,394,940...28,406,410
Ensembl chr10:28,394,814...28,406,309
|
|
| G
|
Pyroxd2
|
pyridine nucleotide-disulphide oxidoreductase domain 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of PYROXD2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:251,472,609...251,498,316
Ensembl chr 1:251,471,849...251,498,008
|
|
| G
|
Qsox1
|
quiescin sulfhydryl oxidase 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of QSOX1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of QSOX1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:70,500,060...70,537,711
Ensembl chr13:70,500,060...70,537,733
|
|
| G
|
Rab11fip1
|
RAB11 family interacting protein 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of RAB11FIP1 mRNA Calcitriol results in increased expression of RAB11FIP1 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr16:71,589,753...71,620,341
Ensembl chr16:71,589,753...71,620,341
|
|
| G
|
Rab17
|
RAB17, member RAS oncogene family
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RAB17 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 9:99,001,044...99,014,340
Ensembl chr 9:99,001,045...99,014,032
|
|
| G
|
Rab23
|
RAB23, member RAS oncogene family
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of RAB23 mRNA Calcitriol results in decreased expression of RAB23 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 9:43,440,047...43,463,327
Ensembl chr 9:43,440,273...43,463,325
|
|
| G
|
Rab4b
|
RAB4B, member RAS oncogene family
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of RAB4B mRNA Calcitriol results in increased expression of RAB4B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:91,589,047...91,600,426
Ensembl chr 1:91,589,047...91,600,337
|
|
| G
|
Rabgap1l
|
RAB GTPase activating protein 1-like
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RABGAP1L mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:74,997,542...75,593,240
Ensembl chr13:74,997,542...75,533,816
|
|
| G
|
Racgap1
|
Rac GTPase-activating protein 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of RACGAP1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of RACGAP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:132,629,789...132,659,738
Ensembl chr 7:132,620,595...132,659,738
|
|
| G
|
Rad18
|
RAD18 E3 ubiquitin protein ligase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of RAD18 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of RAD18 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:147,291,463...147,376,904
Ensembl chr 4:147,291,276...147,376,869
|
|
| G
|
Rad51
|
RAD51 recombinase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of RAD51 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of RAD51 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:126,554,210...126,578,888
Ensembl chr 3:126,554,190...126,579,469
|
|
| G
|
Rad51ap1
|
RAD51 associated protein 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of RAD51AP1 mRNA Calcitriol results in decreased expression of RAD51AP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:161,445,610...161,458,661
Ensembl chr 4:161,445,512...161,458,680
|
|
| G
|
Rad51c
|
RAD51 paralog C
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of RAD51C mRNA Calcitriol results in decreased expression of RAD51C mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:72,702,299...72,728,980
Ensembl chr10:72,702,299...72,729,143
|
|
| G
|
Rad54l
|
RAD54 like
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of RAD54L mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of RAD54L mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:134,812,158...134,841,821
Ensembl chr 5:134,811,532...134,841,425
|
|
| G
|
Radx
|
RPA1 related single stranded DNA binding protein, X-linked
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RADX mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr X:107,877,835...107,965,476
Ensembl chr X:107,877,920...107,965,476
|
|
| G
|
Rag1
|
recombination activating 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RAG1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:108,372,087...108,383,184
Ensembl chr 3:108,371,978...108,383,261
|
|
| G
|
Rai14
|
retinoic acid induced 14
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of RAI14 mRNA Calcitriol results in decreased expression of RAI14 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:61,273,439...61,411,141
Ensembl chr 2:61,273,439...61,409,791
|
|
| G
|
Rai2
|
retinoic acid induced 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of RAI2 mRNA Calcitriol results in increased expression of RAI2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:36,580,406...36,642,943
Ensembl chr X:36,573,917...36,643,240
|
|
| G
|
Ralgapa2
|
Ral GTPase activating protein catalytic subunit alpha 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of RALGAPA2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of RALGAPA2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:154,112,005...154,392,070
Ensembl chr 3:154,112,014...154,392,138
|
|
| G
|
Ralgps2
|
Ral GEF with PH domain and SH3 binding motif 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RALGPS2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:71,474,835...71,654,791
Ensembl chr13:71,474,835...71,606,739
|
|
| G
|
Ramp1
|
receptor activity modifying protein 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of RAMP1 mRNA Calcitriol results in increased expression of RAMP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:99,213,031...99,263,696
|
|
| G
|
Rap1gap2
|
RAP1 GTPase activating protein 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RAP1GAP2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:59,753,822...59,970,946
Ensembl chr10:59,753,822...59,970,887
|
|
| G
|
Raph1
|
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of RAPH1 mRNA Calcitriol results in increased expression of RAPH1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:69,397,272...69,484,174
Ensembl chr 9:69,401,517...69,484,019
|
|
| G
|
Rarres1
|
retinoic acid receptor responder 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RARRES1 mRNA
|
CTD |
PMID:14996990 PMID:26485663 |
|
NCBI chr 2:154,059,761...154,094,021
Ensembl chr 2:154,059,761...154,094,024
|
|
| G
|
Rasd1
|
ras related dexamethasone induced 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of RASD1 mRNA Calcitriol results in increased expression of RASD1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:45,265,975...45,275,279
Ensembl chr10:45,265,979...45,267,710
|
|
| G
|
Rasl11a
|
RAS-like family 11 member A
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of RASL11A mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of RASL11A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr12:13,372,023...13,374,784
Ensembl chr12:13,372,023...13,376,451
|
|
| G
|
Rasl11b
|
RAS-like family 11 member B
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of RASL11B mRNA Calcitriol results in decreased expression of RASL11B mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr14:34,369,029...34,373,250
Ensembl chr14:34,368,726...34,373,250
|
|
| G
|
Rassf3
|
Ras association domain family member 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RASSF3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:58,821,360...58,886,020
Ensembl chr 7:58,821,360...58,886,020
|
|
| G
|
Rb1
|
RB transcriptional corepressor 1
|
multiple interactions increases expression decreases phosphorylation
|
ISO
|
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol results in increased expression of RB1 mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol results in increased expression of RB1 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole promotes the reaction [Calcitriol results in increased expression of RB1 mRNA]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole promotes the reaction [Calcitriol results in increased expression of RB1 protein]; CSF1R promotes the reaction [Calcitriol results in decreased phosphorylation of RB1 protein]; pyrazolanthrone inhibits the reaction [Calcitriol results in increased expression of RB1 mRNA]; pyrazolanthrone inhibits the reaction [Calcitriol results in increased expression of RB1 protein]; ZK159222 inhibits the reaction [Calcitriol results in increased expression of RB1 protein] Calcitriol results in increased expression of RB1 mRNA; Calcitriol results in increased expression of RB1 protein; Calcitriol results in increased expression of RB1 protein modified form Calcitriol results in decreased phosphorylation of RB1 protein; Calcitriol results in decreased phosphorylation of RB1 protein modified form
|
CTD |
PMID:9158000 PMID:9348195 PMID:10825140 PMID:11270487 PMID:11519864 PMID:12954644 PMID:14729647 PMID:16039115 More...
|
|
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857
|
|
| G
|
Rbbp8
|
RB binding protein 8, endonuclease
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of RBBP8 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of RBBP8 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:3,198,188...3,263,643
Ensembl chr18:3,197,310...3,263,985
|
|
| G
|
Rbl1
|
RB transcriptional corepressor like 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of RBL1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of RBL1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:166,226,187...166,289,862
Ensembl chr 3:166,226,198...166,289,376
|
|
| G
|
Rbl2
|
RB transcriptional corepressor like 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RBL2 mRNA
|
CTD |
PMID:14729647 |
|
NCBI chr19:32,049,690...32,096,467
Ensembl chr19:32,049,691...32,096,411
|
|
| G
|
Rbm24
|
RNA binding motif protein 24
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RBM24 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr17:18,481,893...18,494,440
Ensembl chr17:18,481,900...18,494,604
|
|
| G
|
Rbmxl1
|
Rbmx like 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of RBMXL1 mRNA Calcitriol results in decreased expression of RBMXL1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:46,312,176...46,315,802
Ensembl chr19:46,311,280...46,327,195
|
|
| G
|
Rbp7
|
retinol binding protein 7
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RBP7 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:165,169,700...165,177,427
Ensembl chr 5:165,172,785...165,177,399
|
|
| G
|
Rcan1
|
regulator of calcineurin 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of RCAN1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of RCAN1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr11:45,108,123...45,188,065
Ensembl chr11:45,108,124...45,118,236
|
|
| G
|
Rccd1
|
RCC1 domain containing 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of RCCD1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of RCCD1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:143,681,124...143,690,817
Ensembl chr 1:143,681,035...143,690,362
|
|
| G
|
Rdm1
|
RAD52 motif containing 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of RDM1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of RDM1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:87,062,322...87,073,273
Ensembl chr10:87,039,940...87,073,273
|
|
| G
|
Recql4
|
RecQ like helicase 4
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of RECQL4 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of RECQL4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:110,304,092...110,311,426
Ensembl chr 7:110,304,094...110,311,258
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
increases expression decreases expression multiple interactions decreases activity
|
ISO EXP
|
Calcitriol results in increased expression of RELA mRNA Calcitriol results in decreased expression of RELA protein bisphenol A diglycidyl ether inhibits the reaction [Calcitriol inhibits the reaction [Streptozocin results in increased expression of and results in decreased phosphorylation of RELA protein]]; Calcitriol inhibits the reaction [sodium arsenite results in increased expression of and results in increased phosphorylation of RELA protein]; Calcitriol inhibits the reaction [Streptozocin results in increased expression of and results in decreased phosphorylation of RELA protein] Calcitriol inhibits the reaction [Bleomycin results in increased expression of RELA protein] Calcitriol results in decreased activity of RELA protein Calcitriol inhibits the reaction [IL1B protein results in increased phosphorylation of RELA protein]; Calcitriol inhibits the reaction [Lipopolysaccharides results in increased activity of RELA protein]; RELA protein promotes the reaction [Calcitriol results in increased activity of VDR protein]; RELA protein promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]
|
CTD |
PMID:18515093 PMID:19748465 PMID:20206692 PMID:22615136 PMID:26520185 PMID:29953732 PMID:32147540 PMID:39771102 More...
|
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Relb
|
RELB proto-oncogene, NF-kB subunit
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of RELB mRNA [Testosterone co-treated with Calcitriol] results in increased expression of RELB mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:88,385,717...88,413,380
Ensembl chr 1:88,385,717...88,413,420
|
|
| G
|
Ren
|
renin
|
decreases activity
|
ISO
|
Calcitriol results in decreased activity of REN protein
|
CTD |
PMID:10052739 |
|
NCBI chr13:47,348,312...47,359,539
Ensembl chr13:47,348,143...47,359,543
|
|
| G
|
Ret
|
ret proto-oncogene
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RET mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:152,998,344...153,040,556
Ensembl chr 4:152,998,812...153,040,556
|
|
| G
|
Rfc2
|
replication factor C subunit 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of RFC2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of RFC2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr12:27,756,920...27,770,049
Ensembl chr12:27,756,922...27,770,025
|
|
| G
|
Rfc3
|
replication factor C subunit 3
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of RFC3 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of RFC3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr12:5,836,546...5,847,331
Ensembl chr12:5,836,553...5,847,340
|
|
| G
|
Rfc4
|
replication factor C subunit 4
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of RFC4 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of RFC4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr11:91,254,273...91,268,727
Ensembl chr11:91,254,243...91,268,730
|
|
| G
|
Rffl
|
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RFFL mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:68,238,273...68,301,225
Ensembl chr10:68,238,273...68,321,902
|
|
| G
|
Rflnb
|
refilin B
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of RFLNB mRNA Calcitriol results in decreased expression of RFLNB mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:61,391,947...61,398,224
Ensembl chr10:61,390,659...61,398,224
|
|
| G
|
Rfwd3
|
ring finger and WD repeat domain 3
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of RFWD3 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of RFWD3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:56,145,221...56,177,871
Ensembl chr19:56,145,221...56,177,815
|
|
| G
|
Rfx8
|
regulatory factor X8
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of RFX8 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 9:49,453,282...49,517,123
Ensembl chr 9:49,453,289...49,515,134
|
|
| G
|
RGD1359108
|
similar to RIKEN cDNA 3110043O21
|
increases expression
|
ISO
|
Calcitriol results in increased expression of C9ORF72 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:54,562,570...54,587,649
Ensembl chr 5:54,562,570...54,587,637
|
|
| G
|
Rgmb
|
repulsive guidance molecule BMP co-receptor b
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of RGMB mRNA [Testosterone co-treated with Calcitriol] results in increased expression of RGMB mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:65,439,748...65,465,149
Ensembl chr 1:65,441,410...65,465,098
|
|
| G
|
Rgs1
|
regulator of G-protein signaling 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of RGS1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:58,568,844...58,573,187
Ensembl chr13:58,568,844...58,573,187
|
|
| G
|
Rgs11
|
regulator of G-protein signaling 11
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of RGS11 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of RGS11 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:15,727,279...15,735,536
Ensembl chr10:15,727,279...15,735,536
|
|
| G
|
Rgs16
|
regulator of G-protein signaling 16
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of RGS16 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:68,421,480...68,443,312
Ensembl chr13:68,438,120...68,443,313
|
|
| G
|
Rgs17
|
regulator of G-protein signaling 17
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of RGS17 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of RGS17 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:44,627,583...44,729,957
Ensembl chr 1:44,632,964...44,729,945
|
|
| G
|
Rgs3
|
regulator of G-protein signaling 3
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of RGS3 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of RGS3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:81,037,588...81,177,446
Ensembl chr 5:81,056,068...81,177,445
|
|
| G
|
Rhpn2
|
rhophilin, Rho GTPase binding protein 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RHPN2 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 1:97,128,054...97,188,803
Ensembl chr 1:97,127,697...97,188,803
|
|
| G
|
Rin2
|
Ras and Rab interactor 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of RIN2 mRNA Calcitriol results in increased expression of RIN2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:153,540,147...153,756,897
Ensembl chr 3:153,540,214...153,756,897
|
|
| G
|
Rin3
|
Ras and Rab interactor 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of RIN3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of RIN3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:127,196,648...127,305,821
Ensembl chr 6:127,196,632...127,305,821
|
|
| G
|
Ripk2
|
receptor-interacting serine-threonine kinase 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RIPK2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:34,428,573...34,459,808
Ensembl chr 5:34,428,573...34,459,663
|
|
| G
|
Ripk4
|
receptor-interacting serine-threonine kinase 4
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of RIPK4 mRNA Calcitriol results in increased expression of RIPK4 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr11:50,591,926...50,614,169
Ensembl chr11:50,591,936...50,614,169
|
|
| G
|
Ripor1
|
RHO family interacting cell polarization regulator 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of RIPOR1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr19:50,387,447...50,416,323
Ensembl chr19:50,387,523...50,416,319
|
|
| G
|
Ripor3
|
RIPOR family member 3
|
increases expression decreases expression
|
ISO
|
Calcitriol results in increased expression of RIPOR3 mRNA Calcitriol results in decreased expression of RIPOR3 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 3:177,106,436...177,179,423
Ensembl chr 3:177,106,892...177,179,095
|
|
| G
|
Rln1
|
relaxin 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of RLN1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of RLN1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:236,493,532...236,496,541
Ensembl chr 1:236,493,536...236,496,440
|
|
| G
|
Rmi1
|
RecQ mediated genome instability 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of RMI1 mRNA Calcitriol results in decreased expression of RMI1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:6,261,961...6,269,947
Ensembl chr17:6,260,896...6,282,052
|
|
| G
|
Rmi2
|
RecQ mediated genome instability 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of RMI2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of RMI2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:5,336,269...5,344,202
Ensembl chr10:5,338,060...5,344,235
|
|
| G
|
Rmnd5b
|
required for meiotic nuclear division 5 homolog B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RMND5B mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:36,382,212...36,394,801
Ensembl chr10:36,382,213...36,393,154
|
|
| G
|
Rnase1
|
ribonuclease A family member 1, pancreatic
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of RNASE1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr15:26,835,436...26,837,145
Ensembl chr15:26,835,463...26,837,248
|
|
| G
|
Rnaseh2a
|
ribonuclease H2, subunit A
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of RNASEH2A mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of RNASEH2A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:40,091,206...40,100,904
Ensembl chr19:40,091,210...40,100,899
|
|
| G
|
Rnaseh2b
|
ribonuclease H2, subunit B
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of RNASEH2B mRNA Calcitriol results in decreased expression of RNASEH2B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:40,717,252...40,770,826
Ensembl chr15:40,717,232...40,770,825
|
|
| G
|
Rnasel
|
ribonuclease L
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of RNASEL mRNA Calcitriol results in increased expression of RNASEL mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:68,446,641...68,460,804
Ensembl chr13:68,446,882...68,459,557
|
|
| G
|
Rnd1
|
Rho family GTPase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RND1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:131,700,321...131,707,392
Ensembl chr 7:131,700,321...131,707,392
|
|
| G
|
Rnf103
|
ring finger protein 103
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of RNF103 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of RNF103 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:105,084,762...105,100,839
Ensembl chr 4:105,084,686...105,106,809
|
|
| G
|
Rnf128
|
ring finger protein 128
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RNF128 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr X:107,968,973...108,087,037
Ensembl chr X:107,972,348...108,087,288
|
|
| G
|
Rnf138
|
ring finger protein 138
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of RNF138 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of RNF138 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:12,558,430...12,590,849
Ensembl chr18:12,566,502...12,590,848
|
|
| G
|
Rnf144a
|
ring finger protein 144A
|
increases expression decreases expression
|
ISO
|
Calcitriol results in increased expression of RNF144A mRNA Calcitriol results in decreased expression of RNF144A mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 6:48,628,241...48,748,241
Ensembl chr 6:48,631,648...48,748,179
|
|
| G
|
Rnf145
|
ring finger protein 145
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RNF145 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:29,507,779...29,552,153
Ensembl chr10:29,507,772...29,552,151
|
|
| G
|
Rnf149
|
ring finger protein 149
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RNF149 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 9:49,322,524...49,350,361
Ensembl chr 9:49,323,857...49,350,042
|
|
| G
|
Rnf185
|
ring finger protein 185
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RNF185 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr14:82,516,153...82,554,199
Ensembl chr14:82,516,154...82,553,466
|
|
| G
|
Rnf19a
|
ring finger protein 19A, RBR E3 ubiquitin protein ligase
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of RNF19A mRNA [Testosterone co-treated with Calcitriol] results in increased expression of RNF19A mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 7:69,310,947...69,350,567
Ensembl chr 7:69,310,947...69,350,225
|
|
| G
|
Rnf2
|
ring finger protein 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RNF2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:66,103,943...66,136,038
Ensembl chr13:66,083,653...66,133,161
|
|
| G
|
Rnf39
|
ring finger protein 39
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RNF39 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr20:1,610,027...1,615,516
Ensembl chr20:1,610,026...1,612,323
|
|
| G
|
Rnf43
|
ring finger protein 43
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of RNF43 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:72,958,744...73,034,540
Ensembl chr10:72,961,641...73,034,551
|
|
| G
|
Rnft1
|
ring finger protein, transmembrane 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RNFT1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:71,807,403...71,821,132
Ensembl chr10:71,807,456...71,821,141
|
|
| G
|
Rnls
|
renalase, FAD-dependent amine oxidase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of RNLS mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of RNLS mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:240,450,702...240,723,472
Ensembl chr 1:240,450,702...240,723,043
|
|
| G
|
Rom1
|
retinal outer segment membrane protein 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ROM1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ROM1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:215,253,155...215,255,163
Ensembl chr 1:215,253,159...215,255,163
|
|
| G
|
Ror1
|
receptor tyrosine kinase-like orphan receptor 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ROR1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:119,859,744...120,203,573
Ensembl chr 5:119,859,970...120,205,801
|
|
| G
|
Rorc
|
RAR-related orphan receptor C
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RORC mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:184,698,779...184,723,942
Ensembl chr 2:184,698,818...184,724,566
|
|
| G
|
Rp2
|
RP2 activator of ARL3 GTPase
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RP2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr X:4,426,071...4,470,200
Ensembl chr X:4,403,052...4,530,576
|
|
| G
|
Rpa2
|
replication protein A2
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of RPA2 mRNA Calcitriol results in decreased expression of RPA2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:150,260,668...150,271,329
Ensembl chr 5:150,260,723...150,271,546
|
|
| G
|
Rpia
|
ribose 5-phosphate isomerase A
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of RPIA mRNA Calcitriol results in decreased expression of RPIA mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:104,282,081...104,307,732
Ensembl chr 4:104,282,081...104,307,718
|
|
| G
|
Rplp2
|
ribosomal protein lateral stalk subunit P2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RPLP2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:205,975,598...205,978,192
Ensembl chr 1:205,975,894...205,978,191
|
|
| G
|
Rps19
|
ribosomal protein S19
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of RPS19 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of RPS19 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:89,608,408...89,614,390
Ensembl chr 7:104,324,520...104,325,132 Ensembl chr 1:104,324,520...104,325,132
|
|
| G
|
Rps6ka1
|
ribosomal protein S6 kinase A1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of RPS6KA1 mRNA Calcitriol results in increased expression of RPS6KA1 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 5:151,362,819...151,402,064
Ensembl chr 5:151,362,819...151,476,044
|
|
| G
|
Rps6ka3
|
ribosomal protein S6 kinase A3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of RPS6KA3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of RPS6KA3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:39,325,926...39,432,017
Ensembl chr X:39,325,926...39,433,678
|
|
| G
|
Rps6ka5
|
ribosomal protein S6 kinase A5
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of RPS6KA5 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:125,558,434...125,736,576
Ensembl chr 6:125,558,434...125,735,856
|
|
| G
|
Rrad
|
RRAD, Ras related glycolysis inhibitor and calcium channel regulator
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of RRAD mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr19:360,581...363,874
Ensembl chr19:360,973...363,871
|
|
| G
|
Rras
|
RAS related
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of RRAS mRNA Calcitriol results in increased expression of RRAS mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:104,637,061...104,640,841
Ensembl chr 1:104,634,951...104,640,841
|
|
| G
|
Rrm2
|
ribonucleotide reductase regulatory subunit M2
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of RRM2 mRNA Calcitriol results in decreased expression of RRM2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:47,044,755...47,075,370
Ensembl chr 6:47,067,690...47,075,370
|
|
| G
|
Rsad2
|
radical S-adenosyl methionine domain containing 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of RSAD2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:48,774,985...48,788,245
Ensembl chr 6:48,774,985...48,788,320
|
|
| G
|
RT1-A2
|
RT1 class Ia, locus A2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of HLA-E mRNA [Testosterone co-treated with Calcitriol] results in increased expression of HLA-E mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:4,872,720...4,876,425
|
|
| G
|
RT1-Ba
|
RT1 class II, locus Ba
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of HLA-DQA1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr20:4,577,057...4,581,650
Ensembl chr20:4,576,843...4,581,653
|
|
| G
|
RT1-DMb
|
RT1 class II, locus DMb
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of HLA-DMB mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr20:4,695,009...4,702,560
Ensembl chr20:4,695,010...4,702,246
|
|
| G
|
Rtkn2
|
rhotekin 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of RTKN2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of RTKN2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:20,535,553...20,608,863
Ensembl chr20:20,535,553...20,608,899
|
|
| G
|
Rtn2
|
reticulon 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of RTN2 mRNA Calcitriol results in increased expression of RTN2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:88,063,124...88,076,082
Ensembl chr 1:88,063,119...88,076,043
|
|
| G
|
Rtn4r
|
reticulon 4 receptor
|
increases expression
|
ISO
|
Calcitriol results in increased expression of RTN4R mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr11:96,348,613...96,373,554
Ensembl chr11:96,348,502...96,373,554
|
|
| G
|
Rttn
|
rotatin
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of RTTN mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of RTTN mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:84,495,813...84,673,079
Ensembl chr18:84,482,601...84,700,463
|
|
| G
|
Rubcnl
|
rubicon like autophagy enhancer
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of RUBCNL mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr15:56,741,897...56,807,086
Ensembl chr15:56,741,869...56,779,649
|
|
| G
|
Runx1
|
RUNX family transcription factor 1
|
decreases expression multiple interactions increases expression
|
ISO
|
Calcitriol results in decreased expression of RUNX1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of RUNX1 mRNA Calcitriol results in increased expression of RUNX1 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr11:45,325,778...45,560,300
Ensembl chr11:45,329,044...45,564,925
|
|
| G
|
Runx1t1
|
RUNX1 partner transcriptional co-repressor 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of RUNX1T1 protein [Calcitriol results in increased expression of RUNX1T1 protein] which results in decreased activity of CEBPB protein
|
CTD |
PMID:16467308 |
|
NCBI chr 5:31,984,946...32,136,878
Ensembl chr 5:31,984,855...32,132,855
|
|
| G
|
Runx2
|
RUNX family transcription factor 2
|
multiple interactions increases expression decreases expression
|
ISO EXP
|
Calcitriol promotes the reaction [VDR protein binds to RUNX2 enhancer] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]]; Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]; Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]]; Sirolimus inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]]; Sirolimus inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]] Calcitriol results in increased expression of RUNX2 mRNA Calcitriol results in decreased expression of RUNX2 mRNA Calcitriol results in increased expression of RUNX2 protein
|
CTD |
PMID:16002434 PMID:17293108 PMID:19092814 PMID:21542014 PMID:26485663 PMID:28105418 PMID:33450223 More...
|
|
NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:23,664,952...23,990,027
|
|
| G
|
Rxra
|
retinoid X receptor alpha
|
affects expression affects response to substance multiple interactions increases phosphorylation affects localization
|
ISO
|
Calcitriol affects the expression of RXRA protein RXRA protein affects the susceptibility to Calcitriol [Alitretinoin co-treated with Calcitriol] results in increased stability of [RXRA protein binds to VDR protein]; [Calcitriol binds to VDR protein] promotes the reaction [VDR protein binds to RXRA protein]; [Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] inhibits the reaction [PPARGC1A protein results in increased expression of CYP7A1 mRNA]; [Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] which results in decreased expression of CYP7A1 mRNA; [Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] which results in increased expression of CYP24A1 mRNA; Benzo(a)pyrene inhibits the reaction [Calcitriol promotes the reaction [RXRA protein binds to CYP24A1 promoter]]; Calcitriol promotes the reaction [[VDR protein binds to RXRA protein] which binds to CYP24A1 promoter]; Calcitriol promotes the reaction [[VDR protein binds to RXRA protein] which binds to SLC30A10 promoter]; Calcitriol promotes the reaction [MAPK1 protein results in increased phosphorylation of RXRA protein]; Calcitriol promotes the reaction [MAPK3 protein results in increased phosphorylation of RXRA protein]; Calcitriol promotes the reaction [RXRA protein binds to and results in increased activity of VDR protein]; Calcitriol promotes the reaction [RXRA protein binds to and results in increased activity of VDRA protein]; Calcitriol promotes the reaction [RXRA protein binds to and results in increased activity of VDRALPHA protein]; Calcitriol promotes the reaction [RXRA protein binds to and results in increased activity of VDRB protein]; Calcitriol promotes the reaction [RXRA protein binds to CYP24A1 mRNA]; Calcitriol promotes the reaction [RXRA protein binds to CYP24A1 promoter]; Calcitriol promotes the reaction [RXRA protein binds to CYP7A1 mRNA]; Calcitriol promotes the reaction [RXRA protein mutant form binds to VDRA protein]; Calcitriol promotes the reaction [RXRA protein mutant form binds to VDRALPHA protein]; Calcitriol promotes the reaction [RXRA protein mutant form binds to VDRB protein]; Calcitriol promotes the reaction [salvin results in increased expression of RXRA protein]; Calcitriol promotes the reaction [VDR protein binds to RXRA protein]; Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]; NCOA1 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein binds to and results in increased activity of VDR protein]]; NCOA1 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein binds to and results in increased activity of VDRA protein]]; NCOA1 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein binds to and results in increased activity of VDRALPHA protein]]; NCOA1 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein binds to and results in increased activity of VDRB protein]]; NCOA1 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein mutant form binds to VDRA protein]]; NCOA1 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein mutant form binds to VDRALPHA protein]]; NCOA1 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein mutant form binds to VDRB protein]]; NCOA2 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein results in increased activity of VDR protein]]; NCOA2 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein results in increased activity of VDRA protein]]; NCOA2 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein results in increased activity of VDRALPHA protein]]; NCOA2 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein results in increased activity of VDRB protein]]; NCOA3 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein results in increased activity of VDR protein]]; NCOA3 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein results in increased activity of VDRA protein]]; NCOA3 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein results in increased activity of VDRALPHA protein]]; NCOA3 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein results in increased activity of VDRB protein]]; NCOR1 protein inhibits the reaction [[Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] which results in increased expression of CYP24A1 mRNA]; NCOR1 protein promotes the reaction [[Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] inhibits the reaction [PPARGC1A protein results in increased expression of CYP7A1 mRNA]]; NCOR2 protein inhibits the reaction [[Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] which results in increased expression of CYP24A1 mRNA]; NCOR2 protein promotes the reaction [[Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] inhibits the reaction [PPARGC1A protein results in increased expression of CYP7A1 mRNA]]; PPARGC1A protein promotes the reaction [[Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] which results in increased expression of CYP24A1 mRNA]; RXRA protein inhibits the reaction [Calcitriol promotes the reaction [NCOA1 protein binds to VDRA protein]]; RXRA protein inhibits the reaction [Calcitriol promotes the reaction [NCOA1 protein binds to VDRALPHA protein]]; RXRA protein inhibits the reaction [Calcitriol promotes the reaction [NCOA2 protein binds to VDRA protein]]; RXRA protein inhibits the reaction [Calcitriol promotes the reaction [NCOA2 protein binds to VDRALPHA protein]]; RXRA protein promotes the reaction [Calcitriol promotes the reaction [NCOA1 protein binds to VDR protein]]; RXRA protein promotes the reaction [Calcitriol promotes the reaction [NCOA1 protein binds to VDRB protein]]; RXRA protein promotes the reaction [Calcitriol promotes the reaction [NCOA2 protein binds to VDR protein]]; RXRA protein promotes the reaction [Calcitriol promotes the reaction [NCOA2 protein binds to VDRB protein]]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [MAPK1 protein results in increased phosphorylation of RXRA protein]]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [MAPK3 protein results in increased phosphorylation of RXRA protein]]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [RXRA protein binds to CYP7A1 mRNA]] Calcitriol results in increased phosphorylation of RXRA protein Calcitriol promotes the reaction [RXRA protein binds to CYP24A1 promoter]; Calcitriol promotes the reaction [RXRA protein binds to SPP1 promoter] Calcitriol affects the localization of RXRA protein
|
CTD |
PMID:11504768 PMID:15578590 PMID:15647825 PMID:15919092 PMID:16204233 PMID:16368784 PMID:19106115 PMID:19244278 PMID:20153625 PMID:20371703 PMID:21917910 PMID:25279795 PMID:27107558 More...
|
|
NCBI chr 3:31,387,892...31,474,415
Ensembl chr 3:31,388,223...31,474,417
|
|
| G
|
S100a10
|
S100 calcium binding protein A10
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of S100A10 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of S100A10 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:181,904,454...181,913,101
Ensembl chr 2:181,904,261...181,913,103
|
|
| G
|
S100a2
|
S100 calcium binding protein A2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of S100A2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:178,374,659...178,375,903
|
|
| G
|
S100a3
|
S100 calcium binding protein A3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of S100A3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:178,331,856...178,387,280
Ensembl chr 2:178,384,578...178,387,280
|
|
| G
|
S100a4
|
S100 calcium-binding protein A4
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of S100A4 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:178,388,529...178,390,838
Ensembl chr 2:178,388,526...178,390,837
|
|
| G
|
S100a8
|
S100 calcium binding protein A8
|
increases expression decreases expression
|
ISO
|
Calcitriol results in increased expression of S100A8 mRNA; Calcitriol results in increased expression of S100A8 protein Calcitriol results in decreased expression of S100A8 mRNA
|
CTD |
PMID:1733233 PMID:16002434 PMID:20089671 PMID:26485663 |
|
NCBI chr 2:178,464,095...178,465,223
Ensembl chr 2:178,464,702...178,465,221
|
|
| G
|
S100a9
|
S100 calcium binding protein A9
|
increases expression
|
ISO
|
Calcitriol results in increased expression of S100A9 mRNA; Calcitriol results in increased expression of S100A9 protein
|
CTD |
PMID:1733233 PMID:20089671 |
|
NCBI chr 2:178,487,941...178,490,622
Ensembl chr 2:178,487,941...178,490,870
|
|
| G
|
S100b
|
S100 calcium binding protein B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of S100B mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,348...12,381,081
|
|
| G
|
S100g
|
S100 calcium binding protein G
|
increases expression multiple interactions
|
ISO EXP
|
Calcitriol results in increased expression of S100G mRNA perfluorooctanoic acid inhibits the reaction [Calcitriol results in increased expression of S100G mRNA]
|
CTD |
PMID:15824121 PMID:15883024 PMID:16491319 PMID:16857747 PMID:33033332 |
|
NCBI chr X:35,337,636...35,340,205
Ensembl chr X:35,337,675...35,340,205
|
|
| G
|
S100pbp
|
S100P binding protein
|
increases expression
|
ISO
|
Calcitriol results in increased expression of S100PBP mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:146,778,706...146,820,223
Ensembl chr 5:146,780,061...146,819,822
|
|
| G
|
Samd13
|
sterile alpha motif domain containing 13
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of SAMD13 mRNA Calcitriol results in decreased expression of SAMD13 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:238,194,962...238,200,790
Ensembl chr 2:238,194,965...238,233,496
|
|
| G
|
Samd9
|
sterile alpha motif domain containing 9
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SAMD9 mRNA Calcitriol results in increased expression of SAMD9 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:32,119,318...32,139,008
Ensembl chr 4:32,117,137...32,171,759
|
|
| G
|
Samsn1
|
SAM domain, SH3 domain and nuclear localization signals, 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SAMSN1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr11:27,971,565...28,021,944
Ensembl chr11:27,970,564...28,021,944
|
|
| G
|
Sash3
|
SAM and SH3 domain containing 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SASH3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr X:132,204,717...132,219,421
Ensembl chr X:132,204,543...132,219,419
|
|
| G
|
Sass6
|
SAS-6 centriolar assembly protein
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of SASS6 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of SASS6 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:207,231,896...207,263,840
Ensembl chr 2:207,231,333...207,263,851
|
|
| G
|
Sbk1
|
SH3 domain binding kinase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SBK1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:190,237,677...190,282,494
Ensembl chr 1:190,273,642...190,282,473
|
|
| G
|
Sbno1
|
strawberry notch homolog 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SBNO1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr12:37,835,306...37,895,861
Ensembl chr12:37,846,514...37,891,231
|
|
| G
|
Scamp1
|
secretory carrier membrane protein 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SCAMP1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:27,168,863...27,251,637
Ensembl chr 2:27,168,864...27,251,742
|
|
| G
|
Scaper
|
S-phase cyclin A-associated protein in the ER
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SCAPER mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:64,828,789...65,228,240
Ensembl chr 8:64,828,789...65,228,453
|
|
| G
|
Scara3
|
scavenger receptor class A, member 3
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of SCARA3 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of SCARA3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:44,315,422...44,348,416
Ensembl chr15:44,315,422...44,348,551
|
|
| G
|
Scarf2
|
scavenger receptor class F, member 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SCARF2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr11:96,680,237...96,691,686
Ensembl chr11:96,680,243...96,691,626
|
|
| G
|
Scd
|
stearoyl-CoA desaturase
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SCD mRNA; Calcitriol results in decreased expression of SCD4 mRNA
|
CTD |
PMID:12798352 PMID:16002434 |
|
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785
|
|
| G
|
Scel
|
sciellin
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SCEL mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr15:86,754,595...86,871,200
Ensembl chr15:86,754,373...86,871,195
|
|
| G
|
Sclt1
|
sodium channel and clathrin linker 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of SCLT1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of SCLT1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:126,533,436...126,691,879
Ensembl chr 2:126,533,560...126,691,971
|
|
| G
|
Scml2
|
Scm polycomb group protein like 2
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of SCML2 mRNA Calcitriol results in decreased expression of SCML2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:37,331,893...37,486,465
Ensembl chr X:37,334,841...37,439,276
|
|
| G
|
Scn1b
|
sodium voltage-gated channel beta subunit 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SCN1B mRNA Calcitriol results in increased expression of SCN1B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:95,481,298...95,491,211
Ensembl chr 1:95,481,298...95,491,197
|
|
| G
|
Scnn1a
|
sodium channel epithelial 1 subunit alpha
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SCNN1A mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 4:159,809,187...159,832,409
Ensembl chr 4:159,809,170...159,832,405
|
|
| G
|
Scnn1b
|
sodium channel epithelial 1 subunit beta
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SCNN1B mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:185,861,326...185,915,717
Ensembl chr 1:185,854,733...185,916,049
|
|
| G
|
Scoc
|
short coiled-coil protein
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SCOC mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr19:41,564,166...41,593,932
Ensembl chr19:41,564,112...41,597,912
|
|
| G
|
Scpep1
|
serine carboxypeptidase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SCPEP1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:74,200,491...74,230,107
Ensembl chr10:74,200,491...74,230,241
|
|
| G
|
Scube2
|
signal peptide, CUB domain and EGF like domain containing 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SCUBE2 mRNA Calcitriol results in increased expression of SCUBE2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:173,264,862...173,341,323
Ensembl chr 1:173,264,865...173,334,372
|
|
| G
|
Sdc1
|
syndecan 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SDC1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 6:37,282,041...37,304,503
Ensembl chr 6:37,297,010...37,304,500
|
|
| G
|
Sdcbp
|
syndecan binding protein
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SDCBP mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr 5:24,245,279...24,314,712
Ensembl chr 5:24,245,033...24,326,197
|
|
| G
|
Sdcbp2
|
syndecan binding protein 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SDCBP2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SDCBP2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:160,521,309...160,558,452
Ensembl chr 3:160,530,927...160,558,446
|
|
| G
|
Sdk1
|
sidekick cell adhesion molecule 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SDK1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SDK1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr12:17,491,430...18,477,914
Ensembl chr12:17,493,869...18,477,935
|
|
| G
|
Sdr16c5
|
short chain dehydrogenase/reductase family 16C, member 5
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SDR16C5 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:21,816,394...21,841,596
Ensembl chr 5:21,816,394...21,838,551
|
|
| G
|
Sds
|
serine dehydratase
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SDS mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr12:41,743,796...41,751,108
Ensembl chr12:41,743,799...41,748,773
|
|
| G
|
Sec14l1
|
SEC14-like lipid binding 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SEC14L1 mRNA Calcitriol results in increased expression of SEC14L1 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr10:102,818,693...102,865,841
Ensembl chr10:102,818,693...102,865,839
|
|
| G
|
Sec14l2
|
SEC14-like lipid binding 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SEC14L2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SEC14L2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:83,197,384...83,222,059
Ensembl chr14:83,197,387...83,217,317
|
|
| G
|
Sectm1b
|
secreted and transmembrane 1B
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SECTM1 mRNA Calcitriol results in increased expression of SECTM1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:106,822,397...106,832,105
Ensembl chr10:106,822,397...106,832,104
|
|
| G
|
Selenop
|
selenoprotein P
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SELENOP mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:54,225,736...54,236,022
Ensembl chr 2:54,225,152...54,236,019
|
|
| G
|
Selplg
|
selectin P ligand
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SELPLG mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr12:48,457,102...48,470,444
Ensembl chr12:48,456,932...48,473,154
|
|
| G
|
Sema3b
|
semaphorin 3B
|
increases expression increases response to substance multiple interactions
|
ISO
|
Calcitriol results in increased expression of SEMA3B mRNA; Calcitriol results in increased expression of SEMA3B protein SEMA3B protein results in increased susceptibility to Calcitriol Ketoconazole promotes the reaction [Calcitriol results in increased expression of SEMA3B mRNA]; Mifepristone inhibits the reaction [Calcitriol results in increased expression of SEMA3B protein]; telmisartan inhibits the reaction [Calcitriol results in increased expression of SEMA3B protein]
|
CTD |
PMID:12040012 PMID:16002434 PMID:21933904 PMID:26485663 |
|
NCBI chr 8:117,150,307...117,161,570
Ensembl chr 8:117,150,589...117,157,658
|
|
| G
|
Sema3c
|
semaphorin 3C
|
decreases expression increases expression
|
ISO
|
Calcitriol results in decreased expression of SEMA3C mRNA Calcitriol results in increased expression of SEMA3C mRNA
|
CTD |
PMID:15951637 PMID:26485663 |
|
NCBI chr 4:18,538,452...18,702,453
Ensembl chr 4:18,538,454...18,701,740
|
|
| G
|
Sema3f
|
semaphorin 3F
|
increases expression multiple interactions increases response to substance
|
ISO
|
Calcitriol results in increased expression of SEMA3F mRNA; Calcitriol results in increased expression of SEMA3F protein Mifepristone inhibits the reaction [Calcitriol results in increased expression of SEMA3F protein]; telmisartan inhibits the reaction [Calcitriol results in increased expression of SEMA3F protein] SEMA3F protein results in increased susceptibility to Calcitriol
|
CTD |
PMID:16002434 PMID:21933904 |
|
NCBI chr 8:117,236,269...117,265,206
Ensembl chr 8:117,236,269...117,265,206
|
|
| G
|
Sema4b
|
semaphorin 4B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SEMA4B mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 1:143,545,727...143,587,037
Ensembl chr 1:143,537,690...143,587,037
|
|
| G
|
Sema6d
|
semaphorin 6D
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SEMA6D mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:131,801,680...132,394,578
Ensembl chr 3:132,337,343...132,394,584
|
|
| G
|
Septin8
|
septin 8
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SEPTIN8 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:38,185,454...38,214,502
Ensembl chr10:38,185,335...38,214,504
|
|
| G
|
Serinc2
|
serine incorporator 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SERINC2 mRNA Calcitriol results in increased expression of SERINC2 mRNA
|
CTD |
PMID:16002434 PMID:21592394 PMID:26485663 |
|
NCBI chr 5:147,876,477...147,898,797
Ensembl chr 5:147,876,477...147,902,765
|
|
| G
|
Serpina1
|
serpin family A member 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SERPINA1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 6:128,631,101...128,653,125
Ensembl chr 6:128,619,382...128,660,703
|
|
| G
|
Serpina3n
|
serpin family A member 3N
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SERPINA3 mRNA Calcitriol results in increased expression of SERPINA3 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 6:129,088,392...129,095,950
Ensembl chr 6:129,088,398...129,097,415
|
|
| G
|
Serpina5
|
serpin family A member 5
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SERPINA5 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 6:128,774,006...128,793,187
Ensembl chr 6:128,784,991...128,793,186
|
|
| G
|
Serpinb13
|
serpin family B member 13
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SERPINB13 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:23,633,220...23,665,100
Ensembl chr13:23,633,220...23,664,994
|
|
| G
|
Serpinb1a
|
serpin family B member 1A
|
multiple interactions increases expression
|
ISO
|
Ketoconazole promotes the reaction [Calcitriol results in increased expression of SERPINB1 mRNA]
|
CTD |
PMID:15951637 PMID:16002434 PMID:16847355 PMID:26485663 |
|
NCBI chr17:31,799,446...31,807,853
Ensembl chr17:31,799,415...31,808,166
|
|
| G
|
Serpinb2
|
serpin family B member 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SERPINB2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:24,051,933...24,065,032
Ensembl chr13:24,056,021...24,065,031
|
|
| G
|
Serpinb3
|
serpin family B member 3
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of SERPINB3 mRNA Ketoconazole promotes the reaction [Calcitriol results in decreased expression of SERPINB3 mRNA]
|
CTD |
PMID:12040012 PMID:16002434 |
|
NCBI chr13:23,788,758...23,795,298
Ensembl chr13:23,788,758...23,795,298
|
|
| G
|
Serpinb5
|
serpin family B member 5
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SERPINB5 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:23,500,203...23,520,401
Ensembl chr13:23,500,198...23,520,400
|
|
| G
|
Serpinb6a
|
serpin family B member 6A
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SERPINB6 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr17:31,076,811...31,195,035
Ensembl chr17:31,158,622...31,196,545
|
|
| G
|
Serpinb8
|
serpin family B member 8
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SERPINB8 mRNA Calcitriol results in increased expression of SERPINB8 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:24,141,557...24,164,894
Ensembl chr13:24,129,855...24,166,076
|
|
| G
|
Serpinb9
|
serpin family B member 9
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SERPINB9 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr17:31,628,887...31,652,003
Ensembl chr17:31,629,392...31,651,974
|
|
| G
|
Serpine1
|
serpin family E member 1
|
multiple interactions
|
ISO
|
[Benzo(a)pyrene co-treated with Calcitriol] results in increased expression of SERPINE1 mRNA; [Benzo(a)pyrene co-treated with Calcitriol] results in increased expression of SERPINE1 protein
|
CTD |
PMID:29524502 |
|
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
|
|
| G
|
Serpine2
|
serpin family E member 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SERPINE2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 9:88,573,138...88,637,252
Ensembl chr 9:88,573,149...88,637,202
|
|
| G
|
Serpinf1
|
serpin family F member 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SERPINF1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:60,748,504...60,760,898
Ensembl chr10:60,748,506...60,760,898
|
|
| G
|
Serpini1
|
serpin family I member 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of SERPINI1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of SERPINI1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:162,645,209...162,731,737
Ensembl chr 2:162,645,350...162,731,740
|
|
| G
|
Sesn1
|
sestrin 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of SESN1 mRNA Calcitriol results in decreased expression of SESN1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:46,876,918...46,970,010
Ensembl chr20:46,876,895...46,970,010
|
|
| G
|
Set
|
Set nuclear proto-oncogene
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SET mRNA
|
CTD |
PMID:12798352 |
|
NCBI chr 3:33,732,319...33,743,433
|
|
| G
|
Sez6l2
|
seizure related 6 homolog like 2
|
decreases expression increases expression
|
ISO
|
Calcitriol results in decreased expression of SEZ6L2 mRNA Calcitriol results in increased expression of SEZ6L2 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 1:190,987,647...191,007,990
Ensembl chr 1:190,988,055...191,007,973
|
|
| G
|
Sfn
|
stratifin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SFN mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:151,110,582...151,111,854
Ensembl chr 5:151,110,530...151,111,995
|
|
| G
|
Sfrp4
|
secreted frizzled-related protein 4
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SFRP4 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr17:49,974,532...50,026,448
Ensembl chr17:50,015,812...50,026,395
|
|
| G
|
Sftpa1
|
surfactant protein A1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SFTPA1 mRNA; Calcitriol results in decreased expression of SFTPA1 protein
|
CTD |
PMID:15951333 |
|
NCBI chr16:17,042,264...17,045,770
Ensembl chr16:17,042,255...17,045,769
|
|
| G
|
Sftpb
|
surfactant protein B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SFTPB mRNA; Calcitriol results in increased expression of SFTPB protein
|
CTD |
PMID:15951333 |
|
NCBI chr 4:105,917,495...105,926,631
Ensembl chr 4:105,917,578...105,927,646
|
|
| G
|
Sfxn3
|
sideroflexin 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SFXN3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:253,856,935...253,866,219
Ensembl chr 1:253,856,882...253,887,542
|
|
| G
|
Sgcd
|
sarcoglycan, delta
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SGCD mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:31,847,713...32,829,554
Ensembl chr10:31,781,748...32,419,064
|
|
| G
|
Sgk1
|
serum/glucocorticoid regulated kinase 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SGK1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231
|
|
| G
|
Sgo1
|
shugoshin 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of SGO1 mRNA Calcitriol results in decreased expression of SGO1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:6,908,661...6,943,483
Ensembl chr 9:6,908,661...6,924,415
|
|
| G
|
Sgo2
|
shugoshin 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of SGO2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of SGO2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:67,032,083...67,067,439
Ensembl chr 9:67,042,833...67,068,152
|
|
| G
|
Sh2b3
|
SH2B adaptor protein 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of LNK mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr12:40,391,755...40,414,336
Ensembl chr12:40,392,633...40,414,335
|
|
| G
|
Sh2d4a
|
SH2 domain containing 4A
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SH2D4A mRNA Calcitriol results in increased expression of SH2D4A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:26,106,721...26,176,069
Ensembl chr16:26,106,730...26,175,974
|
|
| G
|
Sh3bgrl
|
SH3 domain binding glutamate rich protein like
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SH3BGRL mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SH3BGRL mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:78,242,704...78,343,633
Ensembl chr X:78,242,405...78,343,634
|
|
| G
|
Sh3d21
|
SH3 domain containing 21
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SH3D21 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SH3D21 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:143,713,718...143,729,073
Ensembl chr 5:143,713,718...143,729,257
|
|
| G
|
Sh3gl3
|
SH3 domain containing GRB2 like 3, endophilin A3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SH3GL3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:145,533,728...145,664,881
Ensembl chr 1:145,533,728...145,664,881
|
|
| G
|
Sh3glb1
|
SH3 domain -containing GRB2-like endophilin B1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SH3GLB1 mRNA Calcitriol results in increased expression of SH3GLB1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:236,411,194...236,445,225
Ensembl chr 2:236,410,436...236,445,140
|
|
| G
|
Sh3kbp1
|
SH3 domain-containing kinase-binding protein 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SH3KBP1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr X:38,686,530...39,031,658
Ensembl chr X:38,686,530...39,031,393
|
|
| G
|
Sh3pxd2a
|
SH3 and PX domains 2A
|
increases expression decreases expression
|
ISO
|
Calcitriol results in increased expression of SH3PXD2A mRNA Calcitriol results in decreased expression of SH3PXD2A mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 1:256,094,991...256,301,120
Ensembl chr 1:256,094,991...256,300,967
|
|
| G
|
Sh3pxd2b
|
SH3 and PX domains 2B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SH3PXD2B mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:17,422,906...17,538,977
Ensembl chr10:17,422,947...17,512,854
|
|
| G
|
Sh3tc1
|
SH3 domain and tetratricopeptide repeats 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SH3TC1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SH3TC1 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr14:79,230,322...79,274,622
Ensembl chr14:79,230,371...79,274,620
|
|
| G
|
Sh3yl1
|
SH3 and SYLF domain containing 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SH3YL1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SH3YL1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:53,250,036...53,293,406
Ensembl chr 6:53,249,610...53,293,404
|
|
| G
|
Shc2
|
SHC adaptor protein 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SHC2 mRNA Calcitriol results in increased expression of SHC2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:10,717,320...10,739,539
Ensembl chr 7:10,717,320...10,739,539
|
|
| G
|
Shcbp1
|
SHC binding and spindle associated 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of SHCBP1 mRNA Calcitriol results in decreased expression of SHCBP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:91,373,843...91,405,409
Ensembl chr16:91,373,871...91,405,409
|
|
| G
|
She
|
Src homology 2 domain containing E
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SHE mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 2:177,559,636...177,585,485
Ensembl chr 2:177,560,207...177,588,016
|
|
| G
|
Shisa4
|
shisa family member 4
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SHISA4 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SHISA4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:49,351,518...49,355,599
Ensembl chr13:49,351,518...49,356,227
|
|
| G
|
Shld1
|
shieldin complex subunit 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SHLD1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:140,391,611...140,462,273
Ensembl chr 3:140,389,220...140,462,609
|
|
| G
|
Shox2
|
SHOX homeobox 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SHOX2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:153,524,324...153,537,571
Ensembl chr 2:153,527,571...153,537,161
|
|
| G
|
Shroom2
|
shroom family member 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SHROOM2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SHROOM2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:25,308,163...25,480,194
Ensembl chr X:25,308,163...25,479,385
|
|
| G
|
Shroom3
|
shroom family member 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SHROOM3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr14:15,383,769...15,681,158
Ensembl chr14:15,383,769...15,680,462
|
|
| G
|
Si
|
sucrase-isomaltase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of SI mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of SI mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:159,804,568...159,884,902
Ensembl chr 2:159,804,568...159,883,934
|
|
| G
|
Sipa1l2
|
signal-induced proliferation-associated 1 like 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SIPA1L2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SIPA1L2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:70,287,134...70,437,810
Ensembl chr19:70,287,147...70,437,773
|
|
| G
|
Sirpa
|
signal-regulatory protein alpha
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SIRPA mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:137,272,932...137,311,279
Ensembl chr 3:137,273,042...137,311,279
|
|
| G
|
Siva1
|
SIVA1, apoptosis-inducing factor
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of SIVA1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of SIVA1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:137,526,416...137,530,790
Ensembl chr 6:137,526,031...137,530,790
|
|
| G
|
Ska1
|
spindle and kinetochore associated complex subunit 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of SKA1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of SKA1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:70,069,957...70,080,303
Ensembl chr18:70,069,957...70,080,398
|
|
| G
|
Ska2
|
spindle and kinetochore associated complex subunit 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of SKA2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of SKA2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:72,418,707...72,436,721
Ensembl chr10:72,418,617...72,436,718
|
|
| G
|
Ska3
|
spindle and kinetochore associated complex subunit 3
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of SKA3 mRNA Calcitriol results in decreased expression of SKA3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:36,067,372...36,086,563
Ensembl chr15:36,067,373...36,086,563
|
|
| G
|
Skp2
|
S-phase kinase associated protein 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of SKP2 mRNA; Calcitriol results in decreased expression of SKP2 protein [Testosterone co-treated with Calcitriol] results in decreased expression of SKP2 mRNA
|
CTD |
PMID:12954644 PMID:21592394 |
|
NCBI chr 2:59,888,406...59,916,471
Ensembl chr 2:59,888,413...59,916,438
|
|
| G
|
Sla
|
src-like adaptor
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SLA mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:100,423,467...100,473,840
Ensembl chr 7:100,424,169...100,473,684
|
|
| G
|
Sla2
|
Src-like-adaptor 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SLA2 mRNA Calcitriol results in increased expression of SLA2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:165,821,164...165,848,087
Ensembl chr 3:165,828,657...165,847,062
|
|
| G
|
Slamf8
|
SLAM family member 8
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SLAMF8 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:87,580,081...87,589,941
Ensembl chr13:87,580,182...87,589,560
|
|
| G
|
Slc10a2
|
solute carrier family 10 member 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SLC10A2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr16:91,088,089...91,111,025
Ensembl chr16:91,076,423...91,111,025
|
|
| G
|
Slc10a7
|
solute carrier family 10, member 7
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SLC10A7 mRNA Calcitriol results in increased expression of SLC10A7 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:46,087,440...46,311,753
Ensembl chr19:46,049,631...46,311,753
|
|
| G
|
Slc15a1
|
solute carrier family 15 member 1
|
increases activity increases expression
|
EXP
|
Calcitriol results in increased activity of SLC15A1 protein Calcitriol results in increased expression of SLC15A1 protein
|
CTD |
PMID:21240898 PMID:21341280 |
|
NCBI chr15:104,944,461...104,991,316
Ensembl chr15:104,944,463...104,989,369
|
|
| G
|
Slc15a2
|
solute carrier family 15 member 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SLC15A2 mRNA Calcitriol results in increased expression of SLC15A2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr11:77,519,565...77,548,609
Ensembl chr11:77,519,529...77,548,606
|
|
| G
|
Slc16a14
|
solute carrier family 16, member 14
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of SLC16A14 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of SLC16A14 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:93,558,144...93,585,396
Ensembl chr 9:93,558,144...93,585,396
|
|
| G
|
Slc16a5
|
solute carrier family 16 member 5
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SLC16A5 mRNA Calcitriol results in increased expression of SLC16A5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:101,206,371...101,220,300
Ensembl chr10:101,206,398...101,220,300
|
|
| G
|
Slc17a5
|
solute carrier family 17 member 5
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SLC17A5 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SLC17A5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:88,274,497...88,309,734
Ensembl chr 8:88,274,721...88,309,664
|
|
| G
|
Slc18a2
|
solute carrier family 18 member A2
|
multiple interactions
|
ISO
|
Calcitriol inhibits the reaction [VDR protein results in increased expression of SLC18A2 mRNA]
|
CTD |
PMID:27450565 |
|
NCBI chr 1:268,399,815...268,435,229
Ensembl chr 1:268,400,016...268,435,231
|
|
| G
|
Slc18b1
|
solute carrier family 18 member B1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of SLC18B1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of SLC18B1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:23,447,462...23,490,043
Ensembl chr 1:23,447,462...23,489,962
|
|
| G
|
Slc1a1
|
solute carrier family 1 member 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SLC1A1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:235,963,455...236,043,572
Ensembl chr 1:235,963,437...236,045,469
|
|
| G
|
Slc1a3
|
solute carrier family 1 member 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SLC1A3 mRNA
|
CTD |
PMID:27107558 |
|
NCBI chr 2:59,482,707...59,557,808
Ensembl chr 2:59,482,709...59,557,808
|
|
| G
|
Slc1a6
|
solute carrier family 1 member 6
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SLC1A6 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:11,492,422...11,521,007
Ensembl chr 7:11,492,422...11,553,997
|
|
| G
|
Slc20a1
|
solute carrier family 20 member 1
|
increases expression
|
EXP
|
Calcitriol results in increased expression of SLC20A1 mRNA
|
CTD |
PMID:17989650 |
|
NCBI chr 3:136,880,360...136,894,255
Ensembl chr 3:136,880,290...136,894,249
|
|
| G
|
Slc22a18
|
solute carrier family 22, member 18
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SLC67A1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SLC67A1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:208,100,032...208,124,382
Ensembl chr 1:208,101,136...208,124,380
|
|
| G
|
Slc22a23
|
solute carrier family 22, member 23
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SLC22A23 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr17:30,749,445...30,915,139
Ensembl chr17:30,749,445...30,915,139
|
|
| G
|
Slc24a2
|
solute carrier family 24 member 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SLC24A2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:106,543,867...106,787,810
Ensembl chr 5:106,543,874...106,787,780
|
|
| G
|
Slc25a19
|
solute carrier family 25 member 19
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of SLC25A19 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of SLC25A19 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:101,353,426...101,366,551
Ensembl chr10:101,350,106...101,366,351
|
|
| G
|
Slc25a20
|
solute carrier family 25 member 20
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SLC25A20 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SLC25A20 mRNA
|
CTD |
PMID:21592394 PMID:27107558 |
|
NCBI chr 8:118,243,573...118,265,027
Ensembl chr 8:118,243,519...118,265,027
|
|
| G
|
Slc25a27
|
solute carrier family 25, member 27
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SLC25A27 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 9:24,804,183...24,831,219
Ensembl chr 9:24,804,185...24,831,217
|
|
| G
|
Slc25a4
|
solute carrier family 25 member 4
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SLC25A4 mRNA Calcitriol results in increased expression of SLC25A4 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr16:52,805,521...52,809,316
Ensembl chr16:52,805,523...52,811,700
|
|
| G
|
Slc26a3
|
solute carrier family 26 member 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SLC26A3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SLC26A3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:53,751,415...53,792,300
Ensembl chr 6:53,751,415...53,792,294
|
|
| G
|
Slc27a1
|
solute carrier family 27 member 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SLC27A1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SLC27A1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:18,311,859...18,337,024
Ensembl chr16:18,313,015...18,330,045
|
|
| G
|
Slc27a2
|
solute carrier family 27 member 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SLC27A2 mRNA
|
CTD |
PMID:27107558 |
|
NCBI chr 3:134,258,101...134,295,581
Ensembl chr 3:134,258,101...134,295,581
|
|
| G
|
Slc29a1
|
solute carrier family 29 member 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of SLC29A1 mRNA Calcitriol results in decreased expression of SLC29A1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:22,897,099...22,911,640
Ensembl chr 9:22,902,471...22,914,620
|
|
| G
|
Slc2a2
|
solute carrier family 2 member 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SLC2A2 mRNA
|
CTD |
PMID:16002434 PMID:27107558 |
|
NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:113,537,972...113,568,467
|
|
| G
|
Slc2a3
|
solute carrier family 2 member 3
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SLC2A3 mRNA Calcitriol results in increased expression of SLC2A3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:157,632,887...157,698,034
Ensembl chr 4:157,632,887...157,646,186
|
|
| G
|
Slc2a4
|
solute carrier family 2 member 4
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SLC2A4 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SLC2A4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:55,164,721...55,170,289
Ensembl chr10:55,164,721...55,170,270
|
|
| G
|
Slc2a5
|
solute carrier family 2 member 5
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SLC2A5 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:165,857,412...165,892,928
Ensembl chr 5:165,866,172...165,894,038
|
|
| G
|
Slc2a9
|
solute carrier family 2 member 9
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SLC2A9 mRNA
|
CTD |
PMID:27107558 |
|
NCBI chr14:76,540,649...76,674,277
Ensembl chr14:76,540,571...76,674,277
|
|
| G
|
Slc30a1
|
solute carrier family 30 member 1
|
multiple interactions increases expression
|
EXP ISO
|
[Calcium co-treated with Calcitriol] affects the expression of SLC30A1 mRNA Calcitriol results in increased expression of SLC30A1 mRNA
|
CTD |
PMID:15913539 PMID:16002434 |
|
NCBI chr13:106,022,019...106,025,892
Ensembl chr13:106,022,019...106,025,892
|
|
| G
|
Slc30a10
|
solute carrier family 30, member 10
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SLC30A10 mRNA; Calcitriol results in increased expression of SLC30A10 protein [Calcitriol results in increased activity of VDR protein] which results in increased expression of SLC30A10 mRNA; Calcitriol promotes the reaction [[VDR protein binds to RXRA protein] which binds to SLC30A10 promoter]
|
CTD |
PMID:27107558 |
|
NCBI chr13:99,529,664...99,584,442
Ensembl chr13:99,529,790...99,544,213
|
|
| G
|
Slc30a5
|
solute carrier family 30 member 5
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SLC30A5 mRNA
|
CTD |
PMID:20089671 |
|
NCBI chr 2:33,679,800...33,710,025
Ensembl chr 2:33,679,800...33,712,596
|
|
| G
|
Slc30a6
|
solute carrier family 30 member 6
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SLC30A6 mRNA
|
CTD |
PMID:20089671 |
|
NCBI chr 6:26,772,804...26,802,656
Ensembl chr 6:26,772,804...26,802,656
|
|
| G
|
Slc31a2
|
solute carrier family 31 member 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SLC31A2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SLC31A2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:80,753,589...80,764,126
Ensembl chr 5:80,753,618...80,764,123
|
|
| G
|
Slc34a2
|
solute carrier family 34 member 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SLC34A2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr14:62,123,313...62,153,020
Ensembl chr14:62,123,316...62,143,360
|
|
| G
|
Slc39a1
|
solute carrier family 39 member 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SLC39A1 mRNA
|
CTD |
PMID:20089671 |
|
NCBI chr 2:178,001,052...178,006,689
Ensembl chr 2:178,001,119...178,006,689
|
|
| G
|
Slc39a10
|
solute carrier family 39 member 10
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SLC39A10 mRNA
|
CTD |
PMID:20089671 |
|
NCBI chr 9:62,331,281...62,454,754
Ensembl chr 9:62,370,598...62,454,747
|
|
| G
|
Slc39a11
|
solute carrier family 39, member 11
|
increases expression decreases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SLC39A11 mRNA Calcitriol results in decreased expression of SLC39A11 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SLC39A11 mRNA
|
CTD |
PMID:20089671 PMID:21592394 |
|
NCBI chr10:98,775,155...99,196,302
Ensembl chr10:98,776,525...99,107,368
|
|
| G
|
Slc39a13
|
solute carrier family 39 member 13
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SLC39A13 mRNA
|
CTD |
PMID:20089671 |
|
NCBI chr 3:97,495,229...97,504,279
Ensembl chr 3:97,495,229...97,505,052
|
|
| G
|
Slc39a14
|
solute carrier family 39 member 14
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SLC39A14 mRNA
|
CTD |
PMID:20089671 |
|
NCBI chr15:51,786,517...51,833,260
Ensembl chr15:51,786,623...51,833,229
|
|
| G
|
Slc39a2
|
solute carrier family 39 member 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SLC39A2 mRNA
|
CTD |
PMID:27107558 |
|
NCBI chr15:27,063,699...27,066,349
Ensembl chr15:27,064,237...27,066,349
|
|
| G
|
Slc39a3
|
solute carrier family 39 member 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SLC39A3 mRNA
|
CTD |
PMID:20089671 |
|
NCBI chr 7:9,327,541...9,333,542
Ensembl chr 7:9,327,455...9,335,845
|
|
| G
|
Slc39a4
|
solute carrier family 39 member 4
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SLC39A4 mRNA
|
CTD |
PMID:20089671 |
|
NCBI chr 7:110,214,017...110,218,202
Ensembl chr 7:110,214,017...110,218,202
|
|
| G
|
Slc39a6
|
solute carrier family 39 member 6
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SLC39A6 mRNA
|
CTD |
PMID:20089671 |
|
NCBI chr18:16,139,621...16,160,163
Ensembl chr18:16,135,008...16,160,163
|
|
| G
|
Slc39a8
|
solute carrier family 39 member 8
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SLC39A8 mRNA
|
CTD |
PMID:20089671 |
|
NCBI chr 2:226,845,686...226,992,668
Ensembl chr 2:226,929,644...226,992,667
|
|
| G
|
Slc39a9
|
solute carrier family 39, member 9
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SLC39A9 mRNA
|
CTD |
PMID:20089671 |
|
NCBI chr 6:106,022,858...106,061,734
Ensembl chr 6:106,022,850...106,071,176
|
|
| G
|
Slc41a1
|
solute carrier family 41 member 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SLC41A1 mRNA Calcitriol results in increased expression of SLC41A1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:45,822,999...45,843,364
Ensembl chr13:45,822,999...45,843,657
|
|
| G
|
Slc41a2
|
solute carrier family 41 member 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SLC41A2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SLC41A2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:22,271,298...22,378,764
Ensembl chr 7:22,271,313...22,378,764
|
|
| G
|
Slc43a1
|
solute carrier family 43 member 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SLC43A1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SLC43A1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:90,327,250...90,353,438
Ensembl chr 3:90,327,149...90,353,438
|
|
| G
|
Slc43a3
|
solute carrier family 43, member 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SLC43A3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:90,414,822...90,450,654
Ensembl chr 3:90,415,977...90,436,976
|
|
| G
|
Slc44a1
|
solute carrier family 44 member 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of SLC44A1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of SLC44A1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:72,857,323...73,037,279
Ensembl chr 5:72,858,759...73,037,279
|
|
| G
|
Slc44a4
|
solute carrier family 44, member 4
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SLC44A4 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SLC44A4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:3,907,737...3,923,911
Ensembl chr20:3,907,737...3,923,854
|
|
| G
|
Slc44a5
|
solute carrier family 44, member 5
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SLC44A5 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:245,570,875...245,866,369
Ensembl chr 2:245,570,829...245,867,780
|
|
| G
|
Slc45a2
|
solute carrier family 45, member 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SLC45A2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SLC45A2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:61,690,828...61,723,437
Ensembl chr 2:61,690,828...61,723,437
|
|
| G
|
Slc46a1
|
solute carrier family 46 member 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SLC46A1 mRNA
|
CTD |
PMID:16002434 PMID:26485663 PMID:27107558 |
|
NCBI chr10:63,859,551...63,865,987
Ensembl chr10:63,859,504...63,866,869
|
|
| G
|
Slc46a2
|
solute carrier family 46, member 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SLC46A2 mRNA
|
CTD |
PMID:27107558 |
|
NCBI chr 5:79,594,003...79,603,074
Ensembl chr 5:79,595,150...79,603,114
|
|
| G
|
Slc4a11
|
solute carrier family 4 member 11
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SLC4A11 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SLC4A11 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:138,353,305...138,365,983
Ensembl chr 3:138,353,305...138,365,754
|
|
| G
|
Slc4a7
|
solute carrier family 4 member 7
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SLC4A7 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr15:13,015,854...13,095,485
Ensembl chr15:13,015,854...13,095,292
|
|
| G
|
Slc51a
|
solute carrier family 51 member A
|
multiple interactions decreases expression
|
ISO
|
[Calcitriol co-treated with Chenodeoxycholic Acid] results in decreased expression of SLC51A mRNA Calcitriol results in decreased expression of SLC51A mRNA
|
CTD |
PMID:16002434 PMID:19562681 |
|
NCBI chr11:81,804,141...81,818,539
Ensembl chr11:81,803,972...81,818,539
|
|
| G
|
Slc51b
|
SLC51 subunit beta
|
multiple interactions decreases expression
|
ISO
|
[Calcitriol co-treated with Chenodeoxycholic Acid] results in decreased expression of SLC51B mRNA Calcitriol results in decreased expression of SLC51B mRNA
|
CTD |
PMID:19562681 |
|
NCBI chr 8:74,827,047...74,835,109
Ensembl chr 8:74,827,047...74,835,109
|
|
| G
|
Slc5a3
|
solute carrier family 5 member 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SLC5A3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr11:44,799,787...44,802,233
Ensembl chr11:44,790,297...44,818,157
|
|
| G
|
Slc5a5
|
solute carrier family 5 member 5
|
multiple interactions
|
EXP
|
Calcitriol inhibits the reaction [sodium arsenite results in decreased expression of NIS protein]
|
CTD |
PMID:39771102 |
|
NCBI chr16:18,580,705...18,590,692
Ensembl chr16:18,580,705...18,590,691
|
|
| G
|
Slc66a1
|
solute carrier family 66 member 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SLC66A1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SLC66A1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:156,821,084...156,835,558
Ensembl chr 5:156,825,590...156,835,473
|
|
| G
|
Slc6a3
|
solute carrier family 6 member 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SLC6A3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SLC6A3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:31,537,990...31,578,962
|
|
| G
|
Slc7a1
|
solute carrier family 7 member 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SLC7A1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr12:11,664,488...11,740,030
Ensembl chr12:11,664,399...11,740,030
|
|
| G
|
Slc7a2
|
solute carrier family 7 member 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of SLC7A2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of SLC7A2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:58,115,991...58,174,256
Ensembl chr16:58,120,968...58,174,256
|
|
| G
|
Slc7a7
|
solute carrier family 7 member 7
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SLC7A7 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr15:31,792,122...31,852,732
Ensembl chr15:31,792,125...31,835,683
|
|
| G
|
Slc7a8
|
solute carrier family 7 member 8
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SLC7A8 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr15:32,153,016...32,212,715
Ensembl chr15:32,153,018...32,212,715
|
|
| G
|
Slc8a1
|
solute carrier family 8 member A1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SLC8A1 mRNA
|
CTD |
PMID:16857747 |
|
NCBI chr 6:18,975,498...19,299,704
Ensembl chr 6:18,946,798...19,287,964
|
|
| G
|
Slco1a4
|
solute carrier organic anion transporter family, member 1a4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SLCO1A2 mRNA
|
CTD |
PMID:16002434 PMID:27107558 |
|
NCBI chr 4:176,441,104...176,495,846
Ensembl chr 4:176,441,104...176,495,816
|
|
| G
|
Slco1b2
|
solute carrier organic anion transporter family member 1B2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SLCO1B3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:176,282,577...176,355,557
Ensembl chr 4:176,282,584...176,351,083
|
|
| G
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SLCO2B1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:163,371,410...163,419,412
Ensembl chr 1:163,371,410...163,419,279
|
|
| G
|
Slfn9
|
schlafen family member 9
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SLFN11 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:68,406,641...68,420,062
Ensembl chr10:68,406,642...68,421,134
|
|
| G
|
Slitrk3
|
SLIT and NTRK-like family, member 3
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of SLITRK3 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of SLITRK3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:159,983,650...159,996,194
Ensembl chr 2:159,973,029...159,996,342
|
|
| G
|
Slpi
|
secretory leukocyte peptidase inhibitor
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SLPI mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:173,501,573...173,503,822
Ensembl chr 3:173,501,573...173,503,822
|
|
| G
|
Smad6
|
SMAD family member 6
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SMAD6 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:73,345,457...73,414,985
Ensembl chr 8:73,345,460...73,414,149
|
|
| G
|
Smad7
|
SMAD family member 7
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SMAD7 mRNA FST protein inhibits the reaction [Calcitriol results in decreased expression of SMAD7 mRNA]
|
CTD |
PMID:16002434 PMID:23589129 |
|
NCBI chr18:71,263,508...71,291,849
Ensembl chr18:71,263,508...71,291,849
|
|
| G
|
Smagp
|
small cell adhesion glycoprotein
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of SMAGP mRNA Calcitriol results in decreased expression of SMAGP mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:133,599,043...133,617,492
Ensembl chr 7:133,599,043...133,616,642
|
|
| G
|
Smc2
|
structural maintenance of chromosomes 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of SMC2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of SMC2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:71,592,428...71,648,636
Ensembl chr 5:71,602,308...71,648,632
|
|
| G
|
Smc4
|
structural maintenance of chromosomes 4
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of SMC4 mRNA Calcitriol results in decreased expression of SMC4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:155,550,262...155,578,695
Ensembl chr 2:155,550,262...155,581,937
|
|
| G
|
Smim14
|
small integral membrane protein 14
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SMIM14 mRNA Calcitriol results in increased expression of SMIM14 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:43,136,754...43,180,622
Ensembl chr14:43,136,867...43,183,416
|
|
| G
|
Smim3
|
small integral membrane protein 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SMIM3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr18:56,200,458...56,252,778
Ensembl chr18:56,200,459...56,227,379
|
|
| G
|
Smox
|
spermine oxidase
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SMOX mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SMOX mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:139,184,793...139,220,174
Ensembl chr 3:139,184,798...139,220,170 Ensembl chr X:139,184,798...139,220,170
|
|
| G
|
Smpd1
|
sphingomyelin phosphodiesterase 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SMPD1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:169,304,772...169,308,615
Ensembl chr 1:169,304,708...169,308,614
|
|
| G
|
Snai2
|
snail family transcriptional repressor 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SNAI2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SNAI2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr11:99,686,934...99,690,349
Ensembl chr11:99,686,934...99,690,349
|
|
| G
|
Snai3
|
snail family transcriptional repressor 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SNAI3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SNAI3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:67,425,311...67,437,830
Ensembl chr19:67,425,157...67,434,268
|
|
| G
|
Snapc1
|
small nuclear RNA activating complex, polypeptide 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SNAPC1 mRNA Calcitriol results in increased expression of SNAPC1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:98,420,588...98,442,065
Ensembl chr 6:98,420,340...98,442,489
|
|
| G
|
Sncaip
|
synuclein, alpha interacting protein
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SNCAIP mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr18:48,402,164...48,542,246
Ensembl chr18:48,404,531...48,574,002
|
|
| G
|
Sncg
|
synuclein, gamma
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SNCG mRNA Calcitriol results in increased expression of SNCG mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr16:9,706,765...9,712,072
Ensembl chr16:9,706,753...9,712,076
|
|
| G
|
Snrk
|
SNF related kinase
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SNRK mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:130,657,204...130,711,461
Ensembl chr 8:130,657,266...130,711,457
|
|
| G
|
Snrpb
|
small nuclear ribonucleoprotein polypeptides B and B1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SNRPB mRNA
|
CTD |
PMID:12798352 |
|
NCBI chr 3:137,824,870...137,832,479
Ensembl chr 3:137,824,683...137,832,515
|
|
| G
|
Sntb1
|
syntrophin, beta 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SNTB1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:88,950,642...89,219,017
Ensembl chr 7:88,950,642...89,219,017
|
|
| G
|
Snx18
|
sorting nexin 18
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SNX18 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:46,965,498...46,991,516
Ensembl chr 2:46,965,498...46,991,516
|
|
| G
|
Snx25
|
sorting nexin 25
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SNX25 mRNA Calcitriol results in increased expression of SNX25 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:52,867,102...52,971,028
Ensembl chr16:52,858,532...52,971,008
|
|
| G
|
Snx30
|
sorting nexin family member 30
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SNX30 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:79,478,804...79,608,118
Ensembl chr 5:79,478,912...79,607,052
|
|
| G
|
Snx33
|
sorting nexin 33
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SNX33 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SNX33 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:66,213,133...66,224,926
Ensembl chr 8:66,213,133...66,223,509
|
|
| G
|
Snx9
|
sorting nexin 9
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SNX9 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:48,827,061...48,915,215
Ensembl chr 1:48,830,053...48,915,214
|
|
| G
|
Socs2
|
suppressor of cytokine signaling 2
|
decreases expression multiple interactions increases expression
|
ISO
|
Calcitriol results in decreased expression of SOCS2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SOCS2 mRNA Calcitriol results in increased expression of SOCS2 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 7:31,890,564...31,932,092
Ensembl chr 7:31,874,463...31,930,423
|
|
| G
|
Sod1
|
superoxide dismutase 1
|
multiple interactions
|
ISO
|
[salinomycin co-treated with Calcitriol] results in decreased expression of SOD1 mRNA; Calcitriol inhibits the reaction [bisphenol A results in decreased expression of SOD1 mRNA]
|
CTD |
PMID:35914560 PMID:38421590 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
| G
|
Sod2
|
superoxide dismutase 2
|
increases expression multiple interactions
|
EXP
|
Calcitriol results in increased expression of SOD2 protein Calcitriol promotes the reaction [bisphenol A results in increased expression of SOD2 protein]
|
CTD |
PMID:30194976 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
| G
|
Sod3
|
superoxide dismutase 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SOD3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:62,811,177...62,829,125
|
|
| G
|
Sos2
|
SOS Ras/Rho guanine nucleotide exchange factor 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SOS2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:93,778,971...93,892,161
Ensembl chr 6:93,778,971...93,892,811
|
|
| G
|
Sost
|
sclerostin
|
multiple interactions
|
ISO
|
Calcitriol promotes the reaction [BMP2 protein results in increased expression of SOST mRNA]; Calcitriol promotes the reaction [BMP4 protein results in increased expression of SOST mRNA]; Calcitriol promotes the reaction [BMP6 protein results in increased expression of SOST mRNA]
|
CTD |
PMID:15268896 |
|
NCBI chr10:87,412,722...87,415,766
Ensembl chr10:87,411,721...87,415,766
|
|
| G
|
Sowaha
|
sosondowah ankyrin repeat domain family member A
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SOWAHA mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:38,142,633...38,146,199
Ensembl chr10:38,144,782...38,147,171
|
|
| G
|
Sox10
|
SRY-box transcription factor 10
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SOX10 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 7:112,605,721...112,615,097
Ensembl chr 7:112,605,721...112,615,990
|
|
| G
|
Sox4
|
SRY-box transcription factor 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SOX4 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr17:35,876,298...35,881,004
Ensembl chr17:35,875,756...35,884,024
|
|
| G
|
Sox9
|
SRY-box transcription factor 9
|
decreases expression multiple interactions increases expression
|
ISO
|
Calcitriol results in decreased expression of SOX9 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SOX9 mRNA Calcitriol results in increased expression of SOX9 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr10:98,305,744...98,311,250
Ensembl chr10:98,305,744...98,311,250
|
|
| G
|
Sp4
|
Sp4 transcription factor
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of SP4 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of SP4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:145,330,416...145,395,750
Ensembl chr 6:145,330,416...145,395,146
|
|
| G
|
Spaca1
|
sperm acrosome associated 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SPACA1 mRNA
|
CTD |
PMID:36321694 |
|
NCBI chr 5:53,321,741...53,337,018
Ensembl chr 5:53,321,741...53,337,173
|
|
| G
|
Spag1
|
sperm associated antigen 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SPAG1 mRNA Calcitriol results in increased expression of SPAG1 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 7:69,246,301...69,306,483
Ensembl chr 7:69,246,582...69,306,482
|
|
| G
|
Spag5
|
sperm associated antigen 5
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of SPAG5 mRNA Calcitriol results in decreased expression of SPAG5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:63,693,300...63,714,813
Ensembl chr10:63,696,466...63,714,811
|
|
| G
|
Sparc
|
secreted protein acidic and cysteine rich
|
increases expression
|
EXP
|
Calcitriol results in increased expression of SPARC protein
|
CTD |
PMID:19092814 |
|
NCBI chr10:40,017,065...40,038,816
Ensembl chr10:40,017,075...40,039,268
|
|
| G
|
Sparcl1
|
SPARC like 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SPARCL1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr14:5,937,484...5,968,532
Ensembl chr14:5,914,535...5,969,120
|
|
| G
|
Spc24
|
SPC24 component of NDC80 kinetochore complex
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of SPC24 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of SPC24 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:28,576,409...28,581,481
Ensembl chr 8:28,576,409...28,581,299
|
|
| G
|
Spc25
|
SPC25 component of NDC80 kinetochore complex
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of SPC25 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of SPC25 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:74,337,872...74,396,825
Ensembl chr 3:74,383,548...74,396,718
|
|
| G
|
Spdl1
|
spindle apparatus coiled-coil protein 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of SPDL1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of SPDL1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:19,773,456...19,798,341
Ensembl chr10:19,773,457...19,798,297
|
|
| G
|
Specc1
|
sperm antigen with calponin homology and coiled-coil domains 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SPECC1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SPECC1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:47,138,351...47,412,311
Ensembl chr10:47,138,398...47,412,319
|
|
| G
|
Spin4
|
spindlin family, member 4
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of SPIN4 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of SPIN4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:63,898,338...63,902,427
Ensembl chr X:63,900,148...63,903,811
|
|
| G
|
Spint2
|
serine peptidase inhibitor, Kunitz type, 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SPINT2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:93,685,637...93,708,091
Ensembl chr 1:93,685,641...93,708,091
|
|
| G
|
Spon2
|
spondin 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SPON2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr14:81,713,070...81,742,510
Ensembl chr14:81,731,188...81,742,609
|
|
| G
|
Spp1
|
secreted phosphoprotein 1
|
multiple interactions increases expression increases activity decreases expression
|
ISO EXP
|
Calcitriol promotes the reaction [CREBBP protein binds to SPP1 promoter]; Calcitriol promotes the reaction [EP300 protein binds to SPP1 promoter]; Calcitriol promotes the reaction [MED1 protein binds to SPP1 promoter]; Calcitriol promotes the reaction [NCOA1 protein binds to SPP1 promoter]; Calcitriol promotes the reaction [NCOA2 protein binds to SPP1 promoter]; Calcitriol promotes the reaction [NCOA3 protein binds to SPP1 promoter]; Calcitriol promotes the reaction [RXRA protein binds to SPP1 promoter]; Calcitriol promotes the reaction [VDR protein binds to SPP1 promoter]; zinc chloride promotes the reaction [Calcitriol results in increased activity of SPP1 promoter] Calcitriol results in increased expression of SPP1 mRNA Calcitriol results in decreased expression of SPP1 protein [glyoxylic acid co-treated with Calcitriol] results in increased expression of SPP1 mRNA [Calcitriol co-treated with resveratrol] results in increased expression of SPP1 mRNA
|
CTD |
PMID:7571189 PMID:10777672 PMID:12016462 PMID:15647825 PMID:16267019 PMID:16889531 PMID:19092814 PMID:26485663 More...
|
|
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820
|
|
| G
|
Spring1
|
SREBF pathway regulator in golgi 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SPRING1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SPRING1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr12:43,967,146...43,990,083
Ensembl chr12:43,967,146...43,990,213
|
|
| G
|
Sprr1a
|
small proline-rich protein 1A
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SPRR1A mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:180,750,709...180,752,625
Ensembl chr 2:180,750,709...180,752,991
|
|
| G
|
Spry2
|
sprouty RTK signaling antagonist 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SPRY2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr15:89,106,809...89,111,926
Ensembl chr15:89,103,731...89,115,074
|
|
| G
|
Sptbn2
|
spectrin, beta, non-erythrocytic 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SPTBN2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:211,432,373...211,473,016
Ensembl chr 1:211,432,373...211,473,306
|
|
| G
|
Sptlc2
|
serine palmitoyltransferase, long chain base subunit 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SPTLC2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:112,679,623...112,762,470
Ensembl chr 6:112,679,623...112,762,640
|
|
| G
|
Sptssb
|
serine palmitoyltransferase, small subunit B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SPTSSB mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:156,432,509...156,461,936
Ensembl chr 2:156,432,512...156,460,909
|
|
| G
|
Sqle
|
squalene epoxidase
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SQLE mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:92,758,175...92,773,049
Ensembl chr 7:92,757,409...92,773,050
|
|
| G
|
Srebf1
|
sterol regulatory element binding transcription factor 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SREBF1 mRNA
|
CTD |
PMID:16368784 |
|
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164
|
|
| G
|
Srek1ip1
|
SREK1-interacting protein 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SREK1IP1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:37,709,712...37,733,391
Ensembl chr 2:37,709,768...37,733,383 Ensembl chr 7:37,709,768...37,733,383
|
|
| G
|
Srgap1
|
SLIT-ROBO Rho GTPase activating protein 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SRGAP1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:59,215,007...59,479,600
Ensembl chr 7:59,215,007...59,656,213
|
|
| G
|
Srgap2
|
SLIT-ROBO Rho GTPase activating protein 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SRGAP2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:45,298,192...45,519,330
Ensembl chr13:45,298,192...45,519,330
|
|
| G
|
Sri
|
sorcin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SRI mRNA; Calcitriol results in increased expression of SRI protein
|
CTD |
PMID:14996990 |
|
NCBI chr 4:26,928,338...26,952,980
Ensembl chr 4:26,923,662...26,961,361
|
|
| G
|
Srm
|
spermidine synthase
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SRM mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr 5:164,309,002...164,312,203
Ensembl chr 5:164,308,991...164,332,705
|
|
| G
|
Srpk1
|
SRSF protein kinase 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SRPK1 mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr20:6,647,539...6,684,129
Ensembl chr20:6,649,450...6,683,835
|
|
| G
|
Srrm3
|
serine/arginine repetitive matrix 3
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SRRM3 mRNA Calcitriol results in increased expression of SRRM3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr12:26,445,718...26,515,185
Ensembl chr12:26,445,718...26,515,124
|
|
| G
|
Ssc5d
|
scavenger receptor cysteine rich family member with 5 domains
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SSC5D mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:77,920,781...77,939,284
Ensembl chr 1:77,920,783...77,938,574
|
|
| G
|
Ssh1
|
slingshot protein phosphatase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SSH1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr12:48,281,756...48,343,812
Ensembl chr12:48,281,756...48,343,812
|
|
| G
|
Sspn
|
sarcospan
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SSPN mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 4:180,620,762...180,666,893
Ensembl chr 4:180,627,848...180,662,284
|
|
| G
|
St14
|
ST14 transmembrane serine protease matriptase
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ST14 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 8:37,798,994...37,839,881
Ensembl chr 8:37,798,995...37,855,652
|
|
| G
|
St3gal4
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 4
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ST3GAL4 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 8:41,673,510...41,723,158
Ensembl chr 8:41,673,510...41,712,551
|
|
| G
|
St3gal5
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 5
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ST3GAL5 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 4:105,692,840...105,750,774
Ensembl chr 4:105,692,840...105,750,775
|
|
| G
|
St3gal6
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 6
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ST3GAL6 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr11:55,530,120...55,590,950
Ensembl chr11:55,530,248...55,598,720
|
|
| G
|
St6galnac1
|
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of ST6GALNAC1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of ST6GALNAC1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:102,471,481...102,481,876
Ensembl chr10:102,471,493...102,481,876
|
|
| G
|
St6galnac2
|
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ST6GALNAC2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:102,409,048...102,427,299
Ensembl chr10:102,409,048...102,427,137
|
|
| G
|
St7
|
suppression of tumorigenicity 7
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ST7 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of ST7 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:47,007,568...47,255,639
Ensembl chr 4:47,008,095...47,255,637
|
|
| G
|
St8sia1
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ST8SIA1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:177,513,966...177,651,553
Ensembl chr 4:177,520,926...177,651,553
|
|
| G
|
Stab1
|
stabilin 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of STAB1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr16:6,336,871...6,367,374
Ensembl chr16:6,336,871...6,364,579
|
|
| G
|
Stac
|
SH3 and cysteine rich domain
|
increases expression
|
ISO
|
Calcitriol results in increased expression of STAC mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 8:120,409,165...120,531,394
Ensembl chr 8:120,409,165...120,531,320
|
|
| G
|
Stam2
|
signal transducing adaptor molecule 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of STAM2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:57,597,557...57,643,915
Ensembl chr 3:57,597,559...57,643,915
|
|
| G
|
Stambpl1
|
STAM binding protein-like 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of STAMBPL1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:241,095,695...241,158,225
Ensembl chr 1:241,113,239...241,158,225
|
|
| G
|
Stap2
|
signal transducing adaptor family member 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of STAP2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of STAP2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:915,546...924,604
Ensembl chr 9:915,550...924,380
|
|
| G
|
Stard4
|
StAR-related lipid transfer domain containing 4
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of STARD4 mRNA Calcitriol results in increased expression of STARD4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:25,088,831...25,104,172
Ensembl chr18:25,091,255...25,104,172
|
|
| G
|
Stat3
|
signal transducer and activator of transcription 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of STAT3
|
CTD |
PMID:19603526 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
| G
|
Stat5a
|
signal transducer and activator of transcription 5A
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of STAT5A mRNA [Testosterone co-treated with Calcitriol] results in increased expression of STAT5A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:86,285,859...86,310,187
Ensembl chr10:86,285,547...86,310,184
|
|
| G
|
Stat6
|
signal transducer and activator of transcription 6
|
multiple interactions
|
ISO
|
[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with IL13 protein co-treated with IL4 protein] affects the phosphorylation of STAT6 protein; [Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with IL13 protein co-treated with Nanotubes, Carbon co-treated with IL4 protein] affects the phosphorylation of STAT6 protein; [Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with IL13 protein co-treated with Nanotubes, Carbon] affects the phosphorylation of STAT6 protein; [Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with IL13 protein] affects the phosphorylation of STAT6 protein; [Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with IL4 protein co-treated with Nanotubes, Carbon] affects the phosphorylation of STAT6 protein; [Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with IL4 protein] affects the phosphorylation of STAT6 protein
|
CTD |
PMID:26091108 |
|
NCBI chr 7:65,365,505...65,382,825
Ensembl chr 7:65,365,306...65,383,795
|
|
| G
|
Stc2
|
stanniocalcin 2
|
affects expression
|
ISO
|
Calcitriol affects the expression of STC2 mRNA
|
CTD |
PMID:19918113 |
|
NCBI chr10:16,755,508...16,765,275
Ensembl chr10:16,755,267...16,767,447
|
|
| G
|
Steap3
|
STEAP3 metalloreductase
|
increases expression
|
ISO
|
Calcitriol results in increased expression of STEAP3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:33,904,710...33,950,100
Ensembl chr13:33,904,710...33,950,080
|
|
| G
|
Steap4
|
STEAP4 metalloreductase
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of STEAP4 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of STEAP4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:27,032,096...27,054,769
Ensembl chr 4:27,009,584...27,067,105
|
|
| G
|
Stil
|
STIL, centriolar assembly protein
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of STIL mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of STIL mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:133,757,598...133,810,493
Ensembl chr 5:133,760,417...133,810,494
|
|
| G
|
Stk17b
|
serine/threonine kinase 17b
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of STK17B mRNA [Testosterone co-treated with Calcitriol] results in increased expression of STK17B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:62,801,912...62,832,511
Ensembl chr 9:62,803,005...62,832,511
|
|
| G
|
Stk26
|
serine/threonine kinase 26
|
increases expression
|
ISO
|
Calcitriol results in increased expression of STK26 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr X:135,195,176...135,259,994
Ensembl chr X:135,195,204...135,259,993
|
|
| G
|
Stk39
|
serine threonine kinase 39
|
increases expression
|
ISO
|
Calcitriol results in increased expression of STK39 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:73,321,522...73,588,397
Ensembl chr 3:73,321,522...73,586,740
|
|
| G
|
Stmn1
|
stathmin 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of STMN1 mRNA Calcitriol results in decreased expression of STMN1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:151,964,308...151,970,843
Ensembl chr 5:151,964,351...151,970,842
|
|
| G
|
Stoml1
|
stomatin like 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of STOML1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:67,557,846...67,565,734
Ensembl chr 8:67,557,847...67,565,730
|
|
| G
|
Ston1
|
stonin 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of STON1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 6:11,596,726...11,646,098
Ensembl chr 6:11,572,905...11,615,635
|
|
| G
|
Sulf2
|
sulfatase 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of SULF2 mRNA Calcitriol results in increased expression of SULF2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:175,241,322...175,323,808
Ensembl chr 3:175,241,322...175,323,651
|
|
| G
|
Sult1b1
|
sulfotransferase family 1B member 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SULT1B1 mRNA
|
CTD |
PMID:27107558 |
|
NCBI chr14:20,771,917...20,784,665
Ensembl chr14:20,771,868...20,785,549
|
|
| G
|
Sult1c2a
|
sulfotransferase family 1C member 2A
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SULT1C2 mRNA
|
CTD |
PMID:27107558 |
|
NCBI chr 9:7,075,873...7,103,316
Ensembl chr 9:7,066,905...7,244,132
|
|
| G
|
Sult1c3
|
sulfotransferase family 1C member 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SULT1C1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SULT1C1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:7,548,839...7,594,299
Ensembl chr 9:7,548,622...7,594,295
|
|
| G
|
Sult2b1
|
sulfotransferase family 2B member 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SULT2B1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:105,336,614...105,397,744
Ensembl chr 1:105,336,614...105,397,744
|
|
| G
|
Susd3
|
sushi domain containing 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SUSD3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr17:15,607,259...15,623,322
Ensembl chr17:15,606,906...15,624,262
|
|
| G
|
Suv39h1
|
SUV39H1 histone lysine methyltransferase
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of SUV39H1 mRNA Calcitriol results in decreased expression of SUV39H1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:17,093,059...17,105,942
Ensembl chr X:17,092,986...17,105,942
|
|
| G
|
Suv39h1-ps1
|
SUV39H1 histone lysine methyltransferase, pseudogene 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of SUV39H1 mRNA Calcitriol results in decreased expression of SUV39H1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:146,828,818...146,831,485
|
|
| G
|
Suv39h2
|
SUV39H2 histone lysine methyltransferase
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of SUV39H2 mRNA Calcitriol results in decreased expression of SUV39H2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:79,665,467...79,684,492
Ensembl chr17:79,665,376...79,684,492
|
|
| G
|
Svep1
|
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SVEP1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:77,606,523...77,783,292
Ensembl chr 5:77,606,523...77,783,711
|
|
| G
|
Sybu
|
syntabulin
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SYBU mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:77,731,662...77,833,413
Ensembl chr 7:77,731,605...77,833,686
|
|
| G
|
Syde1
|
synapse defective Rho GTPase homolog 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SYDE1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:11,683,505...11,689,491
Ensembl chr 7:11,681,111...11,690,443
|
|
| G
|
Sync
|
syncoilin, intermediate filament protein
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SYNC mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:146,915,715...146,940,547
Ensembl chr 5:146,916,361...146,943,191
|
|
| G
|
Syngr1
|
synaptogyrin 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SYNGR1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:113,516,246...113,542,918
Ensembl chr 7:113,516,265...113,542,917
|
|
| G
|
Syngr3
|
synaptogyrin 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SYNGR3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SYNGR3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:14,215,088...14,219,844
Ensembl chr10:14,215,088...14,220,179
|
|
| G
|
Synj2
|
synaptojanin 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SYNJ2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:48,923,742...49,027,153
Ensembl chr 1:48,923,737...49,038,650
|
|
| G
|
Synm
|
synemin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SYNM mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:130,743,891...130,774,254
Ensembl chr 1:130,743,897...130,773,824
|
|
| G
|
Synpo2l
|
synaptopodin 2-like
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SYNPO2L mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SYNPO2L mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:3,681,224...3,690,673
Ensembl chr15:3,681,104...3,690,673
|
|
| G
|
Syt1
|
synaptotagmin 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SYT1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:45,699,649...46,244,460
Ensembl chr 7:45,702,228...46,244,213
|
|
| G
|
Syt12
|
synaptotagmin 12
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SYT12 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 1:211,158,745...211,189,780
Ensembl chr 1:211,159,800...211,189,037
|
|
| G
|
Syt8
|
synaptotagmin 8
|
increases expression
|
ISO
|
Calcitriol results in increased expression of SYT8 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:207,017,602...207,023,076
Ensembl chr 1:207,017,461...207,023,076
|
|
| G
|
Sytl3
|
synaptotagmin-like 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of SYTL3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:49,300,935...49,372,533
Ensembl chr 1:49,302,182...49,372,531
|
|
| G
|
Tacc3
|
transforming, acidic coiled-coil containing protein 3
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TACC3 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TACC3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:81,275,755...81,289,894
Ensembl chr14:81,275,755...81,289,698
|
|
| G
|
Tacstd2
|
tumor-associated calcium signal transducer 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TACSTD2 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 4:98,037,620...98,039,320
Ensembl chr 4:98,033,251...98,039,323
|
|
| G
|
Tanc1
|
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of TANC1 mRNA Calcitriol results in decreased expression of TANC1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:64,508,037...64,741,826
Ensembl chr 3:64,508,085...64,741,825
|
|
| G
|
Taok3
|
TAO kinase 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TAOK3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr12:44,973,180...45,134,439
Ensembl chr12:44,973,180...45,134,439
|
|
| G
|
Tbc1d1
|
TBC1 domain family member 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of TBC1D1 mRNA Calcitriol results in increased expression of TBC1D1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:44,289,241...44,489,246
Ensembl chr14:44,289,241...44,488,167
|
|
| G
|
Tbc1d2
|
TBC1 domain family, member 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TBC1D2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TBC1D2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:65,679,670...65,727,978
Ensembl chr 5:65,679,680...65,726,996
|
|
| G
|
Tbc1d8
|
TBC1 domain family, member 8
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TBC1D8 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TBC1D8 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:49,147,109...49,257,140
Ensembl chr 9:49,147,109...49,257,118
|
|
| G
|
Tbx15
|
T-box transcription factor 15
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TBX15 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TBX15 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:189,265,373...189,376,466
Ensembl chr 2:189,265,373...189,376,466
|
|
| G
|
Tbxas1
|
thromboxane A synthase 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TBXAS1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TBXAS1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:68,631,841...68,803,959
Ensembl chr 4:68,631,838...68,803,969
|
|
| G
|
Tcea2
|
transcription elongation factor A2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TCEA2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:189,173,756...189,181,633
Ensembl chr 3:189,165,603...189,182,540
|
|
| G
|
Tceal1
|
transcription elongation factor A like 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TCEAL1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr X:104,850,775...104,852,724
Ensembl chr X:104,850,136...104,853,085
|
|
| G
|
Tcf12
|
transcription factor 12
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of TCF12 mRNA
|
CTD |
PMID:12875902 |
|
NCBI chr 8:81,371,201...81,682,337
Ensembl chr 8:81,373,321...81,679,922
|
|
| G
|
Tcf19
|
transcription factor 19
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of TCF19 mRNA Calcitriol results in decreased expression of TCF19 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:3,223,464...3,227,569
Ensembl chr20:3,223,324...3,230,060
|
|
| G
|
Tcf7l1
|
transcription factor 7 like 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of TCF7L1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:106,238,892...106,404,012
Ensembl chr 4:106,238,896...106,403,421
|
|
| G
|
Tcim
|
transcriptional and immune response regulator
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TCIM mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TCIM mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:74,298,344...74,299,637
Ensembl chr16:74,298,344...74,299,636
|
|
| G
|
Tcof1
|
treacle ribosome biogenesis factor 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TCOF1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TCOF1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:56,537,437...56,570,727
Ensembl chr18:56,537,437...56,570,727
|
|
| G
|
Tdrkh
|
tudor and KH domain containing
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TDRKH mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:184,736,255...184,760,534
Ensembl chr 2:184,737,591...184,762,052
|
|
| G
|
Tead4
|
TEA domain transcription factor 4
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TEAD4 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TEAD4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:163,180,192...163,258,342
Ensembl chr 4:163,180,192...163,258,479
|
|
| G
|
Tedc2
|
tubulin epsilon and delta complex 2
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of TEDC2 mRNA Calcitriol results in decreased expression of TEDC2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:13,750,586...13,755,775
Ensembl chr10:13,750,595...13,755,824
|
|
| G
|
Tenm3
|
teneurin transmembrane protein 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of TENM3 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr16:47,984,732...50,711,352
Ensembl chr16:49,829,750...50,711,352
|
|
| G
|
Tent5b
|
terminal nucleotidyltransferase 5B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TENT5B mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:150,979,238...150,986,548
Ensembl chr11:27,212,316...27,214,238 Ensembl chr 5:27,212,316...27,214,238
|
|
| G
|
Tert
|
telomerase reverse transcriptase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TERT mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TERT mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:31,466,056...31,488,111
|
|
| G
|
Tex30
|
testis expressed 30
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TEX30 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TEX30 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:53,735,512...53,744,672
Ensembl chr 9:53,735,512...53,741,042
|
|
| G
|
Tfam
|
transcription factor A, mitochondrial
|
increases expression multiple interactions
|
EXP
|
Calcitriol results in increased expression of TFAM protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol results in increased expression of TFAM protein]
|
CTD |
PMID:30194976 |
|
NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,355,363...17,369,877
|
|
| G
|
Tfap2a
|
transcription factor AP-2 alpha
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TFAP2A mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr17:24,230,064...24,253,219
Ensembl chr17:24,229,910...24,253,219
|
|
| G
|
Tfap4
|
transcription factor AP-4
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TFAP4 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TFAP4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:11,507,242...11,525,794
Ensembl chr10:11,485,565...11,525,794
|
|
| G
|
Tfcp2l1
|
transcription factor CP2-like 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TFCP2L1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr13:32,286,643...32,346,671
Ensembl chr13:32,286,643...32,346,671
|
|
| G
|
Tfdp2
|
transcription factor Dp-2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of TFDP2 mRNA
|
CTD |
PMID:16129123 |
|
NCBI chr 8:105,640,018...105,781,026
Ensembl chr 8:105,640,033...105,781,001
|
|
| G
|
Tff1
|
trefoil factor 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TFF1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr20:9,237,095...9,240,956
Ensembl chr20:9,237,095...9,240,956
|
|
| G
|
Tg
|
thyroglobulin
|
increases expression multiple interactions
|
ISO EXP
|
Calcitriol results in increased expression of TG mRNA Calcitriol inhibits the reaction [sodium arsenite results in decreased expression of TG protein] [Testosterone co-treated with Calcitriol] results in increased expression of TG mRNA
|
CTD |
PMID:21592394 PMID:39771102 |
|
NCBI chr 7:100,307,349...100,492,246
Ensembl chr 7:100,307,349...100,314,539 Ensembl chr 7:100,307,349...100,314,539
|
|
| G
|
Tgfa
|
transforming growth factor alpha
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TGFA mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:120,175,549...120,258,342
Ensembl chr 4:120,175,593...120,258,339
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
multiple interactions affects response to substance decreases expression
|
EXP ISO
|
[Calcitriol co-treated with TGFB1 protein] results in increased phosphorylation of MAPK14 protein; bisphenol A diglycidyl ether inhibits the reaction [Calcitriol inhibits the reaction [Streptozocin results in increased expression of TGFB1 mRNA]]; bisphenol A diglycidyl ether inhibits the reaction [Calcitriol inhibits the reaction [Streptozocin results in increased expression of TGFB1 protein]]; Calcitriol inhibits the reaction [[Lipopolysaccharides co-treated with Glucose] results in increased secretion of TGFB1 protein]; Calcitriol inhibits the reaction [Streptozocin results in increased expression of TGFB1 mRNA]; Calcitriol inhibits the reaction [Streptozocin results in increased expression of TGFB1 protein]; Calcitriol promotes the reaction [TGFB1 protein results in increased secretion of VEGFA protein]; SB 203580 inhibits the reaction [[Calcitriol co-treated with TGFB1 protein] results in increased secretion of VEGFA protein] Calcitriol inhibits the reaction [sodium arsenite results in increased expression of TGFB1 protein] Calcitriol inhibits the reaction [Bleomycin results in increased expression of TGFB1 mRNA] TGFB1 gene SNP affects the susceptibility to Calcitriol Calcitriol results in decreased expression of TGFB1 protein
|
CTD |
PMID:10750555 PMID:16598785 PMID:19092814 PMID:21788014 PMID:26520185 PMID:29953732 PMID:37968493 More...
|
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Tgfb2
|
transforming growth factor, beta 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of TGFB2 mRNA Calcitriol results in increased expression of TGFB2 mRNA
|
CTD |
PMID:16002434 PMID:21592394 PMID:26485663 |
|
NCBI chr13:100,691,540...100,793,227
Ensembl chr13:100,692,953...100,792,856
|
|
| G
|
Tgfb3
|
transforming growth factor, beta 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TGFB3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TGFB3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:111,435,170...111,457,646
Ensembl chr 6:111,435,170...111,456,946
|
|
| G
|
Tgfbr2
|
transforming growth factor, beta receptor 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of TGFBR2 mRNA Calcitriol results in increased expression of TGFBR2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:124,672,677...124,761,741
Ensembl chr 8:124,674,986...124,761,469
|
|
| G
|
Tgm1
|
transglutaminase 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of TGM1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr15:33,160,985...33,175,632
Ensembl chr15:33,160,987...33,174,463
|
|
| G
|
Tgm2
|
transglutaminase 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of TGM2 mRNA Calcitriol results in increased expression of TGM2 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 3:167,192,612...167,221,845
Ensembl chr 3:167,192,612...167,304,240
|
|
| G
|
Tgm3
|
transglutaminase 3
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of TGM3 mRNA Calcitriol results in decreased expression of TGM3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:137,681,809...137,717,219
Ensembl chr 3:137,681,809...137,717,219
|
|
| G
|
Tgm4
|
transglutaminase 4
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TGM4 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TGM4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:131,566,887...131,603,920
Ensembl chr 8:131,566,887...131,603,920
|
|
| G
|
Th
|
tyrosine hydroxylase
|
multiple interactions decreases expression
|
ISO EXP
|
[Calcitriol co-treated with VDR protein] results in increased expression of TH mRNA; [Calcitriol co-treated with VDR protein] results in increased expression of TH protein Calcitriol results in decreased expression of TH protein
|
CTD |
PMID:26210580 PMID:32147540 |
|
NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:207,500,962...207,557,227
|
|
| G
|
Thbd
|
thrombomodulin
|
increases expression
|
ISO
|
Calcitriol results in increased expression of THBD mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:156,306,632...156,320,582
|
|
| G
|
Thbs2
|
thrombospondin 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of THBS2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:64,343,523...64,372,918
Ensembl chr 1:64,343,523...64,372,918
|
|
| G
|
Thoc1
|
THO complex subunit 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of THOC1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of THOC1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:1,253,041...1,291,956
Ensembl chr18:1,256,637...1,292,630
|
|
| G
|
Thpo
|
thrombopoietin
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of THPO protein
|
CTD |
PMID:18379402 |
|
Ensembl chr11:93,686,834...93,693,320
|
|
| G
|
Thrb
|
thyroid hormone receptor beta
|
increases expression
|
ISO
|
Calcitriol results in increased expression of THRB mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr15:10,115,954...10,465,231
Ensembl chr15:10,115,954...10,313,680
|
|
| G
|
Thsd4
|
thrombospondin type 1 domain containing 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of THSD4 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 8:69,280,397...69,880,144
Ensembl chr 8:69,284,646...69,917,342
|
|
| G
|
Thy1
|
Thy-1 cell surface antigen
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of THY1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 8:53,286,396...53,291,541
Ensembl chr 8:53,286,148...53,291,540
|
|
| G
|
Tiam1
|
TIAM Rac1 associated GEF 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TIAM1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr11:42,517,527...42,866,280
Ensembl chr11:42,517,528...42,646,075
|
|
| G
|
Ticrr
|
TOPBP1-interacting checkpoint and replication regulator
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TICRR mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TICRR mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:143,006,989...143,048,836
Ensembl chr 1:143,006,924...143,049,133
|
|
| G
|
Timm21
|
translocase of inner mitochondrial membrane 21
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TIMM21 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TIMM21 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:80,589,775...80,594,237
Ensembl chr18:80,589,783...80,594,237
|
|
| G
|
Timp2
|
TIMP metallopeptidase inhibitor 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TIMP2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:104,041,604...104,089,214
Ensembl chr10:104,041,604...104,089,214
|
|
| G
|
Timp3
|
TIMP metallopeptidase inhibitor 3
|
decreases expression increases expression
|
ISO
|
Calcitriol results in decreased expression of TIMP3 mRNA Calcitriol results in increased expression of TIMP3 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr 7:19,408,539...19,459,558
Ensembl chr 7:19,409,631...19,459,547
|
|
| G
|
Tinag
|
tubulointerstitial nephritis antigen
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TINAG mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:86,680,441...86,765,485
Ensembl chr 8:86,680,442...86,765,485
|
|
| G
|
Tinagl1
|
tubulointerstitial nephritis antigen-like 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TINAGL1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:147,797,884...147,807,925
Ensembl chr 5:147,797,892...147,807,871
|
|
| G
|
Tiparp
|
TCDD-inducible poly(ADP-ribose) polymerase
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TIPARP mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TIPARP mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:152,063,769...152,090,414
Ensembl chr 2:152,063,751...152,090,406
|
|
| G
|
Tjp2
|
tight junction protein 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TJP2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:231,136,218...231,264,750
Ensembl chr 1:231,136,243...231,264,750
|
|
| G
|
Tjp3
|
tight junction protein 3
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of TJP3 mRNA Calcitriol results in increased expression of TJP3 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 7:9,078,757...9,097,003
Ensembl chr 7:9,084,315...9,096,984
|
|
| G
|
Tk1
|
thymidine kinase 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TK1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TK1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:103,533,449...103,544,818
Ensembl chr10:103,533,449...103,556,228
|
|
| G
|
Tlcd3a
|
TLC domain containing 3A
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of TLCD3A mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:61,556,193...61,563,529
Ensembl chr10:61,556,199...61,563,527
|
|
| G
|
Tlcd4
|
TLC domain containing 4
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TLCD4 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TLCD4 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:211,969,612...212,044,883
Ensembl chr 2:211,974,471...212,026,081
|
|
| G
|
Tlr3
|
toll-like receptor 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TLR3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TLR3 mRNA
|
CTD |
PMID:19918113 PMID:21592394 |
|
NCBI chr16:53,554,916...53,572,321
Ensembl chr16:53,555,131...53,568,385
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
decreases expression
|
EXP
|
Calcitriol results in decreased expression of TLR4 mRNA; Calcitriol results in decreased expression of TLR4 protein
|
CTD |
PMID:32147540 |
|
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
| G
|
Tm4sf1
|
transmembrane 4 L six family member 1
|
multiple interactions increases expression decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of TM4SF1 mRNA Calcitriol results in increased expression of TM4SF1 mRNA Calcitriol results in decreased expression of TM4SF1 mRNA
|
CTD |
PMID:16002434 PMID:21592394 PMID:26485663 |
|
NCBI chr 2:143,606,980...143,616,176
Ensembl chr 2:143,603,271...143,616,176
|
|
| G
|
Tmc4
|
transmembrane channel-like 4
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of TMC4 mRNA Calcitriol results in increased expression of TMC4 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 1:74,455,135...74,467,043
Ensembl chr 1:74,454,909...74,467,043
|
|
| G
|
Tmc6
|
transmembrane channel like 6
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TMC6 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TMC6 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr10:103,480,762...103,498,207
Ensembl chr10:103,480,762...103,497,398
|
|
| G
|
Tmcc3
|
transmembrane and coiled-coil domain family 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TMCC3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TMCC3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:30,781,452...31,058,888
Ensembl chr 7:30,897,991...31,058,889
|
|
| G
|
Tmco3
|
transmembrane and coiled-coil domains 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of SLC9D1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of SLC9D1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:82,919,324...82,956,485
Ensembl chr16:82,919,324...82,956,485
|
|
| G
|
Tmem100
|
transmembrane protein 100
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TMEM100 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TMEM100 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:75,351,891...75,357,748
Ensembl chr10:75,351,271...75,360,364
|
|
| G
|
Tmem102
|
transmembrane protein 102
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TMEM102 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TMEM102 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:55,022,625...55,025,676
Ensembl chr10:55,021,303...55,024,668
|
|
| G
|
Tmem106b
|
transmembrane protein 106B
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of TMEM106B mRNA Calcitriol results in increased expression of TMEM106B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:42,294,074...42,313,426
Ensembl chr 4:42,294,101...42,313,407
|
|
| G
|
Tmem107
|
transmembrane protein 107
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TMEM107 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TMEM107 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:54,268,218...54,273,520
Ensembl chr10:54,271,196...54,278,586
|
|
| G
|
Tmem117
|
transmembrane protein 117
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TMEM117 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:127,636,862...128,098,944
Ensembl chr 7:127,636,825...128,098,941
|
|
| G
|
Tmem121b
|
transmembrane protein 121B
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of TMEM121B mRNA Calcitriol results in increased expression of TMEM121B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:155,367,397...155,372,310
Ensembl chr 4:155,355,267...155,373,376
|
|
| G
|
Tmem156
|
transmembrane protein 156
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TMEM156 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr14:43,568,131...43,606,109
Ensembl chr14:43,577,023...43,606,109
|
|
| G
|
Tmem158
|
transmembrane protein 158
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TMEM158 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:131,791,137...131,792,135
Ensembl chr 8:131,787,277...131,796,882
|
|
| G
|
Tmem176a
|
transmembrane protein 176A
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of TMEM176A mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 4:79,101,946...79,109,499
Ensembl chr 4:79,101,857...79,111,175
|
|
| G
|
Tmem176b
|
transmembrane protein 176B
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of TMEM176B mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 4:79,097,808...79,105,263
Ensembl chr 4:79,097,808...79,105,263
|
|
| G
|
Tmem200a
|
transmembrane protein 200A
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of TMEM200A mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:21,142,500...21,242,022
Ensembl chr 1:21,141,432...21,426,175
|
|
| G
|
Tmem200b
|
transmembrane protein 200B
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of TMEM200B mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:149,391,865...149,394,621
Ensembl chr 5:149,387,441...149,409,282
|
|
| G
|
Tmem201
|
transmembrane protein 201
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of TMEM201 mRNA Calcitriol results in decreased expression of TMEM201 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:165,449,270...165,471,901
Ensembl chr 5:165,449,858...165,471,922
|
|
| G
|
Tmem30b
|
transmembrane protein 30B
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TMEM30B mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 6:97,987,471...97,990,546
Ensembl chr 6:97,987,130...97,991,170
|
|
| G
|
Tmem37
|
transmembrane protein 37
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of TMEM37 mRNA Calcitriol results in increased expression of TMEM37 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr13:33,737,096...33,743,602
Ensembl chr13:33,736,308...33,743,747
|
|
| G
|
Tmem40
|
transmembrane protein 40
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TMEM40 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:150,464,123...150,491,895
Ensembl chr 4:150,464,128...150,492,183
|
|
| G
|
Tmem79
|
transmembrane protein 79
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of TMEM79 mRNA Calcitriol results in increased expression of TMEM79 mRNA
|
CTD |
PMID:16002434 PMID:21592394 PMID:26485663 |
|
NCBI chr 2:176,096,092...176,100,996
Ensembl chr 2:176,096,092...176,100,870
|
|
| G
|
Tmem87b
|
transmembrane protein 87B
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TMEM87B mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TMEM87B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:136,515,155...136,550,644
Ensembl chr 3:136,515,183...136,550,640
|
|
| G
|
Tmem91
|
transmembrane protein 91
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TMEM91 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:90,307,264...90,314,796
Ensembl chr 1:90,306,289...90,313,320
|
|
| G
|
Tmod1
|
tropomodulin 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TMOD1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:65,112,062...65,189,563
Ensembl chr 5:65,134,132...65,189,561
|
|
| G
|
Tmpo
|
thymopoietin
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TMPO mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TMPO mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:27,529,977...27,554,980
Ensembl chr 7:27,529,978...27,554,937
|
|
| G
|
Tmprss11e
|
transmembrane serine protease 11E
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TMPRSS11E mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TMPRSS11E mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:21,638,418...21,683,029
Ensembl chr14:21,638,418...21,683,029
|
|
| G
|
Tmsb15b2
|
thymosin beta 15B2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TMSB15A mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TMSB15A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr X:105,090,980...105,093,094
Ensembl chr X:105,090,980...105,093,094
|
|
| G
|
Tmt1a
|
thiol methyltransferase 1A
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of TMT1A mRNA Calcitriol results in decreased expression of TMT1A mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 7:133,330,141...133,377,172
Ensembl chr 7:133,330,447...133,338,959
|
|
| G
|
Tmtc2
|
transmembrane O-mannosyltransferase targeting cadherins 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of TMTC2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:42,280,746...42,695,651
Ensembl chr 7:42,280,746...42,693,350
|
|
| G
|
Tnc
|
tenascin C
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of TNC mRNA
|
CTD |
PMID:12040012 |
|
NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:82,391,340...82,476,131
|
|
| G
|
Tnf
|
tumor necrosis factor
|
increases expression decreases expression multiple interactions
|
ISO EXP
|
Calcitriol results in increased expression of TNF mRNA Calcitriol results in decreased expression of TNF mRNA [Calcitriol co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased secretion of TNF protein; [CD40LG protein co-treated with Calcitriol] results in decreased secretion of and results in decreased expression of TNF protein; [Testosterone co-treated with Calcitriol] results in increased expression of TNF mRNA; Calcitriol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Calcitriol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Calcitriol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; Calcitriol promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Calcitriol promotes the reaction [Lipopolysaccharides results in increased expression of TNF protein]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [[Calcitriol co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased secretion of TNF protein] Calcitriol results in decreased expression of TNF mRNA; Calcitriol results in decreased expression of TNF protein Calcitriol inhibits the reaction [Bleomycin results in increased expression of TNF mRNA]; Calcitriol inhibits the reaction [Okadaic Acid results in increased expression of TNF protein] Calcitriol inhibits the reaction [[Lipopolysaccharides co-treated with Glucose] results in increased secretion of TNF protein]; Calcitriol inhibits the reaction [sodium arsenite results in increased secretion of TNF protein]
|
CTD |
PMID:1450407 PMID:10757128 PMID:11135059 PMID:17570329 PMID:19186073 PMID:20089671 PMID:21592394 PMID:21788014 PMID:22615136 PMID:26520185 PMID:32147540 PMID:34255241 PMID:39771102 More...
|
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnfaip2
|
TNF alpha induced protein 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TNFAIP2 mRNA
|
CTD |
PMID:16129123 |
|
NCBI chr 6:136,297,388...136,311,106
Ensembl chr 6:136,298,082...136,311,106
|
|
| G
|
Tnfaip3
|
TNF alpha induced protein 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TNFAIP3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TNFAIP3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:15,528,921...15,543,993
Ensembl chr 1:15,528,921...15,543,979
|
|
| G
|
Tnfaip8
|
TNF alpha induced protein 8
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TNFAIP8 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr18:45,370,334...45,486,036
Ensembl chr18:45,370,406...45,486,036
|
|
| G
|
Tnfaip8l3
|
TNF alpha induced protein 8 like 3
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TNFAIP8L3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:63,309,683...63,351,687
Ensembl chr 8:63,310,107...63,318,501
|
|
| G
|
Tnfrsf11b
|
TNF receptor superfamily member 11B
|
increases expression decreases expression
|
ISO EXP
|
Calcitriol results in increased expression of TNFRSF11B mRNA Calcitriol results in decreased expression of TNFRSF11B protein
|
CTD |
PMID:16813520 PMID:19092814 |
|
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:87,456,319...87,485,075
|
|
| G
|
Tnfrsf12a
|
TNF receptor superfamily member 12A
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TNFRSF12A mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TNFRSF12A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:13,211,670...13,213,666
Ensembl chr10:13,211,673...13,213,704
|
|
| G
|
Tnfrsf19
|
TNF receptor superfamily member 19
|
increases expression decreases expression
|
ISO
|
Calcitriol results in increased expression of TNFRSF19 mRNA Calcitriol results in decreased expression of TNFRSF19 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr15:39,268,305...39,334,566
Ensembl chr15:39,268,305...39,356,438
|
|
| G
|
Tnfrsf21
|
TNF receptor superfamily member 21
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TNFRSF21 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 9:25,376,400...25,451,323
Ensembl chr 9:25,376,400...25,451,323
|
|
| G
|
Tnfrsf8
|
TNF receptor superfamily member 8
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of TNFRSF8 protein
|
CTD |
PMID:12441127 |
|
NCBI chr 5:162,406,387...162,451,620
Ensembl chr 5:162,406,387...162,451,620
|
|
| G
|
Tnfsf11
|
TNF superfamily member 11
|
increases expression multiple interactions
|
ISO EXP
|
Calcitriol results in increased expression of TNFSF11 mRNA menatetrenone inhibits the reaction [Calcitriol results in increased expression of TNFSF11 mRNA] Calcitriol results in increased expression of TNFSF11 mRNA; Calcitriol results in increased expression of TNFSF11 protein
|
CTD |
PMID:11113387 PMID:16813520 PMID:17293108 PMID:17352647 |
|
NCBI chr15:60,083,008...60,114,479
Ensembl chr15:60,083,008...60,114,479
|
|
| G
|
Tnfsf13
|
TNF superfamily member 13
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of TNFSF13 mRNA Calcitriol results in increased expression of TNFSF13 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:54,898,805...54,901,815
Ensembl chr10:54,898,805...54,901,815
|
|
| G
|
Tnfsf15
|
TNF superfamily member 15
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of TNFSF15 mRNA Calcitriol results in increased expression of TNFSF15 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:82,150,376...82,171,743
Ensembl chr 5:82,150,376...82,171,882
|
|
| G
|
Tnk1
|
tyrosine kinase, non-receptor, 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TNK1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:55,070,362...55,084,383
Ensembl chr10:55,069,837...55,078,710
|
|
| G
|
Tnn
|
tenascin N
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of TNN mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:74,852,586...74,919,789
Ensembl chr13:74,852,586...74,919,789
|
|
| G
|
Tnnt1
|
troponin T1, slow skeletal type
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TNNT1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 1:78,349,035...78,359,394
Ensembl chr 1:78,349,035...78,359,394
|
|
| G
|
Tnpo1
|
transportin 1
|
decreases expression decreases activity multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TNPO1 mRNA Calcitriol results in decreased activity of TNPO1 protein [Calcitriol promotes the reaction [TXNIP protein binds to TNPO1 protein]] which results in increased activity of MAP3K5 protein; Calcitriol promotes the reaction [TXNIP protein binds to TNPO1 protein]
|
CTD |
PMID:10843682 PMID:16847355 |
|
NCBI chr 2:31,941,731...32,034,366
Ensembl chr 2:31,941,731...32,034,326
|
|
| G
|
Tnpo2
|
transportin 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of TNPO2 mRNA
|
CTD |
PMID:16847355 PMID:18614847 |
|
NCBI chr19:40,004,271...40,024,565
Ensembl chr19:40,004,275...40,024,187
|
|
| G
|
Tns4
|
tensin 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TNS4 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:84,518,179...84,537,558
Ensembl chr10:84,518,180...84,537,558
|
|
| G
|
Tonsl
|
tonsoku-like, DNA repair protein
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TONSL mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TONSL mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:110,226,696...110,241,459
Ensembl chr 7:110,225,525...110,241,397
|
|
| G
|
Top2a
|
DNA topoisomerase II alpha
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TOP2A mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TOP2A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:84,441,954...84,473,093
Ensembl chr10:84,441,954...84,473,366
|
|
| G
|
Top6bl
|
TOP6B like initiator of meiotic double strand breaks
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of TOP6BL mRNA Calcitriol results in increased expression of TOP6BL mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:211,331,973...211,419,015
Ensembl chr 1:211,331,827...211,419,015
|
|
| G
|
Topbp1
|
DNA topoisomerase II binding protein 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TOPBP1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TOPBP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:112,766,791...112,815,203
Ensembl chr 8:112,766,508...112,810,540
|
|
| G
|
Tor1aip1
|
torsin 1A interacting protein 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TOR1AIP1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TOR1AIP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:70,746,941...70,776,382
Ensembl chr13:70,746,941...70,776,123
|
|
| G
|
Tor1aip2
|
torsin 1A interacting protein 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of TOR1AIP2 mRNA Calcitriol results in increased expression of TOR1AIP2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:70,775,483...70,806,794
Ensembl chr13:70,780,275...70,806,789 Ensembl chr13:70,780,275...70,806,789
|
|
| G
|
Tox3
|
TOX high mobility group box family member 3
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TOX3 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TOX3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:32,820,957...32,929,776
Ensembl chr19:32,820,977...32,929,776
|
|
| G
|
Tp53
|
tumor protein p53
|
increases expression decreases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TP53 protein Calcitriol results in decreased expression of TP53 protein Calcitriol inhibits the reaction [bisphenol A results in increased expression of TP53 protein]
|
CTD |
PMID:12071473 PMID:38725370 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Tp53i3
|
tumor protein p53 inducible protein 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of TP53I3 mRNA
|
CTD |
PMID:12798352 |
|
NCBI chr 6:33,537,779...33,545,204
|
|
| G
|
Tp53inp2
|
tumor protein p53 inducible nuclear protein 2
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TP53INP2 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TP53INP2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:164,341,618...164,350,270
Ensembl chr 3:164,343,205...164,350,225
|
|
| G
|
Tp63
|
tumor protein p63
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TP63 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr11:88,343,647...88,554,543
Ensembl chr11:88,343,651...88,554,177
|
|
| G
|
Tp73
|
tumor protein p73
|
multiple interactions
|
ISO
|
[[Etoposide results in increased expression of TP73 protein] which results in increased expression of VDR protein] which results in increased susceptibility to Calcitriol
|
CTD |
PMID:17716971 |
|
NCBI chr 5:169,903,801...169,988,075
Ensembl chr 5:169,903,801...169,963,552
|
|
| G
|
Tpbg
|
trophoblast glycoprotein
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TPBG mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TPBG mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 8:95,673,993...95,677,364
Ensembl chr 8:95,629,267...95,678,394
|
|
| G
|
Tpd52
|
tumor protein D52
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TPD52 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:94,642,514...94,723,442
Ensembl chr 2:94,642,585...94,724,241
|
|
| G
|
Tpd52l1
|
TPD52 like 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of TPD52L1 mRNA Calcitriol results in increased expression of TPD52L1 mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 1:27,991,114...28,109,767
Ensembl chr 1:27,991,131...28,110,158
|
|
| G
|
Tpo
|
thyroid peroxidase
|
multiple interactions
|
EXP
|
Calcitriol inhibits the reaction [sodium arsenite results in decreased expression of TPO protein]
|
CTD |
PMID:39771102 |
|
NCBI chr 6:52,425,998...52,495,793
Ensembl chr 6:52,426,010...52,495,793
|
|
| G
|
Tpst1
|
tyrosylprotein sulfotransferase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TPST1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr12:32,180,688...32,247,478
Ensembl chr12:32,180,936...32,241,821
|
|
| G
|
Tpx2
|
TPX2, microtubule nucleation factor
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TPX2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TPX2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:161,778,709...161,820,941
Ensembl chr 3:161,778,742...161,820,724
|
|
| G
|
Traf1
|
TNF receptor-associated factor 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of TRAF1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:38,607,707...38,639,641
Ensembl chr 3:38,619,506...38,636,264
|
|
| G
|
Traf3ip2
|
Traf3 interacting protein 2
|
multiple interactions
|
ISO
|
Calcitriol inhibits the reaction [Bleomycin results in increased phosphorylation of ACT1 protein]
|
CTD |
PMID:26520185 |
|
NCBI chr20:44,565,992...44,609,240
Ensembl chr20:44,517,242...44,609,618
|
|
| G
|
Traf4
|
Tnf receptor associated factor 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TRAF4 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:63,552,251...63,558,356
Ensembl chr10:63,552,253...63,558,356
|
|
| G
|
Traip
|
TRAF-interacting protein
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TRAIP mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TRAIP mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:117,520,476...117,540,253
Ensembl chr 8:117,520,441...117,540,253
|
|
| G
|
Tram2
|
translocation associated membrane protein 2
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of TRAM2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 9:30,915,624...30,995,162
Ensembl chr 9:30,915,624...30,995,162
|
|
| G
|
Trank1
|
tetratricopeptide repeat and ankyrin repeat containing 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TRANK1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TRANK1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:120,153,381...120,233,879
Ensembl chr 8:120,154,362...120,234,087
|
|
| G
|
Trem1
|
triggering receptor expressed on myeloid cells 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TREM1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 9:20,259,227...20,276,879
Ensembl chr 9:20,261,408...20,276,892
|
|
| G
|
Trex1
|
three prime repair exonuclease 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TREX1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TREX1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:118,585,082...118,586,382
Ensembl chr 8:118,585,081...118,586,083
|
|
| G
|
Trib1
|
tribbles pseudokinase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TRIB1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:93,096,001...93,102,547
Ensembl chr 7:93,095,973...93,117,480
|
|
| G
|
Trim13
|
tripartite motif-containing 13
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TRIM13 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TRIM13 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:39,909,587...39,948,719
Ensembl chr15:39,902,284...39,958,892
|
|
| G
|
Trim16
|
tripartite motif-containing 16
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of TRIM16 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:47,985,235...48,008,242
Ensembl chr10:47,958,677...48,051,136
|
|
| G
|
Trim2
|
tripartite motif-containing 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TRIM2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:171,798,654...171,950,193
Ensembl chr 2:171,798,660...171,913,468
|
|
| G
|
Trim24
|
tripartite motif-containing 24
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TRIM24 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:67,534,240...67,659,014
Ensembl chr 4:67,534,335...67,684,226
|
|
| G
|
Trim29
|
tripartite motif-containing 29
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TRIM29 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 8:52,579,175...52,603,919
Ensembl chr 8:52,579,175...52,603,919
|
|
| G
|
Trim38
|
tripartite motif containing 38
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TRIM38 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TRIM38 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr17:41,774,419...41,787,709
|
|
| G
|
Trim56
|
tripartite motif containing 56
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TRIM56 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TRIM56 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr12:25,193,224...25,204,032
Ensembl chr12:25,188,167...25,206,855
|
|
| G
|
Trim59
|
tripartite motif-containing 59
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TRIM59 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TRIM59 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:155,579,183...155,593,450
Ensembl chr 2:155,567,115...155,598,645
|
|
| G
|
Trim6
|
tripartite motif containing 6
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TRIM6 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:168,095,619...168,108,809
Ensembl chr 1:168,095,564...168,109,719
|
|
| G
|
Trip13
|
thyroid hormone receptor interactor 13
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of TRIP13 mRNA Calcitriol results in decreased expression of TRIP13 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:31,185,700...31,230,638
Ensembl chr 1:31,185,594...31,230,634
|
|
| G
|
Troap
|
trophinin associated protein
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TROAP mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TROAP mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:132,111,892...132,121,296
Ensembl chr 7:132,113,433...132,121,294
|
|
| G
|
Trpm7
|
transient receptor potential cation channel, subfamily M, member 7
|
increases abundance
|
ISO
|
TRPM7 gene mutant form results in increased abundance of Calcitriol
|
CTD |
PMID:30770447 |
|
NCBI chr 3:134,499,617...134,588,113
Ensembl chr 3:134,499,617...134,588,113
|
|
| G
|
Trpv5
|
transient receptor potential cation channel, subfamily V, member 5
|
increases expression
|
ISO EXP
|
Calcitriol results in increased expression of TRPV5 mRNA
|
CTD |
PMID:15883024 PMID:16857747 |
|
NCBI chr 4:71,503,085...71,531,134
Ensembl chr 4:71,503,093...71,529,384
|
|
| G
|
Trpv6
|
transient receptor potential cation channel, subfamily V, member 6
|
multiple interactions increases expression
|
ISO
|
[Calcitriol binds to and results in increased activity of VDR protein] which results in increased expression of TRPV6 mRNA; [Testosterone co-treated with Calcitriol] results in increased expression of TRPV6 mRNA; Calcitriol promotes the reaction [VDR protein binds to TRPV6 enhancer]; perfluorooctanoic acid inhibits the reaction [Calcitriol results in increased expression of TRPV6 mRNA]; Testosterone affects the reaction [Calcitriol results in increased expression of TRPV6 mRNA] Calcitriol results in increased expression of TRPV6 mRNA; Calcitriol results in increased expression of TRPV6 protein
|
CTD |
PMID:15489543 PMID:16491319 PMID:17293108 PMID:18180267 PMID:21592394 PMID:26485663 PMID:27107558 PMID:33033332 More...
|
|
NCBI chr 4:71,474,006...71,489,667
Ensembl chr 4:71,474,007...71,489,671
|
|
| G
|
Tsc22d3
|
TSC22 domain family, member 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of TSC22D3 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr X:109,006,410...109,066,389
Ensembl chr X:109,006,420...109,015,519
|
|
| G
|
Tshr
|
thyroid stimulating hormone receptor
|
multiple interactions
|
EXP
|
Calcitriol inhibits the reaction [sodium arsenite results in increased expression of TSHR protein]
|
CTD |
PMID:39771102 |
|
NCBI chr 6:116,072,321...116,206,009
Ensembl chr 6:116,072,281...116,206,010
|
|
| G
|
Tsku
|
tsukushi, small leucine rich proteoglycan
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TSKU mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TSKU mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:162,071,459...162,082,972
Ensembl chr 1:162,064,126...162,089,272
|
|
| G
|
Tslp
|
thymic stromal lymphopoietin
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TSLP mRNA [BMS 961 co-treated with Calcitriol] results in increased expression of TSLP mRNA
|
CTD |
PMID:16002434 PMID:16880407 |
|
NCBI chr18:24,723,990...24,728,419
Ensembl chr18:24,720,257...24,728,420
|
|
| G
|
Tspan1
|
tetraspanin 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TSPAN1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:134,883,704...134,896,083
Ensembl chr 5:134,883,706...134,888,730
|
|
| G
|
Tspan31
|
tetraspanin 31
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TSPAN31 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TSPAN31 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:64,774,881...64,783,534
Ensembl chr 7:64,774,910...64,777,726
|
|
| G
|
Tspan5
|
tetraspanin 5
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of TSPAN5 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:229,967,521...230,139,012
Ensembl chr 2:229,967,235...230,142,685
|
|
| G
|
Ttc39a
|
tetratricopeptide repeat domain 39A
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of TTC39A mRNA Calcitriol results in increased expression of TTC39A mRNA
|
CTD |
PMID:21592394 PMID:26485663 |
|
NCBI chr 5:129,379,560...129,441,779
Ensembl chr 5:129,380,753...129,433,372
|
|
| G
|
Ttc39c
|
tetratricopeptide repeat domain 39C
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TTC39C mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TTC39C mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:4,043,364...4,162,660
Ensembl chr18:4,080,391...4,165,315
|
|
| G
|
Ttc9
|
tetratricopeptide repeat domain 9
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TTC9 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 6:107,064,527...107,099,361
Ensembl chr 6:107,064,527...107,099,361
|
|
| G
|
Ttk
|
Ttk protein kinase
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of TTK mRNA Calcitriol results in decreased expression of TTK mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:93,632,678...93,672,664
Ensembl chr 8:93,634,319...93,672,664
|
|
| G
|
Ttyh1
|
tweety family member 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of TTYH1 mRNA
|
CTD |
PMID:27107558 |
|
NCBI chr 1:79,125,564...79,144,137
Ensembl chr 1:79,125,574...79,144,091
|
|
| G
|
Tub
|
TUB bipartite transcription factor
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TUB mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TUB mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:172,386,772...172,465,791
Ensembl chr 1:172,382,197...172,465,790
|
|
| G
|
Tuba1a
|
tubulin, alpha 1A
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TUBA1A mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:131,992,151...131,996,850
Ensembl chr 7:131,968,770...131,996,035
|
|
| G
|
Tuba3b
|
tubulin, alpha 3B
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TUBA3D mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TUBA3D mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:180,319,600...180,325,149
Ensembl chr 4:180,319,600...180,325,147
|
|
| G
|
Tubb6
|
tubulin, beta 6 class V
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TUBB6 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TUBB6 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr18:63,213,287...63,222,926
Ensembl chr18:63,213,279...63,224,303
|
|
| G
|
Twist1
|
twist family bHLH transcription factor 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of TWIST1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 6:56,402,309...56,404,303
Ensembl chr 6:56,398,061...56,404,965
|
|
| G
|
Txndc11
|
thioredoxin domain containing 11
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TXNDC11 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:5,022,464...5,079,958
Ensembl chr10:5,022,435...5,079,950
|
|
| G
|
Txnip
|
thioredoxin interacting protein
|
multiple interactions increases expression decreases expression
|
ISO
|
[Calcitriol promotes the reaction [TXNIP protein binds to TNPO1 protein]] which results in increased activity of MAP3K5 protein; Calcitriol promotes the reaction [TXNIP protein binds to TNPO1 protein] Calcitriol results in increased expression of TXNIP mRNA Calcitriol results in decreased expression of TXNIP mRNA
|
CTD |
PMID:10843682 PMID:16002434 |
|
NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:186,781,163...186,785,731
|
|
| G
|
Txnrd1
|
thioredoxin reductase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of TXNRD1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:22,719,317...22,739,817
|
|
| G
|
Tymp
|
thymidine phosphorylase
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of TYMP mRNA [Testosterone co-treated with Calcitriol] results in increased expression of TYMP mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 7:122,318,396...122,323,716
Ensembl chr 7:122,316,520...122,324,003
|
|
| G
|
Tyms
|
thymidylate synthetase
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of TYMS mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of TYMS mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:120,760,057...120,776,149
Ensembl chr 9:120,763,386...120,776,097
|
|
| G
|
Tyrobp
|
transmembrane immune signaling adaptor Tyrobp
|
increases expression decreases expression
|
ISO
|
Calcitriol results in increased expression of TYROBP mRNA Calcitriol results in decreased expression of TYROBP mRNA
|
CTD |
PMID:12875902 PMID:16322758 PMID:26485663 |
|
NCBI chr 1:94,800,372...94,804,307
Ensembl chr 1:94,800,117...94,804,299
|
|
| G
|
Ube2c
|
ubiquitin-conjugating enzyme E2C
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of UBE2C mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of UBE2C mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:173,925,975...173,928,375
Ensembl chr 3:173,925,934...173,932,678
|
|
| G
|
Ube2g1
|
ubiquitin-conjugating enzyme E2G 1
|
multiple interactions
|
EXP
|
[Calcium co-treated with Calcitriol] affects the expression of UBE2G1 mRNA
|
CTD |
PMID:15913539 |
|
NCBI chr10:57,723,660...57,805,284
Ensembl chr10:57,724,485...57,807,853
|
|
| G
|
Ube2t
|
ubiquitin-conjugating enzyme E2T
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of UBE2T mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of UBE2T mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:48,955,166...48,965,668
Ensembl chr13:48,955,183...48,966,646
|
|
| G
|
Ube3d
|
ubiquitin protein ligase E3D
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of UBE3D mRNA Calcitriol results in decreased expression of UBE3D mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:96,125,609...96,293,122
Ensembl chr 8:95,882,167...96,293,078
|
|
| G
|
Ubiad1
|
UbiA prenyltransferase domain containing 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of UBIAD1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:164,139,714...164,167,777
Ensembl chr 5:164,151,802...164,163,400
|
|
| G
|
Ubr7
|
ubiquitin protein ligase E3 component n-recognin 7
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of UBR7 mRNA Calcitriol results in decreased expression of UBR7 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:127,663,454...127,683,302
Ensembl chr 6:127,663,447...127,694,390
|
|
| G
|
Ubtd1
|
ubiquitin domain containing 1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of UBTD1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of UBTD1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:250,743,883...250,795,103
Ensembl chr 1:250,743,883...250,795,096
|
|
| G
|
Uck2
|
uridine-cytidine kinase 2
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of UCK2 mRNA Calcitriol results in decreased expression of UCK2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr13:81,913,732...81,971,036
Ensembl chr13:81,916,818...81,971,091
|
|
| G
|
Ufl1
|
Ufm1-specific ligase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of UFL1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:43,759,271...43,791,682
Ensembl chr 5:43,758,098...43,791,682
|
|
| G
|
Ugt1a1
|
UDP glucuronosyltransferase family 1 member A1
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of UGT1A1 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of UGT1A1 mRNA
|
CTD |
PMID:21592394 PMID:27107558 |
|
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:96,144,786...96,256,264
|
|
| G
|
Ugt2b1
|
UDP glucuronosyltransferase 2 family, polypeptide B1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of UGT2B17 mRNA Calcitriol results in decreased expression of UGT2B17 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr14:21,378,882...21,390,631
Ensembl chr14:21,378,853...21,392,331
|
|
| G
|
Uhrf1
|
ubiquitin-like with PHD and ring finger domains 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of UHRF1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of UHRF1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 9:1,220,162...1,241,792
Ensembl chr 9:1,222,063...1,241,792
|
|
| G
|
Ulk1
|
unc-51 like autophagy activating kinase 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ULK1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr12:51,511,492...51,537,746
Ensembl chr12:51,511,492...51,537,746
|
|
| G
|
Ung
|
uracil-DNA glycosylase
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of UNG mRNA Calcitriol results in decreased expression of UNG mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr12:48,145,838...48,154,789
Ensembl chr12:48,145,838...48,155,257
|
|
| G
|
Uprt
|
uracil phosphoribosyltransferase homolog
|
increases expression
|
ISO
|
Calcitriol results in increased expression of UPRT mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr X:73,582,267...73,612,488
Ensembl chr X:73,582,361...73,612,496
|
|
| G
|
Urb2
|
URB2 ribosome biogenesis homolog
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of URB2 mRNA Calcitriol results in decreased expression of URB2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr19:68,908,466...68,934,058
Ensembl chr19:68,908,590...68,934,057
|
|
| G
|
Usp1
|
ubiquitin specific peptidase 1
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of USP1 mRNA Calcitriol results in decreased expression of USP1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 5:118,703,056...118,714,426
Ensembl chr 5:118,702,868...118,714,434
|
|
| G
|
Usp40
|
ubiquitin specific peptidase 40
|
increases expression
|
ISO
|
Calcitriol results in increased expression of USP40 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 9:96,055,741...96,126,766
Ensembl chr 9:96,055,741...96,126,721
|
|
| G
|
Usp46
|
ubiquitin specific peptidase 46
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of USP46 mRNA
|
CTD |
PMID:14996990 |
|
NCBI chr14:34,504,074...34,573,318
Ensembl chr14:34,504,118...34,573,307
|
|
| G
|
Usp53
|
ubiquitin specific peptidase 53
|
increases expression
|
ISO
|
Calcitriol results in increased expression of USP53 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:213,744,106...213,805,619
Ensembl chr 2:213,744,106...213,790,544
|
|
| G
|
Usp6nl
|
USP6 N-terminal like
|
increases expression
|
ISO
|
Calcitriol results in increased expression of USP6NL mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr17:76,737,870...76,865,953
Ensembl chr17:76,739,906...76,865,373
|
|
| G
|
Ust
|
uronyl-2-sulfotransferase
|
increases expression
|
ISO
|
Calcitriol results in increased expression of UST mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:4,487,316...4,782,579
Ensembl chr 1:4,489,925...4,782,356
|
|
| G
|
Vamp5
|
vesicle-associated membrane protein 5
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of VAMP5 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of VAMP5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:105,982,004...105,993,247
Ensembl chr 4:105,982,009...105,993,247
|
|
| G
|
Vav3
|
vav guanine nucleotide exchange factor 3
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of VAV3 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:199,699,861...200,042,344
Ensembl chr 2:199,700,445...200,042,343
|
|
| G
|
Vcan
|
versican
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of VCAN mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:22,497,035...22,595,955
Ensembl chr 2:22,497,035...22,595,955
|
|
| G
|
Vdac1
|
voltage-dependent anion channel 1
|
multiple interactions
|
EXP
|
[Calcium co-treated with Calcitriol] affects the expression of VDAC1 mRNA
|
CTD |
PMID:15913539 |
|
NCBI chr10:37,029,377...37,060,542
Ensembl chr10:37,023,145...37,060,541
|
|
| G
|
Vdr
|
vitamin D receptor
|
affects binding multiple interactions increases phosphorylation increases expression increases activity increases response to substance decreases degradation affects localization affects response to substance increases localization decreases expression
|
ISO EXP
|
[Calcitriol binds to VDR protein] which binds to HOXA10 promoter; Calcitriol binds to VDR protein; Calcitriol binds to VDR protein mutant form 1,24,25-trihydroxyvitamin D3 affects the reaction [Calcitriol binds to VDR protein]; [[Etoposide results in increased expression of TP73 protein] which results in increased expression of VDR protein] which results in increased susceptibility to Calcitriol; [Alitretinoin co-treated with Calcitriol] results in increased stability of [RXRA protein binds to VDR protein]; [Arsenic Trioxide co-treated with Calcitriol] results in increased expression of VDR mRNA; [Arsenic Trioxide co-treated with Calcitriol] results in increased expression of VDR protein; [Calcitriol binds to and results in increased activity of VDR protein] promotes the reaction [VDR protein binds to CYP7A1 promoter]; [Calcitriol binds to and results in increased activity of VDR protein] promotes the reaction [VDR protein binds to PPARGC1A protein]; [Calcitriol binds to and results in increased activity of VDR protein] results in decreased activity of [HNF4A protein co-treated with PPARGC1A protein]; [Calcitriol binds to and results in increased activity of VDR protein] which results in decreased expression of CYP7A1 mRNA; [Calcitriol binds to and results in increased activity of VDR protein] which results in increased expression of CDH1 mRNA; [Calcitriol binds to and results in increased activity of VDR protein] which results in increased expression of CYP24A1 mRNA; [Calcitriol binds to and results in increased activity of VDR protein] which results in increased expression of CYP3A4 mRNA; [Calcitriol binds to and results in increased activity of VDR protein] which results in increased expression of TRPV6 mRNA; [Calcitriol binds to VDR protein] promotes the reaction [VDR protein binds to RXRA protein]; [Calcitriol binds to VDR protein] which results in decreased activity of CTNNB1 mRNA; [Calcitriol binds to VDR protein] which results in increased expression of HOXA10 mRNA; [Calcitriol co-treated with alpha-Linolenic Acid] results in increased expression of VDR mRNA; [Calcitriol co-treated with Benzo(a)pyrene] results in increased expression of VDR protein; [Calcitriol co-treated with Bezafibrate] results in increased expression of VDR mRNA; [Calcitriol co-treated with Docosahexaenoic Acids] results in increased expression of VDR mRNA; [Calcitriol co-treated with GW 501516] results in increased expression of VDR mRNA; [Calcitriol co-treated with pirinixic acid] results in increased expression of VDR mRNA; [Calcitriol co-treated with Resveratrol] results in increased expression of VDR mRNA; [Calcitriol co-treated with VDR protein] results in decreased expression of MAOA mRNA; [Calcitriol co-treated with VDR protein] results in increased expression of CDH2 protein; [Calcitriol co-treated with VDR protein] results in increased expression of COMT mRNA; [Calcitriol co-treated with VDR protein] results in increased expression of CYP24A1 mRNA; [Calcitriol co-treated with VDR protein] results in increased expression of TH mRNA; [Calcitriol co-treated with VDR protein] results in increased expression of TH protein; [Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] inhibits the reaction [PPARGC1A protein results in increased expression of CYP7A1 mRNA]; [Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] which results in decreased expression of CYP7A1 mRNA; [Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] which results in increased expression of CYP24A1 mRNA; [Calcitriol results in increased activity of VDR protein] which results in increased expression of SLC30A10 mRNA; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [Calcitriol promotes the reaction [VDR protein binds to CYP24A1 promoter]]]; Benzo(a)pyrene affects the reaction [Calcitriol promotes the reaction [VDR protein binds to CYP1A1 promoter]]; Benzo(a)pyrene inhibits the reaction [Calcitriol promotes the reaction [VDR protein binds to CYP24A1 promoter]]; calcipotriene affects the reaction [Calcitriol binds to VDR protein]; Calcitriol analog binds to and results in increased activity of VDR protein; Calcitriol binds to and affects the activity of VDR protein; Calcitriol binds to and results in increased activity of and results in increased localization of VDR protein; Calcitriol binds to and results in increased activity of VDR protein; Calcitriol binds to and results in increased activity of VDR protein mutant form; Calcitriol inhibits the reaction [VDR protein binds to NCOR1 protein]; Calcitriol inhibits the reaction [VDR protein binds to NCOR2 protein]; Calcitriol inhibits the reaction [VDR protein binds to VDR protein]; Calcitriol inhibits the reaction [VDR protein results in increased expression of SLC18A2 mRNA]; Calcitriol promotes the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased expression of VDR protein]; Calcitriol promotes the reaction [[VDR protein binds to MED1 protein] which binds to CYP24A1 promoter]; Calcitriol promotes the reaction [[VDR protein binds to NCOA3 protein] which binds to CYP24A1 promoter]; Calcitriol promotes the reaction [[VDR protein binds to RXRA protein] which binds to CYP24A1 promoter]; Calcitriol promotes the reaction [[VDR protein binds to RXRA protein] which binds to SLC30A10 promoter]; Calcitriol promotes the reaction [CTNNB1 protein binds to VDR protein]; Calcitriol promotes the reaction [MAPK1 protein results in increased phosphorylation of VDR protein]; Calcitriol promotes the reaction [MAPK3 protein results in increased phosphorylation of VDR protein]; Calcitriol promotes the reaction [NCOA1 protein binds to VDR protein]; Calcitriol promotes the reaction [NCOA2 protein binds to VDR protein]; Calcitriol promotes the reaction [RXRA protein binds to and results in increased activity of VDR protein]; Calcitriol promotes the reaction [salvin results in increased expression of VDR protein]; Calcitriol promotes the reaction [VDR protein binds to BGLAP enhancer]; Calcitriol promotes the reaction [VDR protein binds to CAMP promoter]; Calcitriol promotes the reaction [VDR protein binds to COMT promoter]; Calcitriol promotes the reaction [VDR protein binds to CYP1A1 promoter]; Calcitriol promotes the reaction [VDR protein binds to CYP24A1 mRNA]; Calcitriol promotes the reaction [VDR protein binds to CYP24A1 promoter]; Calcitriol promotes the reaction [VDR protein binds to CYP7A1 mRNA]; Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]; Calcitriol promotes the reaction [VDR protein binds to NCOA1 protein]; Calcitriol promotes the reaction [VDR protein binds to NCOA2 protein]; Calcitriol promotes the reaction [VDR protein binds to NCOA3 protein]; Calcitriol promotes the reaction [VDR protein binds to PPARGC1A protein]; Calcitriol promotes the reaction [VDR protein binds to RUNX2 enhancer]; Calcitriol promotes the reaction [VDR protein binds to RXRA protein]; Calcitriol promotes the reaction [VDR protein binds to TRPV6 enhancer]; Calcitriol promotes the reaction [VDR protein results in decreased expression of DRD2 mRNA]; Calcitriol promotes the reaction [VDR protein results in increased abundance of 3-methoxytyramine]; Calcitriol promotes the reaction [VDR protein results in increased abundance of Homovanillic Acid]; Calcitriol results in decreased degradation of and affects the localization of VDR protein; Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]; Calcitriol results in increased expression of and affects the localization of VDR protein; Calcitriol results in increased localization of [VDR protein co-treated with CAV1 protein]; Calcitriol results in increased localization of [VDR protein co-treated with CSK protein]; Genistein promotes the reaction [Calcitriol results in increased expression of VDR mRNA]; Genistein promotes the reaction [Calcitriol results in increased expression of VDR protein]; HR protein inhibits the reaction [Calcitriol results in increased activity of VDR protein mutant form]; HR protein inhibits the reaction [Calcitriol results in increased activity of VDR protein]; Lipopolysaccharides inhibits the reaction [Calcitriol results in increased expression of VDR protein]; MAPK1 protein promotes the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]; MAPK3 protein promotes the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]; maxacalcitol affects the reaction [Calcitriol binds to VDR protein]; NCOA1 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein binds to and results in increased activity of VDR protein]]; NCOA1 protein promotes the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]; NCOA2 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein results in increased activity of VDR protein]]; NCOA3 protein promotes the reaction [Calcitriol promotes the reaction [RXRA protein results in increased activity of VDR protein]]; NCOR1 protein inhibits the reaction [[Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] which results in increased expression of CYP24A1 mRNA]; NCOR1 protein inhibits the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]; NCOR1 protein promotes the reaction [[Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] inhibits the reaction [PPARGC1A protein results in increased expression of CYP7A1 mRNA]]; NCOR2 protein inhibits the reaction [[Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] which results in increased expression of CYP24A1 mRNA]; NCOR2 protein inhibits the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]; NCOR2 protein promotes the reaction [[Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] inhibits the reaction [PPARGC1A protein results in increased expression of CYP7A1 mRNA]]; perfluorooctanoic acid inhibits the reaction [Calcitriol binds to VDR protein]; PPARGC1A protein promotes the reaction [[Calcitriol results in increased activity of [VDR protein co-treated with RXRA protein]] which results in increased expression of CYP24A1 mRNA]; PPARGC1A protein promotes the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]; RELA protein promotes the reaction [Calcitriol results in increased activity of VDR protein]; RXRA protein promotes the reaction [Calcitriol promotes the reaction [NCOA1 protein binds to VDR protein]]; RXRA protein promotes the reaction [Calcitriol promotes the reaction [NCOA2 protein binds to VDR protein]]; saracatinib inhibits the reaction [Calcitriol results in increased phosphorylation of VDR protein]; seocalcitol inhibits the reaction [Calcitriol binds to VDR protein]; trichostatin A inhibits the reaction [HR protein inhibits the reaction [Calcitriol results in increased activity of VDR protein]]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [MAPK1 protein results in increased phosphorylation of VDR protein]]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [MAPK3 protein results in increased phosphorylation of VDR protein]]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [VDR protein binds to CYP24A1 mRNA]]; U 0126 inhibits the reaction [Calcitriol promotes the reaction [VDR protein binds to CYP7A1 mRNA]]; U 0126 inhibits the reaction [MAPK1 protein promotes the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]]; U 0126 inhibits the reaction [MAPK3 protein promotes the reaction [Calcitriol promotes the reaction [VDR protein binds to HNF4A protein]]]; Valproic Acid promotes the reaction [[Calcitriol co-treated with VDR protein] results in increased expression of CYP24A1 mRNA]; VDR mutant form inhibits the reaction [Calcitriol promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]]; VDR mutant form inhibits the reaction [Calcitriol results in decreased expression of PTHLH mRNA]; VDR protein affects the reaction [Calcitriol results in increased expression of CYP3A4 mRNA]; VDR protein promotes the reaction [Calcitriol results in increased expression of ABCB1 mRNA]; ZK159222 inhibits the reaction [Calcitriol results in increased expression of VDR mRNA]; ZK159222 inhibits the reaction [Calcitriol results in increased expression of VDR protein] Calcitriol results in increased expression of VDR mRNA; Calcitriol results in increased expression of VDR protein Calcitriol analog binds to VDR protein; Calcitriol binds to VDR protein Calcitriol results in increased expression of VDR; Calcitriol results in increased expression of VDR mRNA; Calcitriol results in increased expression of VDR protein 1,25-dihydroxy-16-ene-vitamin D3 affects the reaction [Calcitriol binds to VDR protein]; bisindolylmaleimide I inhibits the reaction [Calcitriol results in increased expression of VDR mRNA]; Calcitriol inhibits the reaction [[Lipopolysaccharides co-treated with Glucose] results in decreased expression of VDR mRNA]; Calcitriol inhibits the reaction [[Lipopolysaccharides co-treated with Glucose] results in decreased expression of VDR protein]; Calcitriol inhibits the reaction [sodium arsenite results in decreased expression of VDR protein]; Calcitriol inhibits the reaction [Streptozocin results in decreased expression of VDR mRNA]; Calcitriol inhibits the reaction [Streptozocin results in decreased expression of VDR protein]; Chenodeoxycholic Acid promotes the reaction [Calcitriol results in increased expression of VDR mRNA] VDR results in increased susceptibility to Calcitriol Calcitriol results in decreased degradation of VDR protein Calcitriol binds to and results in increased activity of VDR protein mutant form; Calcitriol inhibits the reaction [bisphenol A results in decreased expression of VDR protein]; Calcitriol promotes the reaction [VDR protein binds to CYP24A1 promoter]; Calcitriol promotes the reaction [VDR protein binds to LRP5 enhancer]; Calcitriol promotes the reaction [VDR protein binds to SPP1 promoter]; Calcitriol results in increased expression of and results in decreased degradation of VDR protein; MED1 protein promotes the reaction [Calcitriol results in increased activity of VDR protein]; pregna-4,17-diene-3,16-dione promotes the reaction [Calcitriol results in increased expression of VDR protein] Calcitriol affects the localization of VDR protein VDR gene polymorphism affects the susceptibility to Calcitriol Calcitriol results in increased localization of VDR protein Calcitriol results in increased activity of VDR protein; Calcitriol results in increased activity of VDR protein alternative form; Calcitriol results in increased activity of VDR protein mutant form Calcitriol results in decreased expression of VDR mRNA
|
CTD |
PMID:7530193 PMID:7662588 PMID:8243807 PMID:8593782 PMID:9348195 PMID:9525346 PMID:10799658 PMID:10875257 PMID:10927029 PMID:11158396 PMID:11504768 PMID:14525957 PMID:15489543 PMID:15572423 PMID:15578590 PMID:15615532 PMID:15647825 PMID:15664452 PMID:15746989 PMID:15824177 PMID:15861036 PMID:15876428 PMID:15890193 PMID:15891005 PMID:15919092 PMID:15922086 PMID:15955619 PMID:15985530 PMID:15992766 PMID:16002434 PMID:16051482 PMID:16076355 PMID:16204233 PMID:16267019 PMID:16280049 PMID:16324150 PMID:16365879 PMID:16368784 PMID:16467308 PMID:16632680 PMID:17035339 PMID:17110116 PMID:17293108 PMID:17444814 PMID:17716971 PMID:17959142 PMID:17997857 PMID:18180267 PMID:18515093 PMID:19106115 PMID:19244278 PMID:19460946 PMID:19562681 PMID:19667161 PMID:20006981 PMID:20043299 PMID:20153625 PMID:20206692 PMID:20371703 PMID:20435140 PMID:21115105 PMID:21291553 PMID:21397016 PMID:21664243 PMID:21742782 PMID:21788014 PMID:21917910 PMID:22466564 PMID:22751936 PMID:22837390 PMID:23723390 PMID:24792400 PMID:25279795 PMID:26038696 PMID:26210580 PMID:27107558 PMID:27450565 PMID:27871908 PMID:28105418 PMID:28887089 PMID:29953732 PMID:29962435 PMID:31195007 PMID:33033332 PMID:34025784 PMID:36321694 PMID:38725370 PMID:39771102 More...
|
|
NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:130,866,745...130,916,757
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
affects expression multiple interactions increases expression decreases expression
|
ISO EXP
|
Calcitriol affects the expression of VEGFA mRNA Calcitriol promotes the reaction [TGFB1 protein results in increased secretion of VEGFA protein]; SB 203580 inhibits the reaction [[Calcitriol co-treated with TGFB1 protein] results in increased secretion of VEGFA protein]; SB 203580 inhibits the reaction [Calcitriol results in increased secretion of VEGFA protein] Calcitriol results in increased expression of VEGFA mRNA Calcitriol results in decreased expression of VEGFA protein
|
CTD |
PMID:16002434 PMID:16598785 PMID:18379402 PMID:19918113 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
| G
|
Vgll4
|
vestigial-like family member 4
|
increases expression
|
ISO
|
Calcitriol results in increased expression of VGLL4 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 4:149,598,151...149,711,186
Ensembl chr 4:149,598,891...149,660,594
|
|
| G
|
Vim
|
vimentin
|
increases expression multiple interactions decreases expression
|
ISO
|
Calcitriol results in increased expression of VIM mRNA [Testosterone co-treated with Calcitriol] results in increased expression of VIM mRNA; Calcitriol inhibits the reaction [sodium arsenite results in increased expression of VIM protein] Calcitriol results in decreased expression of VIM mRNA
|
CTD |
PMID:16129123 PMID:21592394 PMID:37968493 |
|
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746
|
|
| G
|
Vps13a
|
vacuolar protein sorting 13 homolog A
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of VPS13A mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of VPS13A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:223,328,784...223,555,500
Ensembl chr 1:223,328,784...223,555,331
|
|
| G
|
Vps35l
|
VPS35 endosomal protein sorting factor like
|
increases expression
|
ISO
|
Calcitriol results in increased expression of VPS35L mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 1:182,507,576...182,611,021
Ensembl chr 1:182,507,266...182,613,087
|
|
| G
|
Vrk1
|
VRK serine/threonine kinase 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of VRK1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of VRK1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:130,679,400...130,746,089
Ensembl chr 6:130,679,515...130,746,752
|
|
| G
|
Vsig4
|
V-set and immunoglobulin domain containing 4
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of VSIG4 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr X:65,154,422...65,179,708
Ensembl chr X:65,154,424...65,179,708
|
|
| G
|
Vsnl1
|
visinin-like 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of VSNL1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 6:39,757,721...39,878,556
Ensembl chr 6:39,757,722...39,878,556
|
|
| G
|
Vstm2l
|
V-set and transmembrane domain containing 2 like
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of VSTM2L mRNA [Testosterone co-treated with Calcitriol] results in increased expression of VSTM2L mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:166,991,035...167,020,869
|
|
| G
|
Vstm4
|
V-set and transmembrane domain containing 4
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of VSTM4 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr16:8,126,630...8,206,556
Ensembl chr16:8,122,355...8,206,549
|
|
| G
|
Vtcn1
|
V-set domain containing T cell activation inhibitor 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of VTCN1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:190,942,224...191,010,280
Ensembl chr 2:190,942,224...191,010,280
|
|
| G
|
Vwa1
|
von Willebrand factor A domain containing 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of VWA1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 5:171,659,694...171,664,880
Ensembl chr 5:171,659,698...171,664,880
|
|
| G
|
Vwa5a
|
von Willebrand factor A domain containing 5A
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of VWA5A mRNA [Testosterone co-treated with Calcitriol] results in increased expression of VWA5A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:47,712,352...47,745,847
Ensembl chr 8:47,712,369...47,736,307
|
|
| G
|
Vwf
|
von Willebrand factor
|
increases expression
|
ISO
|
Calcitriol results in increased expression of VWF mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:160,047,982...160,177,757
|
|
| G
|
Wbp1l
|
WW domain binding protein 1-like
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of WBP1L mRNA [Testosterone co-treated with Calcitriol] results in increased expression of WBP1L mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:255,413,701...255,470,026
Ensembl chr 1:255,413,524...255,470,026
|
|
| G
|
Wdfy2
|
WD repeat and FYVE domain containing 2
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of WDFY2 mRNA Calcitriol results in increased expression of WDFY2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:41,259,840...41,385,549
Ensembl chr15:41,259,884...41,385,549
|
|
| G
|
Wdhd1
|
WD repeat and HMG-box DNA binding protein 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of WDHD1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of WDHD1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr15:22,957,492...23,002,820
Ensembl chr15:22,958,069...23,002,820
|
|
| G
|
Wdr36
|
WD repeat domain 36
|
increases expression
|
ISO
|
Calcitriol results in increased expression of WDR36 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr18:24,747,812...24,783,704
Ensembl chr18:24,747,832...24,783,110
|
|
| G
|
Wdr62
|
WD repeat domain 62
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of WDR62 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of WDR62 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:94,618,992...94,658,097
Ensembl chr 1:94,618,992...94,658,223
|
|
| G
|
Wdr72
|
WD repeat domain 72
|
increases expression
|
ISO
|
Calcitriol results in increased expression of WDR72 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:83,718,897...83,902,128
Ensembl chr 8:83,718,914...83,900,286
|
|
| G
|
Wdr76
|
WD repeat domain 76
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of WDR76 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of WDR76 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 3:128,910,500...128,945,241
Ensembl chr 3:128,910,503...128,945,239
|
|
| G
|
Wdr86
|
WD repeat domain 86
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of WDR86 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 4:11,315,826...11,335,932
Ensembl chr 4:11,316,534...11,335,932
|
|
| G
|
Wdsub1
|
WD repeat, sterile alpha motif and U-box domain containing 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of WDSUB1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 3:64,749,118...64,781,525
Ensembl chr 3:64,749,259...64,787,231
|
|
| G
|
Wfdc17
|
WAP four-disulfide core domain 17
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ANOS1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr10:69,059,451...69,060,298
|
|
| G
|
Wfdc2
|
WAP four-disulfide core domain 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of WFDC2 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:173,706,091...173,735,055
Ensembl chr 3:173,706,460...173,712,161
|
|
| G
|
Wipf1
|
WAS/WASL interacting protein family, member 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of WIPF1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 3:78,721,486...78,824,199
Ensembl chr 3:78,714,299...78,780,277
|
|
| G
|
Wipi1
|
WD repeat domain, phosphoinositide interacting 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of WIPI1 mRNA Calcitriol results in increased expression of WIPI1 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr10:95,042,451...95,079,679
Ensembl chr10:95,042,441...95,079,293
|
|
| G
|
Wnk2
|
WNK lysine deficient protein kinase 2
|
increases expression
|
ISO
|
Calcitriol results in increased expression of WNK2 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr17:15,709,648...15,818,874
Ensembl chr17:15,710,657...15,818,869
|
|
| G
|
Wnt5a
|
Wnt family member 5A
|
increases expression
|
ISO
|
Calcitriol results in increased expression of WNT5A mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr16:3,702,300...3,724,860
Ensembl chr16:3,703,665...3,724,860
|
|
| G
|
Wnt7b
|
Wnt family member 7B
|
decreases expression multiple interactions increases expression
|
ISO
|
Calcitriol results in decreased expression of WNT7B mRNA [Testosterone co-treated with Calcitriol] results in increased expression of WNT7B mRNA Calcitriol results in increased expression of WNT7B mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 7:118,514,684...118,559,316
Ensembl chr 7:118,514,684...118,559,316
|
|
| G
|
Wnt9a
|
Wnt family member 9A
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of WNT9A mRNA [Testosterone co-treated with Calcitriol] results in increased expression of WNT9A mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:44,593,691...44,620,682
Ensembl chr10:44,593,691...44,620,682
|
|
| G
|
Wrap53
|
WD repeat containing, antisense to TP53
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of WRAP53 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of WRAP53 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr10:54,780,873...54,797,919
Ensembl chr10:54,773,282...54,797,651
|
|
| G
|
Wsb1
|
WD repeat and SOCS box-containing 1
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of WSB1 mRNA Calcitriol results in increased expression of WSB1 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr10:64,700,752...64,717,038
Ensembl chr10:64,700,762...64,716,832
|
|
| G
|
Wwc1
|
WW and C2 domain containing 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of WWC1 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr10:20,804,173...20,958,437
Ensembl chr10:20,799,237...20,958,437
|
|
| G
|
Xcl1
|
X-C motif chemokine ligand 1
|
increases expression
|
ISO
|
Calcitriol results in increased expression of XCL1 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr13:79,781,784...79,785,440
Ensembl chr13:79,781,784...79,785,440
|
|
| G
|
Xiap
|
X-linked inhibitor of apoptosis
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of XIAP protein
|
CTD |
PMID:12479363 |
|
NCBI chr X:125,756,107...125,803,979
Ensembl chr X:125,737,971...125,803,978
|
|
| G
|
Xkr5
|
XK related 5
|
increases expression multiple interactions
|
ISO
|
Calcitriol results in increased expression of XKR5 mRNA [Testosterone co-treated with Calcitriol] results in increased expression of XKR5 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr16:77,577,387...77,595,377
Ensembl chr16:77,577,481...77,595,376
|
|
| G
|
Xpo1
|
exportin 1
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of XPO1 mRNA
|
CTD |
PMID:16847355 PMID:18614847 |
|
NCBI chr14:101,434,450...101,476,705
Ensembl chr14:101,434,517...101,476,714
|
|
| G
|
Xpo5
|
exportin 5
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of XPO5 mRNA
|
CTD |
PMID:16847355 PMID:18614847 |
|
NCBI chr 9:22,237,760...22,275,745
Ensembl chr 9:22,237,760...22,275,745
|
|
| G
|
Xpo7
|
exportin 7
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of XPO7 mRNA
|
CTD |
PMID:16847355 PMID:18614847 |
|
NCBI chr15:52,151,743...52,237,729
Ensembl chr15:52,151,743...52,237,729
|
|
| G
|
Xpot
|
exportin for tRNA
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of XPOT mRNA
|
CTD |
PMID:16847355 PMID:18614847 |
|
NCBI chr 7:58,997,025...59,037,506
Ensembl chr 7:58,997,025...59,037,502
|
|
| G
|
Xrcc2
|
X-ray repair cross complementing 2
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of XRCC2 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of XRCC2 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:10,157,130...10,237,089
Ensembl chr 4:10,157,800...10,176,407
|
|
| G
|
Xrcc3
|
X-ray repair cross complementing 3
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of XRCC3 mRNA Calcitriol results in decreased expression of XRCC3 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 6:136,684,558...136,694,822
Ensembl chr 6:136,684,558...136,694,822
|
|
| G
|
Xrcc5
|
X-ray repair cross complementing 5
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of XRCC5 mRNA
|
CTD |
PMID:15951637 |
|
NCBI chr 9:81,404,507...81,493,293
Ensembl chr 9:81,375,863...81,493,293
|
|
| G
|
Xrcc6
|
X-ray repair cross complementing 6
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of XRCC6 mRNA
|
CTD |
PMID:15951637 PMID:16847355 |
|
NCBI chr 7:115,423,026...115,443,884
Ensembl chr 7:115,422,662...115,443,884
|
|
| G
|
Zbtb38
|
zinc finger and BTB domain containing 38
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ZBTB38 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:106,124,181...106,231,215
Ensembl chr 8:106,157,084...106,230,951
|
|
| G
|
Zc3h12c
|
zinc finger CCCH type containing 12C
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ZC3H12C mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:61,340,446...61,404,932
Ensembl chr 8:61,345,271...61,400,610
|
|
| G
|
Zfhx4
|
zinc finger homeobox 4
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ZFHX4 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr 2:98,131,996...98,321,070
Ensembl chr 2:98,131,996...98,315,469
|
|
| G
|
Zfp185
|
zinc finger protein 185
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ZNF185 mRNA
|
CTD |
PMID:16002434 PMID:26485663 |
|
NCBI chr X:155,874,138...155,919,921
Ensembl chr X:155,874,127...155,917,077
|
|
| G
|
Zfp324
|
zinc finger protein 324
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of ZNF324B mRNA Calcitriol results in decreased expression of ZNF324B mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:82,663,611...82,672,785
Ensembl chr 1:82,663,594...82,670,096
|
|
| G
|
Zfp36
|
zinc finger protein 36
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of ZFP36 mRNA Calcitriol results in increased expression of ZFP36 mRNA
|
CTD |
PMID:16002434 PMID:21592394 |
|
NCBI chr 1:92,796,628...92,799,108
Ensembl chr 1:92,796,628...92,799,108
|
|
| G
|
Zfp362
|
zinc finger protein 362
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ZNF362 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 5:146,403,469...146,437,707
Ensembl chr 5:146,404,294...146,437,163
|
|
| G
|
Zfp367
|
zinc finger protein 367
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of ZNF367 mRNA Calcitriol results in decreased expression of ZNF367 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr17:970,896...990,025
Ensembl chr17:970,741...990,029
|
|
| G
|
Zfp462
|
zinc finger protein 462
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of ZNF462 mRNA Calcitriol results in increased expression of ZNF462 mRNA
|
CTD |
PMID:16002434 PMID:21592394 PMID:26485663 |
|
NCBI chr 5:74,465,383...74,606,020
Ensembl chr 5:74,468,643...74,606,020
|
|
| G
|
Zfp469
|
zinc finger protein 469
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ZNF469 mRNA
|
CTD |
PMID:26485663 |
|
NCBI chr19:67,190,901...67,232,569
Ensembl chr19:67,190,901...67,232,569
|
|
| G
|
Zfp488
|
zinc finger protein 488
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ZNF488 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr16:9,289,286...9,299,928
Ensembl chr16:9,280,322...9,300,400
|
|
| G
|
Zfp551
|
zinc finger protein 551
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ZNF551 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of ZNF551 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 1:81,615,977...81,626,233
Ensembl chr 1:81,617,869...81,626,234
|
|
| G
|
Zfp641
|
zinc finger protein 641
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ZNF641 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 7:131,313,620...131,324,149
Ensembl chr 7:131,313,624...131,323,691
|
|
| G
|
Zfp697
|
zinc finger protein 697
|
decreases expression
|
ISO
|
Calcitriol results in decreased expression of ZNF697 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:188,659,294...188,692,611
Ensembl chr 2:188,659,076...188,692,611
|
|
| G
|
Zgrf1
|
zinc finger, GRF-type containing 1
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ZGRF1 mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of ZGRF1 mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 2:218,687,413...218,750,104
Ensembl chr 2:218,687,505...218,750,104
|
|
| G
|
Zkscan7
|
zinc finger with KRAB and SCAN domains 7
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ZKSCAN7 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 8:131,379,514...131,397,065
Ensembl chr 8:131,378,013...131,397,065
|
|
| G
|
Zpbp
|
zona pellucida binding protein
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ZPBP mRNA
|
CTD |
PMID:36321694 |
|
NCBI chr14:90,047,207...90,244,727
Ensembl chr14:90,047,212...90,244,437
|
|
| G
|
Zswim6
|
zinc finger, SWIM-type containing 6
|
increases expression
|
ISO
|
Calcitriol results in increased expression of ZSWIM6 mRNA
|
CTD |
PMID:16002434 |
|
NCBI chr 2:40,944,617...41,112,340
Ensembl chr 2:40,946,435...41,112,519
|
|
| G
|
Zwilch
|
zwilch kinetochore protein
|
multiple interactions decreases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in decreased expression of ZWILCH mRNA Calcitriol results in decreased expression of ZWILCH mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 8:73,532,968...73,566,214
Ensembl chr 8:73,533,703...73,571,299
|
|
| G
|
Zwint
|
ZW10 interacting kinetochore protein
|
decreases expression multiple interactions
|
ISO
|
Calcitriol results in decreased expression of ZWINT mRNA [Testosterone co-treated with Calcitriol] results in decreased expression of ZWINT mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr20:15,502,559...15,953,701
Ensembl chr20:15,937,396...15,953,203
|
|
| G
|
Zyx
|
zyxin
|
multiple interactions increases expression
|
ISO
|
[Testosterone co-treated with Calcitriol] results in increased expression of ZYX mRNA Calcitriol results in increased expression of ZYX mRNA
|
CTD |
PMID:21592394 |
|
NCBI chr 4:72,203,991...72,213,181
Ensembl chr 4:72,204,007...72,213,181
|
|